/*Accordion Page Settings*/

Revisiting Maintaining Clinic Culture Amidst Continental Growth: Is It Possible? An Interview With Dr. Michael Levy

Deciding to expand your practice, either by acquisition or starting new, is an exciting time. But, adding new staff, physicians, and equity partners can come with a handful of problems. On this episode of Inside Reproductive Health, originally aired in 2019, Griffin Jones, CEO of Fertility Bridge, talks to Dr. Michael Levy, IVF Director and President of Shady Grove Fertility. Shady Grove Fertility is the largest independent fertility group in America. Griffin and Dr. Levy discuss the implication of having such a large staff base and just how they manage it, all while keeping the patient at the forefront of their culture.


Transcript



Dr. Michael Levy  00:00

They transform lives, but it works. And we have to help them through difficult journeys, but it doesn't work. And we need every one of those people to feel the support that we give them. And you know, we do really well about patient satisfaction surveys, but not unbelievably well. And I'm much more anxious about it now, given our size and our geographic diversity than I was with our staff meeting was 15 people in the entire practice.


Griffin Jones  00:32

My podcast manager, and my audio producers suggested something that the audience has been asking for, for some time, which is on to bring back episodes that were popular so that we can listen those again, maybe offer some new context and go back in the annals of it and find things that you can listen to now to see how they hold up the test of time. And so one that I went back to was episode 36. That's with Dr. Michael Levy. Most of you know him as one of the founding physicians of Shady Grove fertility. And put that episode two, your attention now, because a lot of change was shaved off fertility. When we recorded this episode, they were the largest practice group in the country of courses three years ago. But they did not have any private equity partner. They were not part of the network. They were almost a network in themselves, because they were so big. But since then, US fertility has come to be they're backed by amulet capital. So now there is private equity, behind shale boom, they're part of a network that includes other practice groups. And in this episode, Dr. Levy talks a lot about partnerships with younger physicians and attracting younger Doc's. Well, what's that like now, where the fellows were not being offered 500k signing bonuses three years ago, when we recorded this episode, and I've seen that now. And so how does that all stand the test of time at the time of this episode, the Shady Grove didn't have to necessarily, itself? And I'm not saying it does that. But I this is a question that I keep forgetting to ask. Yes. But when you belong, when you're so big of a group, and you're part of a network, what happens like she drove bought a practice in Houston, and one of us fertility or one of the other groups suggest fertility wanted to open a group in Houston. So I want you to listen to this interview and see what still holds up to you and see what you think is completely off from three years ago. And then if you want to share that with maybe an email that feel free to and I will, I'll get follow up with you, as I ask these types of questions. Look into them. But enjoy this episode about building a large fertility group with Dr. Michael Levy. I'm interested in this conversation, mainly because I want to go into the brain of someone who helped found the largest fertility group in America. And maybe I'll back up and give a little bit of context. Because I think while we assume that everybody knows about Shady Grove, there are a lot of people in this country and other parts of the world that are listening, that are just practicing medicine in their little practice that listen to this show. And they actually probably don't know a lot about it, because they don't often check out necessarily the other things that are happening with other people in the field. They're doing their thing. You're a group that started in Maryland, in the DC area, you now have close to 1000 employees. Is that right? Correct. Yep. And how many Rei is now


Dr. Michael Levy  04:16

stopped losing count, but I think 5858


Griffin Jones  04:19

Which is just an extraordinary number, considering that a group that had nine or 10 would be most folks would consider a big group and I'm very interested in how that starts. So you're one of you, you have to found this practice. A lot of people will start their own practice and have 10 people work with them and that's a good life and a good career for them. You've got a 58 physician group with almost 1000 employees now 950 When we spoke to Marian credit earlier in the show, did you set out to do that?


Dr. Michael Levy  05:00

Absolutely not. So my goal, career wise was to? Well, first of all, I had a mandate from my wife that I was staying in DC. So I wasn't able to look further afield. There were no jobs available in DC wanted to join Frank Chang who ultimately became one of the partners in our practice. But my goal, when I set up this practice was we had three or four physicians and that three or 400 cycles, I would have signed on the dotted line right there. So there was no grand roadmap or ambition created at all?


Griffin Jones  05:34

Well, it wasn't an accident, either. Because if it were an accident, everybody would have done it. How did it happen?


Dr. Michael Levy  05:41

So every quarter, I speak to our new hire orientation. And these days, that's about 25 or 30 people, which was bigger than type of stuff in 1991, when we started the IVF program, and I'll say the same thing to you that I say to them, we never had Grand Designs to be as large as we are, we focused on one core issue. And that led to a virtuous cycle, which I think allowed the practice to expand before, you'll know what that is. But before I articulated properly, Paddy style, who you probably know, who was, you know, Director of Marketing, or is our Director of Marketing, not the not the correct title, by the way, it's a bit, she has a better title than that. But she started at the very beginning with me, and about seven or eight years into the practice when we were about 10 physicians and growing rapidly. She was cornered at ASRM by a couple of physicians who said, Okay, Patti, you've been at Shady Grove for eight years, what's the secret sauce, and she said, you know, the, the absolute central tenant of the practice is always do the best thing for the patient. And immediately their eyes glazed over, they say, Stop bsabs, we want to know the secret sauce. She says they really she says always do the best thing for the patient. And I think we we've absolutely adhered to that. And that's allowed us to have patients feel very good and comfortable and refer their friends or physicians to know that that's the way in which patients are gonna get treated. And what I mean by that is, not only do we have to have very good success rates, we have to be incredibly transparent with patients, we have to have financial programs that are affordable. And that in turn attracts physicians who want to work in that environment, patients and staff who want to work in that environment, we have very low staff turnover. In 28 years, we've had one physician leave the group. And that was because she got divorced and wanted to work part time and live in California. No other physician has ever left the practice. And that I think speaks volumes to the environment. And we have a true partnership. We are 100% physician owned and we have 28 equity partners. And the model is everyone becomes a true equity partner. So everyone has skin in the game and feels engaged from day one.


Griffin Jones  08:06

I don't even know how to break this out from here with 20 equity partners. Maybe I'll come back to that, because I'm really interested on how you manage direction with 28 equity partners. So let's let's talk a little bit about doing the right thing for the patient. And I can see the physicians eyes glazing over when Patty gives them that answer. They are it tell us tell us what they're looking for one or two tactics, right, they're looking for something that's a specific process that they used are some very specific thing as opposed to seeing it as an attitude. And I wonder if that just speaks to? Well, there are hundreds of tactics right there, there can be 1000s, there are hundreds of different or dozens of processes. There's hundreds of key players. There's however many techniques, but they're all grounded in that one, in that that virtue of doing the right thing by the patient. I think we need to explore it a little bit more because to me, it just seems so subjective. And we were talking about this with I think I was talking about this on another podcast interview where I said it's very often like the local restaurant owner that says yeah, we've got the best service in town, but sometimes they just don't sometimes there's just a local a local restaurant that perceives that they've got the best service in the place across the street does. So as you're growing, that means you've got to measure things and now you have people in place like Marianne and Patti and some of whom started from the beginning. But when when you're measuring in the beginning, as Michael levy someone that's starting off with a handful of Doc's and now you're at nine doctors and you go invest, how are you measuring how you're How are you keeping the pulse of how you're serving the patient have a


Dr. Michael Levy  09:58

formal basis we serve it have the patience on a regular basis, and we get constant feedback. And we're never satisfied, which is good and your work life not good in your personal life. So, you know, we constantly pushing each other and ourselves. And, you know, any negative feedback freaks us out. And we look carefully at, you know what the root cause was, and welcome that. I think most importantly, we've attracted staff and retain staff who get that. And we, we were never good at letting anyone go, which was an early problem with Maryann and a more professional HR team. Occasionally, occasionally, someone doesn't fit in, and we will let them go. But I think that everyone is a role model for everyone else. So from the front desk to the new patient call center, which was a modification we made about seven or eight years ago, in typical doctor's offices, you got someone at the front desk, checking you in checking you out, answering the phone and make a new patient appointment. So when a patient calls our practice, we now have a call center. You know, in our office, very well trained individuals who know a lot about infertility, we give them a completely different experience with that first phone call. And we look at the whole patient journey, and make sure that it's going well, you know, there's some large practices, you don't give monitoring appointments at SEC first, come first. So you can wait an hour or two for your appointment, you know, we're upset if a patient's not in and out of the office in 20 minutes for their monitoring visit, we'll bend over backwards, because everyone knows I had a patient last week, who with the floods in in the Washington area, came in two hours late for appointments, I mean, really shut monitoring that at a relatively new front desk person was telling her well, you know, there's no one there, we can't do your monitoring. And she came to me expecting I was gonna say, yeah, she's out of lack, it's two hours late. And she's, you know, very frustrated, you know, understood that she was two hours late, but she showed me a video of a basement flooding. And we turned the machines back on, and we got staff there within a monitoring visit. And there was no question that that's what we would do. And I'm sure many, many practices would do that. But we also modeling that for the staff. So that person on the front desk knows that, you know, next time, this should be no question, you know, we're going to accommodate, you know, a difficult situation for a patient. So, I think you create a norm, and when people come and visit our practice, almost across the board, what I hear is, what do you put in the water? You know, everyone seems happy, everyone seems into it. You know, we remind our staff that we we started lackey to work in this field, you know, unbelievably motivated patients, we transform lives, whether it works, or we have to help them through difficult journey, but it doesn't work. And we need every one of those people to feel the support that we give them. And you know, we do really well about patient satisfaction surveys, but but not unbelievably well. And I'm much more anxious about it now, given our size and our geographic diversity than I was with our staff meeting was 15 people in the entire practice.


Griffin Jones  13:12

And love that you just said that every year you're coming from a practice group that is doing very well just in terms of what the practice is doing. And when it comes to, when you're talking about patient satisfaction survey like that we're doing well, we're not doing that great in terms of what I would want us to be doing. I think that is pretty telling, I often hear people think, Oh, we've got the best patient satisfaction, whether they're looking at any surveys or not. And I just I often think about a lot of different groups, I just think you're not hungry enough for me, you're not you're not paranoid enough for me that somebody else could be serving the patient better. And I tried to run my businesses the same way every single thing was like yeah, we could be doing that better. This is pretty good. We we've had a lot of success with this but I'd still like to be doing this much or have the client this happy instead of this happy and I think that's a really important attitude. I also think the example that you gave about a woman comes in she's two hours late she shows you the video on her phone or her basement flooding you make the call to turn the machines back on and get her in that particular example I think is some version of that is one that I hear small practices tell a lot about the advantages of a small practice that that large groups don't or can't do. So and here you are bringing up that particular example for you. How do you though I mean is it you Michael levy that can make that call? I mean, are there cuz an associate doc make a call like that? How do you you know, when it's when it's your practice, and it's So eight people on your staff, it's pretty easy to say, Okay, this is my bottom line, my top line, I can make a call if I'm going to help somebody out. Once you got 58 doctors, and 950 employees, it's a lot harder to make these sort of judgment calls. So you can make it in your practice, but can other folks in how do you maintain that if you can.


Dr. Michael Levy  15:21

So that's an important point. And one of the things I say to all the new physicians and all the new stuff, is, we want fresh eyes to see situations and make it better, and empower people to I'd be really disappointed if a soul should have been with us for one week didn't make that same call. And I would, you know, I'm pretty easygoing, and I never want to make anyone feel bad about anything. But I would sit someone down, and I'd expect any physician in the practice to sit someone down and say, you know, accommodate the patient, you know, that's the culture, we had a physician join us as a senior partner that in his first couple, and he'd been in practice elsewhere. And in his first couple of weeks, he then embryo transfer. And there was some communication issue between him and the embryologist. And he was frustrated with it. And he walked into the lab, and he started yelling at the embryologist and everyone like looked around and cracked up. Like, where the hell do you think you are? You know, that is not what happens at SGF. You know, if there's an issue, you're come and discuss it, and we'll explore it, we'll make sure it doesn't happen again, that type of hierarchy, that type of, you know, bad behavior just doesn't exist. And what was great for me was, it's organic to the practice of this point. So it's not that, you know, we're not of a very hierarchical organization at all. And everyone who's been here a while, gets the culture and buys into it and reinforces it. So you know, it's, it's not just, I could make that call, or half a dozen physicians who've been here for 20 years could make that call, we would we empower people, the physicians know more about the business realities of this practice. Within a week of joining us, then many physicians that have worked so well for 10 years, and they've got a, you know, senior partner who's keeping everything close to the chest. So transparency and empowerment are at the core of our model.


Griffin Jones  17:19

That's part of the culture and you say it's organic. But as you start to grow partly by acquisition, and you talked about that 50 positions, we had one lead and that whole time one for personal reasons. I imagine that doesn't mean doctors have practices that you've acquired, but as you as you start to acquire practices in other areas, how do you make sure that it fits with that organic culture, because you've grown it from the beginning, you're in the offices in the DC area, you and the founding members now, in once you start to get to other states, you're further away from that base, and you might be hired, you might be buying practices of people that have no problem, dog cussing their embryologist in front of the rest of the staff? How do you part ways with them? If that's the case? Or get them on board? How do you decide what's the root there?


Dr. Michael Levy  18:18

So I think it first goes along with who you partner with so many of the physicians who have joined us or we've hired, we just know they're a good fit. And they get the right combination of clinical skills, personal commitment, entrepreneurial instincts, and we want them on the best. And when we looking at a practice to acquire, that is probably the most important issue. Well, these doctors fit in with the culture, it could be a great business opportunity on paper. But if on a personal level, you've got a very egotistical physician who is never going to let go. That's a non starter for them and for us, because, you know, but at the same time, we don't straightjacket and the personality of our Tampa office and Richmond office in Philadelphia will be different to rock for that there's enough commonality. And we so one of the other critical issues we have is we meet on a regular basis. So three out of four Monday nights, we have physician meetings, we have a clinical meeting, we have a journal club, we have a business meeting, everything is discussed. And as I said, it's important that transparency, so that helps build the culture. And one of the things we had a very difficult situation. A week ago we had to deal with and a senior partner in Richmond and a senior partner in Atlanta, both spoke up in such a moving way to say we get the culture we get how this needs to be handled, and were fully on board. And that may not have been the case and I think it's a combination of we had the right people who we merged with and acquired and they got the culture in wreck. implies that the greater good is served by all of us reinforcing it. So so we're not competing with each other. You know, our compensation formula is a very well balanced and fair, largely rewarding productivity, you know, not seniority, not equity. In fact, the opposite is the case, you have to sell your equity and 65, we did not want to have top heavy situation where you've got, you know, a 70 year old physician working part time and trying to take the lion's share of the income, you know, you're phasing out at 65.


Griffin Jones  20:32

All the 20 equity holding physicians all come to those meetings. So they all go to the business meeting, via video conference or whatever means.


20:42

So not only that, but all 58 physicians come to the business meetings,


Dr. Michael Levy  20:47

every Monday are average to me every business Monday, which is what I said now, we probably them to two out of four Mondays a month we have a meeting, because that's become unwieldly with 58. So now we have an elected board, and no one has tenure on that board. So anyone can get voted off every two years. So we have seven physicians on a board that that meets every Monday afternoon with our executive team. We have a shareholder group of with everyone with equity, which is 28 physicians. And that's a quarterly meeting. And then a business meeting. I think we have one or two a quarter all physicians associated physicians know our revenue. Now our profit, though I expenses in detail from day one. And, you know, we've always held that transparency as a key to the culture.


Griffin Jones  21:37

There's a reason why Dr. Lee talked about EngagedMD In this episode. This was long before EngagedMD was a sponsor, Dr. Levy helped found EngagedMD and they because he saw the need for news willing to help in enrollments in the biggest program in the country. And since then, their market share has only exploded the Devon almost half the centers in North America using EngagedMD, why did Dr. Levy? And it why did he end up becoming a sponsor? Why have they expanded their market share so much? It's because it's a technological solution, where we have long been aching for one to have our nurses not have to do the type of pre education of pretreatment education that can be done in a module that is much better suited for the patient so that nursing time provider time is personalized to the patient so that the patient can do it on their own time, enjoy their experience more, go back and learn again come in with a much better foundation so that informed consents aren't being lost or taking time to make sure that they're each in the right file and then moved from one location to another. They're all in one place with a much greater informed consent to because it's tied to a module that you can show people watch all of these things, and they engaged in the what it is. And that progress has been amazing in the last few years. And if you're one of the few people that hasn't taken advantage of that, in that time, you can get going new engaged.com/grif. And you have to do the slash grif. And you have to tell them you saw them on inside reproductive health you don't, but it will get you a free assessment of your workflow, which is really good to do right now. And also just create more content for the show. So we're gonna engage them the slash Griffin, and enjoy the rest of this conversation with Dr. Levy. Dr. Levy seen from RSC and back on the show as well. And he talked about how those his partners and the physicians that his group meet, and they meet each Mondays and one one day a month they talk about business with his shape position, that's a lot harder. So I see the importance of having a group but I can't stress the importance of reserving time for all of the partner Doc's to talk about business, not just oh, let's let's pick a time here, and we'll get to it, but then so and so's on vacation, something happens with so and so and then someone else is covering their patients. And those meetings that are supposed to happen every two weeks happen every six weeks, or every two and a half months, and so on. And that time of reserving the attention and focus for everybody to meet and talk about the practices of business, I don't think can be understated. And to me it often seems that the smaller the group, sometimes very often, the less likely that is to happen. One of the things that we do as a company when we start working with someone is we need to make sure that they have Time, focus and attention to be a part of whatever engagement that we go through with them, which is why we start off at a very small little level. And when people sort of can't get into that little level, they want to, they want to jump forward and say, Well, can you just put together some service package for us? I say, I am not going to put together anything that is destined for failure. And if there isn't the ability of the leadership to say, Okay, this is important, then there isn't the ability of the subordinates underneath them to say, this is what we need to be working on. Because we know it's important because the leadership is, is meeting on it frequently. How do you decide who gets on that? Board? You said, it's not tenured? So people can sometimes people leave you said it's 65 people start to phase out is the board sort of a volunteer, we work with some bigger practices that they have like a marketing committee and some of the partners and they might have a finance committee and other types of, of committees, but how do you decide who sits on the board?


Dr. Michael Levy  26:08

So it's a mix about all the shareholders. So we have an election every two years,


Griffin Jones  26:15

we tried to 28 physicians. So it right now, it's different, because your group that is entirely physician known, one of the concerns that a lot of people have is about the consolidation that's happening in our field from for from groups that are backed by private equity firms. And it would certainly be easier to become the largest fertility group in the country, if one had private equity, that things can move really fast or venture capital, for that matter. You haven't yet. So I'm assuming that means that there's some concern, but that's an assumption, do you share the concerns about what's happening with consolidation? And if so, what are


Dr. Michael Levy  27:07

so many facets to that I was going to disagree with you that it would happen, you could become the largest group more quickly, if you have private equity, I'd say the opposite is true. Because I think you get distracted by your quarterly performance. And you have pressures that don't allow you to be as strategic, especially if they've got a short term exit plan. And they're trying to micromanage without the clinical insight and experience needed, you know, they may be very well trained business people, but it's, you know, we're not widgets. And I think that to a certain degree, private equity is discounted, you know, the importance of individual physicians, and how much of an impact that has on the practice that they are appropriately motivated, you know, we've probably get two calls a week for private equity groups wanting to get into the space. And we've resisted that, at a certain point, we're going to have capital needs that we're going to have to address, but we've managed to finance it internally and with, you know, into, you know, and with bank funding, and it is tempting, to be honest, but I think that our structure is such that it precludes all the physicians wanting to exit and get a nice multiple for private equity. Because if you're 35 years old, and a new partner, you know, you're not as excited about private equity as if you're 60 years old. I happen to be 60 years old, but like, my primary responsibility is to the practice and to the 35 year old doctors in our group, and I'd be averted, which is good. So I think looking long term is is important for future growth, and private equity doesn't look as long term. And, you know, we recognize that there probably four or five networks in the country, most of which are private equity backed at this point, and they are good competitors. But when I started in practice, 28 years ago, a really lovely colleague in the area said to me, you know, I'm sorry, you weren't able to join us because there was no space, but it's a big space. And there are lots of patients, and we'll all do well. And that was true, then, and it's true. Now. I think the market is underserved. I think we're too expensive. I think there are patients who don't have access to care who should be accessing care, and if we find ways to accommodate them, the whole pie grows, and we will do well.


Griffin Jones  29:24

Not. This could be an entirely different topic, but maybe it's worth it's worth bringing up because I completely agree that the market is underserved. We yet that I talk a lot on the show about the interior of the country, especially because I think we're seeing in even more disparity, a lot of the younger areas are moving to the DC, Boston, New York, Los Angeles, San Francisco, and very often the only doctors moving to the smaller markets are those that are from there. They grew up there and they just want to be by their family. Those practices are having a much harder time. and recruiting folks. And I think that ultimately limits the number of people that they can serve in those areas as well. And this might be a little bit of a side topic, but you did talk about were too expensive. I had Rob kilts on the show to talk about that particular topic. And I could probably have more guests just to talk about that. Why are we so expensive when so much of what we do is a cash pay the criticism of, of health care and why health care is cost increase, while most consumer technology cost goes down, is that it's because you have the government or an insurance who's not really insurance, because so much of their liability is mitigated by the government or someone else inflating the costs in our field, the majority of it is self pay, at least for IVF. And so why are we still so expensive,


Dr. Michael Levy  31:00

you touching on a topic that I'm very passionate about, and have always looked at ways to ensure better access to care. And if you look at our field, the the rate of inflation in IVF, is much, much lower than in other fields of medicine. One of the facts I'm most proud of is when we started the shade rose program in 1992. Our package was $19,000, led up to six cycles, full refund of it on every baby, we just modified our shaders program into three tiers. And for patients under the age of 35, we reduced the price from $21,000 to 90,000. To 28 years later, it's the same cost. That's that's the opposite of what's happened in medicine. And by the way, as you obviously figure out immediately, we do much better because our success rate is double. So you know that's so as technology improved as it does in other areas, you should become more cost effective. I think the fact that there's such huge barriers to entry allows practices to charge more, which is problematic, you know, costs do go up in general. So our margins are lower now than they were 10 years ago, our pricing has not kept pace. I'm also very frustrated at the cost of medication. I think this is a problem across the board in medicine, at the cost of gonadotropin to have more than doubled in the last 20 years. And certainly the cost of an IVF cycle has not come close to that. So whereas early on, it was about 20% of the cost of an IVF cycle now can be 50% of the cost of an IVF cycle, especially when the prices are going to bash pharma a little bit here with this opportunity. But especially when you look in Europe, where the cost of gonadotropin is a fraction of what our patients pay here, that's very problematic. So I think our whole health care system is messed up. I do believe and I'm not. I guess it's ironic, given my career, but I'm not that much of a capitalist at heart. But I do do believe in transparency and price compensation. And I think the fact that it's a self pay market has kept prices down. If you look at the cost of a knee replacement 28 years ago, versus IVF. And you're looking at now, it's exponentially higher with the rate of inflation with the knee replacement. patients aren't looking closely, you know, I could go on and on about this topic, I'd love to talk to you about it again, I became very interested in it. In our practice, our health insurance is our biggest expense after occupancy. And we're now exploring becoming self insured, because we want to control costs better. And I think medicine has failed dismally at controlling costs. And I do think if you look at the rate of inflation, in fertility, it's much much lower than medicine as a whole.


Griffin Jones  33:55

I think that we definitely could have you back on about that. But it does explain why you got into some of these other ventures and I want to talk about how one gets into those because I think a lot of especially principles of fertility groups have the opportunity to maybe be a co founder of a of a new software a new EMR a new maybe a new workflow, where or or have the opportunity to get involved in physician owned pharmacies or a number of different side ventures sit on an advisory board for some large tech startup or existing farm company. One of the things you started with this passion that you talked about you started the share price financial program, then you also helped co found donor egg bank and I think you're involved with my friends at EngagedMD How do you make those decisions to you've got your your your main focus, which is presumably the practice group, and then there are different than Churches and there could be 1000. As the field needs technology and meets all of these new opportunities, how do you decide which ones are a good fit? What advice would you give for principals that are thinking about maybe getting involved in some sort of venture that is ancillary to their practice, I think we


Dr. Michael Levy  35:18

always do better in an area that we know well. So you know, for me to say I think I'm going to invent some kind of, you know, it opportunity unrelated to infertility would be completely crazy. And that is almost certain to fail. But I think if we have an entrepreneurial instincts, and we see areas within our field that open up new opportunities, I think the egg bank exemplifies that, and we pursue it with a vigorous focus will be successful. So when the new technology for egg freezing was developed about 10 years ago, I think that it opened up a big opportunity with egg donation, where typically one egg donor was matched with one recipient, and it was extremely expensive. So egg banking allowed one to decrease the cost by less than half of what it used to be. And there was, was we were early adopters of it and started the egg bank in partnership with a number of other groups.


Griffin Jones  36:19

And maybe a good place to conclude is with the model that you talked about, because you made a really great point, which is when you're 35, the private equity offer isn't so excited when you're 60. The private equity offers a lot more exciting because the buyout is essentially one's golden parachute retirement. And I have made this argument on the show very often that I think no small part of the reason why a lot of retiring physicians or doctors that are within five years of retirement are taking this exit because they don't have another exit because they don't have a doctor that wants to take over their practice. Or if they do, there's trapped equity that the incoming doctor can't afford what the practices were. And even if they can they're the expectations aren't set. Well. We've talked about that with Holly I just said on the show of why associated Doc's would leave after two or three years before ever becoming a partner and why that happens fairly frequently. So if her the I think maybe the five to seven Doctor groups, because there's still a decent number of those, and they haven't sold equity yet, but they're probably around that age where they're really thinking about it. Does the Shady Grove model work for someone that sized where you're getting people in, they're meant to be on a partnership track. And then the older Doc's are meant to phase out, or is it too late if the doctors are at certain age or a certain career?


Dr. Michael Levy  37:53

So so we refer to our Constitution as a critical components of our practice. And that's all embedded in our Constitution. And I don't think it's too late. For any practice. I think that you absolutely correct that if the only avenue for excellence in significant ways private equity, and you don't have younger physicians who are going to purchase your equity in the practice, you're in trouble. So we have a very clearly defined internal, multiple and excellent we've had three physicians, or more probably at this point. So when I started the IVF program, I joined us a Gascon and Bob Stallman have been our fellowship director, GW, he joined us five years later, both Alice and Bob have now sold the equity in the practice. And that was very orderly, the younger physicians bought the equity. If they can, and it's a win win, they got a good, you know, valuation, and the younger physicians, you know, got a good deal being able to acquire that equity. So, I think ensuring that that is in place at the earliest stage is a good idea.


Griffin Jones  39:03

Can doctors do that, like in owner financed home, I buy the home from the older couple who's going into the nursing home, we don't get the banks involved, we we draft a contract that maybe I put down a down payment, and I owed them directly as though I'm paying them the mortgage and not the bank. Can it happen that way? Or does it have does do younger position typically have to get a loan in order to be able to buy that equity.


Dr. Michael Levy  39:29

So the way we structure that when physicians buy into the practice is we do the practice guarantees a bank club for the CIO, and it's a significant amount but the return on that and they own that equity day one and the return of the profit pool that is returned according to equity pays more than pays for them right away. So we will ensure that they will do better from day one as a as an equity partner. They'll also purchase them there'll be It's a you know, everyone can get about the same amount of equity in the practice. But someone who's got less productivity would not be able to afford to buy the maximum amount of equity that they could, because it would be too expensive. But I think it could be financed internally, by the practice, I don't think that you have to involve a bank to do it effectively. But I really do think that it's when we interviewing, it's interesting, you know, that I think the incorrect stereotype apply to millennial physicians or graduating physician fellowship is they want to check in and out, they want to get a nice salary, they're not interested in the business side. And they're not that focused on the long term partnership track. Now, I think many of those probably exist. And those are the ones will attract most of the physicians who come to us from word of mouth, know that they are going to have the opportunity to be true partners, it is important to them, they have to be productive and fit in with the culture in order to achieve that opportunity. But I think we have in a in an era in which there are fewer fillers graduating than there are positions. So So most veterans get multiple offers. We have almost our pick of the finish of graduates who not going into research who want to be in clinical practice, because of that model that I


Griffin Jones  41:21

think that that point of there are still so many entrepreneurial RBIs coming out of fellowship. So many of the some of the millennial areas that I know, some of whom are still in fellowship are among the most entrepreneurial that I know with their involvement in Silicon Valley with their following funds and Wall Street, they are really dialed in. I think from a recruitment standpoint, why it sometimes appears that way is because these minor positions are going to show you go there some often times not going other places because you have a structure for them. A lot of times there isn't a structure in place. And the ambiguity that was that suffice 25 years ago doesn't suffice anymore, they need to go to a place that has a human resources department that that's active on social media that isn't using paper charts that is forward thinking because I think very I make the analogy. Very often that it's like buying the the old house, but the work needed on the house is so much more than just the the Biden and especially if there's going to be someone in place that's fighting you on the changes that you need to make before they retire if they ever retire. And I think that that you all have that structure in place, it seems so definitely I'll give you the final thought what would you want to conclude on? I like that you counter my point that it would be easier to use private equity to build the largest practice group in the country, you counter it because you've actually done it so clear, because evidence that it's true, you said that you didn't set out to do that. But for someone who wants to grow or sustain their practice, for your general view of the field, how


Dr. Michael Levy  43:08

would you want to, you know, one area that you had a question or which we didn't touch on, which I'll finish with is like one of the other really key decisions we made early on is that physicians need to be fully engaged, but they should not be the business leader of the practice. So we have a really superb executive team, led by Mark Segal is our CEO. And I think Mark had the vision and ambition to grow as big as we did. And we went along with him and supported that. So we have the right balance between not trying to micromanage. I do see physicians fall into the trap of we know a lot about a little so we assume we can know a lot about everything. And, you know, that's risky. So we have, you know, as you said, great HR, great marketing, you know, administration accounting, you know, and we don't micromanage that group at all the board meets every week with that team, do we know what's going on, and we involve the important decisions, but finding the right balance is critical for the right foundation for the practice. I spent 80% of my time practicing typical medicine, I still enjoy it the most, which is why I keep doing what I'm doing, and certainly want to be involved, as do all our physicians. And lastly, I love the fact that you said that you familiar with a lot of entrepreneurial young fellows and reproductive endocrinologist and send them our way, but I wouldn't want that to be the primary driver. The right physician in our practice is going to do what's right for the patient every time. My favorite patients are those with sexual dysfunction. We send them home with a 10 cent five cc syringe and tell them to inseminate themselves at home, and they don't need us for anything. And we make because we're doing right by them. It's the most cost effective treatment. And, you know, if everyone knows that That's what we get to do. The practice is strong before because they're going to send their friends or staffs gonna know that's what's required. And they're going to act like that in every situation. And of course, I love the patient way too complicated situation. And we need to use all the bells and whistles of technique, bells and whistles of the top technology to get a good result. But we've got to tailor to the patient. So do right by the patient but be entrepreneurial and successful follow


Griffin Jones  45:27

Dr. Michael Levy, thank you very much for coming on inside reproductive health.


45:32

You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society. Visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health





Griffin Jones  00:04

You don't have to make less money. In a recession, you do not have to, you don't have to provide less care, you don't have to lay people off, don't have to have everything blown to smithereens, it doesn't have to happen in a recession very often it does. I for one did very well, in the last recession, who worked really hard, I was younger, that helped. But in a sense, that helped me to rise, because I saw other people phrase like deer in headlights, and I focused on trying to create value and just doing whatever I possibly could, there's a couple of pieces of value that you can shore up, that will help you to do better. And it's knowing where your patients are coming from investing in those sources, and not investing in other sources has to do with attribution, I have a very strong opinion. On attribution, I've had people come work for my firm that have had opinions on attribution. And they're not nearly as thought out as this point of view, because there isn't a perfect way to do it. And I've tested lots of different ways of doing attribution, I'm gonna give you some ways that work. But the first rule of attribution knowing where your patients come from, is stop looking for the perfect source of attribution, it doesn't exist. So sick of hearing that these these while this type of patient that comes from paid search, they're better or, or they don't convert, or they do convert, it doesn't work like that it can work that more patients that are more qualified for treatment sooner come from certain channels, but it isn't that there's one channel, that means other qualified patients, one channel that brings in pages that are qualified to go into treatment, one channel, that doesn't work at all, that's not how it works. This is 2022, God to be 2023. Maybe when you hear this episode, I don't know, there isn't three channels on the television is not one newspaper, and a handful of radio stations are market, there's infinite number of ways that people can come to hear about you. And they can even just be siloed to media, because if I see something on Instagram, or Facebook, is it because I was in that Facebook or Instagrams, that ad reach for was it because a friend of mine communicated to me through Instagram or Facebook and was word of mouth, these channels are not perfectly siloed. So don't expect them to be perfectly siloed. And also don't expect them to just be perfect, because until we have 1984 style, whatever he does, or whatever dystopian show, you're watching on Netflix right now where you can put in your wig in somebody's brain, and map all of the ways they came to make a decision. Perfect attribution doesn't exist. And in our field, even now, it's hard to make excellent because there is no CRM, that's a customer relationship management, software, HubSpot, a Salesforce that most of you don't have, and those of you that do have it using a very cursory level, because none of them perfectly communicate with your EMR, most of them don't at all, and most your EMRs are not set up to be able to track this kind of flow. So we're getting rid of the fact that, that we can't have perfect attribution, that it doesn't exist. That doesn't mean that we shouldn't get the best information that we can have, and use it to make decisions make decisions. We're looking for directional attribution, not perfect attribution. So how do we get directional attribution after you train the same triangle and the three, but you can subdivide a couple of these into four, the first thing that we have to be doing is tracking volume to marketers should be tracking volumes did an article I updated a year or two ago called shut fire my practices marketing director, that's still a good article, because it's about all of the different roles within marketing teams. And so you might say you have a marketing person, that doesn't mean anything, look up what role that is, and what outcomes they're actually responsible for, but at the tippy top, that somebody has to be responsible for volunteers. When marketers don't achieve an outcome. It's because there are lots of variables for that outcome one, and they either don't have the capacity with the autonomy to achieve to be able to work on all of the variables that improve that outcome. So you can't call the paid search person to new patients in the door. or, because all they all paid search person can do is get you more leads from paid search can't pull the brand new person to more new patients because all branding person can do in and of themselves is make good messaging and nice design. And so it all has to come together if you're going to be achieving the outcomes, that's whoever is in charge of that you're holding that accountable to, they got to have that number front and center number of new patients in the door number of IVF, cycles, retrievals, then whatever other procedures that you're trying to increase, but especially as we start to go into a recession, depending on how bad this thing is, the more you have to be able to do that. So the first thing is having the persons responsible for monitoring those outcomes. And the second point of the triangulation is the digital attribution. This can come from multiple sources and very often dies. But one of the one of the main ones, this is what I mean by you can even sub split the triangulation, but where you sub split, the digital attribution is Google Analytics. Everything that's important has to be accounted for in Google Analytics, in your form fills your request appointment submissions, if those things are different. For example, if you have a request an egg freezing appointment, that's that counts as a lead. That's a goal that has to be measured in Google Analytics that comes from a thank you page on your website, it's got to be in Google Analytics, if you have a different request appointment for anything that is about becoming a patient needs to have a page. So that can be a goal that's in Google Analytics. And last I checked, you can have like 15 goals and Google Analytics. One of them has to be phone calls, to need dynamic number insertion, and your website and the ads that you run, because you have to have, you have to know how many calls you're driving that and your marketers have to be able to know that because they have to be able to make decisions based on us, especially if we're heading for a recession, you gotta be driving towards these things, not just eyeballs not just clicks. And then from there, you can quit, especially when you're using dynamic number insertion, you can use that to actually measure the calls and the number of calls that that fall off and what you can do to do that, but I'm starting to veer off on sticking with attribution right now. But that takes you to the point of attribution, where you can see, okay, this is this is where leads are coming from. And then you can assess quality of leads after that and quality of process. Also, within your visual attribution is any place that you're running ads in, in that native in that native ads platform. And that ads platform that Google ads are running ads on Facebook and Instagram, Facebook ads, in those platforms, you're going to have some different points of attribution that need to be reconciled with Moulinex. They don't, they don't always go perfectly. Yeah, that you think is frustrating for you try doing it for a living. But Google, for example, will sometimes optimize for goals that you don't want or that you want less of sometimes you want to use the artificial intelligence and go bid right below what they're recommending. So it makes the AI work harder, sometimes Google will be lazy, and they'll just try to automatically get you into more clicks or their geographic targeting is broader than you would then what you're actually intending to do, because they want to just get the spend up. So those need to be accounted for in those digital platforms. And the third sub point of the the second Digital Point of attribution is your CRM. So upset does not perfectly talk with Google ads, or Google Analytics for that matter. But you can get a lot more information from BRM by using CRM, and at least don't have didn't did these people and then import the leads from your ads platforms into CRM, you won't get all of them. But did of the people that we have how many of them convert to treatments that you can use or how many of them at least made an appointment so that you can use some of that as part of your digital marketing as you start to build campaigns and and optimize more you can see how well this works. So we have volumes IVF volumes by month. New patients by month and then any sunbird eight Using patients, any third party patients, if that's what you're in marketing for, then digital, Google Analytics, the ads platforms themselves, your CRM. Finally one of the third point, triangulation, which is self reporting, it's still important, it still makes sense. Their self reporting in and of itself is not reliable. People will say sources that you don't even advertise on or they will totally, maybe they'll just do the last thing that they can think of. But it wasn't the most effective, it's incomplete. But triangulated with the other two points of attribution, it's very useful, and you can make it more reliable in and of itself is that we do? Every question needs to be binary, yes or no? If you're advertising the ton, the traditional radio or TV or whatever, need to ask people, did you see us? On TV? Yes or no? Did you? Did you hear a radio commercial? Yesterday? You least need to know? Are they perceiving it in someone? Did you see us on social media? Yes or No? Were you referred to a friend? Were you referred to us by a friend? Yes or No? Were you referred to us by a doctor? Yes or no? So these are binary questions has to be yes or no, you have to calculate the acids, you have to calculate the numbers, you do at least be able to see, is this particular channel, registering with them? In some way? And if it's not, then you get rid of it. The final question is not binary. It's a drop down of all of these ways. What was the most influential in your choice to selecting our practice? And then it's just all the the what had been questions are now your options. So social media, referred by that groups, or by friends, etc. Those two pieces of information help to balance each other out. So you can see, okay, are these things even registering with people is, is this making an impact and have all of these things what seems to be making the most impact because when you balance those two stories together, you'll see different stories 60% of patients, fertility patients, our patients are referred to their AI by a doctor. But only 21% of total patients say that being referred to their Rei by a doctor was the most influential factor in choosing their their doctor location is number three areas number two, at 20%, referred by a friend is 90%. So I will often see this with digital marketers is that pesos is a marker sit at all time paid social work, paid social doesn't work. It's all about paid search. Gotta do higher intent, keyword search. That's what that's what's driving traffic. See, you look at the Google Analytics, you can see it, yes. Who you can't see is all of the things that people are saying to each other because they saw it on their social media, we didn't have that 20 years ago, we didn't have people telling their friends that they went through fertility quest more than they saw specialists at their throat. And when I first got into the field, do nothing but organic social media, because I didn't have any of the background do this other stuff or any money to hire other people that did this other stuff. I got results for people using organic social media, because it was just the word of mouth friend referral. And that's the number three influential reason why somebody chooses to practice it's 90% of fertility patients that have the most influential factor. A lot of that's coming from social media. So you got to put all of these things together. To make the story clear, and you're not doing this in the EMR. EMR is not the place to report attribution doesn't belong in some of these charts. It's not one question such as one question that happens at the at the phone call, because it's got to be done in this way. Prior to COVID. Now, a lot of you are still doing just telemedicine for for new visits or for many of you are doing a hybrid choice. We used to just have clients buy a tablet, put Survey Monkey on the tablet, and we just make the client do it for every single patient that work the best. Since COVID, it gets trickier you have to be you just have to be more on top of that. If you're doing this type of new patient attribution for for new patients, but you can require that when they when the rest of their forms are due. But it is more operationally intensive. So doing these three things, properly tracking volumes against digital attribution coming from Google Analytics, the ads platforms themselves and CRM if you had one against self reporting, that is multi question binary and then final question, non binary, that is not done in an app, not multiple choice, I should say for that last one. It is not done in your EMR. Doing all of these things is going to give you the best information that you need to see where your patients are coming from. So you can invest more indoors those sources so that you spend less money during our session, and that the money that you are investing, you keep investing in because it's the one bring people in, it's not an expense, it's an investment. You need that information all the time, but you can't get away without in a really bad recession. Hope this is really useful to you, and I hope you are able to implement soon if you need some help with it. Just email me Griffin that fertility bridge.com

You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society. Visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health


159 Attribution: Discovering Where Your Patients Are Actually Coming From

This week, Griffin unleashes the secrets of client attribution in a Marketing Secrets Short episode. Tune in to understand how you can avoid making less money in a recession with proper attribution tracking on the latest episode of Inside Reproductive Health with Griffin Jones.

Tune In To Hear:

  • What you need to STOP looking for when it comes to attribution tracking.

  • How to get directional attribution through Grif’s secret method of triangulation.

  • Which metrics you can forget about, and which you should be looking at closer.


Transcript




Griffin Jones  00:04

You don't have to make less money. In a recession, you do not have to, you don't have to provide less care, you don't have to lay people off, don't have to have everything blown to smithereens, it doesn't have to happen in a recession very often it does. I for one did very well, in the last recession, who worked really hard, I was younger, that helped. But in a sense, that helped me to rise, because I saw other people phrase like deer in headlights, and I focused on trying to create value and just doing whatever I possibly could, there's a couple of pieces of value that you can shore up, that will help you to do better. And it's knowing where your patients are coming from investing in those sources, and not investing in other sources has to do with attribution, I have a very strong opinion. On attribution, I've had people come work for my firm that have had opinions on attribution. And they're not nearly as thought out as this point of view, because there isn't a perfect way to do it. And I've tested lots of different ways of doing attribution, I'm gonna give you some ways that work. But the first rule of attribution knowing where your patients come from, is stop looking for the perfect source of attribution, it doesn't exist. So sick of hearing that these these while this type of patient that comes from paid search, they're better or, or they don't convert, or they do convert, it doesn't work like that it can work that more patients that are more qualified for treatment sooner come from certain channels, but it isn't that there's one channel, that means other qualified patients, one channel that brings in pages that are qualified to go into treatment, one channel, that doesn't work at all, that's not how it works. This is 2022, God to be 2023. Maybe when you hear this episode, I don't know, there isn't three channels on the television is not one newspaper, and a handful of radio stations are market, there's infinite number of ways that people can come to hear about you. And they can even just be siloed to media, because if I see something on Instagram, or Facebook, is it because I was in that Facebook or Instagrams, that ad reach for was it because a friend of mine communicated to me through Instagram or Facebook and was word of mouth, these channels are not perfectly siloed. So don't expect them to be perfectly siloed. And also don't expect them to just be perfect, because until we have 1984 style, whatever he does, or whatever dystopian show, you're watching on Netflix right now where you can put in your wig in somebody's brain, and map all of the ways they came to make a decision. Perfect attribution doesn't exist. And in our field, even now, it's hard to make excellent because there is no CRM, that's a customer relationship management, software, HubSpot, a Salesforce that most of you don't have, and those of you that do have it using a very cursory level, because none of them perfectly communicate with your EMR, most of them don't at all, and most your EMRs are not set up to be able to track this kind of flow. So we're getting rid of the fact that, that we can't have perfect attribution, that it doesn't exist. That doesn't mean that we shouldn't get the best information that we can have, and use it to make decisions make decisions. We're looking for directional attribution, not perfect attribution. So how do we get directional attribution after you train the same triangle and the three, but you can subdivide a couple of these into four, the first thing that we have to be doing is tracking volume to marketers should be tracking volumes did an article I updated a year or two ago called shut fire my practices marketing director, that's still a good article, because it's about all of the different roles within marketing teams. And so you might say you have a marketing person, that doesn't mean anything, look up what role that is, and what outcomes they're actually responsible for, but at the tippy top, that somebody has to be responsible for volunteers. When marketers don't achieve an outcome. It's because there are lots of variables for that outcome one, and they either don't have the capacity with the autonomy to achieve to be able to work on all of the variables that improve that outcome. So you can't call the paid search person to new patients in the door. or, because all they all paid search person can do is get you more leads from paid search can't pull the brand new person to more new patients because all branding person can do in and of themselves is make good messaging and nice design. And so it all has to come together if you're going to be achieving the outcomes, that's whoever is in charge of that you're holding that accountable to, they got to have that number front and center number of new patients in the door number of IVF, cycles, retrievals, then whatever other procedures that you're trying to increase, but especially as we start to go into a recession, depending on how bad this thing is, the more you have to be able to do that. So the first thing is having the persons responsible for monitoring those outcomes. And the second point of the triangulation is the digital attribution. This can come from multiple sources and very often dies. But one of the one of the main ones, this is what I mean by you can even sub split the triangulation, but where you sub split, the digital attribution is Google Analytics. Everything that's important has to be accounted for in Google Analytics, in your form fills your request appointment submissions, if those things are different. For example, if you have a request an egg freezing appointment, that's that counts as a lead. That's a goal that has to be measured in Google Analytics that comes from a thank you page on your website, it's got to be in Google Analytics, if you have a different request appointment for anything that is about becoming a patient needs to have a page. So that can be a goal that's in Google Analytics. And last I checked, you can have like 15 goals and Google Analytics. One of them has to be phone calls, to need dynamic number insertion, and your website and the ads that you run, because you have to have, you have to know how many calls you're driving that and your marketers have to be able to know that because they have to be able to make decisions based on us, especially if we're heading for a recession, you gotta be driving towards these things, not just eyeballs not just clicks. And then from there, you can quit, especially when you're using dynamic number insertion, you can use that to actually measure the calls and the number of calls that that fall off and what you can do to do that, but I'm starting to veer off on sticking with attribution right now. But that takes you to the point of attribution, where you can see, okay, this is this is where leads are coming from. And then you can assess quality of leads after that and quality of process. Also, within your visual attribution is any place that you're running ads in, in that native in that native ads platform. And that ads platform that Google ads are running ads on Facebook and Instagram, Facebook ads, in those platforms, you're going to have some different points of attribution that need to be reconciled with Moulinex. They don't, they don't always go perfectly. Yeah, that you think is frustrating for you try doing it for a living. But Google, for example, will sometimes optimize for goals that you don't want or that you want less of sometimes you want to use the artificial intelligence and go bid right below what they're recommending. So it makes the AI work harder, sometimes Google will be lazy, and they'll just try to automatically get you into more clicks or their geographic targeting is broader than you would then what you're actually intending to do, because they want to just get the spend up. So those need to be accounted for in those digital platforms. And the third sub point of the the second Digital Point of attribution is your CRM. So upset does not perfectly talk with Google ads, or Google Analytics for that matter. But you can get a lot more information from BRM by using CRM, and at least don't have didn't did these people and then import the leads from your ads platforms into CRM, you won't get all of them. But did of the people that we have how many of them convert to treatments that you can use or how many of them at least made an appointment so that you can use some of that as part of your digital marketing as you start to build campaigns and and optimize more you can see how well this works. So we have volumes IVF volumes by month. New patients by month and then any sunbird eight Using patients, any third party patients, if that's what you're in marketing for, then digital, Google Analytics, the ads platforms themselves, your CRM. Finally one of the third point, triangulation, which is self reporting, it's still important, it still makes sense. Their self reporting in and of itself is not reliable. People will say sources that you don't even advertise on or they will totally, maybe they'll just do the last thing that they can think of. But it wasn't the most effective, it's incomplete. But triangulated with the other two points of attribution, it's very useful, and you can make it more reliable in and of itself is that we do? Every question needs to be binary, yes or no? If you're advertising the ton, the traditional radio or TV or whatever, need to ask people, did you see us? On TV? Yes or no? Did you? Did you hear a radio commercial? Yesterday? You least need to know? Are they perceiving it in someone? Did you see us on social media? Yes or No? Were you referred to a friend? Were you referred to us by a friend? Yes or No? Were you referred to us by a doctor? Yes or no? So these are binary questions has to be yes or no, you have to calculate the acids, you have to calculate the numbers, you do at least be able to see, is this particular channel, registering with them? In some way? And if it's not, then you get rid of it. The final question is not binary. It's a drop down of all of these ways. What was the most influential in your choice to selecting our practice? And then it's just all the the what had been questions are now your options. So social media, referred by that groups, or by friends, etc. Those two pieces of information help to balance each other out. So you can see, okay, are these things even registering with people is, is this making an impact and have all of these things what seems to be making the most impact because when you balance those two stories together, you'll see different stories 60% of patients, fertility patients, our patients are referred to their AI by a doctor. But only 21% of total patients say that being referred to their Rei by a doctor was the most influential factor in choosing their their doctor location is number three areas number two, at 20%, referred by a friend is 90%. So I will often see this with digital marketers is that pesos is a marker sit at all time paid social work, paid social doesn't work. It's all about paid search. Gotta do higher intent, keyword search. That's what that's what's driving traffic. See, you look at the Google Analytics, you can see it, yes. Who you can't see is all of the things that people are saying to each other because they saw it on their social media, we didn't have that 20 years ago, we didn't have people telling their friends that they went through fertility quest more than they saw specialists at their throat. And when I first got into the field, do nothing but organic social media, because I didn't have any of the background do this other stuff or any money to hire other people that did this other stuff. I got results for people using organic social media, because it was just the word of mouth friend referral. And that's the number three influential reason why somebody chooses to practice it's 90% of fertility patients that have the most influential factor. A lot of that's coming from social media. So you got to put all of these things together. To make the story clear, and you're not doing this in the EMR. EMR is not the place to report attribution doesn't belong in some of these charts. It's not one question such as one question that happens at the at the phone call, because it's got to be done in this way. Prior to COVID. Now, a lot of you are still doing just telemedicine for for new visits or for many of you are doing a hybrid choice. We used to just have clients buy a tablet, put Survey Monkey on the tablet, and we just make the client do it for every single patient that work the best. Since COVID, it gets trickier you have to be you just have to be more on top of that. If you're doing this type of new patient attribution for for new patients, but you can require that when they when the rest of their forms are due. But it is more operationally intensive. So doing these three things, properly tracking volumes against digital attribution coming from Google Analytics, the ads platforms themselves and CRM if you had one against self reporting, that is multi question binary and then final question, non binary, that is not done in an app, not multiple choice, I should say for that last one. It is not done in your EMR. Doing all of these things is going to give you the best information that you need to see where your patients are coming from. So you can invest more indoors those sources so that you spend less money during our session, and that the money that you are investing, you keep investing in because it's the one bring people in, it's not an expense, it's an investment. You need that information all the time, but you can't get away without in a really bad recession. Hope this is really useful to you, and I hope you are able to implement soon if you need some help with it. Just email me Griffin that fertility bridge.com

You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society. Visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health


158 Demystifying REI Partnership With “Forever Fellow”, Dr. Eduardo Hariton

Griffin Jones hosts guest Dr. Eduardo Hariton to break down everything you should know before accepting a position as an REI. Having recently undergone his own selection process, Dr. Hariton discusses what you truly “bring home” when you sign on the dotted line. What is your risk tolerance? Do you know what questions to ask?  Tune in to the latest episode of Inside Reproductive Health today, before you sign that contract tomorrow.


Tune in to hear:

  • Dr. Hariton and Griffin hash out the importance of understanding profit-sharing vs. equity and what questions to ask to get honest answers when interviewing for your potential partnership.

  • A shares vs. B shares.

  • What “partnership” truly means- and how to determine if it is the right fit for you.

  • What questions you need to ask to understand your compensation, incentive structure, and to gain clarity on your career track.

  • The importance of sharing ethos and fitting into work culture for long-term success.



Dr. Hariton’s Info:

Company: US Fertility/RSC Bay Area

Instagram: https://www.instagram.com/haritonmd/

LinkedIn: https://www.linkedin.com/in/eduardo-hariton/

Website: https://dreduardohariton.com/


Transcript


Dr. Eduardo Hariton  00:00

But not all practices are the same; other practices are going to be around in the way that they are in the future. So you have to really, and this is a hard thing to do evaluate whether you think your practice is going to do well in the market, right? Whether it's part of like a large multinational network, US based network, you know, geographic behemoth, as solo practitioner and academic center, like you're coming in to spend a lot of time and effort to come into a market and in a lot of markets, you're tied because you have a noncompete. Is your practice going to succeed in that market? Are they good points for long term success? And what does that mean that you join in the rocket ship at this point where they're already here? Those are hard questions to ask but important because you don't want to join a failing practice as their lifeboat. You do not want to be the lifeboat of the sinking Titanic, like you want to jump onto a rocket ship, or at least something that has a good trajectory.


Griffin Jones  01:03

How are young doctors getting screwed? Who cares how young doctors are getting screwed, practices are getting screwed, too. We don't talk too much about either party getting screwed. We do talk about pitfalls that employers face, practices face networks face, we talk about the pitfalls that younger Doc's face because Dr. Eduardo Hariton is the Forever Fellow. Hope he likes that nickname. Let's start it now. Everybody just call him that now. Because he went through this himself very recently. He's also written about it a lot and interviewed a number of experts himself. He and I have talked about it quite a bit. And there's a reason why he's been on the show three times. He gives a really good roadmap for younger Doc's. And I talked to him a bit in more detail than just the types of career paths that you could choose. We've talked about that a lot on the show, we talk more, we get more into the nitty gritty of the type of control that you're gonna need. If you're on the hook for certain KPIs. In order to be able to qualify for partnership, we talk about things that should be considered in contracts that both of us are loud about the disclaimer that we're not lawyers, you need to get proper legal counsel, we talk about what buying into a practice means or what partnership means, because that word is used to mean different things. We talked about different kinds of equity, like equity in the parent company versus equity in the local practice that while Class A shares, Class B shares, and the things that are important to you, that might not be in the KPIs, but that have to come out in the self discovery process as much as it has to come across in the discovery process with the people that you're interviewing. So I like to have both sides on the show. I like to have younger docs talking about what they're looking for. I like to have practices talk about what they need from docs. So if you have a different perspective, you're welcome on. Eduardo has been on the show three times. This is the sharpest conversation he has. He and I have had on this show. And my apologies to Matthew McConaughey. I didn't mean to say he was creepy. It was his character. I'm sorry, Matthew. Enjoy this episode with Dr. Eduardo Hariton. Dr. Hariton, my good friend Eduardo, Welcome back to Inside reproductive health for a welcome back for the second time, because this is your third time on the show. Welcome back.


Dr. Eduardo Hariton  03:41

Thank you. Thanks for having me. It's always a pleasure to be here and catch up and excited to chat more today.


Griffin Jones  03:47

You and I just talked about what we want to talk about, which is career trajectory for doctors in different phases, maybe mid level down to fellow and what they should look at. But we have something to solve first, Eduardo, which is the wager that you and I have, which we never actually specified a wager it was an I'm thinking it was more than a year it goes by a year and a half ago. Yeah. And we're talking about is fertility treatment going to be more or less expensive for the patient. In five years. I said more. You said less. I think that I'm we're a year and a half in three and a half years left. I think I'm right. What do you think?


Dr. Eduardo Hariton  04:27

Well, I think that you're a visionary. I knew that before. But I did not see the rate of inflation rising coming like you did. So well done there. I still got three years, we'll see what happens. And I think our wager was a donation to do believe your foundation. So


Griffin Jones  04:46

we never we never we never picked one for you. We also never pick this specific metric of the exact specific metric of what we're going to measure. So we hedged a little bit, but I'm I'm always happy to make a donation. But I do want to rub it in when I'm right. And I still think that I'm going to be right now maybe, maybe I lack imagination, as you did with the inflation, maybe I lack imagination of the economy takes a major dive. And that changes things. But I think that's what would be necessary. I don't I just don't see supply and demand consolidation. I don't see the prices coming down.


Dr. Eduardo Hariton  05:25

Well, yeah, I love to be right. But I acknowledge if I'm wrong, we'll see in three and a half years, don't don't take your victory lap too early.


Griffin Jones  05:32

Say, right. It is the first quarter. So let's talk about let's talk about something that you're far more right about, which is how doctors should be considering their careers. And let's maybe just give a little bit of a background for what you've done. I think it was summer of 2020. You that was one of the first things that you did where you did a digital event. For fellows. I was one of the speakers there. But tell us about fertility explained and then and then how that ends up being part of what you're doing for younger Doc's.


Dr. Eduardo Hariton  06:10

Yeah, absolutely. So we were stuck in COVID, take it back two years, we were at home, no one could go out on the weekends, everything was closed. And I had always had this idea that, you know, we're great at training, medical people who will train great training, and how do we physicians, we don't really share what else they need to know. So you get most of our area's go to private practice. And then they get this crash course and all these other things that they never learned about. So I wanted to use that opportunity where I had focused attention to teach the fellows about the business of fertility, you know, what is consolidation? What is a p&l? How do you market to physicians? How do they benefit manager industry works? And so I sent a bunch of emails expecting to get nothing back or maybe a few. And then everybody got back to me, you know, the CEO of the largest networks, you, David say, Well, David Adam, so like a bunch of people that really knew their industry, Natalie craft on social media, and I'm missing a ton. But they said, Yeah, I would love to teach the fellows. So we put together to four or five hour days, over two weeks of people coming and giving talks where they were open to questions. And it was an awesome event. People really liked that the feedback was solid. I found that it wasn't just fellows, I get emails from a bunch of people mid career and late career that said, this should be part of our education curriculum. It doesn't exist, because it's not our focus. But how do we keep this going? So over the last two years, I've kept that going, I haven't organized a conference. But I've done you know, usually monthly webinars with people that come and talk about how to get a job, how to, you know, get a job that you love, and it's people that been in the same job for a decade, I've had people who have switched jobs within two years, and they come and they say, this is what happened. This is how I got screwed. This is how they move my goalposts. I have people that talk about negotiation. I've had employment lawyers from my thermal come speak. And it's turned into this kind of more topical session where, you know, part of it is still teaching fellows about the business of fertility. We have one on the pharmaceutical industry, one on benefit managers, quite recently, we have one on high volume providers, and what do they do differently to be able to do 567 100 cycles coming up? But it's also turned into how do we help fellows equip themselves with the right information to get the job that they want? And that means understanding the right questions to ask understanding the timeline, understanding the process, and being empowered to say, you know, I have trained for 11 years medically, and probably a decade before that, I should be in a position to negotiate for the things that really mattered to me. And the reality is, we don't know what really matters to us as we're coming out of this process, because we haven't been prepared. But I hope to just give fellows a flavor of how to do that, and help them through that journey. And that's something that I went through two years ago, I interviewed at a bunch of places, and learned by doing with the support of some helpful mentors. But I hope to give the fellows those tools as well.


Griffin Jones  09:07

Let's talk about the job that they want. Because I suspect there's something operative about the front part of the phrase, the one that they want. I might regret saying this, it seems to me if you can't get a job. Right now, as a ra, you suck. That in fact, if I might even say if you can't get the one that you want, or at least go to the place that you want to go to that there's something that you're not doing right, given the demand. If you can't do it now, would love to see you tried doing it in the 90s when people like Dr. Serena Chen, Dr. Nedley told me that our eyes were delivering babies because there wasn't Rei jobs in in the 90s. And so let's talk about that. Do you think that I'm failing burning too much the demand side of the market right now. And if I'm not, then tell me more about what, how we define the job they want.


Dr. Eduardo Hariton  10:10

Right? So I'll say your second question first, I'd say yes, there is a huge supply side constraint, the very eyes, there are not enough of us being trained to meet the demand that exists, and certainly not that demand that is coming. So it's definitely the market that has shifted, as my partners like to remind me as well, 1015 years ago, how difficult it was to get a job. I would say, you know, if you can find any job, there might be something going on. Because I'd say the number of open positions and people looking far outstrips the number of people coming out of fellowship. But I would say if you can, even


Griffin Jones  10:46

ones that aren't open, Eduardo, people will say, yeah, we'd hire, we would hire somebody we might not like be actively recruiting right now. But almost everyone will say that they would hire someone, virtually all of


Dr. Eduardo Hariton  10:59

them. But I think the the other side of that is we are recruiting pretty early. And it's you could want a job. And if you decide that you want to start looking in your third year, that job for your year might be already filled. And some practices have an easier time than others recruiting. So some practices do feel some of those positions early. And there's only it's not that you don't have a need or that patients are incoming is that it takes a lot to open and find either the physical space or the support team. Because they're, you know, if you hire an REI, you don't just hire an REI, you need to hire two to three nurses, you need to hire case managers, you need to hire embryologist to support the volume that's going to come with them. So it's not just oh, I'll hire in Rei and everything else just happens on the line. It is a big process and clinics that do it, well do it really thoughtfully. So you could find yourself in a position where like, this is my dream job. But someone from that fellowship just took it. So I can either wait a year or go to their competitor. And that I think can happen if you don't time it correctly.


Griffin Jones  12:01

So let's talk a little bit about that. If there are universal must haves to for getting the job you want the audience might remember I had Dr. Dwayne o Welch on she's from outside of our field. She's a PhD psychologist and studies mating and dating behavior. I had her on the show, because I just wanted to show people part of the reason why their patients are delaying, why they're delaying family building. There's multiple reasons. But I think mate selection is a big one of them. So that's why I had Dr. Welch on. And it's my show. So I get to say, who comes on, she talks about having must haves for selecting a partner, and it's up to you, the whoever the selector is, to decide what their must have, I have to have someone who's politically liberal, I have to have someone who is religious, I have to have someone that loves the outdoors or loves animals, but she talks about there's two or three must haves that are absolutely universal kindness and respect. That they're not any of the three A's an alcoholic, an abuser or an adulterer, those those must haves are built in. So I suspect that many of the must haves will be people's preferences. And I want to talk about what they can be. What are the universal must haves, in your view, if there are some?


Dr. Eduardo Hariton  13:23

I mean, I would say, because the fellow that's coming out has usually trained for seven years in an academic center, that's usually all they know. So their view of what it is to be an area is very much clouded by the experiences that they've having training, which are for the most part academic, I think, if I think there is one must have, and this is not the most important, but you need to get paid, right? Most of us come out with that burden. In the six figures from training, most of us, by the mid 30s, are thinking about a family or already have one. And we have been pressed a paid what I think it's a suppressed salary for seven years of training based on the number of hours that we work and our expertise. So we're ready to make some money. Money is not the main driver. For most people. This is not the most you know, it's your it's a very lucrative career, you're going to do quite well. But there's a big opportunity costs, you're ready to make some money to pay some of your loan backs to buy the house that you've been waiting to buy. So money matters. It's not the main driver, but they need to pay you more than they paid you in residency and that's universally true. What else you care about. I do think it's very dependent. And we can talk about a path to partnership. We can talk about clinical autonomy, we can talk about protected time for whatever else you want to do, whether it is research, surgery, family, administrative, whatever it is, if it matters to you, that's something that that might be a deal breaker for you. And then there's all this other kind of you No smaller things that are more or less intangible. Can I teach residents? You know, who does my marketing? What does the IVF lab look like? Can I go into the IVF? Lab? You know, how am I paid? Is it what your kid model? I said a salaried model? Do I have an incentive to work? How much vacation do I have? How much leaves? Do I have? What complete looks like? Can I keep my own IP? Is it all owned by the company. So there's a million things that might matter a little, ultimately, for each person that's different. And what I hope to get Fellows is the ability to at least know the questions to ask so that they can form their idea. There's no perfect job for everyone, you just gotta find the perfect or the most close enough to perfect job for you as an individual. And I think the interview process is not something where I'm like, I know where I want to be. Let me just see who can get me there. It's a self discovery process in a way, because as you go, and you meet these practice owners and these physicians and see what their career like, you're like, Wow, I never imagined going to a place where you could have eight weeks of vacation that wasn't even in my idea. But now that I think about it, and how I grew up with my summers in my house with my grandparents, that might be nice. So your priorities might change as you explore the breadth of opportunities that exist outside of your traditional academic medicine path.


Griffin Jones  16:21

But I'm a millennial, Eduardo, I want all of it. I want all of these things. So I let's I do want to go down that potential different paths. Maybe we talk about how to rank order them. And maybe we talk about, well, maybe we talk about how much of them it is possible to have because this is not unique to our eyes is not unique to physicians happening everywhere in the marketplace where it used to be, well, maybe I'm willing to trade off some work life balance for a higher salary, maybe I'm willing to trade off some of each of those. If I work for something that's mission driven, I really identify with and a luxury, one sampled becomes a necessity. And that's what we're seeing when there is a undersupplied high demand dynamic in the market, which there is in the job market, which there is in the REI market. And people are like, Well, I just want I want I want the mission driven, I want the benefits, I want the salary I want the 40 hour, week or less I want the professional development. Everything that was once a trade off becomes table stakes is that not senior doctors very often feel this way about this is what's happening from younger ducks. Do you share that perspective?


Dr. Eduardo Hariton  17:51

I mean, I think yes, and no, I'd say you can't get everything you want. That you know that if and if you find that job, then good for you. Like that's great. Like, if someone's willing to give you everything you want in the location that you want for the salary that you want, then you did really well it means that you have come into a market that is favorable to you. This is a capitalist economy, someone thought that you were worth all of the things that you wanted. You know, my advice for Fellows is like, Yes, this is a fellow's market, but you gotta come in humble, like you can come into these conversations being like, you know, I work on gold, because I just did training for seven years, and everybody's looking for fellows and coming cocky, because it's not that they can give it to you or that you're not worth it is that they're not gonna want to work with you, right? Like, you're recruiting the person that's going to take care of your patients. And at the end of the day, we're all here to take care of patients. So if you don't like the interactions that you have with someone during the interview process from the practice owner side, it's not that they're not the right person for the job clinically, or they don't have the right expertise is a you don't want that partner, you don't want that person taking care of your patients. So it's really important to Yes, advocate for what you want, but come humbled to the conversation. We don't learn everything we need to learn. I mean, I've been at my job for a month and a half. And I'm learning a ton every day from my partners, and I went to a great fellowship program where I had great faculty. So this career is a lifelong process. We need to continue to learn throughout. So come to that conversation humble as to like whether you can get everything to one. The answer's no. Like there's an idea that the practice will have of what they want to offer to you. And you come with an idea of what you want. You know, ideally, you're coming from a place where you're close together, because this is the right job for you. But you might say no, it's really important for me that I'm able to take six weeks off a year, even though your standards for because my family is abroad in Asia in India and I want to take some time to go see them. And the practice has to decide, is that something that we can do in our model, can we make this work for this person we'd really like them otherwise So I'd say, some practices, you're so far apart that, you know, even though they want you and you want them, you just can make that work, someone has to compromise. When you're close together, it's a matter of saying what really matters to me, you're not gonna get everything you want, that is very rare. But you got to figure out what's really important to you and ask for a couple of things. And I think that that can be done in a tasteful matter where you come from a place of compromise and trying to make this work. Or it can be done in a place where you feel like you're negotiating with someone that you don't ever have to see again, and that's the opposite, you're gonna see them every day. So you have to be really thoughtful about how you approach those conversations,


Griffin Jones  20:42

I want to jump back to that process of prioritization, I want to stay for a second on the employer side with a notion that you mentioned of the interview is essentially a sample of the working relationship. If you're not getting along and the interview process, if you can't see eye to eye, then that's going to be indicative of how it would be like to work for work with each other. That is fairly conventional wisdom across hiring. And many of us. Probably the vast majority of us at one point or another in the last two years or so have ignored that conventional wisdom have ignored that. Gut feeling intuition, because of the necessity if you have embryologists that are about to all quit, because the because they're so slammed, and there's one or two in there that that's not a good cultural fit. I don't like having them in the office, it's really hard to fire that person or part ways with them, because it will hurt the others, and it will be really hard to replace them. So many have ignored that wisdom. And and so what is your view on that? To the extent you can speak to it?


Dr. Eduardo Hariton  22:11

In terms of like, what happens when you have a bad apple in? Yeah, yeah. So


Griffin Jones  22:16

you said, Okay, you'd said to the employers, like, if it's not a good fit, just, you know, it's not a good fit. But if almost all of the cohort is coming in, and they're all wanting things that aren't a good fit, and the leverage is so tilted in their favor, and you've got a 10 week waitlist, and or you've got five years to sell your practice or three last, let's say you have two or three years to sell your practice. And you know, you're not going to get that much for it unless you have somebody underneath you or somebody else working alongside you. What about that concept when it's tilted so far against your favor, that it's hard to do the right thing?


Dr. Eduardo Hariton  23:01

Well, I mean, I'd say that's a complex question. You know, if you have someone in your group, that is a bad apple, but you need them for a certain expertise in a market that's really tight. That is a very tough situation. And you have to weigh, you know, is this person bringing down my employee morale, that my overall productivity of the company is suffering, and we that we would be slammed, but I'd rather take his salary and give it to other people and pay overtime. And that's going to make people happier, because they're getting more take home pay, even though they're working lower hours, maybe, maybe it's worth having this bad apple because the system breaks without them. I can't get rid of them, I'll do my best to replace them. So that's a very complex decision. I don't envy the lab directors that are trying to hire embryologist. They are in a similar bind, that sometimes the practice owners are in recruiting areas, because we are growing too fast. And you've had a lot of smart people thinking through solutions on how do we address that gap? How do we increase access? Not our topic today, but I'm sure you and I will talk about it at ASRM over lunch. That being said, on the hiring side, it is challenging to hire someone and you have these things were like yeah, they're not the right fit. But it's the only person that wants to come to my small market in the last two years. And I'm looking at an exit. So from on one hand, yes, that, you know, practice director might say I don't care about the working relationship, or their personality quirks. I need a person and I need them now. But when you think about it from the shallow side and your like, this person really needs you. They don't want to hire you but they will for their own interests. You think our from the fellow side that's not fair to the fellow either, right? You're going to a market so that someone can sell their practice. I bet you they didn't hire you and tell you how I'm gonna exit in two years. You're gonna be you know, your job is gonna completely change. I bet you they said, Hey, this is a partnership track and we are going to give you a great salary and support you and I'll mentor you and you know, I'm there He's still here for like 510 years, which is probably true, at least for five. So, you know, that dynamic plays both ways. And and I think that, yes, the standards might be lower for some people, because they don't have a lot of options. At the same time. You know, it is important for all of those to come to the table and be forthcoming. And, you know, you might not walk away from the person like you did before as a practice owner, but you should really think about and if you need them, you need them. I don't think we're going to solve that one today.


Griffin Jones  25:34

Well, let's talk about some more of that when we talk about how young dogs can get screwed. But let's revisit the prioritization self discovery process, you mentioned that the interview process is a self discovery process, that very often you're finding out what's most important to you by being exposed to others that know how much self discovery should be done early on, I believe that's just, that's inherently true as sales process I learn more every time I have a sales conversation, I learn more every time I interview or hire someone, the more that I have up front, the more sophisticated I can be with that discovery process, the more and the better experience it is for the other person to because it's a better way of assessing fit. And you yourself, when we were friends, when you were going through all this stuff, and you knew what was important to you at a general level. Like I think you learn more along the way of what was possible. But you thought about what you wanted. And then it became more refined as you went through the process. So what what should it be to start with? Is it as simple as writing down the must haves and putting one at the top and trying to clarify them as much as possible?


Dr. Eduardo Hariton  26:57

Yeah, I mean, I think I would say I kind of knew what I want. And I still discovered a lot, but I had a sense of things that mattered to me. And I think that that's important. You know, when I think about them, like you kind of know if you have a location preference or not. And that may make your sense search really broad and not separated at all, you kind of understand the the practice type you want to be and the usual split is academic versus not, although now we have a lot of private EMIC practices, which have academic affiliations, but are still working in the traditional private practice model? And then from there, the list goes on, do you want to be fully clinical? Do you not want to be fully clinical? And you make this list of things? So I kind of wrote those out. And they said, You know, I want how do I want to spend my time? How do I? How do they want my week to go? And, and you craft that vision? And then you look at the options. Like let's say you were someone like me who wanted to be in the San Francisco Bay area, I sketched out all the practices that were out there. I talked to mentors who knew them to get a sense. And then I talked to the people at the practices and said, What's your day? Like, you know, how, you know, how many patients do you see how does it work, etc. And you can go down the line. So yes, you have to have a sense of what you want, because that's going to help guide your conversations. And that might save you some time. Like this is a hard, long process, you get to meet people who are also busy, you take time out of your day. So if there's 10 practices in your market, you automatically can probably discard half of them by just knowing that the model might not be somewhere where you want to work. And they can tell you, you know, intangibly like there are practices that are very set in their ways, because they're part of large systems. You know, someone like me, I like to go and I'd like to see a problem and try to fix it and like talk to my nurse and talk to my practice manager and be like, how about we try this? I think this might be better. How do we flip these things around? I knew that at some of those places, there is no way that that could happen. That's a great, we put it on the agenda for q2 2023. And we'll talk about it then. And that would slowly kill me inside. So I knew that yes, that play, plays well, and does good IVF and has great colleagues. But that was not a right fit for me, in terms of the place that I needed to work. So you, you figure out these things as you go. There's all of the things that through the process of talking to people, I was like, wow, this is really valuable. I didn't even think of that didn't even make my list. But let me go back and ask these other four practices, how they do this thing? Because that's something that's informative, and that's part of the self discovery process. Should you know what you want? Yes, absolutely. So that you know what questions to ask. But I guarantee you that even if you're the most prepared person, you will figure out a couple other things that you care about through the through the process.


Griffin Jones  29:58

That's absolutely right. And especially Sometimes you see the limit to your own imagination. Once you see something else that's possible, we could exactly further develop that thread and talk about potential career paths. I do want to touch on it, but I kinda want to bring them in tangentially, because we have talked them about them in the show, I want to talk, I want to introduce them as they become relevant in the conversation, I want to tilt a little bit more to the direction we touched on 10 minutes ago of how young doctors can sometimes get screwed, because that's what that's what a lot of people are tuning in for. And we talked a little bit about how employers can get screwed. And I do want to talk about that too. But what are the pitfalls that you're seeing that are common when when fellow fellows or other associate Doc's, or even folks in their halfway through their career are running into when they're signing with groups?


Dr. Eduardo Hariton  30:53

Well, I'm no longer a fellow fellow, and Associates now. But I do feel like I'm still in practice, because I spend a ton of time talking to fellows going through this process. And it's one of the parts Yeah,


Griffin Jones  31:04

you're not always fellow you're, yeah, you're the the non creepy Matthew makhana, hey, Rei fellowship, you're always going to be around the high school in a good way.


Dr. Eduardo Hariton  31:17

That's why shave everyday still look young and not out of place. But that's an important question. And I spend a lot of time talking to fellows for that exact reason, because I hate seeing the other side, when they're like, Man, I got to this place. And like, that is not what I felt my contract said, and I didn't realize I was going to be in a satellite in like, you know, the third ring of this major city. So it is really important to do a couple of things. And this is not an exhaustive list. But I think you really need to get to know everybody in your practice. So I joined that seven physician practice. And I am incredibly lucky, because it's exactly what I expected coming in, but I spoke for at least an hour to every single person there. I wanted to know where they're from, how they came, how they were treated throughout a, you know, I spoke to a person who left the practice to understand why did they left? How was that relationship? You know, was there a sour taste, I wanted to know what happened. And you know, it was a positive experience, which made me really reassured, but you want to really spend the time getting to know the people that you work with. And listen, you know, some practices are so large in a given market, that you might not get to talk to everybody, they might not want to talk to you. But if you can only talk to one or two people, and they really keep the other ones at arm's length, that's probably not a good thing. So spend the time especially as you narrow down into your top choice top couple, spend the time getting to know those people, I talked to the nurses because I wanted to see how they felt. I talked to the lab director because I wanted to see what the lab culture was like, You know what that, you know, what's the lab hiring practices going to change my decision? No, but this is someone that's gonna be your go to person to call. So you kind of want to know what that buyer is, like, I like think that that's important. There's this


Griffin Jones  33:08

piece of advice to get to know everyone in the practice come from people running into Well, I I love Dr. Hariton. When and I really got to know Dr. Erickson, but then I found out Dr. Jones is total aihole. Or that the nursing manager has Dr. Hair done in a vise and, and nothing gets done? Because she's the bottom eight are you hearing about these things happen, and that's part of the dissatisfaction?


Dr. Eduardo Hariton  33:39

Well, it's more of like, hey, like the person that they put in front of you, it's either happy or really incentivized to, or you, but you have might have a group of people that's not happy, that feels like their contract, and, you know, they're not gonna come out and like, you know, spill their beans to you. But you can get a sense from a conversation, is this person super satisfied? Are they you know,


Griffin Jones  34:00

exciting times, they will. Sometimes they will sometimes saying like,


Dr. Eduardo Hariton  34:05

but that's what you want. That's exactly what you want. You want the canary to sing before you get into the coal mine. Like, you really want to know what's happening. And then there's imbalance, there's like, everybody's so good. We love working with our doctors, like, you know, they really take the time to teach us they give us independence, or like, yeah, you know, you know, the doctors are nice, we have a couple of things to fix. We're always working on it, you know, we're excited to have some fresh blood, like, you know, it's a different conversation. It doesn't mean you can't go there, but go there with your eyes open. So that's one thing. I think the other thing is compensation, right? We all want to be paid fairly. And it's not all about the money, but that money, the money is a reflection of what you're worth to them and the value that you're bringing to the table. And let's be real, like this market is growing and we need more physicians. So you are very valuable. You might lose money for the practice as first as you ramp up, but over the you know, Multi decade career, you're going to bring a lot of value to this practice. So you need to be paid fairly. And there's multiple compensation models, when there is salary, salary plus bonus, eat what you kill. And more importantly, that changes over time and usually changes to become a partner. I think a big pitfall I see is people going from a high upfront salary, without realizing there's a reason why they're paying you so much. It doesn't mean that, you know, a high salary is a bad thing. But if someone's offering you something that's like 50, or 100%, higher than everybody else you've talked to, there's probably a catch, right people and don't just dole out money for no reason. So understand how you're being paid, understand what your metrics are, understand what you control on your metrics, right? Because if they say, this is what you have to do to get your bonus, but you have no control over that, then you don't control your ability to get your bonus. And that is challenging, and a bad incentive design. And I think more importantly, understand what your career trajectory at that practice looks like, you know, everybody says, you have a partnership track, you know, except if you're in academia, for the most part, most people say, you know, after X time your partner, well, what does it take to get there? Like, I like, I asked practices, like, you know, what are the metrics, and some of them put in in contracts and say, once you hit this revenue, by this time, you know, that you're considered a third partner, so you know, what your goal posts are. And some say, once you get to three years, we consider you for partner, but you don't know what you're shooting for. You don't know if you're doing well. So I think really defining that is important. And even more important that that is, what does being a partner mean, you know, everybody calls it partnership, but are you actually buying into the medical practice? Are you putting money down? You know, are they lending you the money? Are you taking a bank loan or taking it out. But also, some people call it profit sharing a partnership, there is no equity exchange, there's a profit pool that you get to participate in, that is not a partnership, that is profit sharing. And you know, sometimes there's now a lot of like the back companies, a lot of which you've talked to, that have equity in the MSO, or the top organization? How are those shares are located? Are they class A? Are they Class B? What does that mean? Are you actually gonna get it? Are there options that are worth nothing unless a company doubles, or triples in value, and they go in the money? All of these things? You know, I don't feel like even after doing this for years, and trying to understand that I have every little part figured out. And they spend a lot of time on this. So how can you expect someone who has been in a traditional academic career for seven years to get handed a multi page contract and understand that you can't, but as a fellow, you have to spend the time and you have to spend the money understanding with a lawyer what these contracts mean, and you might have nothing to do to change it. And it might be a great structure. I'm not saying one way is better than the other, although I did vote with my feet. But I think it's if you don't understand what you're signing, then that's a real setup to being screwed. And then the last thing is, understand your clinical practice, understand? Are you going to work in the satellite? Or are you going to work with people in the main campus? What does your schedule look like? Do you have control? If your kid needs to be picked up for school at 3pm? On Wednesdays, can you actually make that decision to make that, because you don't want to figure out what the bounds of your schedule are? When you show up the first day, that's a setup for failure, you want to ask and say, Listen, I don't need this every day. None of these things are non negotiable for me. But I want to understand, can I start at seven, so I can be done at three, or mindset for a number of hours like getting you actually Lilly put me in a satellite that wasn't even built when I started two years ago, because you might not want to drive an hour here, there. We put that in writing. So if you don't want to drive an hour, just say I want to be working at the main campus. And you know, there could be a ton more. That's why I spend time talking to fellows. But there are a lot of ways and the best thing you can do is equip yourself with the right questions. So as I have a list that I circulated that I made for myself, and then I send it out to the fellow so happy to share it around. I'm sure it's floating somewhere. But you really got to ask the questions and spend the time.


Griffin Jones  39:30

One thing that you can think about when you're looking at which practice to go to to judge how forward thinking they are, how state of the art they are, how embracing they are of the new technology to improve patient relations to improve workflow for staff is are they using engaged me I wish I could remember who first said that to me was the younger doc when they were talking about what type of practice they were looking for and what other people should look for. Everybody can say that They're forward thinking. But what's the evidence and one great piece of evidence is using engaged MB when half the practices in the United States and Canada are using engaged MD. It's something that dramatically improves workflow for staff, especially nurses, but also providers and other staff, it helps improve the quality of informed consent, it improves patient relations, because it puts the experience on their time in a cadence that allows them to be informed and then use their time with providers and staff and nurses to be personalized, personalized, individualized care for them engaged md.com/griffin We'll get you a free workflow assessment. Should you be using engaged MD as a means of flexing to attract Doc's it'll help, but it's really going to help your patients and your staff go to engage them d.com/griffin. Now back to enjoying this episode with Dr. Eduardo Hariton, we've got a ton of meat here. So I want to go through it surgically. And I want to start with something that you said about salary, how often people get big eyes when they see a salary number, and maybe they're leaving something on the table of for equity, for example. I want to talk about what the things that you think that they're leaving on the table for salary? Is it just equity that they're leaving on the table? When they when they see big salary numbers? What else do you think they're overlooking,


Dr. Eduardo Hariton  41:40

they're probably overlooking controls. Because like with equity comes saying the decision making and some degree of control. So it doesn't mean that you can be a practice, like, if you're in a market that is hard to recruit, you might need to put out a pretty big salary. And you might still have a true partnership track. So I'm not saying that if you have a high number, the rest of the salary, the rest of the experience, or the practice is gonna be negative. Sometimes it's not. But you gotta really, you know, open that second eye and really look deep. And understand if that's the case, you could if you have a high salary, what does that mean? Do you mean, you have a high base and not a ton of productivity incentives? Is that a long term sustainable model for the practice? are, you know, are your partners working really hard anyways? And are they paid in the same way? Or do you have a high salary, but it's, you know, a very low base, and the rest is incentives, right. So if it's production incentives, you're getting paid up to this high salary based on the number of retrievals, you do. And then you look at your contract, and you look at the volume that they're doing. And you say, Wait, in order to get to the highest salary, I have to do the same number of retrievals, as the top producing doctor in this practice, who has been here for 17 years, that's gonna be hard to do in your first couple years, right? So don't you know, the numbers are six figures and look impressive, when you've been making, you know, a fifth of that, but you really got to understand like, how is that money going to flow through you? And do you really have the ability to get there? And I will tell you sometimes, yes. And a lot of times no, like, these contracts are written in a way that they look exciting. But when, when push comes to shove, you know, you can, you know, their most productive fellow out of practice will never meet the numbers that they need to get to there. So it's important to understand that, well,


Griffin Jones  43:33

let's talk about equity and control, starting with equity and understanding a little bit of different kinds of equity. So you have a lot of people reaching out to you. So President, I have a lot of young doctors, bye, bye. Eight or 12 times a year, I have young doctors reaching out asking me about what they should do. And I do the advisory for free, because unless they're unless they're thinking of starting a practice and like they have plans to start a practice, I'll charge them a little bit for a consulting engagement. But the reason why I do it for free is because they have just enough knowledge for it to be valuable for both of us to have the conversation, but not enough to be able to tell them what to do they, they like me because I get to talk to so many people and I don't have a dog and fight. I don't work for practice or anything. But there's still a lot that I don't know. So in many cases, I can just tell them, what I see. And something that I'm seeing recently that I don't know how to say I can't categorically say which is better. Maybe one isn't universally better than the other but there's parent there's equity in the practice itself, the established business in most cases, or there's equity in the parent company. Sometimes there's both I can see pros and cons to each of those. The the if it's equity in the locally owned practice, then there's that's the established business. That's the one that's already made money that's probably going to continue to be there. Whether they're under different ownership in the future or not, I can see pros to the parent company and that they're growing. That's the one that the PE firm hopes to flip for a lot more. And you can increase that multiple by acquiring more practices and making the network bigger. But you could also go bottom up like Integra med. And so what do you see as the pros? And is do you think one is generally better? Or worse for equity in practice versus equity and parent company?


Dr. Eduardo Hariton  45:34

I would say that, you know, after spending some time they said, say, you can't answer that question with looking at the specific company. Because the way that the structures work has gotten incredibly complex in terms of how they're issued, how the transaction happens. So saying, broadly, you can say yes, you are incentivized with the investor. In the same way, if you have equity at the parent company, and you can say, you have a little bit more control over how much your individual practice produces, because you're working there. But you might not benefit of what the other markets are doing, if they're doing really well. One might be more risky, one might be less. But the reality is, you can answer that question unless you're comparing, like one deal at one structure at one company versus the other. Because the way that they're issued to you whether you have to buy them, whether they're options, whether they have, you know, some sort of strike price, the tax implications, sometimes you get granted equity, and you have to pay the tax bill when you're granted the equity, but you have no cash to pay the tax bill with. So all of these things are difficult to you know, talk about in you know, kind of broad terms, because they are so different. And you have to really understand the the nitpicky parts of each, I would say, I find, at least for me, it was important to be able to share in the value of what I helped build. And I work very hard. And I love what I do every day, I love what I do. So I want to make sure that I say work hard and keep growing and hopefully add value clinically to my practice and add value to my network in terms of my other roles, I am able to share in in that and that profit. So you you I don't want to give advice of what model is better, because it truly depends on the individual situation with the employer that you're looking at. But I do think it's important for you to understand how and when that value might come. And also know what kind of incentives does the value that you're getting, provide not only for you as an individual, but for everybody else around you. Because if you are incentivized only for an Exit Multiple, that's going to drive a much different behavior in your partners and the people around you than if you're incentivized on a clinical production site or whatever else it might be. And, and you have to be really thoughtful about what what culture that builds.


Griffin Jones  48:17

So did you focus more on the parent company or the practice as you are having the attitude of I want to be I want to have a piece of what I'm helping to build,


Dr. Eduardo Hariton  48:27

I wanted to focus on a model that would allow me to have a partnership that over time became equal to the people I worked with. And I didn't really care if it was one or the other. Ideally, it's both right. So you have partnership in your local level, and then you have partnership in the parent company. Because it's truly well aligned. I think the other part that was important to me was that he was completely transparent. What that was like that it was, you know, I know exactly where I need to be in three years, how much I need to produce, I know. And I know what that means for me. So over time, every three months, I plan to truly track Am I on track to get there? You know, what am I doing better? Let me sit in the console with a cup of my amazing partners and see, what is it that they do differently than me because they're converting better, or they're patients like, stick with them. And I think that's the whole culture of learning. That's also why I joined a network because I also don't think my practice I love it. We are not the best at everything. But someone down the street on the other side, like we are part of us fertility, someone on the other side of the country might be doing something better than us. Let's fly there. Let's check out that lab. Let's check out that marketing department. Let's share best practices. And I think that that was part of the value of of having a bit network is that we can learn from each other. I think another thing that I didn't mention that I find important is not all practices are the same and not all practices are going to be our around in the way that they are in the future. So you have to really, and this is a hard thing to do evaluate whether you think your practice is going to do well in the market, right? Whether it's part of like a large multinational network, US based network, you know, geographic behemoth, as solo practitioner and academic center, like you are coming in to spend a lot of time and effort to come into a market and in a lot of markets, you're tight because you have a noncompete. Is your practice gonna succeed in that market? Are they well points for long term success? And what does that mean that from you join in the rocket ship at this point where they're already here? Those are hard questions to ask. But important because you don't want to join a failing practice as their lifeboat, you do not want to be the lifeboat of the sinking Titanic, like you want to jump on to a rocket ship, or at least something that has a good trajectory. And you have to figure out what that is.


Griffin Jones  50:57

There were a lot of people on lifeboats in the Integra med situation that they wish that there were a lot of people that went other places after that, that happened. Not at every practice, of course, it's different, but that the lifeboats happened a lot. And I do want to talk about the type of control that's necessary to achieve the outcomes that are specified should be specified for sponsorship, I want to say a, for a second on the equity of, of parent companies and versus salary versus practice, because I looked at an agreement recently, that the salary was high man, and the and the the signing bonus was high and it could have been taken in could have been taken as equity could have been taken as, as cash, it was gonna be more if it was equity, and less if it was cash. And so that was a that was a scenario of both both like the the equity signing was high and the salary was high. It's, I've found that the networks that are overpaying the most both for practices in terms of multiple, and for Docs, are the new ones on the block, that they just got that, that huge money from the PE firm, they just found a practice to buy, and they're putting the networks together. And of course, there's been several of those in the last year and a half. So when I'm looking at this agreement, and I'm trying to advise these, I can only tell I can't tell them what to do, I can only tell them, what I'm seeing is that, yes, it would ultimately be more valuable to take the equity. But what do we know about these guys? Like they just came in from Wall Street got a couple docs together? And, you know, it's like to even know the chief medical officer is yeah, do they even have their flagship center purchased yet? And they're like everybody else are gonna be putting all of this stuff together as they're flying the airplane. And so it was hard for me to say what was more valuable, the cash or the equity? Because what if there is a 40% drop in the market? What if the Fed does have to raise interest rates to 10%? There's no more free money. And some of these people have to cash out for their limited partners, and it just goes belly up, like, what do you see?


Dr. Eduardo Hariton  53:38

I think it depends on the network. Right? It's a hard question. I don't know. I'm talking about one of


Griffin Jones  53:42

them. Like, it's not a specific one. But it's a but it's somebody that's come around in the last year and a half, let's say, and we're not singling anybody out. Because there's multiple yeah, there's enough. Yeah. And there's gonna be yeah, by the end of this episode, there's gonna be five more so. So like, it's one of the new ones. They're just get people to gather, whether they've come out in the last two years, or in the coming two years. So it doesn't even have to be somebody now, but they they're clearly building the airplane as they're flying it is, is is the equity still worth more than the cash with all those unknowns?


Dr. Eduardo Hariton  54:22

You will know the equity is gonna be discounted discussion, head is always king. But if you want some upside and meaningful upside into the future, you should take that equity. So this is how I don't know the answer to that. But this is how I would evaluate a decision. I went to lunch for two and a half hours with the managing director of the PE firm before I joined because I wanted to understand their goals. I want to understand who they were, where they were coming from, what was their vision, how do they see physician autonomy? Like how how do they partner like people, you know, just


Griffin Jones  54:50

want to be clear for the listening audience. While you're not talking about Mark Segal, the CEO of us fertility just stepped down. You're talking about the managing director of have you on Capitol?


Dr. Eduardo Hariton  55:01

Yes, J rose went to LA. I mean, I was lucky, we live in the Bay Area 30 miles from each other. It was important for me. And I'm not saying everybody has to do this. But this is a way to approach it. We went to lunch. And he asked me questions about myself and my vision about the future. And it seemed questions about himself and his vision about the future. And you want to make sure that you're joining a network that sees the future fertility in the way that you do. And the network that where they are willing to make investments behind things that might pay off during their holding period. And some that might not, but are important to the success of the business or at least are important to you. You want to understand how they see physician autonomy, what are the things that they think we should centralize? What are the things that should say at the practice level? It's kind of the US, you know, there's states and there's the federal government, and there's decision making that needs to be outlined. And you know, in our network, physicians have a lot of autonomy, because they are still owners, and they are still on the board. So these are the kinds of things that you can do. I think the other way to do it is that that private equity networks, those networks that are growing fresh with cash just off the boat, they have managed to convince physicians that they have the right vision. So you're joining a medical group of ARIA eyes that was already convinced for the vision. So you can ask your partners and say, What was it about private equity X or Y or Z? I mean, I'm sure you had five offers, why did you pick this one? What is their vision? What do you hope will change over the next five years, private equity gets a bad rap, some of it deserves some of it not. But all not not all of them are alike. And they're actually very different in their strategy and approach to entering our field. Some of it is a traditional rollout calling cards growing, you know, margins, EBITDA, and selling, some of them are thinking of doing different things. And the value that they hope to bring to the table is different. And I tell this to fellows, and it's something that I think about myself, the lifespan of investment for these companies is three to seven years plus minus a few, right? So we recruit two years ahead of time, sometimes longer, there is a good chance that the person who is partnering with your network, by the time that you're illegible for partnership will be different, there's nothing we can do about that there's no fellow that can negotiate that, oh, I want to say in this exit, that just doesn't exist, right? It's an investment, it might happen. So you really gotta trust the vision of the network. And you have to trust the vision of your partners, because they make that bed with a lot more at stake than we do when you're joining a job. You know, this is their baby, their practice. And they chose to partner with this group. And they bought into the vision knowing that that vision is going to change, you can choose your second wife before you choose your first one. But you really got to be comfortable with the attributes that you care about. Hopefully, you'll make the decision. And you're going to have less control about the second one that the first, but you really gotta believe that both the private equity company and the network of physicians are aligned in what that looks like. And unfortunately, in some cases, they need Him because that's the way it works. And in some cases, they don't need to be aligned at all. So it's a leap of faith. And that's why I think it's the most important thing to me, is, am I working with partners that I trust and respect because at the end of the day, 90 plus percent of your interaction will be with the people around you at your clinic, not with everything else, and you just need to be comfortable with that.


Griffin Jones  58:42

Fair enough that they won't have a say in the exit. But should younger Doc's be looking to have a no assignment clause in their contracts. And if they do go for that, is that something that the that the other party, the network, or the practice would, would would stomach in a negotiation? So a lot of people don't even know what an assignment clause is, meaning if there's no assignment, if I can't sell the contract, or the contract doesn't transfer if I sell the business, but in an assignment clause, one party can have assignment and the other cannot, they can both have assignment. You wouldn't really be able to sign your contracts some other doctor because that wouldn't work with it. But can you ever notice Yeah, no, I work as a doc that says if you sell my contract does not go to the I don't know if that's something that I


Dr. Eduardo Hariton  59:39

think that's really challenging though, because, you know, you have to understand like yes, you have leverage and you're coming out and you're in demand, but the practice invest a lot in getting you to play right, right. They they build a team for you. They lose money for on you for about a year it takes a while to get ramped up, your new patient visits will trickle through. They get to me so it's up They get investment for the practice. And so I don't think it's fair to say to a practice, like, yes, our investor change, you know, all of our partners are still here, everything is still the same. We haven't changed anything of the goalposts that we gave you. But now you can walk away with, you know, and void your noncompete and go to our competitor, when we build you up for two years, because they now have a ton of cash and when, you know, incentivize you, I think that's unfair to the practices in some regard. So if you can negotiate it more power to you, but I think realistically, you know, no, that diminishes the value of the whole network. Because if you have, you know, 20% of your physicians or 30% of our associates, and the moment you sell all 30%, can walk out the door with no ramifications, the person buying is not going to want to pay for that. And that's going to take a hit. So, you know, I don't see that as a super viable model long term. But at an individual level, if you're a felon, you can negotiate that. And that's how you feel protected that your family's in Houston, you're wondering, you're stoned, no matter what you want to stay. So you need that safety. Maybe, maybe that's something you can do. That's why every contract is different. And you need an attorney to walk you through what those means. But I think at a broad level, that's probably not something that's going to work for most.


Griffin Jones  1:01:19

It's also different from a non compete. So okay, so that's generally probably not in the interest of the employer. That's how the employer could get screwed. Let's talk a bit more about the type of control that you need for Revit. Well, actually, let's first specify the market. So you said, you know exactly what you need to do to hit partnership. And this is what over two years or three years? Three years? And you're reviewing it quarterly? What are you reviewing quarterly? Is it IVF? cycles? Is it billing in dollars? Is it number of patients,


Dr. Eduardo Hariton  1:01:55

everything like I you want to practice subtracts those, all of those things, because those are all important. I want to know how many new patients I So how many of them converted? What dollar amount, those lead to how many cycles I'm doing, and knowing that this is where I need to be, like, Am I on track? Like, you know, if I keep going at the same trajectory? Am I gonna hit that? What do I need to do? You know, if my conversion rate is not what I would like it to be, I can work on my conversion rate, or I can add more new patients. So maybe I just need to work a little harder there. There's no right answer there. But you need to know what you need to hit to make it to where you want to be. And, you know, this is a separate question. But I talked to a lot of practices that don't track anything, they don't track productivity, they don't have a dashboard to see what people are doing. Some people don't even track the lab on a weekly basis, they track the lab on a monthly or quarterly basis. That to me seems


Griffin Jones  1:02:51

the bridge makes them. Yeah, there's a lot of people that don't


Dr. Eduardo Hariton  1:02:54

listen, you cannot improve what you don't measure, I'm gonna save it again. Because it's really important, you cannot improve what you don't measure. So it's really important to go to a place that knows how to measure, you will not know if if things go south, and you can pinpoint the problem, because you did not establish the systems that you needed to understand what has changed, it's going to be a fire, like you're really need to measure. And it doesn't mean you know, people are moving that direction. This is all like CEOs breathe. And I think that's part of the value of these networks. professional management does this across healthcare, and they're bringing it to fertility to some degree. Sometimes it doesn't feel good because you you're not doing so well. It's uncomfortable to be measured. And it's especially uncomfortable to sometimes measure against other people, we are uncomfortable with that. But that is the only way we're going to improve. So me as an individual, I want to be measured, I want to know what I'm good at. I want to know what I'm bad at. I want to know who's good at what I'm bad at. And I want to go spend time with that person to get better. And when you leave that ego at the door and say these metrics are not meant to put you down or single you out. They're meant to bring you up to standard and make you better. And by that, you know, racing tides. What's the saying like racing tides, you know, make all boats go out for boats are lifted in a rising tide? Yeah, this is the lighting way of the thing that code, everybody will go out before measuring. So I found that that was another thing I didn't really think about when I was going through but as I saw, I thought everybody measured because where I trained, we had a methodical lead director that was good at measuring. So, you know, is it important? I didn't think so. But now absolutely through the process. I found that out. And it is really important.


Griffin Jones  1:04:48

Are all of those things in your employment agreement as the criteria for partnership track that the if it this much in volume is are those things special? To find in your employment agreement as a clause of for partnership track.


Dr. Eduardo Hariton  1:05:04

Yeah, I mean, they're, they're specified as like, once you get to X percentage of what your partners are doing. So it's not a static goal, because things change, right? Like, it doesn't mean that like, you know, that you have to hit this number, which might be meaningless in three to five years, like you signed this contract two years before starting, it's a three year partnership drag somebody places is three to five, so you don't know what they got, you know, but you know, it should be relative to what your partners are doing, because you're gonna become one of them, right? So I know that I need to hit X amount of what my partner started doing by a given time, and they'll know what they're doing, and they know what I'm doing. And they know what I need to do to get


Griffin Jones  1:05:42

there also alliance partners interests


Dr. Eduardo Hariton  1:05:45

100%. And then the other thing is, there are some times in bad economies where your base salary might be higher than what your partner started taking home. Like, you know, being an associate or being an employee is not all bad, you might not have the upside. But you also don't have the downside, guys, like, you know, if there's a bad economy, if we get a big hit your base salary comes home every day, some people like that, like, you know, partnership is not for everybody, some people want to come in come out, not worry about hiring, the worry about firing, not have the downside of a lab failure, they just check in and check out and that's okay. So there are situations where your nice cushy, associate salary might be good enough. And your partners might be taking from less than a month, you don't want to enter into that partnership at that time, because you're going to pay to take a pay cut. And that's something that you want to understand and your partners are going to want to do. And my partner said, there are situations where that might happen, we would never make your partner to have you take a pay cut. And that is a nice thing to do. So really understanding where to go and where you are is super important. And I cannot stress that enough. And if no one can give you an answer, and it's just we're just talking about it when we're three years, that seems suspect. And that's when I say talk to the people who stay talk to the people who left and get get out of their experiences, you will learn a ton from doing that.


Griffin Jones  1:07:14

There's way too much of that that happens in sales. We call it mutual mystification. It's the reason why I ended up making my sales process so rigorous sometimes over the top, but I made it really rigorous because it just that was how practices wanted to engage. They're like, Oh, yeah, you know, we'll just kind of do this. You're the guy in the red pants in the haircut. And I said, No, we have to have measurements, we have to agree that this is what's going to be required to achieve the measurements. And I want to talk about that with you the outcomes because you talked about the relationship of control to those KPIs that are necessary for partnership, I'm gonna write a book someday wardo called delegate to outcome, because I'm really figuring this out. And by the way, I have not mastered it. The reason why I am going to master it is because I've sucked so bad at it at times in my career, because it's simply not as easy as saying delegate to outcome. There's variables that affect the outcome, there's specificity, and, and, and just there's expectations. So one of these days, I'm really going to be able to I'm like, halfway there. I've I've improved so much in the last three months, because there have been people that I micromanage that never should have been micromanage. And people that I didn't fire that I should have fired in short order. And I'm figuring those things out. But when you have the outcomes they need to be they need to be specific. That's it's on the the person who's who's proposing it to say, okay, these are the outcomes that we need in exchange for this. And then what I do when I'm hiring people, as I spell out, here's what I have for you to achieve the outcomes, here's what I don't have for you to achieve the outcomes. So when we're talking about hitting IVF volumes, when we're talking about hitting certain patient numbers, we're talking about hitting a certain amount of billing and doing a certain percentage that other partners are doing, what are the factors that we have to have in our control in order to be able to achieve them?


Dr. Eduardo Hariton  1:09:21

Well, you want to make sure that you know sometimes you don't have them in your control in a way in what he says like, you want to be able to see if they pay you a new patient visit you know, can you add slots, right? Like, you know, how are they filled? Who's your marketing ended? Are you going to practices are they investing in you filling your slots? What how long is the waitlist, like if the senior partner has a two week waitlist and everybody else can feed a patient the next day or two, it's gonna be hard to get your feet you know, patient slots filled out type of thing, etc. Same thing with IVF cycles like what are the benchmarks that you need to hit to get your at risk compensation or your bonus time? sensation, and then is everybody else hitting them are all the partners hitting them, if the partners are not hitting the numbers that you need to start getting your bonus, you're probably not going to hit them. So that is that is the kind of thing you know, if you cannot near patients basics, and you can get a, you know, a controller the right way. But if you can add and work harder there to get your bonus compensations, which I would say, in most cases, you can, because they want you to work hard, they want to get the bonus, because if you're getting the bonus, it means that they are also getting some upside, right. But if there's no way to get there, and it's just a number on a page to get you to sign the contract. That's not good. So that's what I meant about kind of those control control scenarios. It's like, is it feasible to get to where they say you can get, and it's not always obvious, and you have to push and see whether everybody else got there. I also think another nice thing that I didn't mention before now that I think about it is the value of talking to people that have been through there. And I asked all the practices, like how many people have joined in the last 10 years? Where are they? How many of them are still around? What percentage of people that join as an associate become partner? You know, the best way to predict history is to learn history, right? You know, you want to see what happens to people, yes, talk to them. But if 95% of people become part there, you should feel pretty good. That's not a group of partners that are in the business of screwing people over. If 25% of people become partners, this is like an investment banking firm like it's a steep pyramid, only few are going to make it so if you're looking for your forever job, you got a one in four chance of making it to partner who knows after that, so that history is also important. There are related to control, but I wanted to drop that in.


Griffin Jones  1:11:57

Yeah, but those are really actionable things that people should be looking because I always tell people to look for the KPIs you did a good job of, of hitting on some of those things are necessary in order to be able to achieve the KPIs. What about outside of measurable KPIs like, especially with independent practices, they have to split business responsibilities among the partners. So sometimes this partner is responsible for marketing, this partner is responsible for HR, this partner is responsible for keeping the p&l this this partner is responsible for if they've they do building, if they acquire by billing. Are there other other other responsibilities that are necessary for partnerships in your agreement that aren't KPIs like that?


Dr. Eduardo Hariton  1:12:48

I mean, the other responsibilities like be part of a team. I mean, the reality is, is you will never find an agreement that forces the practice to make your partner at a given point. So, you know, I could you know, Bill more than all my partners, if I'm not a team player, if the nurses hate me, if they don't want to work with me, they have no obligation to make me a partner. And I would never expect that, like, you know, you don't marry without dating, you want to get to know someone, and some people are not the right fit. They might be nice doctors, they might be crushing productivity. But there is something about bringing you into a partnership that you need to share that ether. So yes, no one, you cannot force someone at the time of signing the contract to say if you do this, you will come a partner. Because there's a lot in between culture wise and you need to fit in there. Can that screw you? Yes, practice might say, I did everything I could I thought I was part of the thing. You always give me good feedback, year five came you're gonna sell tomorrow, you didn't make me a partner when I thought you would. Yes, and this is why the track record is really important. This is why you really want to know who you're getting in bed with an A, becoming a an associate for because they will take care of you most likely, like they took care of everybody else, you know, you feel special, you are just as special as every other area that have joined them. So really pay attention to that. But for the most part, they they can decide at the time when you get there, whether it's the right fit or not, hopefully, in the three to five years where you're an associate that will become clear so that someone doesn't string you along. If it's not the right fit. I think that's usually the case either you don't want to be there or they don't want you to be there and you part ways, but it is always up to the partners whether to make your partner or not. And I think that is the the right way because they they're bringing you into their family for long term. And they want to make sure that you're the right person for that.


Griffin Jones  1:14:46

See this. This is the light bulb going off over my head because you said that it's a place where fellows could get screwed because you can't you can't have something that's that wouldn't be in the interest of the practice to do They, that you, you are going to be a partner just because of these things. But I can think of a middle ground. And that would be a non compete, that if I hit these numbers, I'm out of my non compete the entire argument against a non compete is we invest all this money, but it's like, okay, even if we're not a good fit for partner after the fact, if I hit these numbers, my non compete doesn't stand anymore, because I've made, I've made my money for you, you see that as a potential middle ground?


Dr. Eduardo Hariton  1:15:28

You know, I've learned with talking to enough business people that I'm not an attorney, I don't know enough about these non competes. But what I will


Griffin Jones  1:15:35

say in some states are enforced in some states are not in California, you can enforce them in Texas, you can you very often, you can you certainly most places you


Dr. Eduardo Hariton  1:15:44

do have it. What I would say is like, if you are worried, like if you are joining a practice, they have a really bad track record, but they really have you and you're worried, I don't know that getting to a certain number is the right way to get out of a non compete, because they knew are very valuable in that market. But you could say something like, if you don't hit this by a given, if you hit this way, given time, and you've been this for this long, and XYZ and you're eligible for partnership, and the partners decide not to grant you that option, then you could explore having something that lets you add to your non compete, so that you don't get scared in that way. You know, again, why not go to a place that allows you to, to really feel comfortable, like, you know, it sucks to go into a job where you're like thinking every day that am I gonna get screwed at year 5am, I not gonna get screwed at year five XYZ, I hope that that's not the place that you're going to. So hopefully you join somewhere we say I trust these people, they're gonna do right by me. And over time without being worried and not get screwed on the backend.


Griffin Jones  1:16:51

Let's talk about class A's and Class B shares before you go because a lot of people don't even know what they are. So what should people be looking for? Look


Dr. Eduardo Hariton  1:17:01

with an attorney is the best advice I get, you know, Class A shares might have more control, so they have more votes. So this is a way where you know what happens with Facebook, Mark Zuckerberg controls Facebook, because he even though he doesn't own most of the company, he has like control. So not immediately obvious, you're getting shares, it's really important to understand shares of what and what you're getting. So you gotta look with them during the you got to understand that doesn't mean that there's a wrong structure if someone else has control, but at least you go in and understand what that looks like. Another thing that I talked to fellows, they're like, they gave me 500,000 shares, like, that must be amazing. I was like, 500,000, out of 10,500,000 out of 1 billion, like shares mean, nothing shares mean a part of something else, you need to understand the denominator to understand the value, you need to understand the price of the shares. And you need to understand the plan, and what you have those shares with go to. So all of these questions. This is why build fertility plane, because you don't know what questions to ask until you ask them until you learn until you see. So I hope to empower fellows with the ability to understand all of the ways in which they can get screwed all of the questions that they might need to ask, and you're not gonna be able to, like answer them yourself, you're not gonna be able to answer all of them. But my hope is that you're able to answer the majority of them use look at your blind spots, you get help. And I'm happy to talk to everybody, I do it for free I make, you know, it's, it's something that I enjoy. I do it while I drive. Hopefully it helps some people, it makes me a talk to the next generation and feel young and like a millennial, I guess they're forever fellow. I like that. But I hope it adds value. And I hope it helps people get their dream job. And I hope it helps people not get screwed. And some of them come work with their network, and it makes me happy. And some of them go work for our competitors. And that's a great job for them. And it also makes me happy. Like I have great relationships with some people at the other networks at solo practices. And now help a fellow get any job that they want. That helps them realize their career. Because this is a small field, we're all going to work together, we're all gonna see each other at conferences. And it's not about you know, I want my network to do well, but I want my field to well, and I want the areas that work so hard and got there to have a meaningful career at a place that values them. So that's why I love doing this because I truly think that it's not all about the money. It's about what you do day in and day out and you're gonna bring a nice paycheck to your kids and you don't want to get screwed in a big transaction. But ultimately, it's about getting the setup where you can be happy take care of patients and feel valued both in the environment around you and the financial rewards of your work.


Griffin Jones  1:19:50

That's a good place to conclude I've got to hit up some more of your content. I got to hit up Investopedia a little bit for just going back to basics. For a little bit, you were smart enough to have my assistant extend this time, because you knew we could go over because I can always go over with you. I could I could talk to you for another hour and a half and it would be valuable for the audience. So next time, I will be smart enough to schedule more time at a time, and I will have you back on because people will absolutely love to hear more from you. Where can people find you?


Dr. Eduardo Hariton  1:20:29

So you can Yeah, me. Everybody usually gets my fertility explained emails, you can email me@hariton.md at gmail, you can find me on Instagram, you can find me at SRM. You can email grief, and He'll put you in touch. I'm happy to chat. If it's helpful. I'm happy to send you resources. We do have a lot of our webinars taped. And I do always recommend people just spend a couple hours go through them in the car, when you're home when you're doing this is just listen, listen to the questions, listen to how all of these people in employment, etc. Think about their contracts. And if you want to chat, I'm happy to ultimately, you know, you are in a great field. You know, I've been in practice for a month and a half. So I say this humbly, like we picked a good field not only because what we get to do as doctors is incredibly satisfying, but we happen to be at a time where our field is growing. So hopefully you have a place where you can take care of your family, pursue your career vision, take care of patients and also be meaningfully rewarded for the growth that you help create and the families that you help build.


Griffin Jones  1:21:39

My good friend, Dr. Eduardo Harrison, thank you very much for coming back on inside reproductive health.


Dr. Eduardo Hariton  1:21:44

My pleasure, Griff. Thanks for having me. I look forward to seeing you. In a few weeks.


1:21:49

You You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society. Visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health




Revisiting Improving Patient Experience by Building An Empowered Team, An Interview With Dr. Peter Klatsky

There’s a challenge in finding the balance between keeping both your staff and patients happy. On this episode of Inside Reproductive Health, originally aired in 2020, Griffin gets Dr. Peter Klatsky’s take on managing everyone’s satisfaction while providing a new standard of care. Working with his partners at Spring Fertility in California, their goal is to provide their patients a level of service that isn’t seen anywhere else, all while keeping their employees happy and in for the long haul. 

Learn more about Dr. Klatsky and Spring Fertility by visiting www.springfertility.com/

Read about the work done by Mama Rescue and support their vision by visiting www.mamarescue.org/

To get started on a marketing plan for your company, complete the Goal and Competitive Diagnostic at FertilityBridge.com.

Other episodes mentioned in Episode 54:

Ep. 50, Dr. Pietro Bortoletto

Ep. 54, TJ Farnsworth


Transcript


Dr. Klatsky  00:04

I've learned that not every single patient is going to have to have perfect experience. And our commitment is when we have a patient who had an experience that didn't live up to our goals that we listen and react immediately and try to improve our system.


Griffin Jones  00:18

Here's another flashback episode for you tell me if you do, or if you don't like these flashback episodes, email me, text me, many of you thought that they're a good idea. I always hated them, watching them on sitcoms, as a kid couldn't stand when they did that. So you tell me, if you liked them, I think it's useful to go back and see the growth that some of these folks have done. And for those of you starting your career, growing your practice, calling on some of these practices, it can be useful to go back and listen, I had Dr. Peter Klasky, on in the winter of 2020. Anything big happened since then. And we talked about the growth of spring fertility. And at that time, there was a handful of practices that were on the up growing fast and new practices, I should say a lot of established practices were still growing. And many networks were forming to buy practices, there really only handful of groups starting at that time, kind of it made it may have not even had a brick and mortar that time. I don't remember, there was spring and there was bias. And and then you know, maybe a couple others in different senses. But if like these brand new practices that were moving real fast, then of course we know Vioxx was acquired by combat even know that kind body went on to raise a lot more money and make an acquisition, like viruses grow to a number of different marketplaces. Spring fertility also has grown quite a bit in that time and time. When I spoke with Dr. Klasky. There, he was just they were just in San Francisco in the Bay Area, at least. And I don't know how many providers a day at that time, but I think it was Dr. Klasky, Dr. Trim and a few others. Now they're 1314 physicians are 1314 rei physicians, and a number of advanced practice providers. They're in different marketplaces that include scheme self was practicing in the Bay Area at that time that was back in New York, that are in Canada now with an acquisition of Genesis Fertility Center in Vancouver. And so this has been tremendous growth. And and it's from one of these brands that was meant to be one of the new exciting practices, one of the new exciting ways of opening up a practice. So you decided is spring fertility, done it the way they said they were going to do I think model for others going forward? Are they a new contender they they now part of the establishment? Are others going to do what they do love to hear your thoughts about spring fertility student group based on this old episode with Dr. Klasky, from January of 2020. Enjoy. So I want to talk about what that means to the standard of care not seen anywhere. But I want to talk about what that vision for spring fertility is because there's a pretty common trajectory for a lot of people to either join up with an existing group or to maybe start their own, which is less common because it's harder to start one's own group. Now you've done it with a pretty impressive speed and starting to be scale. So what was it that made you want to do that in the first place? What was the void in the marketplace that you thought? This is what I could add to it?


Dr. Klatsky  03:46

Well, you know, I think it starts with seeing an opportunity to practice medicine the way I always dreamed. And I felt that it for a variety of reasons in this places that I was I wasn't able to practice the kind of medicine that I wanted to practice. I was fortunate enough to have a best friend from residency, who I went through fellowship with and that was Dr. Nam Tran. He was practicing at UCSF, I was practicing in Albert Einstein College of Medicine. And we both had wonderful academic medical careers. But when it came to the practice of seeing patients and the way in which we wanted to deliver care for a variety of reasons, we weren't able to practice the way we wanted to in a larger academic center. We then also noted that most of the major innovations in our field had come from the private sector. And so they had come from people came before us who we were fortunate enough to follow people like Bill Schoolcraft and CCRM, where he worked with one of our partners. Now Dr. Devin haras, who's brilliant and amazing people like Richard Scott who really really innovated people like on at Cobo and our colleagues over in Spain and So nominate woke up. And we said, Gosh, the really big game changing innovations in our field seem to have come not through NIH funding, which is near to absent in our field, or at least in the IVF component of our field. But we're coming from from the terrific world class private Fertility Centers that invested their own money and time to research and develop. So there was a combination of one, we could leave academic medicine, and still do provide the cutting edge care and actually provide it in an even more cutting edge and even more rapid way we could control the kind of research that we wanted to, and try to push the field forward one and then two, from a patient experience standpoint, there were so many areas where we felt like we wouldn't have been, we were not able to serve patients the way we would have wanted to be cared for if we were the patient. And so we may add to that, that I'm having this conversation with my best friend, who we happen to be on different sides of the country. But we blue sky, what would it be like if we had our own practice, we could do it the way we wanted to do it? And what would that vision look like? And then we were fortunate enough to have two other close friends who happened to be the best embryologist on the West Coast, who also shared our vision. And they wanted to push the field forward. And, you know, in their words, they felt like they were what they were wonderful institutions, but felt that if they had stayed there, they wouldn't, they wouldn't be practicing the same way 10 years from now that they were at that time. And so the four of us came together and sort of had this idea that, what would it look like if we were starting from scratch? From the patient experience from the patient care? And what would it look like in the lab, if we could take the best technology available? And then imagine what technology might bring us over the next 10 or 15 years? And how would we design and build a lab. And then after about a year to a year and a half of planning and thoughtful analysis, we then decided to take this job.


Griffin Jones  07:06

So I want to come back to that question of the lab and springs perspective on the lab. But I want to explore this idea of why you felt you couldn't pursue the way you wanted to practice medicine or build your own infrastructure in the Academy because I've only talked about the academic side of our field really once on the show with Dr. Petro Borgia Leto, and I'm having a few more guests on to talk about it in 2020, because I realized that it's a void that we really haven't covered. I've done a little bit of business with academic centers, and the very smallest consulting engagements are like a bureaucratic nightmare to go through the red tape. So I can infer why you might not have been able to realize the practice of medicine that you would want to realize in the academy. But describe why you had to take your vision out of it. And it's probably beyond NIH funding, I'm guessing.


Dr. Klatsky  08:08

Yeah, I think one of the draws to an academic centers to do amazing research, and to do amazing teaching. And the thing that you still can do in a one in a great academic institution is provide terrific teaching. And you can teach residents, medical students fellows, and that is incredibly rewarding. In a private sector practice, you can also continue to teach, we have residents come to spring fertility from an endocrinology group, we have new physicians who are when you join spring fertility you before you see a patient, you probably spend another two to three months just training with us learning our protocols and our perspectives on how to deliver care in so we haven't lost that that teaching angle from public funding the NIH, whether it's the NIH or somebody else, there's just not a lot of research dollars into the really exciting stuff that we do when it involves human embryos. And too, it's not a high priority for the NIH. From a bureaucratic standpoint, I share some of your frustrations I one point had over a quarter million dollars of funding from the World Bank to do maternal mortality research in Uganda. And that was matched by several other private foundations. And being able to deploy funds that we already got, you had to go through multiple layers. And so you can imagine what it's like as a vendor trying to, you know, work with your services. But But even more than that, from a patient that to get what it means to be a provider, occasionally to have a patient who wanted to be seen earlier so she could get to work and you knew she had a very stressful job. And it was important for her to be seen and out of the office by 730. So Nam or myself, we're pretty committed to our patients. We're not pretty but we're very committed to our patients. And we're willing to come in at 7am but in you know, essentially that you don't have control over the resources. There might not be a nurse or a medical assistant to help you do it all For Sale, and therefore you can't do that. So I've noticed you'd say, well, I, I'd like to come in and see this patient this time. No, that's not available, we don't have the staffing for that. And so when you have control over the system setup, you can set up so that something that would be incredibly popular, like earlier monitoring hours is a viable option for your patients.


Griffin Jones  10:22

Yeah, it seems to point out, the nuance between where the standard of care begins in the form of whether it's best business practices or simply is now the standard of care. To me, it's not immediately obvious. It's something I talk a lot about on the show, but you're talking about being able to accommodate patients in a way that works for them. That might be best business practices, and therefore, is favored by the private sector. But at what point? Is it just the standard of care?


Dr. Klatsky  10:57

Yeah, I don't like to think in terms of best business practices, but I like to think in terms of what's best for my patient. And well,


Griffin Jones  11:04

that's what I mean, Peter, I think we divorced those two concepts. And but Customer Service at one point is patient service.


Dr. Klatsky  11:13

Yeah. 100%. And so, you know, that's where you we, and all it really takes us is looking at, what would I want if I was a patient? Right? And then it takes a little more effort to figure out how would I change my system, for example, we have two shifts of nurses. Why do we have two sets of nurses because that's the only way we can have patients come in early. And also get results to patients in the afternoon. But that, but that's not the way most larger institutions are set up. And that's also not the way an institution, even private sector institutions are set up. Because if you if you were the only Fertility Center in New York City in 1992, you didn't have to worry about what patients wanted, right? You had 612, month, waitlist, whatever you did, and you could make the patient's jump through whatever hoops were necessary. And, and they could go through that bureaucratic maze, and the doctor could get there, you know, have the best parking spot in the lot and then show up at the time that was convenient for the clinic or for the provider, and patients would wait. And what we're seeing today, you know, is that patients do demand more and a place like spring fertility that actually thinks what would I wanted I was the patient is going to continue to grow and have incredibly positive patient experiences, if other centers aren't going to do the same thing,


Griffin Jones  12:32

which really makes me wonder how someone can worry about what the patient wants, while also serving the patients. So we've had others on the show and have talked about the CEO role. And a lot of companies now have a chief executive officer who is in charge of the C suite, and they manage all of the business. And mostly the physicians are often their advisors, but it's effectively the employees of the company. There's a few folks like yourself who are physician led groups who are in the entrepreneurial seat and in the physician seat, so you didn't have to worry or a physician didn't have to worry about what patients wanted in 1992, you Peter Klasky, very much do. And you also have a patient caseload, you have to do retrievals you're still an REI, within the practice group, as well as being an entrepreneur that leads the vision and the scale and the future value of the group. How are you able to do both things at the same time? Because I'm just running a client services firm. And it ain't frickin easy. How do you manage it?


Dr. Klatsky  13:49

Not alone. And so I focused during the day from 7am until 6pm, I focused entirely on my patients. And when I'm focusing on my patients that's going to inform what spring fertility should do from an operational perspective. I'm lucky that I don't it no part of spring has been Peter Cloudscape. Alone at all. I have the best partner in the world. Dr. Nam Tran, who is the smartest person I know. And in addition to being the smartest scientist in position, I know you he's also the best operational leader that one can have. And we were very fortunate early on to hire really terrific people. So I we have a chief operating officer who is excellent at taking our vision. And in managing the day to day operations. We just hired an amazing woman who is running our VP of operations. And she came from, from the Vita which is a large healthcare organization where she takes a lot of the structure and organizational stuff. And so you know, between Derald and Marin, and then we've got an array of additional folks who we have both given direction to and who who we trust to carry out that direction and trust to check in with us. So we have weekly check in meetings. And when Nam and I are seeing patients, we're getting feedback so that we know how to adjust operations, right? When we when I'm seeing patient nice to hear somebody's frustrated about something, we respond not, you know, in a month or in two months, we respond that day. And our team is all motivated. So the other important important thing is to make sure you have a happy team, and that you empower those people. So we were so fortunate to hire Dr. Devin unharnessed, who is now the CO medical director of spring fertility, and overseas medical operations and process on par alongside of Dr. Trump non track. And so the way we do it is not the way your question was sort of, Peter, how do you do it? I don't, you know, we have an amazing team that together functions really well. And we complement each other. And what we share also is a vision for how to be everybody join spring wants to deliver the best service for their patients. And we define services in equal parts, patient experience, and clinical outcomes. And, and everybody knows that that second best isn't good enough. And so we're united by a desire to deliver the best experience for our patients, the best care for our patients, and a desire to be the best at that. And then we hire wonderful people. We hire people who are effective operationally, but also fun to hang out with. And so we have a great time hanging out tonight, I'm going out to dinner with all of the providers and we've got a dinner for eight with some of our key management people and the providers. And it's going to be our end of year last physician meeting, we have a physician meeting every month, everybody has an equal weight, everybody has an equal say. And we take feedback, whether it's from our patients, or our teammates, or their physicians incredibly seriously, if you joined spring, and now we're seven positions, if you join spring, and you have a suggestion for something you think we can do better, we want to hear, right, we don't want somebody else to come up with that idea. And and we want to make sure that we hire the best Doc's and that we keep those Doc's in New, and then we, we make sure they're happy. And in California, there's no non compete either, right? So so it is all about making sure your team is empowered, you have the right people, and everybody communicates well. And so a lot, also a lot of hard work, right? late hours, but I think the thing that's you allowed spring to, to effectively scales thus far, has been a team of people who will complement each other.


Griffin Jones  17:42

It started with two, how does your skill set and Dr. Trim skill set? Where do they overlap? And where do they diverge?


Dr. Klatsky  17:53

You know, usually, this is where I would make a joke and say that I'm better looking and more charming. And he he's good at managing the plantings around our office and some of the wires that sometimes get tangled. But all kidding aside, there's a total joke, I think that nom is these isn't has always has been the smartest guy in our field for for as long as I've known him. And he's just one of the smartest people I've ever met. And I and I'm comfortable enough to recognize that and confident, are smart enough to recognize that and confident enough to let him run most operational practices and not feel threatened by him saying, Hey, I think we should do it this way. When I've been doing it a different way. I think that there are areas where I have strengths that may be complement areas where he's not quite as strong. And both of us if we had to, or you're over everything, or if we had ego around who would get to do this or who would lead that it would just slow us down and get in our way. And it would affect our relationship. We really also liked each other. So even though we're quite different, and but because we like each other, it creates an environment where the nurses like working with us because we're because we're going to be having more fun, we're going to probably be making fun of each other. And we're going to be supporting each other. And we're never going to worry about who took more calls or who had a little bit more work on one thing or another. We're both trying to make sure we're not holding the other person back. And then when you have that environment, and you bring in somebody like dedmon, Horace Uzziah Harris, these are are incredibly brilliant physicians who are also committed to that same vision, give patients the best clinical experience possible. And, and one of the most amazing things that I've experienced and then on the lab side, we're led but by just to an amazing team of embryologist. And you know, in as to married embryologist, who we started with Sergio Bukhari, he's to monitor Porsche. And they just delivered the best not only the best quality work, and constantly trying to push the envelope for innovation and to improve outcomes. But they also create an environment in the lab, that is a wonderful place to work. So we're able to attract and retain top embryology talent. But But I think, if I were to shorten it, and try to make it more concise, NOM manages detailed operating protocols. And I probably manage some of the vision voice. And I'm very attentive to the patient experience.


Griffin Jones  20:42

When you're growing up fertility practice fast, you need the best that there is. And the best that there is that I'm hearing from half of the Fertility Centers on this continent is engaged in the with regard to the informed consent, the pre treatment, education, and the workflow assistance that engaged in the software provides engaged MD is over and over again, something I hear from clients and from you all, at SRM and a meetings about how useful it's been for staff how useful it's been improving patient satisfaction, because the patient gets to go through the modules on their time that makes their care with you their time with you personalized, and you'd have a much more defensible informed consent. As you can see, people were watching these modules, they have the time to do it, they agree that these different phases, and you don't have to track down all this paperwork, all the time that you save your staff, how you make them more efficient, and improve the satisfaction of the patient. That's part of the standard of care, the patient has to go through paperwork, if they have to do all the education themselves, they're a deer in their headlights, they're a deer in headlights in their interactions with you is that the highest standard of care, engage them the input improves these things. And you can get on board with engaging in the you're among now the minority that are not going to engage md.com/griffin to get a free workflow assessment, assessment from engaged and V. Team. And you'll also help to create more inside reproductive health content, because you let a sponsor know that this is one of the places that you've heard them. I heard from the show you heard that from me. But it's an advantage to your team. And it's most necessary if you're going fast. It's a competitive advantage engaged in the.com/griffin. Now back to this conversation to Dr. Peter Klasky. Spring is often known for its vision for the lab, it's its functional outlay of the lab and looking at the lab very differently from how IVF labs have been structured in the past. When people say that, what are they referring to?


Dr. Klatsky  23:04

Well, there's a lot of things we do uniquely in the lab. But we the flow in our lab is extremely efficient, and designed to prevent minimal movements and to minimize any risks to embryos or eggs. With regard to egg and embryo storage. There's everything has not just redundancy, but two layers of redundancy. There are some things we do very uniquely in our lab. We are the only I believe we are the only practice in the country that injects in those ACCION eggs in a hypoxic environment. That's the same ambient air quality that exists in the incubators. We are the only lab in the country that does the same thing from egg retrieval. So when the eggs are being retrieved from somebody's body, they immediately go into an isolette while the embryologist is looking at them, where the carbon dioxide level is 5% and the oxygen levels 5%. So that's matching what it is in the fallopian tubes. I don't believe I don't know of any center that's doing that currently. And to be honest, we weren't able to do that when we built the lab because the technology didn't exist to lower the oxygen to displace oxygen in a nice sight. And within two years of opening, we were able to do that. But we built the infrastructure in our lab that can do that. So we have nitrogen gas and co2 Gas throughout our lab. And we have other infrastructure that's anticipating what technology will bring five years from now. That is amazing innovation that we you know, I credit 100% to Dr. Trump, and his vision for what the lab, the IVF lab will look like in 2025.


Griffin Jones  24:41

I think innovation like that, which is groundbreaking in some ways and other things that other people are doing and it harkens back to something that TJ Farnsworth had said on the show a few weeks ago and I actually really agree with that I've thought about both before and even more since I want to see if Few agree. First off, if you if you don't why, and if you do, what do you think can be done about it, but his sentiment was coming from the oncology field was that there? There is less peer to peer sharing of best operations practices of best practices, both from a business and clinical setting. And I really do see that, Peter, I really see it from independent owners, especially I think everybody feels like they've got the secret sauce. And maybe you're a guy that really does have the secret sauce. And you think Well, I do. And I don't want to share with folks that are doing the same. First, do you see it that way? Do you see that our field isn't nearly as collaborative as it could be? Why or why not?


Dr. Klatsky  25:45

I don't, you know, I think we I don't see it that way. And I'm sad that TJ doesn't feel that way. It feels that way. I actually think that there. I started this off by saying, we followed great minds and great practices that shared their advances in our field. And he, I don't think oncology even moves as quickly as the field of fertility does and oncology moves incredibly quickly. But why do we have egg freezing because of a commitment of somebody in Japan, carried forth with clinical trials performed in Spain. And those publications came out in 2010. And by 2012, egg freezing was no longer considered experimental in Europe or the US. And it was, and people were traveling to other places to learn how to do that. I think that Richard Scott and Bill Schoolcraft, shared advances in pre Implantation Genetic testing with the field. So I don't know that there's been a lack of peer to peer sharing, even when even when people have secrets. When we opened up the lab, we had Barry bear, who's whose lab director for Stanford, which is maybe 40 miles away, walk through our lab, and tour it with us and in the professionals in our, in our field, I expect that they do share. So I know the embryologist are constantly sharing with each other what they're doing, because they have long standing relationships. It's kind of like when Nam was at UCSF and I was at Einstein, we'd always talked about what each other was doing. So and, you know, all of us had peers and colleagues and other centers of so I've not seen that that much. I do think people are tied to their practices, I think maybe some of the border docks, and we're pretty young group, but maybe some of the older dots don't want to change the way they're doing it. And that's what he's referring to. And so they say, Oh, this is really special. Because this way, I've always done it. But I think most innovations have been pretty. It's hard to keep secrets in our field, you know, trade secrets, because our trade secrets are information and knowledge. For example, what I just shared with you on your podcast, everybody I know nobody else is doing hypoxic xe made me you know, but I'm not. I haven't been shy about that, since we've opened that, you know, and maybe people will start doing it, people have to buy into something and believe that there's a benefit to it. But I don't think people are really secretive.


Griffin Jones  28:08

I see both sides, I definitely see enough examples of both. And perhaps you're right, that there is an age difference. I think there's probably a practice structure difference. The people that I see sharing are the people that you mentioned, plus yourself plus TJ, the people that are growing groups pretty quickly, and adding a lot of new things tend to share. And then there are probably another class of folks that they want to hold on to their piece of their particular market. And I often find those folks are reluctant to talk to the folks across the street or have nice things to say about the folks across the street are reluctant to meet with them or join some of the broader groups. And so


Dr. Klatsky  28:57

we all just do. And that's where so if they're acting that way, that's what's silly. Like, they may not be but you but you're embryologist are when you're nurses aren't as RM they're sharing. Your your junior Doc's who both went through fellowship together are sharing with each other. So that's where we try not to be, you know, we try to have good collegial relationships with everybody. And, and, and we always want it and the great thing about our field is it doesn't stand still. So what is amazingly cutting edge today in five years, four years, maybe standard of care, and you'll have to continually move the needle. And that's really to really really keep growing, you're gonna have to attract and keep the best people who all have that future in mind, you know, want to move the field forward. So we have better patient outcomes, so we can provide a better patient experience and I guess that part you need to really give voice to your your new hires. So that doc who is straight out of fellowship Hey, you know Meet me. Maybe that's the person who's going to be Richard Scott or Bill Schoolcraft, you know, in 20 years. So listen to the suggestions that they have. And that opportunity.


Griffin Jones  30:12

Yeah, that was gonna be my next question is does it become binary for Talent Recruitment and how you're able to build your group because I belong to a few different masterminds of owners of other creative firms. And our fertility marketing blueprint took us years to build the way it is a really good strategy piece and allows us to make sure that almost any group is going to be successful if it's if it's done right. And took us years to do, and I willingly share it with other agency owners. And I just tell them, if you decide that you're now going to go into fertility field with this, you'll burn in business development, hell, but other than that, I'm not making people sign an NDA, I'm not, I'm just sharing it with other peers. And so that they can use it to help


Dr. Klatsky  31:08

like you, Griffin, and in your your, your becoming a thought leader in our field. So people are gonna want to always have your, your thoughts and opinion and I think that makes sense.


Griffin Jones  31:20

Well, to your point, though, I can't keep secret sauce anyway, there is no secret sauce. The embryologist are talking to each other, the nurses are talking to each other, the Jr. Doc's are they're talking with their pharma reps who come in who are talking with other folks. And so it's either you're either offense of this is what we're doing. And I'm doing a podcast episode every single week, and Peter is sharing his version of xe on the podcast with everyone and sharing that and bringing that to the field on offense, or on your or your you're on defense. And I'm starting to see the folks that are struggling with that. But to me, it's binary, there is no maintaining the secret sauce, you've talked about how you are building a team based on that ethos, how else are you building the team to be collaborative, like what's the structure of springs team that makes sure that it's one of as you say, advancing the core value of what's in the best interests of the patient, we


Dr. Klatsky  32:21

onboard people slowly providers, you know, most places, you're seeing patients a week out, provider out of fellowship will probably take a minimum of two months before they're seeing their first new patient. And more likely closer to four, we maintain regular full team meetings where we talk about clinical issues and also practice issues. And what we have built in, I guess, modeled from the top down is a relatively flat system or flat operating system. So that medical assistant, you may have just heard somebody knock on my door, nobody feels timid about knocking on anybody's door, it's spring fertility, and if a physician is running five minutes late, that means a patient's been waiting for too long. And so everybody's instructed to let that patient that physician know and empowered to do so. So we've actually a small waiting room has been virtually every year in San Francisco combined. And people are usually surprised because these patients don't wait here. And that's because you know, the physician would be in trouble, regardless of who the physician is, if the patient's waiting for them. And that's, you know, a core value is that the patients come first. And everybody gets a copy of our mission statement. Everybody knows what our pillars are. And everybody is oriented for two days, every single hire, whether you're in the finance area, or whether you're in a clinical operations area, to understand what that mission is, and we try to hire Well, we try to screen for people who are interested in that mission before we bring people on.


Griffin Jones  33:55

Yeah, other thing when I say binarias offense and defense, it's really Who do you want to work with and for? And who do you not want to work with and for and in order to attract people who are self motivated. The values and the reinforcement of the values, the reiteration of them, I think, is critical. And I think in that group of clinics that were founded in, let's say, the mid into late 1990s, many of those don't have them. And I think part of the reason why some of them are starting to struggle now is because they're not built in this way, which is not only just built for talent shouldn't be built for patients but also built to attract talent. So where do you see this going in the next decade, let's say in terms of I guess what you want to do with spring but where you see the field, really starting to bear to some of the demands that have been eking the past couple years,


Dr. Klatsky  35:05

I think the field is growing expansively they massively. And so I think I think that it will continue to be growth in our field, driven by demand for IVF services as women continue to have their first child and start families later on in life, but also with the advent of egg freezing. And as people get more comfortable with that technologies, we have more data on the on the viability of that technology, I think people will demand more and our patients are are more demanding. And they're used to having an individualized and personal experience. And so the centers that are able to provide that enable to provide a patient experience will grow in those that want to continue putting the doctor first as opposed to the patient will see you know, probably see a retraction in their market share and clinics like ours, where people like working together. I said last night, we went out to dinner with a candidate, a new physician recruitment candidate, and she was lovely, and the team was just happy to be out together for dinner. And mentioned tonight, we're having another dinner with all the physician and providers, and then we're having a party for our entire staff and their partners on Friday night or holiday party. And so sprint like spring is a fun place to work. We every quarter, we do something as a team and not, you know, they're usually not boring. And, and sometimes, they're arguably too fun. But we really try to make sure everybody in the in the organization feels valued, and that people enjoy being around each other. And so if you can do, and I think that's a critical element to the patient experience, it is almost impossible to deliver a wonderful patient experience. If your team does not like working together. In order to make patients happy, you have to start by making your staff ensure that vision that we're all what we're doing is important, and it's about the patient.


Griffin Jones  36:57

The old adage had been shareholders first customers second, employees. Third, I think many forward thinkers have corrected in our field, you could say its employees first patient second, in that case, the for the for the exact reason that you described


Dr. Klatsky  37:16

would be very, I don't want to say that because I still think the patients come first. But but almost like in order, you have


Griffin Jones  37:22

to say that because you're a doctor, if you were if you were just a business owner, not a physician, you wouldn't have to say that because I'll say it right now in front of everybody, clients come second, if any of my clients are listening, and most of them do, they know, my employees come first. And if I felt like my employees, were not someone that put the client's interests at the top of their mind, and we're willing to go the extra mile, they wouldn't be on my team to begin with. But if it ever came down to, you know, if client ever dog cost an employee, I would rip them apart in front of the whole team just to boost morale.


Dr. Klatsky  37:59

Yeah, wouldn't rip apart a patient. We're very sensitive with our patient, but but you can have both. Let's agree you can both they're both critically important. Your mission is about your patients. But you can't fulfill that mission. If you're if your staffs unhappy or feels like you're in any way not doing right. But


Griffin Jones  38:17

I just don't think that point can be understated that when employees when team members are happy, they take really good care of the people that they're supposed to be taking care of. And that's true in medicine, as well as client services I wasn't going to ask you about this wasn't on my list. But I do want to talk about your endeavors for social good particularly in Uganda. One of the reasons why I started my own company is because I want to be a philanthropist. But for me, they're very much separate I guess that my business is what I do to make money so that I can give money to the organizations that I care about. We're not like TOMS Shoes where we're selling a pair of shoes and then another pair it goes to the individual in need for you are your endeavors for social good, very much infused with spring or is spring a business venture that helps you to contribute in the ways that you want to.


Dr. Klatsky  39:14

I think it's all in so so first spring is about providing really excellent care to people on a really important level. So if you're an infertility patient been trying for the last 12 months to get pregnant, and every period feels like a wound in a stabbing, you know, insult and pain and injury, then providing sensitive, compassionate fertility care, you know, is a social good in its own right, helping somebody preserve their future fertility and their options and empowering them to go on their next date and not feel stressed. Like it has to be the guy they're going to marry. You know, for somebody who's going to freeze eggs is a social good so I feel like I'm so fortunate that the business or profession that I'm in just doing my job is a social good No, no, I'm passionate also about just reproductive health globally and in reducing disparities in care. And so the mama rescue program that I started in Uganda was really successful. And we were funded by the World Bank by UNICEF. And I basically had a decision to make whether I was going to get out of the fertility space, and go full time into the nonprofit space, or go all into the fertility space. And I chose the ladder in the way we sort of marry those two things right now is it spring fertility is actually making a donation sort of like TOMS Shoes. And so we make a donation for every person, we get pregnant. To spring fertility last month, we authorized the $24,000 payment to the organization's running mama rescue. And that will provide for every pregnancy, we have, we provide for two women in rural Africa to get an emergency transport in the event of an obstetric emergency, and to transport 10 women to a health center for skilled obstetric care. And so and we do that, with every pregnancy achieved at Spring. And so so that's where we get to marry, you know, helping women who can afford advanced reproductive technologies have gradually built up care in the United States, with women who are no less deserving in an environment in an area with far fewer resources, and try to connect those two worlds through our shared humanity. And that's something that's been important since we started in, I mentioned that, that Nam Tran is the smartest person I know, you know, he came to United States as a refugee. Like, my God, like if Donald Trump was President, you know, 40 years ago, we might not have had the benefit of having somebody like him in our country. And so we still believe in that shared humanity and that shared reproductive health, and I sort of pivoted off on the politics, but I like to, but we're real infertility is real. And in frankly, like, I'm disgusted with our current administration, and as a CEO of a company, or as a founder of a company, I probably shouldn't say that. But I don't care. Because it's reproductive health, right. And that's what we're passionate about. And so we're passionate about helping improve the lives of women, both in our own community. And if we can tie those eyes to women who are deserving and caring and, and underserved. We want to and so that's what we do with every pregnancy we we actually support access to skilled obstetric and antenatal care in in western and central Uganda.


Griffin Jones  42:36

How do you want to conclude with our audience of how spring fertility is going to build this new standard of care that's not seen anywhere.


Dr. Klatsky  42:46

I hope that we continue to have great feedback from our patients. I've learned that not every single patient is going to have to have perfect experience. But our commitment is when we have a patient who had an experience that didn't live up to our goals that we listen and react immediately and try to improve our system right now. I think we deliver amazing care. And I hope that we can continue to hear the kind of feedback from patients that they have pregnancies quicker, that the experience is less uncomfortable and more empowering. And if we can continue to do that, and continue to empower our patients provide a more comfortable, compassionate and efficient experience. Those are words that don't always go together. It spring will continue to grow. It will continue to grow in the Bay Area. And as well as new geographies. And anybody who's interested in that mission should give me a call or send me an email because we are hiring


Griffin Jones  43:48

new geographies, watch out folks that are coming to your town. Dr. Peter Klasky. Thank you very much for coming on inside reproductive.


43:56

Thank you. You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society, visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health


157 How to Phase a Fertility Brand Update: Secrets from Griffin Jones

This week, Griffin Jones hosts a Marketing Secrets Shorts episode, disseminating branding phases. Whether you are considering a rebrand for your clinic, beginning de novo, or somewhere in between, it is important to know where to start out if you want to end up with a marketable brand in the end. Listen now for tips and tricks to properly phasing your branding efforts, on Inside Reproductive Health with Griffin Jones.


Transcript




Griffin Jones  00:04

Here's a tip on differentiators, guys, if the next person next to you can say it, it's not a differentiator, I'm going to give you some marketing gold inside reproductive health audience before we start making an editorial transition, there's gonna be less fertility bridge content, more content about news coverage and fields of reporting news stories, as they have a list of new podcasts with guests. But I want to bring you more news coverage because that's what people are asking for. And we don't have a Forbes of our field, you don't have a Bloomberg of our field, we don't have that trade media outlet. It's always been the insight, reproductive health podcast, I want to bring that to you in other formats, in weekly digest and in the podcast, as well. And then others, to the extent that we get more people behind it and build out more, but the types of things we want to report on is Mark Segal stepping down as CEO of us fertility, John Pardew is stepping down as CEO of CCRM fertility, what does that mean? People doing fundraisers, and closes like engaged MD closing around recently, and so I want to bring that type of news to you, because you all are hungry for it. And for the most part, it's not being reported in other media outlets. So you're gonna have less of this type of marketing advice, or the things that fertility bridge does, those brands are starting to separate. But I want to give you some brand wisdom before I do. And I want you to do this and think about this, whether you use fertility bridge, my firm or any other I don't care, I don't care guys, this is the way it works. 


When I talk about Kindbody, I'm not talking about frickin’ yellow colors, I'm talking about the power of Apple, the power of things, the power of Nike coming to the fertility field, and many of you are positioned on the complete opposite spectrum. I'm not saying that you have to go to that level of global consumer branding, most of you wouldn't be able to even if you want it to cost a ton of money. It takes a ton of effort and institutional structure to be able to accomplish it. But you can at least make sure that you're not positioned like an old general practice firm. When do I want to go there? Or do I want to go to the place that looks like it is most in line with my values and what I'm comfortable with. So I'm going to phase it out for you. And, and I want you to approach it in this phase. Because you can err on either side, when you start to do a brand, you can err on the side of the creatives and doing all of the work and you get something that isn't you or you can err on the side of you feel like you're doing everything. And like what did I even hire these designers, this brand manager, these writers, this creative team for? 


So the first thing is positioning has to be done. I recently had a client ask that when we're talking about core values, isn't this like this like kind of like millennial fluffy stuff? It is if you don't do anything with it, if it's just words on paper than it is the first thing that you have to do is say these are our practices, core values, our purpose our differentiators. Here's a tip on differentiators: guess if the next person next to you can say it. It's not a differentiator. If the next person next to us said yeah, we offer personalized care to Yeah, we offer state of the art technology. Yeah, we have the best doctors. That's not a differentiator. A differentiator is something that someone else can't empirically say. We were the first egg freezing practice in town. We do the most cycles in this marketplace. We're the biggest independent practice in this state, whatever it might be. Those things are your differentiators. And with regard to your values, your purpose, your mission statement. If it feels fluffy to you, make it less make it less than but make it the things that you can point to if this person isn't these things, then they have no business working at our firm. They have no business working In our practice that is, and, and you should have no less than three of them, you should have no more than seven. 


Here's a tip for you too. This is what I do with our clients. So clients that are spending more money on branding, we will actually talk with employees, and we'll do surveys, and we'll do surveys with patients and get them to sign they have authorizations that we can talk to them all that sort of thing actually have a number of the creative team talk to these folks. But for clients that spend less on branding, we will go through fertility IQ, we'll go through Google reviews will go through Glassdoor if they have enough reviews and see what people have said about them. And then when there is something that they can use, that is that is said enough, this is a frequent pattern, everyone talks about how this practice to hold your hand through the way and maybe that becomes a something that has to compassion become your core values.


 Conversely, if they do something, that if there's a common pattern of you know, your your, your nurses dropped the ball or, you know, an example of you know, they they were slammed, were slammed so busy that we don't get back to people, we want to have a value that addresses that. So that people you're getting people in that aren't totally floored by it. So if you, if you're if you have the type of managerial behavior where you just tell people how it is, you have to have some type of value for directness, that you're getting people that that are aligned with that. So that's your position, you do that, first, you do that with your partners, that has to be done by the Chief Executive, the managing partner, whoever the senior partner is, has to be done at the very top marketing director can't do it for a CMO can't do it for you, a firm can't do it for you, you have to do the position. Those a firm can facilitate it for you. But you have to do it yourself. 


Now, when you move on to the actual brand, the first thing that you want to have done is have the creative should be doing an assessment and they should be coming to you with more specific questions. Remember, the erring on either side, you can err on the side of the creative team is doing everything for you. They're suggesting everything and it's not your brand, it's something that just gets slapped on you. Or you're doing everything to change that color, change that word. And then it's like, Why did I even hire these people? And so because you can do that they should be coming to you with specific questions. I notice when we ask, you've got somebody new uncrating for example, we ask general questions. That is, is the client off? pisses me off, too. It's a bit counterintuitive, because normally the more open ended questions that you ask the more of a true authentic listener, you are right. And often the more someone feels hurt, because you're not coming in with any assumptions. But when you do that, and branding it, it especially with physicians and people that this is not their main thing that they want to be doing. They feel less heard, like, why don't you know that? Why? What did we hired you for? What does that even mean? 


If you watch the movie, The Greatest Movie Ever Sold, it's Morgan Spurlock, the filmmaker from Supersize Me. And he does a movie entirely about product placement. And they go to the big creative agency in Pittsburgh. And they're asking him these very open ended questions like what does that mean to you? How do you feel when you see this and his brain starts to spin? So I try to pair up creative team down more than they probably like. But if they had their way it would be infinite and the client doesn't want that. So you want to have an assessment where they're coming to you with some specific questions, not so open ended a couple open ended questions and not the infinite number of questions to six or eight questions, and then you can go down some rabbit holes. And they should also be coming with what they're ready to challenge you about your brand. If there's something about the logo that they see, not right but the marketplace, your colors, your design, your messaging, they should be able to have that in the brand assessment that discussion happens after position, that it's what helps to establish the voice in the image later on, to done positioning, then you've done an assessment which leads you into voice and image. And it's good to voice first come up with that mission statement. They can come up with options for you or you can do a workshop and come up with a tagline or a slogan for you. And then come up with your brand voice. We do taglines and slogans for people we have taglines and slogans for both inside reproductive health and for fertility bridge. And they're different the slogan, it's like the rah rah. And the tagline is literally what you do that you can explain to somebody. It's never heard of you in one sentence ever inside reproductive health. Our slogan is takeaways every time the rah-rah sounds good, if you know it inside reproductive health is, you know, that means you don't own reproductive inside reproductive health. that would just be a platitude, too. So the tagline is the media outlet for the business side of infertility. Oh, I know what that is tagline, literal slogan, rah rah. And your brand voice. We've done big brand voice sections in brand guides before. And we've also done smaller ones, for most of you for dealing feel the smaller ones are better, what happens most of the time is writers look at a big brand voice. And they end up not using it because it's not communicated what they're supposed to write. So we make a page, half a page, sometimes this how we sound and, and then make sure that your writers actually use that anybody writing for you, whether it's web content, or social media, or for stuff you're doing internally, make sure that they actually use it the length isn't, isn't the biggest deal. Like, yes, I can see why Disney would have a big brand voice. But for most of you smaller, and then just make sure that they use it. So you've done a positioning, you've assessed your brand. You've done your voice, and you're proving all of these in sections, because our goal is that you have a really nice brand guide. Before you implement anything you don't want to be not implementing. While you're doing it. You're not like, Oh, we got our slogan, let's update this on the website, or we have our mission statement. Let's make sure we got this up on the wall right now not doing any of that until your whole brand is done in that guide. You're getting your Bible first before you go out and and start changing everything. Otherwise, you go into revision hell, and everyone will hate you. 


Once you've done voice, now you're ready to do image, the first thing should be your image guy. And yeah, taking photos or doing videos. At this point, it's just this is what our images look like. This is the style that we use our lab posts, we don't use our lab coats, we take candid fun ones or we don't. You should have images that represent that style. And that should be your guide before you start doing video and photo. Do your fonts and your colors separately isolate the variables. I've seen clients and creatives do this opposite that they've each erred on either side, the best way to think of this is you make you pick out your dress first positioning, then you pick out your shoes, then you pick out your belt, then you pick up the accessories not have to wait for to see which one looks for best with this one. It's which shoes look best with this dress right now which belt looks best with this shoes. And this. And this, I understand that some of you are going to buck from that. And there's probably some brands where it makes sense to buck from that for the vast majority, especially those multiple partners having say, do it that way, pick up your fonts, pick up your colors, pick out your image guy and do this all before you do the next phase. Because you will you'll you'll run into less of those variables. 


So when you're looking at fonts when I have our creatives present fonts, I have them present the fonts in the clients normal colors or in there or in black and white. And then when I have them do colors I have them do with their existing font in their existing logo. So they're not, they're not seeing so many variables at once. Okay, I like those fonts. I like those colors. So, if you've improved your positioning, you had an assessment that set you up for your voice and you went through and you improved your voice and your mission statement, your tagline your slogan, your voice guide, then you've approved then you went on to the next phase with the image and you prove Jeremy's guide your fonts or colors, then you can start to make some of the the templates and And that is a great brand story.


 If you know that you're going to be wanting doing video soon, and I recommend most people do have a brand story for videos, it's awesome that gets everybody excited, it can last for years, it's worth spending a ton of money on. And it's worth closing your office on Thursday or Friday. And coming in on a weekend, if you have to do it, as long as you do it, right. So that's where the brain storyboard is, if you if you're going to make a video about your brand story, build out the whole storyboard first, prove that first. That's where your logo your redoing logo, that's where that's going to come into play is that now you have a new logo. And because you've already approved the fonts have already proved the color. So you're just looking at what any approved your voice, so the logo should be representative of that it should, it should be some kind of symbol for that, even if you're just updating your logo. So we have some clients that would really like this, though, tell us more about what you'd like to buy, tell us more. And then and then we'll often end up updating. So you know, we'll come to them with the design principles or other things to consider in the marketplace. And and then we're updating it based on net. So when when you're approving your logo, it should be you're looking at the logo, and you're not thinking about all the other potential things because it will it will drive you off track. 


And that's when you start creating templates before you start implementing. And this is the web page mock up this is the social media mock up our business cards. And so at the end of this, you want your final brand guide, it can be maybe 12 pages you have most of you probably should be more than 20. There are some of you that might have really long brand guides for those of you that are like consumer brands, global consumer brands, but that's only a few of you listening for the most part, it's going to be somewhere between 10 and 20 pages for your final brand guide. The point is that people use it, it's not. It's not how long it is. And that's worth spending time on it's worth spending some money on. And then you can implement those things, we do it in that order, you got to have a brand you're happy with that your position well, but against the consumer global brands coming in, you don't look like an old doctor's office, old pharmacy or whatever kind of company you are. But you also haven't just copied somebody else and you haven't forced yourself so much into the rah rah or the fluffy that doesn't feel like you do it in that order to thoughtfully spend some money spend some time but those are the phases you do those things you're going to have a successful brand.


 So I hope this has been useful too. And if you like some of my tips on it, just send me an email Griffin at fertility bridge calm. And I hope you enjoy this episode because there's only gonna be a couple more like them. And as we start to cover more of the news content in separate the fertility bridge, and inside reproductive brands, some more anti reproductive health brands some more. I should be reading from my guide.


18:22

You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society. Visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health


156 6 Of The Biggest Fertility News Stories You Should Know Before ASRM

Just in time for the ASRM conference, we share insights on the hottest fertility field news stories you can take with you to the Networking Lounge.


Listen to hear:

  • About the acquisition that took place, which was not reported in the US or Canada.

  • US Fertility’s recent change of CEO.

  • KKR’s debt for the IVIRMA deal.

  • The recent celebrity embryo lawsuit that has now turned against the clinic


With this roundup, Griffin offers a sneak peek into the future of Inside Reproductive Health and news coverage of the business of the fertility field.





Transcript


Griffin Jones  00:04

The biggest Fertility Center in Canada being sold to an overseas company and it not being reported on in North America KKR the global investment firm be behind the EV RMA deal. And the banks behind them selling off their debt, getting rid of their debt to private lenders. CCRM expanding into New Jersey with an acquisition, kind body expanding into Houston and getting the Walmart deal, a major lawsuit happening with that you knew about but now being directed towards the fertility clinic. The this is the news that I'm going to try to give you some insights on today. This is the type of news that inside reproductive health wants to report on in the future. This news content that I'm giving you today is not reported on by us. I'm giving you kind of a preview of the direction that inside reproductive health is going on. Many of you are coming back from SRM. Many of you talking about these things, at SRM. So I wanted to give you some water cooler topics to think about and reflect on catch you up a bit. By the time this episode airs. I'm sure there's probably a big announcement or two that happened today. That didn't make it to this episode. But inside reproductive health is moving in the direction of news media outlet of being able to cover more of these stories, we're still going to do the podcast where we go more in depth. But we also want to cover new stories like these. And many of you listening may have had a meeting about sponsorship with me at ASRM because we are starting to close those sponsorships and only a few companies are able to get in now. And for you, the listening audience, the docs, the CEOs that listen in to reproductive health and read, it's for the aim of getting you more content, some of which is is like this. So I'm gonna go through these stories today, I'm going to try to give my insights. As always, if I get something wrong, please email me and tell me and we can correct on a future episode or you can come on to give more insights or just complain about it quietly to a friend, whichever you prefer. First story is an older one I'm gonna go from older to more recent. And the reason I still want to talk about a story from over a year ago with the Yujun deal of TRIO fertility is because it was never reported on in North America. If you Google Eugin, TRIO, fertility, there's no story that I can find from the Toronto Star from the from Bloomberg from any US or Canadian media outlets. Eugin. If that name sounds familiar to you, is the health system out of Spain that bought Boston IVF. Some years back, they're owned by a another company that's a public traded company. And I think this is significant for two reasons. One is that I think that trio was the largest center in Canada, if you recall, there was a merger some years ago, between five and 10 years, probably seven, eight years ago, something like that, where there was a merger that made trio fertility between life quest and T carts. And then they became true, I believe there were the largest center in Toronto, according to this Spanish media outlet lab on guardia the they did 2700 cycles a year. And so I think that's significant. But I also think it's significant of parent companies that are buying centers, when some of their subsidiaries are large enough to also have done this acquisition. So just just like by you, just by numbers and speculation, Boston IVF could have done this deal. I don't know, I have no idea if they wanted to go to Canada or not. But I think about this when Shady Grove buys CRM and Houston that it's like well, did somebody else in US fertility want to do it? Do it will will these parent companies opened de novo clinics as part of the bigger brand or or will one of their subsidiaries. So I think that's significant. And I also think that it's significant that none of us knew about that. And it shows that there is a lot of strategy happening not just from Wall Street private equity, but European health systems and, and health systems and large networks in other countries that are still TGT coming to different markets in North America as far as I can tell, this is the their first acquisition in Canada, but with their, with their, all their acquisition of Boston IVF, or at least partial acquisition of Boston IVF as well. This media outlet plus mundo se is reporting that Eujin covers more than 37,000 IVF cycles in 2019. So you might infer how much they're doing. Now. Next story also a little bit older, but there's been an update in the last month or so is the what's behind the KKR deal of edrms. So many of you know that there was RMA of New Jersey, and then there was there were armies that are not affiliated with RMA of New Jersey, and there are their armies that were and then they merged with EV of Spain to be to form their global company, EV RMA a few years back. And then the company, the global investment firm KKR made an acquisition of e vrma. Global back in early 2020. To deal that is reported by Axios to have been $3 billion euros at the time, that would have been 3.2 million US, but they're probably paid in euros, at least according to that report. And but the latest development is that the banks that helped to finance that deal the some of them like Morgan Stanley, and Credit Suisse AG, according to this report by Bloomberg, have decided to sell off that debt to private credit firms. So instead of them getting the interest from that, that loan, there, they'd sold it, according to what Bloomberg says, for 96 and a half cents on the euro. So these banks took a little bit of a loss on it. And in order to sell it to the private lenders, they're not going to be getting that interest, the private credit firms will be and they sold what they had for a little bit because KKR they're using some of that some of what they're buying, you know, some of what they paid for is going to be from their limited partners. The pension funds, the the high net worth individuals, the these these big funds that they used to purchase, make a 3 billion euro purchase, according to this article, 800 million of that came from debt. And so that's been sold, what the greater applications are beyond that. That's beyond my paygrade right now, but if you know you can come on in, we could do an analysis of that. Next door is ecrm made a big acquisition of IRM s in New Jersey and I rms used to be part of the St. Barnabas health system there they were a private center on probably one of the largest independently owned private centers on the East Coast, they have 11 rd eyes. And that acquisition was officially announced at the end of August. And so this is going to add to CRMs footprint in the northeast, it may give them more leverage with insurance companies because they have CCRM, New York they also just added a doctor there. And so they may be able to have more leverage with insurance companies there may be more efficiencies in marketing and some of the services that they're offering that allows them to expand but this is a group that a lot of people wanted and was independent for a long time. And it's it's really big. There's not so many of these size groups anymore. There's there's very few and and CCRM got one of the last ones of that size. Next story. There's a big CEO change at one of the largest fertility companies in North America. That's us fertility. You of course know them from Shady Grove fertility Mark Segal, having been the CEO there then going on to be the CEO of the newly formed parent company that was formed in 2022. With the backing of the private equity firm amulet capital they took. They took one of the groups in Florida fertility Fertility Center of Illinois and RSC of the Bay Area to form us fertility at that time. Mark Segal, who had been the CEO for 25 Five years at Shady Grove, went on to become the CEO of that company. And it will be stepping down come the New Year, the new CEO is Richard Jennings. Jennings was the CEO of California cryo bank and then went on to be the CEO of generate life sciences, Derek lifesciences was acquired by Cooper in 2021. What this could mean is I wonder if this means companies like us fertility will be looking to expand more in the third party space, acquiring companies that are either surrogacy agencies or donor agencies or both. I think a lot of networks are creating their own. And it might make sense to do some acquisitions, it probably does make sense to do some acquisition. So I wonder if this would if Jennings being CEO of us fertility will help with something like that, if that's part of their vision. And I also wonder what this means for Shady Grove, because I don't know who the shady the CEO of Shady Grove is right now. I probably should. I don't know if Mark Segal held that position as he became the CEO of us fertility, according to his LinkedIn profile. He didn't I don't know what that means, if you just marked it, as you know, through that time through 2020. Or if if he was concurrently serving in that position, if they filled that with someone else, or if they decided not to feel that because they then had a parent company and US fertility and didn't feel that they needed that role, but perhaps a different type of President role. I don't know that somebody's probably going to get a bunch of texts saying how do you not know who this is and update me and you are absolutely free to do that. A big story on the fertility benefits coverage front is Walmart signing with kind body for a number of years, I thought that it was a one horse race with progeny, maybe it would become a two horse race with carrot, and then kind body started adding employer benefits as they grew into the company that they're building. And now maybe it's a two horse race, maybe it's a three horse race. Walmart's a pretty big deal. Insider reports that the benefits include financial support of up to $20,000 lifetime for eligible surrogacy and adoption costs that they are rolling this out company wide. And this is a company with 1.7 million associates but insider doesn't report how many of them will have access to that benefit or what the vesting terms are in other kind body news channel too. And Houston reports that came about he is opening and clinic there is that big news. I think it's big news because of what Houston is. Houston is sort of the anti Phoenix in terms of consolidation of clinics. Houston was a market that consolidated relatively early relative to the rest of the country. Of course, you had HFI Houston fertility Institute, which had sold their lab or at least part of their lab to Vera that was in the early days, sometimes in the mid 2000s. And then we've seen a lot more acquisitions since a spire had acquired Houston fertility specialists to have a spire Houston. They later went on to buy after they merged with Prelude and who had already acquired the Vera at that point merger acquired with Vera at that point they had, they had HFR as part of their portfolio, but then went on to buy the rest of the practice. The center of reproductive medicine was the last sizable independent practice in Houston. And then last year, they were acquired by Shady Grove fertility. So Houston has been a very consolidated market, there still are a few, much smaller independent practices there. Maybe they'll grow. But now there's more competition coming into that marketplace. Finally, the media outlets suggest reports on a update to a story that you've probably known about for some time, but this is the first time I've heard about this. And it sounds like they're now going after the clinic. So you've probably heard about the Sofia Vergara lawsuits that have been happening for the last decade or so with her ex fiance, Nick Loeb, if I'm understanding that correctly, where he was suing her to prevent her from taking the embryos from destroying the embryos. And he did not win that lawsuit over several years of litigation suggests now reports that the clinic itself is being sued. that art reproductive services, which I believe is our Reproductive Center in Beverly Hills, is now being named by Nick Loeb in the latest suit. This is reported as of October 9 22. I can't give you too many more legal insights here. I'm happy to have one of the reproductive attorneys that we've had on in the past, come back on and talk about more protection for you doctors and covered entities. But what I can see happening here is that the plaintiff, the ex fiance, didn't win against his ex fiance, who was probably well lawyered up. And so now he's going after another target. He didn't go after the fertility center at first went after his ex fiance he lost. And now for whatever reason, perhaps for this further say I have no idea is now going after the clinic. So I think it's something to think about for Fertility Centers that even if you might feel that, okay, this clearly isn't between us, you may need some extra legal protection, simply because you might be the easier target to go after in terms of arsenal of legal defense. That's a bit of my speculation. But that's the latest on that case that's being reported in the news. These are the insights that I have for you. Hopefully, you're talking about them at ASRM and sharing this episode and talking about these headlines, because we want to create a lot more news for you. In the future. We're working with journalists to bring original news stories for you. I've given you the stories that are currently in the news. We will expand the podcast coverage, we'll expand the news coverage. It's for you, the doctors and the nursing managers, the practice managers, the executives working in the fertility field, so that you have this news firsthand, into your mailbox. And thanks to the sponsors, that will be a part of it. And thanks to you all for listening. And if you've enjoyed this direction, please let me know please send me an email because it helps us to decide what content to cover next. Hope I got to see you at SRM and hope you have a safe journey back.


17:23

You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society. Visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health


155 Where does the money go? What's new? What's different? With Executive Director, Dr. Jared Robins

This week on Inside Reproductive Health, Griffin Jones hosts guest Dr. Jared Robins, Executive Director at ASRM, to discuss all things conference. Tune in to hear what innovations are coming to the annual gathering for 2022, where all that endowment money comes from (and what it goes toward), desired outcomes for the future of ASRM, as well as an exchange of ideas on the business of business in medicine.

Listen now to hear:

  • What Dr. Robins has been working on since being named Executive Director of ASRM.

  • What the new and improved events and features will be at the conference, and how you can benefit from them. (Hint: fireside chat, networking lounge, interactive e-posters, Med-Talks, and more).

  • Where ASRM endowment money is procured and what it funds.

  • Griffin question Dr. Robins on the validity of disclosures in the medical field regarding business interests.

  • Griffin press about the level of influence business and medicine should have on each other, both financially and philosophically.


Dr. Robins’ information:

LinkedIn: https://www.linkedin.com/in/jared-robins-68a2825b/

Transcript


Dr. Jared Robins  00:00

As the healthcare providers and the business people should can't work, can't make decisions in isolation of each other. And they need a forum by which to come together and make those decisions.


Griffin Jones  00:14

Dr. Robbins, Jared, welcome to Inside Reproductive Health.


Dr. Jared Robins  00:19

Thanks, I appreciate you having me. Having me. join you. I'm excited to be here.


Griffin Jones  00:25

Your motto could be I'm not always the executive director of professional societies. But when I am, it's ironic because I don't want to call you the most interesting guy, Jared, because I don't like I don't like inflating egos that much. But I think it bears a little bit of talking about on the show you and I had dinner together in Atlanta, and I got to learn a little bit about your life. And I always say, Wow, this is like the Dos Equis guy. Is it you know, you said oh, yeah, I used to live in Atlanta. Oh, yeah. What? When was that? Oh, back in the 80s when I was a firefighter what? Oh, yeah, I was a firefighter for five years before I went to film school. What? And so let's can we tell people a little bit about your life before med school before we get into your trajectory as around?


Dr. Jared Robins  01:09

Sure. So I was doing some fire did some work because mostly working as a paramedic with the fire department in the northern suburb of Atlanta, what,


Griffin Jones  01:21

what brought you down there because you grew up in New Yorker, Long Island. Yeah, I


Dr. Jared Robins  01:25

i grew up on Long Island, I always wanted to be a firefighter paramedic, long wait to do such in the New York area, was looking at schools in order to really in most fire departments. In order to advance through the ranks, you had to have an associate's degree or a bachelor's degree, depending on how high you want to join the ranks. I always wanted to be chief, you know, and so I knew I needed a bachelor's degree. And I applied to schools, Emory was one of the schools I applied to the firefighting magazine was advertising heavily for fire departments in and around the Atlanta area. And so I applied to needed to pay for school. And also, I mean, I think that that was a big, big concern for me, as I wanted to go to


Griffin Jones  02:09

college, I had to pay for college. So you were a paramedic while you were at school. Correct? Yeah. And that why film school.


Dr. Jared Robins  02:19

So I was a, I was had an interest in in film and arts, and, you know, what creative thinker, and, you know, it was going to college really, for the degree more than for the knowledge and so I thought I would do something that was gonna be really fun. So I was a film studies major with the bio minor, and then, you know, as kind of progressing through school, decided, I think, really, through my experiences, as a paramedic, really decided that that medicine was going to the way I was going to be the way I went. And so, you know, made sure I hit my medical school prereqs. But I'm not really sure that that was the way I was gonna go when I was when I started the application process, but wanted to make sure I had those prereqs in case I decided that that was an avenue that I wanted to pursue.


Griffin Jones  03:05

Do you ever end up working on any films or TV? Do you


Dr. Jared Robins  03:09

did some short, you know, some short school type programs, but never anything professionally? Now?


Griffin Jones  03:14

How did the transition to medicine happen?


Dr. Jared Robins  03:18

Really. So, you know, had a strong interest in science. And so was taking some of those science classes along, you know, in school nature, like I said, I hit those prereqs I was in a fraternity as well, a lot of my fraternity brothers, were taking the MCAT, my girlfriend at the time was studying for the MCAT. So I thought I would take the MCAT to just see how I did and did well on the MCAT and just, you know, sort of almost out of fun applied for to Emory into state university of Stony Brook for to see if I would get into medical school and I did and had a long, you know, sort of inner conversation, you know, deciding is this really what I wanted to do talk to my friends, my advisers, my parents, you know, prayed on it a little bit and decided, you know, I thought let's go to medical school and see what happens. It doesn't mean I can't be a fireman in the end. But let's see how back to school goes. So State University of New York at Stony Brook was relatively inexpensive at the time. Not anymore. But and so I would be able to go there to school and not have to worry about taking out a whole bunch of loans. And so I went to medical school and I loved it.


Griffin Jones  04:29

So that brought you back to Long Island and then and then did the did you immediately do residency and OB GYN and then immediately sub specialize or was there a time between no being an OB GYN and sub specializing?


Dr. Jared Robins  04:45

So it's interesting. So obviously, when I went to medical school, I thought I would, at first I didn't know what I wanted to do, you know, my interests were trauma and, you know, trauma surgery, you know, and those sorts of things and you know, So I took my you know, in medical school, for those that don't know you do in your third year, you do what's called clerkships where you essentially spend time on the wards in the different fields. And knowing that I wanted to do surgery, and OB GYN is a surgical subspecialty. And this is actually a common story about what we do when I scheduled my OBGYN rotation immediately before my surgical rotation. So I would have that surgical experience, I would feel like you know, more confident when I walked into the AOR to impress the surgeons, and I loved OB GYN, I felt like there was a lot of some of the things that OBGYN had that that surgery really didn't have, is that idea of really being part of really developing a relationship with you, with your patients being part of the family. And, and I really love that idea of having that, that, that closeness with your patients with that ability to really impact, you know, someone's life over the course of their life. And so, but I also wanted to be a surgeon, so obviously weren't really was the best of both of those worlds, you had that ability to, to, to be a doctor, you know, to be a part of their family as a doctor and to also, you know, be a surgeon. And then we presented the chronology, which was relatively new, you know, this is now 1990, early 1990s. So it's a relatively new field. And there's this that ton of creativity currently going back to those roots of I was a film studies major. You know, there was that idea of being able to be creative and innovative and really thinking, you know, long term about how to solve problems. And so I was really drawn to that reproductive endocrinology can making families what can be more fun and exciting and rewarding than building families and, and at the same time, being creative and innovative and being able to do surgery that so it really


Griffin Jones  06:56

was often here are you guys that like surgery say that Rei isn't enough surgery for them that they miss surgery? Do you find that to be the case?


Dr. Jared Robins  07:05

So you know, I think that the art, the art world has definitely changed a lot. Since the 1990s. We did a lot more medicine back in the 1990s. You know, we we were this you know, we started laparoscopic, laparoscopic surgery in many ways, it's was started by the RBIs. And so, a lot of that, you know, we now consider make surgeon make surgery. It's it was an offshoot of REI I think that um, you know, we become very, we become less surgical, surgically focused a lot of the reprogramming chronologist out there, there's still a bunch of us that still do a lot of surgery now. And so I think it's, you know, I think we as individuals have to sort of find our way, ASRM, through the Society for Reproductive surgeons actually has a surgical track that surgical scholars track for reproductive endocrinology fellows. So those fellows that really do want to be more surgically involved can be part of that reproductive surgical tract. And and, you know, these are programs that have higher volumes of surgery. So there is so it is out there for a lot. I mean, my practice certainly became much less surgically heavy as I as I got older.


Griffin Jones  08:11

Well, that's a good thing for the fellows and residents to learn about. If you're listening, if you've been on the show before and you're wondering, Hey, Griffin didn't ask me that much about my backstory. Why not? I don't know go to film school and be a fire department paramedic for years and and tell me about it dinner sometime because I think it's interesting. So let's fast forward a bit. And, and let's get to the position that you are that you now hold that ASRM, which is a full time position as executive director for the American Society for Reproductive Medicine. And let's talk about how that came to be.


Dr. Jared Robins  08:51

So gosh, so you know, I, I went to business school. I graduated from Kellogg with my MBA in 2020. And was thinking about ways in which to really have an impact on, you know, on our health system. Really my interest in,


Griffin Jones  09:12

in what did you decide to do the MBA, so I


Dr. Jared Robins  09:16

really wanted to learn to be more involved in healthcare operations that I felt like to after the healthcare system is rapidly changing. You know, big health systems are not run by physicians, they're run by MBAs and attorneys. And and but why


Griffin Jones  09:33

why an MBA and not an M H A, then if it was healthcare operations that interested you. Yeah.


Dr. Jared Robins  09:39

I mean, it's its business. It's really these big businesses that are having such an impact on our health system, not just in reproductive biology, but throughout the whole entire health system. For me, getting my MBA was just learning a language right? I never had any business classes again, film studies many directly weren't, you know, we weren't looking at business classes. And so, you know, as a division chief, so I was division director of reprogramming chronology at Northwestern. And, you know, so much of my job was understanding business. And, you know, we all Northwestern worked as a dyad. So it was a physician and a business person sharing the role of running these practices. And I really felt like there was a language that I understand that, you know, medicine has its own language. And we know that when we talk to patients, we have to remember that we have to read, you know, think in lay language, not not thinking in medical language, and business has its own language as well. And I just didn't need to know what that business language was in order to really be able to effectively run a practice.


Griffin Jones  10:48

And you say business language, what are you referring to financial modeling? What do you answer


Dr. Jared Robins  10:52

modeling, p&l sheets, even in marketing, I mean, there's just a whole, you know, the way in which the way in which people spoke was very business oriented, right, it had its own focus. You know, when when they're talking about the price setting, and that and I cannot economic, the economic modeling behind that, and when, when we're dealing with insurance companies, and you know, talking about how, you know, to negotiate, and all of that was stuff that I had really never learned, I was terrible negotiator, 233 courses, and, you know, I took 12 negotiation credits at business school, I think that was really important to understand that and really looking at the system, even how to do things like how to affect change, how to how to lead up, you know, these are all business concepts that physicians really never learn. And so I really felt if I was going to be effective at changing the way the health system is that there needed to be more doctors involved in that. And in order to be at the table, we needed to know the language. And because, you know, we were being told as physicians by these health care, business practitioners, that you know, we should stay in our lane, you do the doctoring, and we'll do the operations. But I felt like how can they do the operations if they don't really understand what we do? And so they really needed to have that physician voice at the table until we understood the language, we wouldn't get that voice. And so really, I was like going to language school for me to go to business school.


Griffin Jones  12:30

Were there any other physicians in your class at Kellogg at that time?


Dr. Jared Robins  12:33

So Kellogg actually has an interesting program. So first of all, there's a lot of business there's so the executive Health Program has a bunch of doctors in it. And then they also have a joint MBA residency program with a couple of the residency programs at Northwestern. I wasn't in any of those because I really didn't know anything about business. I felt really like a blank slate. I wanted to do a traditional MBA school. So, you know, Kellogg was like, Are you sure you want to do this? You don't want to be in the executive program, you know, you're kind of old. And I said, No, I really want to do a traditional program. So I actually did what they call the managers program, which is a part time evening and weekends program, where it's typically young managers, the average age in the class is around 27. It was definitely the oldest by far. I didn't have any other doctors although after I joined the program, a couple of doctors joined a couple of young doctors behind me. So but it was not a program that was aimed at physicians, it was really aimed at managers. And so for me, it was really getting that basics. I mean, basic accounting, right? Financial accounting and managerial accounting. It's one of those real basics that they may not have covered as in depth and a more senior program.


Griffin Jones  13:51

I want to talk about how that led you day is around. But I do you think it's interesting enough for the audience to sidebar for a moment on the type of negotiation that taught you at Kellogg, because from what I've come, Kellogg seems to be the greater proponent or perhaps a louder proponent of anchoring in negotiation. Whereas mo very often negotiation schools and teachers in negotiation will say, Never say the first number never give a number first. And I've done both in my career a lot. And I see that there are uses for each tactic. But generally speaking, I think it does make sense to say the first number in many cases. What were you taught there?


Dr. Jared Robins  14:41

Yeah, so College definitely is about first of all, Win Win, win win win win negotiations, right? I mean, that's a big belief in the Kellogg community is that your negotiation should always be win win. But but they do focus a lot on anchoring. I think that you do. You know, I think the anchor thing is important because it sets the tone of the negotiation. But you know, the fear of anchoring is that you could, you can anchor yourself out of a negotiation as well, right? If you, you know, if you think, all right, I'm gonna anchor high because I know we're gonna settle somewhere in the middle, you got to make sure you're not too high, because that just, you know, anchor yourself out. And so I think anchoring is definitely a big focus of, you know, and being the first to make an offer, I think it's often a really good strategy doesn't always work. And, you know, in a lot of ways that I took 12 credits, I took a bunch of negotiation classes. You know, it doesn't always, you don't always want to be the first anchor, there are definitely situations where you where that may work against you. But, you know, I think that there is definitely a focus on making that first offer. And making it realistic.


Griffin Jones  15:52

Negotiation is interesting, because you have so much to gain in a negotiation. You know, when you come by, if you go and buy a car, you buy a house, you buy a mattress, it doesn't matter, just by asking, sometimes one question can save you hundreds of 1000s of dollars, but you can, and you couldn't make that money in that in in a 10 second timeframe doing anything else. And that's what makes negotiation so valuable. And then on the other end of the spectrum, is that sometimes it's negotiation can just really hamper speed and say you want to you want to get out of there. And so anchoring does have to do with with that sometimes, sometimes you don't, it ties back to value based pricing, too, right? Yes. Let's use an example outside of medicine, so that we're not putting anybody on the spot. But let's pretend we're a web development agency. And we are a niche agency for financial institutions. If we're just selling website development, that we're being commoditized against every other web developer, that's an area where we actually do want to do value based pricing, because we want to see how many more loans do you want to sell? How many more? How many, how many more credit card applications do you want to bring on, because we know how to increase those by X percent. And so you would want you do want to do value based pricing. And you might, you probably don't want to anchor in a situation like that, because you want to see what it's really worth to that person because you're going to help them get a certain amount of outcome. And then there's other times where you just want to move as quickly as possible, and maybe not as quickly as possible. But you but it is better just to have a good position, say this is what the price is either you want it you don't and you can move through engagements more rapidly. Do you have a view on two views?


Dr. Jared Robins  17:49

So I think, you know, the kind of bring it back to kind of the question as to how I got to SRM. You know, or what, you know, what did my MBA teach me that brought me to SRM. I think that what negotiations to me was more was not only learning about how to, you know, work your way through a dealings, it's, you know, in order to be to be good at negotiations, you have to ask good questions of your of the person with whom you're working. And that brings you back to that whole idea of values, like, what's important to you, you know, where you're under, you know, really understanding where, what, what is what's critical to them, and that in their need, so that you can make your offer, you know, to fit that what that value structure is. And so it's for me negotiations was about how to ask good questions about person's values, and what's important to them, and, and, you know, where they're, you know, where their needs are. And that's what I feel like, I have to do a lot of this around, like, you know, my goal is to create value for our members. And that's about, you know, arrows say that I'm negotiating with them, because I don't, it's not like, you know, again, it is that idea of a win win. But, you know, it's about understanding where their needs are and what and, and what their values are. And developing programming and value based on those needs.


Griffin Jones  19:10

Depends on how semantic we're being right, expansive enough definition, everything's in negotiation. But tell me about the Win Win concept. And what did you learn there at Kellogg, and how do you think you're into that? How do you think you're using that principle in your position today? So I'm the Win Win concept of negotiation?


Dr. Jared Robins  19:33

Yeah, I think that. Again, I think we have a very diverse membership that, you know, very interesting and diverse membership, and we, you know, we need to make sure where we're fitting a lot of different needs, right. And as ROM, you know, it's we're not just an organization of physicians, where, you know, we're an organization that's actually 50% of us are physicians, and the remainder of the organization are business people and, you know, nurses and radiologists, mental health professionals, genetic counselors, and we have this diverse group of people, and we need to be really, you know, make sure that we're fitting everyone's needs. And so we know and with limited resources, and so there is definitely that negotiation among, you know, I often negotiate with my, with my, with my executive team as to, you know, what is going to be the next thing that we do have to negotiate with our, with our, with the board, right, to make sure that we're, you know, that we're, you know, fitting everyone's needs and, and, you know, and with members who are, you know, went when, you know, who, who want things done now, or, you know, what is, you know, who, you know, to develop the right programming, I think that there's, there's, there's lots of opportunities for negotiation. But, you know, we definitely don't want to see any of that negotiation is adversarial, right, I think that we, you know, my job is to is for everyone to, to get what there was to meet everyone's needs here. Right. And so, definitely thinking about ways in which to try to, you know, accomplish that with limited resources, limited time, small staff.


Griffin Jones  21:17

I want to talk about what you're trying to accomplish, given those considerations in wrapping up this, this negotiation side segue, did Kellogg teach you all to use the word fair, early? And often? I forget where I picked that up, but I find that it is it's perhaps even more for me than it is for the other person using the word fair, when I'm talking to them. Do you find this to be fair? Do you would you agree that this is fair? I when I do that, it makes me scrutinize my interests more. Is this really is, is the other party really going to gain from this and and then I'm also detaching from something where if it just isn't a good fit for me that we part ways friends. And so I find it really, really useful. Did that come up at all?


Dr. Jared Robins  22:10

Again, values, that idea of when we're in fairness, using the term is this fair, it's something that we definitely do a lot.


Griffin Jones  22:19

So, so I'm getting how, like, you had this interest for really figuring out how the healthcare system works, not not just your fertility practice, but like really getting a handle on how healthcare works, and that it's inseparable from business in many ways. And in order to understand that language, you had to get your MBA and that gave you a foundation for being able to run SRM and being able to bring in this this Win Win sense from of negotiation and and problem solving. But how did like, but how did like it actually be the SRM position.


Dr. Jared Robins  23:03

So the SRM position was available. As firms and organization I've been involved in over 20 years, I think that it has a great opportunity to have a strong impact on the field of women's health and men and construction of the Women's Health Organization. Let me back that up and say, on reproductive health, both for men and women, and from an advocate education standpoint, from an advocacy standpoint, from a research standpoint, but like it really answer him encompasses everything that that has been important to me, as I move through my career as a Republican technologist. And so given the opportunity to lead an organization that that has such breadth and reach was, was just an office and opportunity I couldn't pass up I'm really excited to, to be here. It's been eight months now, drinking from the firehose really learning about the organization from the inside. You know, I think that I mean, I've done the organization, I've been a part of this organization and a leader in this organization for a long time. But being on this side of the curtain has really been been eye opening in terms of just opportunities and creation of opportunities. And it's been really fun. It's been a great, it's been a great eight months. So I'm hoping that it's a lot longer. And it will see some of the fruits of that of that work as we get to our annual meeting in a couple of weeks.


Griffin Jones  24:33

And so everyone listening knows you're not doing this remotely from Chicago, you moved down to Birmingham. I did


Dr. Jared Robins  24:39

I happen to be in Chicago today because I'm going to be at a Chicago meeting tomorrow, but But yeah, I moved to Birmingham and I'm living you know, our headquarters are in Washington DC, but we have administrative offices in campus in Birmingham as well. And you know, because of the fact that that are so much of our operations happen out of Birmingham, I felt it was important to be close. To those people and so I'm living in Birmingham. Now,


Griffin Jones  25:02

I want to hear about the fire hose that you're drinking out of. But I thought this could be interesting as from history, because I bet you most people don't know how did alstrom end up being headquartered in Birmingham, Alabama,


Dr. Jared Robins  25:16

we had a, we had a leader, you know, a CMO that was part of UAB. And so that's how that's how it became part of it. Yeah,


Griffin Jones  25:27

it was, it was the inception of the society or years after,


Dr. Jared Robins  25:32

sorry, it's actually been around since the mid 1940s. But the headquarters was actually, you know, it. It rotated from sort of President to President and you know, before it became, you know, before it became established, you know, with a full staff and, but when it when it finally got headquarters, and when it finally really bought a building in the 1970s in Birmingham, so it was that building that that started at sort of headquartered,


Griffin Jones  26:01

low, some, you know, you sponsors that do all of these little events for trivia night, go ahead and stick that one in there for your for


Dr. Jared Robins  26:09

your whole answer. I'm trivia. Either do with our board, we'll do


Griffin Jones  26:15

a whole episode on SRM trivia. Somebody would somebody would sponsor it. Anyway, let's let's talk about like you said, you're drinking from the firehose, which is the case in many leadership positions, and certainly one with society's largest ASRM. What, what are the things that you're like getting your hands around right now?


Dr. Jared Robins  26:38

Yeah, so, you know, I think that, um, obviously, you know, we have a, I had to learn a lot about, about our budget, about our endowments. So that was a, that was learning a lot, I learned a lot about, you know, where the money goes. So that was a, that was certainly something we can talk about, you know, focusing on our meeting coming up really how the meeting is run, you know, I think that we all go to this meeting, I've been going, I've been at this meeting every year for almost the last 20 years. And, and the meeting just just happens, right? I mean, we have no idea when we're attending this meeting, the amount of work that goes on behind the scenes to get to make this meeting happen, the numbers of vendors that we that we have that necessary in order to make sure the meeting runs properly, from the electronics and the lighting to, you know, to staffing the rooms, I mean, it's just, there's so much that goes on in running this meeting, and I just had no idea how just how much there was and how hard these people work, in order to really, you know, the SRM staff is just unbelievable, when it comes to me, you know, when it comes to running this meeting, and, you know, the entire staff is, is actually at this meeting, making sure that it runs smoothly. And so, you know, I suggested changes, as you know, because you're involved in some of these changes at this meeting. And to make these happen, I was like, Oh, this will be so easy, let's just do that. Let's just do this. And, you know, the dominoes that that suggestion created, and in order to make it happen, and the staff did, I mean, you know, I came in with this idea that I wasn't going to make any changes, because I really just wanted to learn the organization. You know, I came in at a time when it was sort of at the end of the planning of the meeting in January, because the meeting is planned at months in advance. And, and I was like, oh, you know, we should really have more of this at the meeting. And we should really do this at the meeting. And, you know, my staff was like, alright, well, we're just gonna listen to this crazy guy and make these things happen. And, and I think that, you know, learning what, what actually took to me, these small, what seemed to me to be small changes happen was, was amazing. And I'm so lucky to have this incredible staff that I work with


Griffin Jones  28:50

every day. I want to talk about a couple of those. Let's let's you said we could talk about where where the money goes. So where does the money go? Jared?


Dr. Jared Robins  28:59

Yeah, so, you know, we we have? We have a lot of endowments. Right. So a big focus of our money is the Research Institute. Right? We have, we've established the Research Institute was established in 2019. By committee, and, and that, and that is to put that the purpose for the research institute is to make sure we're getting projects funded that wouldn't be funded through traditional funding mechanisms. So, you know, stem cell research, we know we can't get funded through through the NIH, or we're trying to do nursing research. We have, you know, funds set aside for that. I mean, really, you know, things that are very relevant to our field that are going to move our field forward, but when they get funded through traditional funding mechanisms this year would give me over, you know, over a million I want to say, as close to a million behalf, but I don't want to overstate the truth, but it's definitely over a billion dollars in grants this year. And so a large part of our endowment. You know, when you look at how much money we have, you know, a large part of that is committed to the Research Institute, in order to make sure that we can do that funding, and in order to really have that endowment fully funded, we needed a whole lot more money. Right now, you know, we're trying to only use, you know, interest generated from the research institute in order so that we don't have to touch the endowment. But we all know what's happening in the financial world right now. And so, you know, our endowment is certainly not going to last, that market doesn't turn around. You know, another big part of our endowment is the Center for Policy and Leadership that that recently launched, we're really we're pushing the launch for the Center for Policy Leadership at the at the annual meeting this year. And that is a nonpartisan Think Tank. Right, we know that reproductive policy happens. And and there are a few things tanks out there that are that are helping to inform our policymakers and the public about what the implications of these policies have the of developing this, this policy and law, we, you know, a lot of them are biased. And these think tanks and a lot and none of them are really run by reproductive medicine specialists. And so we have put together a Center for Policy and Leadership to the SRM to be a nonpartisan at, you know, think tank to help provide policymakers with data. I think the PERT the example that we're that, that they're focusing on a lot now is just data to access to care. So we, you know, the we're helping the military to develop an Access to Care policy for Reproductive Medicine. And, you know, our one of the white papers that we put out is what would that cost the government in order to do that, so again, it's non partisan, partisan, and just information, research developing concept. And so that's, you know, that's a lot of went in depth. So we have some educational endowment. So you know, this money isn't just available for us to use, when we look at our endowment, we have about two and a half times our operating budget and on declared funds. But that's fairly modest for organization of our size. You know, the rest of that the rest of that the money that we have sort of as our as our, you know, money in the bank, they're committed or dominant. So, you know, people have donated that money for specific purposes, and we really can't touch that, but except for the purposes for which they're, you know, have been, have been endowed.


Griffin Jones  32:34

Did the endowment, did the damage just come from donor funds? They also come from sponsor funds. How does that work?


Dr. Jared Robins  32:41

Yeah, so some sponsor funds, some donor funds, it's also it's donated money, right, where we're a 5013 c organization. And so it's money that's been donated to answer for for these purposes.


Griffin Jones  32:55

So but it does, like, when a company gets a big boost, or does a Ruby sponsorship at SRAM, does that ever go to the endowment? Does that go to OP X for earmark for the event? How does that work?


Dr. Jared Robins  33:08

Yeah, so the funds that we raised, say, I thought at the Expo at Amsterdam, that's all going towards operating funds.


Griffin Jones  33:16

So he talked a little bit about the things that you want to do. And you did. The Research Institute was established in 2019. Before you there's also the Center for Policy Leadership. But you also said that I want to start doing some things that ASRM and your staff said, Okay, well listen to the crazy guy and do what he wants. I know what a couple of those things are, because you did the SRM med talks, for example, business of medicine. There's probably others that I don't know about. So why don't we start with those to tell us what's going on?


Dr. Jared Robins  33:55

Yeah, so let's talk about SRM med talks. One of the criticisms I've heard in my years as an SRM member is that we should have, you know, some, some might some some small clinical focus, right, let's let's focus on what can we do clinically? And so what we conceived of was these short macro learning this, you know, short talks, 15 minute lectures on clinical topic. I wish I had them in front of me, I would have been really smart to have for this meeting. So one of them is like disasters in the in the IVF. Center, right? So we have someone who is going to talk about how to prepare your lab, you know, your to protect your cryopreserved tissues in the case of a disaster. We're going to talk about, you know, the what, how, how Kerrygold medicine talked about how she responded to Hurricane Sandy at NYU when they had to worry about, you know, protecting their tissues. And so we're going to do these short 15 minute talks. That like crossover, the different specialties, right? So we're going to have maybe a talk from our urology group, talk from our we're going to be chronology group, and maybe a talk from the nurses, you know, so that we're covering all the areas,


Griffin Jones  35:13

I'm giving a talk on how to use messaging to engage patients and staff,


Dr. Jared Robins  35:17

so I could have helped you. One of our topics is, is actually how to improve patient engagement. And so you're going to be talking about patient engagement, we're talking the urology group, and that same lecture group is going to talk about when you know, appropriate referrals to the urologist and how the urology in the REI should partner to, you know, improve patient engagement and in that fashion. So, again, so that way, we have a business person, we have virologist, you know, we're trying to cross over, I think that same group, we have a talk on, on the use of EMR, for instance, I think in that group, as well. And so, you know, this idea of the EMR portal, so this whole, this whole idea of how, you know, we want to be we want to a group of talks that have clinically oriented, but that span the whole society, so that the our business people, our medical people, and our nurses, for instance, could get together here a group of talks, and that would spark conversation about ways in which we could practice better. And that was really the idea behind the that talks is, you know, is to create, just to create a conversation, where everyone is where all the different areas of our field are able to get together. And here are a series of talks that that can, that really could could interest all of them. And spark conversations, sparking conversations is right next to where the man talks are going to be in the exhibit hall, we've developed that networking lounge. Again, one of the can, one of the concerns and complaints about SRM is that there's no place to just network with people that you know, there's, there's often like, chairs or tables set up in the in the hallways, but not really, you know, those could often be taken, you know, if you want to sit down with a group of like minded people, there wasn't really a good place to do that at the meeting. And networking, when we when we polled people about what they're what the value they get out of the meeting, a big part of that is networking. And that's why it was so important for us to be back in person this year. Because, you know, the online meetings were great from a content perspective, but miss that idea of being able to just network with your colleagues. And so this year at the meeting, we've established a networking lounge, that networking lounges will have some some programming there. So we're going to do, for example, meet the editors. So you have an opportunity to get together with the editors in an informal setting. But the whole idea is it's it'll be a place for us to be able to sit down and talk and network with each other without having to go searching for a place somewhere in the convention center. You know, if you want to get a group together, you can say, you know, meet us in the networking lounge at 1030. And, and I think that that is sitting right next to these med talks. So you'll be able to if you know, we just had a really great talk, let's all go chat about it. Now. You know, let's we're you know, we're going to talk about it the business of medicine session, too. So we did create the business of medicine session, the our association for reproductive managers, which Griff is a very, I think it's I think you're on the board right? Is a board member of that organization and really important organization to ASRM, it's, you know, it's a group of managers of IVF programs and of REI programs. And we turn to to arm and said, we need to we need to have more business at this meeting that, you know, I think one of the things that we hear often is that our physicians and again, I can speak personally about this don't have an opportunity to learn much about the business of medicine. And we we have a lot of business people that come to the meeting, we want to make sure we're creating value for them as well. And so we're, this year we're doing two sessions on the business of medicine is involved in involved with them. We're doing a TED talk session, four or five hours for five sessions, rather five TED talks, I think it's five TED talks, maybe three TED Talks. We're doing a group of TED talks like God, we're doing a group of TED talks on the business of medicine on Monday. So with question and answer sessions, we have some excellent speakers that are coming to give those TED Talks and then the following day, so that's Monday and then on Tuesday, we're doing a CEO fireside chat that Griffin's gonna be moderating for us, where you have an opportunity to talk to we have representatives from a variety of different types of practices from private equity to physician owned academic practices, and private Demmick and private dynamic practices and we're going to talk about how we how What the What the similarities are and differences are and really give an opportunity for people to ask questions of these leaders. And the second half of that session, we're going to do an open brainstorming session about how to create a business of medicine track today is around. So really trying to engage our members to tell us, what do you want, right? I mean, I think, you know, I can sit down and figure out what I think you want. But, but more importantly, we want to sit down and hear from you say, what do you want and learning about business of medicine so that in 2023, we can, we can have a real business of medicine tract at our meeting,


Griffin Jones  40:39

I want to introduce a philosophical question for that, it will be useful as people come to show up and give feedback on the business of medicine track, I'm interested in what you think about it. I remember, years before I ever got involved, before I ever worked in health care, one to one of my more hippie cousins, were sitting around and said health care shouldn't be a businessman, you know, my family leans a certain way. You know, I'll nodded and, and, and I remember thinking, but, but how can that be? And I think that attitude still prevails a little bit even in our field. And in many cases, I don't think it's useful. But but the first one, the first is, is that it? How could How could it not be a business, it's in it, there are craftsmen and craftswomen there, there are people that are providing services, and there is a race to constantly improve and, and provide advantages, and by nature, that is business. And so how could you ever totally remove it? And the second one is, how much harm are we doing when we pretend that that it isn't intact? Because we want to, we want to, we want to, we want to make sure that the tone is right. And we do have did providers certainly have a responsibility to patients, patients have a certain set of rights, and those have to be protected? But I don't I don't see it as being useful to say that it isn't a business I'd see that as being disingenuous almost like, you know, abstinent, you know, it's, it's 100% abstinence on sex because sex is sex can be dangerous, it sure can. But, but pretending that people aren't doing it often leads to all kinds of perversions. So what is your view on the role of, of, of how much business and medicine should be constrained versus should be facilitated in some way like this?


Dr. Jared Robins  42:45

Look, there's all kinds of philosophies about how you know about how we should have medicine should be. I don't, I don't want to wax philosophical about that. I think right now in the world of rebirth of Endocrinology, whether you're in the US or abroad and can serve as an international society, it is a business. And, you know, I think whether whether that is a government run business, or it's a private equity run business, or it's a physician owned business, there's, we have to, you know, we have an obligation we I think we do as physicians have an obligation to meet the needs of our patients, but we have to do that in a way that, that it's, you know, economically feasible, in order to, to achieve that. And I think that the business of medicine is changing over time, you know, I think that the, that we need to understand as physicians and not even just as physicians, as a society, we need to understand that we have to understand we have to negotiate and come back to negotiations, we have to be able to negotiate and negotiate with our insurance industry, and we have to be able to negotiate with our, with our media providers, right with our, with the people of whom we're going to buy our band aids from, you know, I think that there there are, there are needs that we have, as a group of, you know, have have providers in order to in order to be able to give the best quality care, which is what we all want, right? I don't care what type of practice you're in our ultimate goal is that we want to give the best quality of care to our patients. We have to figure out a way to do that without, you know, with was still being able to make a living and keep are and you know, we all have employees. I mean, as I have nurses, we have nurses that that work for us and embryologist and, you know, cleaning people that are that we need to make sure clean our rooms. I mean, I think everyone is equally important. So we need to make sure that we can stay solvent and the way in which to do that is changing dramatically and as a society, we need to understand that In order to make sure that we can keep our practices afloat. And that's what we want to make sure SRM is providing value to help us to do that, as that business of medicine changes, we, we will continue to evolve. I think that, you know, that idea of evolving as a society is really, really important to make sure that we're constantly meeting the needs of our of our members. And I think right now, the needs of our members are to understand how to do better business.


Griffin Jones  45:28

Maybe it's always been a business, right? In the 19 centuries, somebody still made the blinkers, right. So it was just all business was smaller back then. And some businesses have gotten so good at providing certain needs, whether it be entertainment or food, that the frontier really is madness, as human beings, we don't want to die, and we don't want to get sick. And medicine is the is what allows us to constantly push the limit of those two otherwise, natural limits. And and so the the things that contribute to that, and you said, you know, it's it's affecting reproductive medicine, I think it's it's affecting all medicine, whether it's single payer, whether it's public payer, that how many companies are in Israel alone, right now working on artificial intelligence, they're not, they're not doing it just for they're doing it as part of because they know that by innovating this way, that's going to give them a competitive advantage. The people that creates laparoscopic technologies and improves the quality of health care, they're doing it because it's going to give them a competitive advantage. And so to for systems like engaged MD that didn't exist 10 years ago, improves the quality of the experience for patients. And, and, and it's a value for them to enter the marketplace. But what constraints Jared need to be in place, say, Okay, you guys aren't running the show. And I think it during COVID, we saw pharma companies take a little bit of say, doctors eventually had to say, so it's like, alright, slow down, like, Okay, once we look at the research, then we'll tell you, it's safe. You're telling us it's safe early, like we'll agree, or we won't, but But it's us that make the call. So what constraints need to be in place so that it isn't just businesses manipulating? The system for lack of a better word?


Dr. Jared Robins  47:36

Yeah, that's a really hard question. I think that, you know, I think society is like, like the American Society of Reproductive Medicine is a great could provide a really great vehicle by which people to bring people together to have those conversations. Right. I think that


Griffin Jones  47:54

lets you and I have the conversation now.


Dr. Jared Robins  47:58

Even about where what I don't know, I think the constraints are gonna be really situational. Right? I think that, um, I don't think that, you know, I think that we need to make sure we're again, we're meeting everyone's needs, right. And so, you know, I think COVID was a really difficult COVID was a unique and really difficult situation where we were getting, were we getting lots of different inputs of information. And not everyone was getting that same information, and there was a ton of misinformation. And so, right, I think that I think, ultimately, it should be, again, I think the physicians and the health, the health care providers should control healthcare, right. And it shouldn't be a bunch of attorneys and business people that necessarily tell us how to take care of patients. But we need the input of everybody, right, we need the input of the of the health, that's where that dyad, if it would work would really be a good diet, where you have a healthcare provider and a business person sort of working together. I think that neither one of those, the healthcare providers and the business people should can't work, can't make decisions in isolation of each other. And they need a forum by which to come together and make those decisions. I think that, you know, the government also had there was biases in the government and COVID was incredibly politicized. And so, you know, what I think is what the I think the can, I don't I wouldn't say constraints. I think it's about decision making and being you know, intelligent and decision makers and having a a buyer and not a non partisan like an unbiased forum like our Center for Policy of leadership being a place where we can bring those leaders together to have conversations because you know, I think that that none of those groups should be able to work in isolation of each other.


Griffin Jones  49:46

I'm going through this same how I don't know exercise, I guess you would say because I want to expand inside reproductive health beyond the podcast that it's been. It's it has been so Serving as a trade media outlet. So I want to make it more of a trade media like Wall Street Journal for the fertility field. And that means I've been working on the sponsorship structure, the advertiser structure, I haven't had many I've had very few advertisers on because I don't, I don't want to do an endorsement for most people, I simply can't. So I couldn't sell advertisers until I came up with an advertising structure. But now the audience is there and, and I'm, I'm ready to do that. But I've been putting in the policy like we have editorial control. We're going to cover the news that's at mergers, acquisitions, layoffs, lawsuits, think sometimes it's going to be flattering for businesses, sometimes it's not going to be flattering for businesses, and you get editorial control over a featured content piece, where it says sponsored feature content, and nothing else you don't get to tell me not to write about these other folks are. And I know that we're probably going to write some things about sponsors that aren't great for this company sponsors, and then they just laid off 500 people. That's but but so that's one constraint that I that I view, is there any place that you think, like we should have no industry side, industry citing quotes representation in this part of ASRM or in this type of policy?


Dr. Jared Robins  51:23

I don't know. I have to, I'd have to think about that more. Nothing really, honestly, I feel like disclosure is the key there. Right. I think that when when there is industry sponsorship, that that conflict should be disclosed. But I feel that industry is a big part of our organization, and, you know, and a big part of our of our field. And, you know, I enjoy talking to the industry and learning from them. from the business perspective, do I think that they, you know, industry should be teaching physicians how to practice, you know, no, I mean, I think there's a bias there. But I do think that, you know, we learn a lot, even when we get, you know, our industry, you know, salespeople come tell us about a product. And so, you know, do you think that, you know, as long as that disclosure is there, and people have the ability to to, you know, to hear the that, that perspective, without understanding that it's a bias perspective, it's a sales oriented perspective.


Griffin Jones  52:29

Well, this is a great question for you then and then I'll let you conclude how you want to conclude, but is, is the scope for disclosures, too narrow Jared, because I don't remember if it was asked from or PCRs or both. But I had in my disclosure, in my speaker disclosure, I own a client services firm called fertility bridge, I am a paid endorser of engaged MD, I just felt like people should know those things. And it was either ASM or PCs or both. That said, take that out of your slide. You don't you don't need that. It's just It's just if you're, if you're related to pharma, and I think as I high if you want me to take it out, I'll take it out. But I still tell people in the talk I because I think they should know, I think they should know any financial interest that I have. So is our is our disclosure system or a rubric to limited in scope?


Dr. Jared Robins  53:21

So are, so we follow the rules that are set out by the ACC or VI. Right. And so that, so our disclosures for our particular, are there,


Griffin Jones  53:29

are there rules?


Dr. Jared Robins  53:30

I do think that, you know, I think it's important to know, I mean, if you're not talking about something that, you know, you're really engaged in D, as you mentioned, and, you know, then maybe it's not as important to me to know that. But I think it's important to know, those disclosures, you know, and one of the questions that we ask is, you know, are is are you going to discuss anything that is involved in one of your conflicts of interest, essentially? Right, I mean, that is part of the disclosure. So it may be that they asked you to check it out, just because the answer that question was no, but, but, but yeah, I do think that being aware of, of educators, speakers, conflicts of interest is important, because it creates wealth, it creates a bias that's both conscious and unconscious, right? I mean, you know, I think that unconscious bias is something we really need to think about.


Griffin Jones  54:23

I want to let you conclude, and I'm gonna, I'm gonna work hard to make sure that this episode comes out before the ASRM meeting, especially you sweat. You spent half the episode talking about the meeting. So I want to, we might be able to squeak it out the week before, which would be perfect timing. And knowing that the majority of our audience are members of ASRM. How do you want to conclude either about the meeting to come or just what you'd like to see from them in the coming year?


Dr. Jared Robins  54:52

Yeah, so let me say first of all, thank you for allowing me to be on definitely I thought we were going to talk only about the meeting. So this is It's really fun to sort of talk to wax more philosophically around a number of different items and topics. I do think that I, what I do want people to know about the meeting is that we do have a bunch of new things. In the meeting, we talked a little bit about the networking lounge, we talked about the business medicine track, but I think it's really important. We, we are doing things to try to appeal to younger members and to create to creating greater values. So we are having an electronic poster hall this year, so no more printing of the posters, that's all going to be electronic. And we'll see how that works like flat screens, flat screens, yep. Flat Screen poster presentations, everyone's gonna have a specific time to present. So you're not just standing there for an hour waiting, hoping that someone's going to find interest in your poster, smaller groups of poster presentations, but, but also we're going to have the posters are going to be available throughout the meeting. So if for instance, you go to that you are scrolling through the posters, and you see my poster, I don't really have a poster. So that one happened. But you know, you see a poster from Dr. Robbins or whatever and you want to speak to that person, you can contact him through the app. And I'd say aren't, you know, I like to speak to you about your poster, can we meet in the networking lounge and chat about it. So that is hopefully going to change the way in which we view our posters. And we were going to get feedback from that at this meeting and continue to adjust that for the next for next year's meeting. We are doing, one of the big value that our organization provides, I think is through our special interest groups. And only 50% of members are are a part of a special interest group. And so we aren't trying to highlight the special interest groups by doing a what we're calling are all in reception. And that is going to be on Monday night. Where we are highest, where we're going to have our special interest groups and our professional groups and our affiliate societies all present sort of as a career fair, where you get to go around and talk to people about the different special interests and find a place that you might, you know, create more value for yourself in our organization. We're doing we talked about answering trivia, we are doing what we call live cube boost. Cube boost is a product that we've had available for answering for a while now. It's a just in time, just in time micro learning platform where you get a question sent to your email every day. And then you get to answer that question. It tells you if you're right or wrong, and then gives you links and other information around that question. Yes, my turn off. Notifications. So so. So Q boost is this micro learning platform, you get opportunities, you get a daily email, which is sent to your inbox, you get to answer the question tells you if you're right or wrong. If it's if you're wrong answering that question, it goes back into that question bank for you. And you'll get asked that question again later, and then it gives you a bunch of links to further information about that question. And in addition to a brief summary. So in cumulus has been available, it's not many of our members are really aware that keeping us out there. So we're actually going to do live cube news this year. Where we're going to it's going to be trivia, you're willing to do it as a big trivia contest, five to 10 questions and with prizes, so really trying to promote that educational opportunity. And then the last thing I just wanted to mention it is camp SRM. So again, trying to appeal to young to young families, again, we were all about building families, and we want to make sure that we're, you know, supporting our families. And one of the biggest challenges I think, to come into the meeting for many young families is they're having childcare. So this year, we're sponsoring camp Amsterdam, where


Griffin Jones  58:54

we had to big deal I didn't know about that. Yeah,


Dr. Jared Robins  58:57

and we've been advertising and advertising and people keep telling me they don't know about it, so


Griffin Jones  59:01

well don't don't know about it, when they is going to be at the convention centers, they're gonna be


Dr. Jared Robins  59:06

it's actually gonna be in the hotel, and I think in the Hilton because we didn't have room we're with all of our new with all of the new offerings and our meeting we didn't have any space for it at the meeting itself, but we will be marketing it at the meeting as well. But we want people to know about it so that you know if one of the reasons they're not coming to the meeting, I mean, the meetings in Anaheim it's across the street from Disney, you know, come to the meeting, bring your kids put them in camp ask around and at the end of the meeting, head over to Disney with them or spend an extra day before after the meeting and, you know, go over that to to Disney and


Griffin Jones  59:39

I wonder if Disneyland be being there will mean more people staying through Wednesday. You know how a lot of people often leave Tuesday or they'll leave Wednesday morning or I wonder if if Disneyland being there means more people staying through Wednesday because they want to take the rest of the week with their family at Disneyland. But that's it Yeah, you know, the in 2020 I was like, how much are in person events gonna come back? And so, you know, I think that there's always going to be a need for them they'll have to be redone in different ways than they were done previously. And you're coming back to in a big way. This is like rocket just like you're like Rocky for with in person events. Jerry, you like it coming back in a big way? Well, so this episode, we will make sure that it airs beforehand. And part of the reason why you're covering so much is because you have so much to cover. And there's just so much into those interesting side. rabbit holes for for me to go down. I hope the audience agrees. But everyone will be able to hear this episode before the meeting. It should be in great time. Dr. Jared Robins, Executive Director of VA SRM. Thank you very much for coming on inside reproductive health.


Dr. Jared Robins  1:01:06

Griffin, thank you so much for having me.


1:01:10

Inside reproductive health podcast with Griffin Jones, if you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society, visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health


Revisiting the Affordable IVF Model

This episode, originally released in 2020, Griffin revisits Secrets of The Affordable IVF Model, as we head into what could be another recession. Is your practice prepared for the potential downturn? Listen now, as Dr. Robert Kiltz, Dr. Paul Magarelli, and Dr. Mark Amols discuss their implementation of the Affordable IVF Model, and how it benefited their programs.

This episode was recorded during a live webinar, originally released in 2020

On this special live episode of Inside Reproductive Health, Griffin spoke with three leading doctors whose clinics follow the Affordable IVF Model: Dr. Robert Kiltz of CNY Fertility, Dr. Paul Magarelli of Magarelli Fertility, and Dr. Mark Amols of New Direction Fertility Centers. Together, they talk about just how they make the Affordable IVF Model work, as well as answer common objections to their services. 




Transcript

Griffin Jones:

CEOs are preparing for recession, and they don't think it will be short. That's the headline that I'm looking at on CNN RIGHT NOW. Headline Schmedline, Griffin, you can't predict the future. I cannot I have thought that the recession much sooner than it's happened, it does appear that it's here could be a bad moment. I've been preparing for recession since 2008. Because I'm Irish Catholic, from Buffalo, New York, and you should always be prepared for the worst things to happen. Some of you are also prepared for a recession, and some of you are not. And when recessions happen, bad things can happen. People lose their livelihoods, the impact that that has on health and family for people is really sad. And so for those people and those concerns, it's something I take very seriously. And then there's a part of me that for some people, I don't feel bad for when the fat cap that they had before, is no longer before them, because they could have made so much better structural improvement when times were good. Their design. No, we're getting patients now. We're getting customers now, people are offering us six 810 times, done now. And I don't feel bad for those people. In either case, now is a new time, you can decide what you're going to do. So I want to revisit this episode of Secrets of the Affordable IVF Model, how it's totally poised to win market share. Because originally did this as COVID was breaking, clinics were shut down. We didn't know how much money the government was going to pump in how long that effect would be for. And so we talked about market downturns and what's behind the affordable IVF model. And this was a really popular app. So we actually did it live first did live with Dr. Paul Magarelli, Dr. Kiltz, Dr. Mark Amols, from Colorado Springs, New York State and Phoenix respectively. And we had we had over I remember, you know, I only had 100 People limit on the zoom at that time that we, we felt that we had to turn people away and then made it into a podcast episode. So as you start to think of what it's going to be like if if companies might maybe drop coverage or if people lose employment, they don't have fertility benefits. So people have less discretionary and disposable income. And waitlists aren't eight weeks, and they start to drop down and more. How will you respond? I hope this episode is useful for you and your possible recession planning. 

GRIFFIN JONES  0:55  

I just want to maybe start the conversation off with the reason why I invited the guests that I did-- Dr. Kiltz, Dr. Magarelli, and Dr. Amols--is because they've all used the affordable IVF model in different parts of the country. And I have said for years that I think that it's going to be an economic downturn that makes that model scale. And I want to explore what that is like for those that are curious, for those that think that it's the end of IVF as we know it, for those that think it’s the best thing, I want to solicit the experience of our guests that are on board. I want to start with this concept of timing and Dr. Amols before this kicked off, you and I were talking about the fact that you were surprised that this hadn't taken off sooner. Meaning, I think what you meant by that, and I'm paraphrasing, that there hasn't been a scale of affordable IVF. What did you mean by that? And why do you suppose that is?

DR. MARK AMOLS  1:54  

Yeah, you know, I think if you look at the industry in other places they'll say like, plastic surgery, look at dentistry, almost all of those medical treatments had to eventually go down to kind of a more affordable scale and more volume. And usually when you have something that's a high cost, eventually people find a way to make it lower cost, and then it takes over, because volume will always make more money in the end over just a few cycles at a high cost. And so I'm surprised it hasn't because, again, we're doing it very well, Dr. Kiltz is doing very well, Dr. Magarelli is doing very well. It's not a hard model. And eventually, I mean, like I said, like anything, even when it comes to all the other fields of medicine, people seem to eventually narrow it down to lower cost, you know, and help more people. And it’s the concept of a big pond versus small pond, do you get a lot more fish for a lower price and then you have more patients or do you keep going after these individual fish? And it's just harder. So like I said, What's nice About our model is you really benefit from a downturn like this. So you know, when when things go down, we still do fine when people are doing well, we still do well. And so I'm surprised the model hasn't taken off more. I mean, look at Target, WalMart, those are examples of, again, high volume, affordable cost.

JONES  3:17  

And so for those that aren't familiar with you, Dr. Amols, you are in suburban Phoenix, is that right?

AMOLS  3:22  

Correct. We're in one of the suburbs of the Phoenix Metropolitan.

JONES  3:26  

So you're in one of the largest markets in the country. Dr. Magarelli and Dr. Kiltz have both done this model in smaller markets. Dr. Mag, you're in Colorado Springs, why did you decide that this model could work in a market that size?

DR. PAUL MAGARELLI  3:42  

Well, I wasn't looking at it as simply a market issue. I was looking at more of an access issue. So for me, when I sort of gravitated towards doing an affordable model, I mean, I live near Denver, I mean, I'm 45 minutes outside of Denver, so that’s certainly a big market, a famous IVF market.

JONES  4:03  

Well, now that Denver has grown out so damn far!

MAGARELLI  4:09  

Yeah, so  it was more--I have about 40,000 military folks who every two years go through the bases here in Colorado Springs. So we have an influx of very young, reproductively-active couples. So that was a resource that I knew that A) didn't have a lot of money, you know. B) at the time when I introduced it, we were in the middle of the Iraq and Afghanistan war, and so a lot of folks really needed help gaining access to what I consider one of the best fields of medicine. So it was a risk. I mean, I don't have a population 2-3, 5 million, but it turned out we grew 600% in less than four months in terms of my market. So as Dr. Amols was describing, once you give access to care, you'll be surprised at the number of folks that want it. And we, as a country, have one of the lowest utilization rates for IVF compared to most industrialized countries. And that is because of the fees. Really no other reason we have high success rates, so it's not performance, but it's really just access. And so by making access available, instead of doing, which we've done in the United States, 200,000 cycles, that hasn't changed really in about 15 years. 2 hospitals in China to do approximately 200,000 cycles! So it was more a matter of let's get more folks care.

JONES  5:38  

Dr. Kiltz, you have one of the most-known operations for the affordable model in the East Coast. And people might think New York, and they might hear Central New York and think of the New York part of it, but Syracuse is a small market--600,000 in the metro of Syracuse and maybe some more throughout Central New York. And you have one of the highest volume programs in the country because you're bringing in people from out of state and from New York City. When did that start to happen?

DR. ROBERT KILTZ  6:11  

25 years ago, nearly when we started. Obviously, Syracuse is a small market, small town. I'm from Los Angeles, been here, and I came up here to get away from the big city! But the recognition that people are travelling--

JONES  6:27

Mission Accomplished!

KILTZ  6:29

Well, that wasn't my intention, though. My intention was to come and practice medicine, do what I love to do. But I realized that there were some barriers from the way we were doing it. When I started IVF in 1997, here in Syracuse, I charged $2,000 for a self pay IVF. We have gone up a little bit over the years, but we've always been focused on affordability, access, and quality, and people are traveling for medical care and have been for many years. In IVF and Fertility Care, for sure they're traveling. And we know the very largest programs in America bring people from all over the world, and all over the country. So just like the more expensive places do that, recognizing that there's a much greater pie in the lower cost IVF than there is in a more expensive IVF. If, as Mark was saying, you know, the models of Target, and you can just say Walmart, and many other companies that are highly successful. And so that wasn't our plan, in our mission. Again, we became doctors and I became a physician in order to help people not, you know, sit around and do five cases a month, which made no sense. And if you look at the ability to be efficient, we are highly inefficient in this fertility world. And so that's not to tell anyone that they should do it differently. I just chose to do it this way. And I know Paul and Mark did the same thing. So I think there's plenty of access opportunities, but in general, most people are not going to lower the prices because there's so few of us that do what we do. There's not a need to do that.

JONES  8:12  

We have a question that came in from that discussion of quality. And I'll let any of the three of you take a stab, but I want to give it to Dr. Mag first because he talks often about making the state-of-the-art the standard and the question Dr. Mag is how is quality defined?

MAGARELLI  8:28  

Well, for me, quality is defined as performing a medical procedure in a method that has been demonstrated to be most effective for the outcome desired. So for me, quality is utilizing all of our technology and techniques for that patient, to optimize the response to the medications, to optimize the growth and development of the blastocysts, to optimize the way in which you do the transfers, and you manage the patients, to optimize and use all of the systems that have been known to be effective like ICSI, like a 5, 6, 7 blastocyst culture. vitrification, you know, frozen embryo transfers, use everything possible. It's like, if you break an arm and you go to the emergency room, quality care would be a cast. Something that isn't quality would be a bunch of band aids to help you. It'll work. With enough band aids, it might help your broken arm, but no other field in medicine can give what I consider less care and consider it good care. So to me, quality is providing what we all know and all of us here are board-certified, all of us have been in this for many years. We know what works, the patient doesn't. So let's provide them with the best of the best that we have to offer, and then let their biology determine their success. So for me, quality is defined that way.

JONES  9:59  

I'm not a clinician, but I know that not all of our clients use ICSI on every cycle for example, what about those that say, well doing ICSI on every cycle, that's not necessary? Or do we really know how much PGT impacts successful pregnancy rates? Should we really be doing that on every cycle? How do you respond to questions like those?

MAGARELLI  10:18  

Generally? Or just me?

JONES  10:24  

I brought you on because I want to hear the Magarelli answer!

MAGARELLI  10:28  

Okay! Well, the answer is yes and no. The answer is not every technology works for every person in every situation in every circumstance. You can offer it, you can offer it in those circumstances. We are a learning profession. It’s the art of medicine. We grow and discover and yes, when ICSI first came out, it was considered only for a certain subset of male factor. And then it was broadly used and it is broadly used in about 80% of most are somewhere between 60 and 80% of most IVF cycles, not because it's better for the sperm, it’s because you make more embryos. PGT-A was hailed as a miracle and I embrace it completely--85% of my patients do PGT-A. However, with increasing data there may be a loss function to wastage--they call it embryo wastage--where you may lose a high quality embryo because it was misread. So you have to be flexible, you have to--you don't just fix it. But my issue with those who are detractors is that they may not offer it to all patients because they “want a low cost IVF” rather than is that right for the patient? To me, there's a big difference between How can I make it look cheap, and then hence possibly have a poor outcome, versus How do I make it optimal and let the patients choose. It’s not going to discount their cycle. You don't have to do ICSI in my place. There's no charge for it up and there's no charge for it down. It's your choice. But it's easy to say, Oh, well, I only grow to day one, because that's the most optimal. Whereas for someone, a day five transfer might be the best for them, you have to look at that and offer all of it. And then the patient can subtract. Or the experience. I know all of the doctors here have had the same experience where some folks just magically do better with a day three transfer. And, and it goes against logic, but they do. So you offer it. I had a patient today who failed a day five and now I'm going to try a day three transfer. Why? It might save me a little money. But the goal is how do I get her a baby? So that's kind of my short answer to that detractor.

JONES  12:46  

So this concept of quality comes a lot when we're talking about the Affordable model. Dr. Amols, you mentioned earlier the Target model, the Walmart model, if we're thinking of just bringing something to bare at scale. And some people will say, well, Walmart that's not Saks Fifth Avenue, that's not Barney's, it's a lower quality in their mind. How do you respond to this issue of cost must be related to quality?

AMOLS  13:14  

So I wanted to take a step back. So earlier you asked me, we talked about why I didn't think this model had taken off. I'm just talking from a business standpoint, when you see these CCRM’s down building on their stuff. From a business standpoint, I meant, I'm surprised it hasn't. When I use Walmart/Target example. I'm purely only talking about the example of volume. Okay? You're absolutely right when you said I think what you were asking earlier about the quality issue is that we're under the gun more than any other clinic. When the other clinic pays $15-20,000, amazingly, they get nothing out of that cycle. They walk away and go, Ah, this didn't work. They go to a clinic like mine, Dr. Kiltz, Dr. Magarelli’s, and they don't get through they go Oh, it's probably because it was lower cost. So we are really actually under the gun more than I think most clinics because we're always against that. And that's one of the reasons you rarely hear anybody say we're the cheapest. Our goal has never been to be the cheapest. We've been wanting to be affordable. And the definition of quality is if you're doing best practices, and as long as we're doing best practices, you know, I would consider us quality Now, one thing I want to talk about is, what got me into this actually is because my own personal IVF story. So my wife and I spent $20,000, my wife doesn't make many eggs. And so we had to go through IVF. And we spent a lot of money and we barely got pregnant, but we did. We were very fortunate. And it just was curious. I've always been a numbers person, I’ve always been a business mind, I wanted to figure out how much does it cost per IVF cycle? Why is there a difference in cost between clinics? And when I looked it up, what was surprising was it actually isn't that expensive. And so it's interesting, like your title is Secrets of the Affordable IVF Model. But really, there's not a secret. None of us are doing anything tricky. None of us are getting less. If anything, we're probably getting more than most clinics. We're just not overpriced. So when I first started and people said to me, You know what’s the trick? What are you doing? I said there's no trick, I just make less. And I'll even give you another thing that's really interesting about my client is that I love what they're doing. In fact, when I was going to start, I was scared to death I called up Dr. Magarelli and I said that I had this idea, I heard you're doing it. I'm scared to death, am I gonna go poor? Like what's gonna happen here and he told me, Don't worry, it's gonna go fine. It works. And so one of the things I wanted to do was, I actually want to be one of the top clinics in the country, meaning success rates. So if you look at all of us, you look at national rates, we're doing well, but we're-- the 2018--we’ll probably be in the top 10-15. So it has nothing to do with quality and anyone who says that is just saying that to distract from it. Again, we have some of the highest rates in the country. And yet we're a third the cost of the most of them. This is about all of us are in this for the same reason, which is we want to help more people. We want to be able, as you said, more accessibility for people who can't afford it. Dr. Kiltz said, and I agree hundred percent, there are people who come to us and say, “I would have never had a kid if it wasn't for you. I could never afford to go anywhere else.” And that's a great feeling when you know that someone who scrounged up from family members to make $5,000 and have a baby, it's a great feeling. 

JONES  16:14  

Dr. Kiltz, this concept, you and I have talked about it before, which is who's responsible for making care affordable. And as Mark says, maybe it's maybe I'm making a little bit less money. And you have mentioned that before. But I remember one thing that you said to me, that always stands out to my mind, Rob, is you and I were in Washington, DC a few years ago. We were there for access to care, and we're advocating for insurance coverage. And at that time, we're advocating for benefits for veterans. But you said at the end of the day, these folks, meaning everyone that was there, and I'm paraphrasing, so I'll let you clarify that, but who's responsible? It's us and so talk a bit more about how you're able to do that.

KILTZ  17:04  

So the question is, why does it cost what it does? And I got paid $2,000 for nine months of OB care and deliver a baby. And when I started my practice, I was delivering babies. And I was trying to come up with a price of IVF. And I realized, well, I no longer do a nine months of care, up at two in the morning to deliver a baby, why should it cost more than it did? And I actually didn't know what it cost around the country. I just charged $2,000. But I would say ultimately, we're all running our own businesses. We're all practicing medicine. I think on the quality side, we're all members of the societies, we’re inspected by every organization, and our numbers are all reported. And we understand that outcomes that are shown in the statistics aren't always apples to apples, and we all know that. But, it's really a decision of how do we want to practice and how do we want to run our businesses? And the model of of how many IVF cycles do you do in a day, or in a month, or in a year, each of us has to pinpoint that for ourselves, and the amount of people that we work with and the team members we have and putting it all together. I know that I run a very large ship today, that our overhead is very different than it used to be. So when it was just me in a smaller space and fewer employees, 14, it was easier than now it's 300 employees and having all of that to run. So you got to keep the machine working a little bit in the process. But ultimately, we each decide. You know, there's no magic, that some big something in the skies, gonna, you know, tell us all what to do. We just have decided to do it the way we do it. And sometimes it's difficult as human beings to do it that way because we all feel like we have to conform. But really, all new things, changing things happen through nonconformity. And no one's here to try and tell everyone else they should do it this way, I wouldn't suggest it actually. But you know, it's something we are passionate about and enjoy doing. And we definitely--we do internal financing for everyone. We sell IVF on Shopify, and really just kind of offering new and different things, which aren't so crazy when you look at medicine in so many other areas or selling any other widget. But at the end of the day, it's not a Ford, a Porsche Ferrari, we're comparing, it's a baby. And they're all babies. And ultimately, people are traveling to Europe and all of the places to get affordable IVF. We just happen to put it right here in our backyard.

JONES  19:48  

So I want to come back to some of those new and different things and how you do some things in house, so I've made a note of it. We've had a couple of questions that are coming back to the same thing. It has to do with this issue of quality, and so I feel like we need to address it some more because one question, one person asked, What about pregnancy rates? And then the other person asked if rates would indicate that someone would need to go two or three times at one center and only one time at another center? How is that more affordable? That sounds like a loaded question to me. But I think it also goes back to Dr. Amol’s point. So you can look at at the success or you have the same data that everyone else does on CDC--

KILTZ  20:34  

May I interrupt, Grif?

JONES  20:35

Please!

KILTZ  20:36

So first of all, should we be comparing clinics outcomes? 

JONES  20:40

Not according to start for marketing,

KILTZ  20:46

Then why are we having this conversation? 

JONES  20:47

Because that's the--

KILTZ  20:28

But it is not true. Because it depends on the patient population, if it depends on many, many things, okay? And so it also depends when you're doing PGS or freeze all or not, whether you're doing blasto--there's so many things that come into this, that we can spend the rest of our lives talking about that. I would say, in general, across America, the real numbers are probably very, very similar. It's just a matter of who you're taking care of as much as anything else.

MAGARELLI  21:18  

If I can interject--I agree with Dr. Kiltz completely. That's been the biggest bugaboo since the 1980s when this idea of we're going to report data, and that data is going to be put out there, but please, please, please don't compare clinics. And of course, what is the first thing that happens is people compare. But I want to get to the heart of the issue. Look at the CDC data. Look at the live births since 2010. And the live births per IVF start is declining. It is not increasing. pregnancy rates are increasing and they're impressive, but live births per cycle stored has been declining precipitously, almost 30% since 2010 with the onset of a lot of technologies. So there may be a biologic potential there that we're hitting. But if you really--if let's say we homogenize all 400 IVF centers in the United States, and it comes out to approximately 2.2 IVF cycles if you do a fresh, untested embryo transfer. If you look across the board for the past 10 years it’s 2.2 IVF cycles per baby. And that's not counting regions, that's the United States: 200,000. If you do IVF with PGT-A, it's approximately 1.8. So let's say in every case, everyone's going to do two cycles to make a baby, regardless of where you are, what country, what elevation, New York, California--it doesn't matter. If that's the case and just let's flatten--I hate to use the term flatten the curve--but let's just let's just look at that number. In Denver, it's approximately $25,000 per cycle, two cycles, let's say two cycles is $50,000 to a baby. My clinic, that would be probably around $14,000 to a baby. Very different, very different model, but still, it's 2.2 tries to make a baby. In Dr. Kiltz’s situation, it would probably be about $6,000 to a baby. Now, as Rob said, it's to a baby. So if nationally our numbers are 2.2, it hasn't changed or even gotten worse to a baby over the past 10 years, that supposition of quality is in error because it's to a baby. It hasn't changed. There aren't really that many--there might be five or six outliers, but that doesn't count for the field. So if you go to the field, 2.2 is a good number. Just figure out what it's going to cost you, if it's in your budget and you want to go to a place that has a two story waterfall, and it's got a, you know, Mercedes outside, great. Or you just go to the regular folks, get your baby, and that's what you do.

AMOLS  24:06  

So I don't mind being the devil's advocate here. I think that Dr. Kiltz is absolutely right. When we talk about statistics, you have to look at the patient population, there's no question about it. And when you're doing what we're doing, you get people who have failed multiple times, who are coming in now for their six, seventh, eighth IVF. So you have to understand it is a different population. And none of us--one thing that's really unique, all three of us--none of us turn patients away. We take all the CCRM patients that they get canceled in the middle of their cycle, and we take them over. So he's right. However, it's a fair question. Because the point is people do know the difference between Walmart, and you know, a really high-quality store. And so I think the thing here is, is that, in the end, as Dr. Kiltz said, we're using the same places they are. We use the same equipment, my clinic, we use only benchtop incubators. That's it. Every patient gets their own incubator. And if anyone's concerned about the rates, the thing is that again, you have to look at is donors, that would be the only thing I would tell you to never really compare donors, because that's really the same population. But it's a fair question to ask. It's one of the things when I started, I felt there was a thing I had to defend more than anything. And that's one of the reasons like I said, that we want to be better. So just for the people who are asking that I just want to--I got the statistics here. So the national average in 2018, for the percent of live births for retrieval was 54.5%. For transfer, and it was 48.5%. Now, I'm not going to talk about other clinics, I’m just going to talk about mine. But just to show you, our retrieval percentage for live birth was 64.1%. So we were 10% above the national average, when we look at the transfers were 61.4%, almost 15% higher than the national average. So the point I want to make here is that being low cost doesn't mean low quality. They have nothing to do with each other. Now, can another clinic have lower rates? Well, yeah, if they're seeing more older women. We're very fortunate, I'm in the population where I see a lot of young people. And matter of fact, we don't even tell our patients our actual pregnancy rate because we don't think it's fair. You know, when I'm getting same sex couples who I'm doing, you know, reciprocal IVF on, that's not a fair rate to give to someone who's been trying for six years. So we actually give a lower rate than with our actual real--we have a very high percentage--but we give a lower rate because we know it's not a fair number. And so that's why he's right. You can't compare it. But what I would say to people is, if we have this high rate, and we're this affordable as well, and then other places have a lower rate and they charge the full amount. Clearly, cost and quality are not together. And I think another thing that's really important is not just that we're lower cost, we're transparent. I mean, if there's anything that I think is great about us, all of us have our costs on our websites, you know, we're not trying to hide anything, we're telling everything and we're packages. That's the thing I love about what we all do is no one comes to my place and goes okay, so is $6,000 for IVF, $3,000 the walk in the door, $4,000 to ICSI by the time they get done, they're like, oh, wow, I thought was only $6,000? And it's $18,000. Whereas all of us, you can look at our website and go, that's what I'm walking out the door with. Other than medications, obviously no one is selling their medication, other than that, that's separate. That's another thing that I think makes us a really unique model. And so when I go back to the point of why I say, I'm surprised everyone hasn't got there yet. We are going to become a mandated country, it's going to happen. It's just a matter of time. And we talk about the secrets of the affordable model, one of the things that's most important, Kiltz hit on it earlier, it’s got to be efficient. There is so much inefficiency in IVF. The places I worked at before, I can’t imagine going back to what we used to do--spending an hour with someone talking about something that literally in five minutes, we could talk about or my nurse could do in 15 minutes. The point is, is that the reason everyone should start doing this model is because when it goes to a mandated country, and they're only making $4,000, $5,000 per IVF cycle, you're going to need more volume, and if you can't do it, then you're going to be in trouble. And so one of the things we are poised I think to do well, no matter what happens. And I do have one question I’d like to ask them as well. One of the things that's funny when I started with everything included. Matter of fact, we included anesthesia, ICSI, it was hundred percent out the door, and we had to remove it, not because we needed money, but I actually ran into issues that when you are a low cost model, people for some reason don't see the worth in things. And so for example, I would have a patient perfect sperm, I'd say we did standard insemination, hundred percent fertilization, and they get mad at us and say, I'm so upset. Why didn't you do ICSI? Well, we had 100% fertilization that seems pretty good. And they're like, Yeah, but I wouldn't have done this if I would have known you weren't gonna do ICSI. And, and so we finally had to charge even $500 for it, just to make it worth something. And so I wanted to talk to you guys and ask you, do you run into those same problems where something so goofy as ICSI with someone at 100% and they're saying, you know, Why didn't you do it? And I just wonder if you guys run into those issues, too?

KILTZ  29:06  

It’s the nature of human beings to find something to complain about. If you just accept it and listen to it and move on, that works really well. So no matter what you do--and I wanted to make a point that almost all clothing is made in Bangladesh or Pakistan, it doesn't matter whose label is on it. So ultimately, there's no difference in quality, in general, in most everything and anything. Walmart, that has the same stuff that's sold pretty much everywhere else. So I think that we're all really just out here to practice what we do and help people out. And the fact that we are lower cost, and I don't think the higher cost models are going to go away. They will continue to be successful as we will continue to be successful because it's a blue ocean and blue sky, it's huge. The amount of people that don't get served by what we do is tremendous. And so there's plenty of room for everyone. And I always come back to you can never compare the numbers, because there's so many variables and as scientists, and the fact that we are members of a society that say you can't compare them, I'm still always amazed by the fact that we try to.

JONES  30:30  

What about this idea? Because it harkens back to what Dr. Amols was talking about, and Dr. Magarelli, you mentioned, when you're talking about per baby price, if you're thinking of it in terms of outcome, and Dr. Amols, you’re talking about different packages. One thing that--a hypothesis I have is that if you are goingfor  the affordable model, you can't half-ass it, at least from a marketing perspective. What I've seen is you--let's say someone's in the backyard of someone doing $13,000 average cycle price and they say we're gonna market that we do 10, that it doesn't work. That what makes it work is having a huge delta and really letting that be a big part of the differentiator that you all are using. Do you think that that's true? That's what I've found to be the case. That I don't recommend people say yeah, we've got a $9,500 base IVF cycle price that I think people get killed in the middle. What do you all think?

MAGARELLI  31:36  

Oh, I think people get killed in the middle. And I think that what happens is that they substitute or subtract services to get to that number. That's what I think. And then it’s like half in half out. When I decided to do this high quality, affordable model, I just have to say this out loud because Mark mentioned that he called me, well I called Robert, so this troika we have here is how this all--it started with the man on the bottom of my screen, Robert Kiltz, then it came to me then it went to Dr. Amols and it's amazing that you've got us all here because this is the family, The Three Musketeers. And what I had to do, and it took a lot of conversations with Dr. Kiltz was, this doesn't make sense. He’d say Okay, let's do the numbers. So you have to jump in. When I jumped in, I told my team, ti's very likely all of us are going to take a pay cut. Absolutely, everybody across the board took a 15% pay cut. And I said, and all of us have to be in it. Because quite frankly, I don't know if the volume is going to be growing fast enough to meet the bills. You know, and at that time, I was a fairly large program. And so you can't just discount a little. You have to make--if this is the area you want to be, look at your numbers, look at your costs, your real cost--not your cost plus profit--your real costs, figure out what margin you want and then probably don't accept the margin, subtract that margin and just go for the raw score. I don't think you can do this one toe here, one toe there, and you can't do it by subtracting services. I mean, I know I'm harping on that. But that's the key is none of us subtract services. All of us have all services at the highest level. And I think that would be my answer to your question about the middleman doesn't work. Because I had a marketing person who told me to raise my prices, which put me in the middle and my volume immediately fell. So I had to scurry back to where I had been. And so that's would be my recommendation.

KILTZ  33:42  

Fixed costs. We have a tremendous amount of fixed costs in this business. The variable costs are actually small. So our buildings, the rent, insurance, the staffing. And so I equate us like a bus or an airplane. You have seats that are empty, and you have capacity to grow. It's just basic economics of running a business, right? Obviously, if you're charging $20,000, you know, people can do that. But I looked at my model where I was and what I was doing and made a decision that my capacity was greater and we can do more. I even lowered my prices more in order to fill the capacity, at the same time, was able to meet our goals and greater.

AMOLS  34:36  

I want to address your question. So you were asking the question about the middleman. 

JONES  34:40

Yeah, do people get squashed in the middle?

AMOLS  34:42

From a business standpoint, this is actually very common for humans. If you have a great steak that costs 20 bucks, and then the other guy says to you, Hey, I got steak, too. It's 15 bucks. It's pretty common sense. Most people go, You know what, for 25% more, I'm just gonna go with what I know works better. I'm going to go with the filet mignon. But when you drop down to let's say, five bucks or six bucks, then most people go, you know, it's worth the risk. It's worth at least trying. And I used to even tell patients, I used to love when they came to me and they said, Oh, well, what if your lower rates. I said, well, let's do an experiment, let's say I am 20% lower, you can do three cycles at my clinic for the cost of one cycle there. So if you actually look at cumulative pregnancy rate, we would actually have a higher rate than them at the same cost. And I want to make one comment about Dr. Kiltz said, and I'm just gonna give a real world example versus using a plane. If I put one person's embryo in my liquid nitrogen containers, I still pay the same amount to keep that liquid nitrogen in that container. So if I don't fill that thing up, it's just wasted money. And that's what he's talking about. You know, when you buy equipment, when you buy a media, they don’t give you one one per patient. You get a whole bunch. Remember, if you buy more of it, you get a better discount, and so it actually lowers your costs. So as Dr. Magarelli said, you got to jump into this. You can't do this kind of half in, half-assed type of thing. You got to do it 100%. You jump in. And like I said, your costs will go down, your overhead will go down at first, because, again, you're spraying it over more patients, and you're being cost efficient. And I ran to the problem, unlike Dr. Kiltz, we actually are so packed, I can't take any more patients. So really the smartest thing for me, I'm a bad business person, I should raise my prices. But again, that was never my goal. My goal has always been to make it affordable. So I'm also looking to get more doctors to build on to what he does. And that's he's right. I mean, you just keep it full like a plane, don't let it be half empty.

JONES  36:34  

Well, that's I think that's a really good way of describing why the middle gets squashed. Because to that point earlier, when someone asked, well, isn't doing three cycles at one place, less cost effective than doing it one elsewhere. That's probably why the middle doesn't work so well because that would be true if it were the middle, but when you're talking about $4,000 IVF base cycle prices, or you’re talking about real affordable, that'd still be more cost effective--doing three with one model than doing one at another place. I think that's a really good way of putting it. You also--Go ahead.

AMOLS  37:16  

Are you familiar with the concept of cost-disruptive model in business?

JONES  37:20  

In business? No, not if it's the same thing as price anchoring.

AMOLS  37:24  

So when you look at the Walmarts and the Target, one of the things they looked at in businesses, is that when you just went a little bit lower, you looked cheap. When you went ultra lower, then what happened is people were willing to take the risk. And what ended up happening was a lot of your competition had a more difficult time because now people were going there. And so this is actually a very common model in business called the cost-disruptive model that is used and like I said, it works. It's worked in every industry.

JONES  37:54  

It's a really great point. And for those--there are some people on this call that I have counseled  against marketing towards that middle. And now you know why!

**COMMERCIAL**

Hi everyone, it's Griffin. This is the break in the show where normally, I do a little commercial for our small engagement. And we do have a small engagement that's relevant to the COVID-19 business response. If you're cutting marketing. if you're trying to bring back your people as quickly as possible. If you're trying to build a cache of treatment ready patients. We do have that, but I would rather use this break to just ask if you find this useful if you would share it with a colleague, either via email or on social media. We're doing everything we can to put out as many webinars, articles, free podcasts, all free resources to include as many people from the field as we possibly can to give you resources on how to manage and operate a fertility business or an IVF center during this time. And it's changing so quickly. 

So if you find this useful, I would really appreciate it if you would please share it with a colleague via email or via social media and help us grow the audience, but only if you find it valuable, and hopefully you are. Now, back to your program.

JONES  39:12

You concluded your point with another point, which is now I'm at a point where I'm so busy, I can't even see all of the patients. One way would be to raise prices and make demand go down a bit. The other is to scale and Dr. Kiltz, that's probably what you have really, that you've really focused on the last some years and when I had you on my show last year, you talked about the bottleneck often being the REI. And you've talked about training, OB/GYNs and Physician Assistants and perhaps Nurse Practitioners or just advanced providers in general. And when I sometimes will, we work with groups and we will get them to a point where it's like, what more do you want? You’re at a four week waiting list and we got to do a six week waiting list, it's like there's a bottleneck here. Does the use of advanced providers and other physicians--is it requisite to scaling a model like this?

KILTZ  40:13  

Well, it's not requisite, it's just another way to do it. There are a limited number of REs and our model has typically been to spend an hour with the patient and do our consultations and our follow ups. That gives us limited time due to retrievals and transfers and maybe surgical and other things. And as we're seeing this shifting and changing the way we practice medicine, just in the last several months, we realized that to do an ultrasound and IUI and even managing and monitoring our patients can be done a lot more efficiently. That can be done by a skilled fertility RN and also our practitioners. And also as we've utilized gynecologists for a number of years to do retrievals and transfers that can be well trained and do an excellent job at it. So we know some of the top fertility doctors in the nation, in the world, are not board-certified or even trained in a fellowship in REI, which I think is unnecessary, but it just happens to be where we're at. But I think the way to scale and provide more access, more affordability is to look to those methods to do that. My practitioners will do consults, either video, phone or in person in the past. Our gynecologist will help us with our surgery, retrievals, and transfers. At the same time, we’re able to focus on the things that I think we're really trained to do, which is manage and develop and teach and train others to be part of this because the only way we're going to make it more affordable and more accessible for more people is more of us to be able to do that. And it's happening in more and more areas of medicine all the time. That's where it's branching out. Anesthesiologists, I have mostly Nurse Anesthetists doing the anesthesia today. And we can look at that in every other area of medicine. I think we need to open that up and even trained practitioners to do potentially retrievals and transfers. I'm throwing it out there. I think certainly, they're doing IUI and most everything else in our practice.

JONES  42:22  

I see a little bit of reluctance to accept this. I also see a general acknowledgement that this is the case. I can't consult on it because it's clinical. The only reason it touches my purview is because it has to do with capacity and how many people we bring in. And if that capacity is raised, we bring in more people. But I have heard people raise the objection, or the concern that they'll be--well is the REI just going to be useless in 20 years? And I don't see that unless, you know, Watson and artificial intelligence has evolved to the point where we're all useless and that's going to happen eventually, hopefully not in 20 years. But I see a little bit of this idea that well, I need to--as the REI, the patient is paying to see me or expects to see me. And I don't know that that's always true. And I use this analogy and I know it's gonna piss off every REI on this webinar because I know you're not dentists and we're not talking about dental and I know that Fertility Care is much different from dental. So I'm providing that--I'm laying that down right now. But I went to Inspire Dental which is one of these large scale affordable dentists backed by or owned by either private equity or on the public market. And I go in, it's a nice experience. It's very standardized. I go back, the dental hygienist almost diagnoses me. He's cleaning my teeth, says what he thinks it is. The dentist comes in for two minutes, really confirms that, leaves and then when my follow up is scheduled. It's the dental hygienist doing the advanced cleaning. And I as a patient, I'm okay with that. And I think the bottom line is that patient needs to be and feel cared for. And I think that there's a little bit of reluctance. The doctor feels like, well, I need to be--I need to be in every ultrasound. I need to be doing retrievals, whatever it might be. And I don't know that the patient necessarily sees it that way. Can you all talk a little bit more about what really should be the role versus what should be support staff or advanced providers?

MAGARELLI  44:33  

Well, I'm not going to say what should be, but I will tell you my thoughts about that. I was one of those Duke-trained, UCLA-trained, big headed, egocentric, narcissistic physicians who felt if I didn't do it, it wasn't done and it wasn't done right. And that does work if in a model in which you're seeing very few patients and you're all getting that personal care, and as long as you're not worried about that many 10s of thousands or millions of people who aren't getting care, you can feed your ego that way. Over time, what I've come to learn is, it is really my responsibility as a professor or professional, to make my team provide the service, make my team be able to manage issues, and I be the guy who takes care of the fascinomas or the oddities to allow for efficiency that Dr. Kiltz was mentioning. And I will tell you like Dr. Kiltz, I have been fascinated and scared at first, but fascinated with the use of gynecologists, but these gynecologists are doing major surgeries that I wouldn't do and why would I be concerned about them sucking some eggs through a small little needle through the vagina. It doesn't make--it's almost illogical that they couldn't do it. So by utilizing them, I was able to grow the practice rapidly. Patients were getting care and I followed them point by point, number of eggs retrieved, number of embryos created, embryo transfer rates, pregnancy rates, and I could not find a difference. We both went up and down 1% depending on the month because we split it. So from the standpoint of it is always going to be the reproductive endocrinologist, just like any captain of a ship, you don't expect the captain of the ship to be down in the in the propeller room and in the ballast tanks and in the mess, you expect the captain of that ship to manage the ship to go in the direction and reach the port safely. That's what our jobs are as reproductive endocrinologists and we are a lucky field. We deal with healthy folks. So it's even less risky because we are not dealing with sick folks. We're dealing with very vigorous young, 18 to 40 year old folks. So that risk equation is lower than persons dealing, you know, 90 to 100 years old with a cardiac condition. So it does work. It is safe. As Dr. Kiltz mentioned, the 1, 2, 3, or 4 most famous reproductive programs in the country are run by either gynecologists, Maternal Fetal Medicine doc, or a perinatologist and yet, the impression is they're the best and they're the ones we should go to for because they're good marketers. So that is not going to give you the qualification. It is exactly like Dr. Kiltz said, my job is to train them, to follow up on them, to QA QC on them, and to ensure that the quality is always there, and to innovate. That's the other part. You don't expect your gynecologist or your practitioners to innovate, to take a new concept to apply it. And that's my job as the professor or Captain, down the future, is to help them just to separate the wheat from the chaff about what are the technologies that are effective, cost-effective, efficient, and perform. I can't have everybody in my clinic doing that. But I can do that if I had them doing these other tests, which are easily trained as well. And they're actually better at it because they're focused on one thing. We have to be focused on 100 things. So that would be my answer to that situation.

JONES  48:17  

Dr. Amols, you want to add to that?

AMOLS  48:19  

Yeah, I can. So I think there's a couple things there. It depends on the patient that's coming in, right. So obviously, if someone's going for egg freezing, they don't care [inaudible] they just want to freeze eggs. You have a person trying to come for a baby, they want that kind of touchy, touchy feeling. And I think that's a normal thing. As a doctor, we want to have that. And I would say it's not so much--there's almost nothing that has to have a doctor. I mean, I think nurse anesthetists have shown, if you teach someone a specialty, they can do it very well and as well as a physician. So I think there is this point where there's nothing we really have to do, but we do still have to be involved. And I think part of the art of what we do is being able to make the patient feel where they're 100% when we’re not. I have patients tell me all the time. I'm in the room for five minutes sometimes. And you know, I tell them sorry, if you felt rushed or like, No, I never feel rushed with you. But I'm with them for five minutes. They're with another doctor for 20-30 minutes in the room. And then they come back and tell me that they learned more from me in five minutes than they did from them in 20-30 minutes. So I think part of what you're seeing is true. You have to as a doctor be able to engage your patients. And I agree completely with what Dr. Kitlz said earlier. I mean, you could have practitioners doing I mean, you really could there's no reason they couldn't. It's not like this skill is this amazing skill that we learned in fellowship. I mean, most of us didn't even do some of them in fellowship. But the point is, is that there are these certain patients though, who absolutely want the doctor every visit so at my clinic, it's a little bit different. Everyone does it different. Doesn't make a right or wrong. I do all the ultrasounds for IVF. Only IVF. Everything else I do have people doing for me. So I have an ultrasonographer checking for cysts. Nurse Practitioner helps me. There are patients who I tell them right from beginning, if you are wanting me at every visit or you wanting 20 minutes from every time, I'm not the right clinic for you. You're better off going down the street paying someone $20,000 who can do it. And that's where I'd agree with Dr. Kiltz because they're gonna be clinics like that forever. These clinics that people want the doctor doing everything 100%. But in reality, there are studies that have shown a nurse, nurse practitioner doctor during the IUI, no difference in pregnancy rate. And I'm pretty sure if you look at even the nurse practitioner probably doing the retrieval, there probably would be no difference at some point, you know, if again, if they've been taught the skill set. So it really doesn't need all of us. None of us are that powerful. It's the lab. The lab is what gets people pregnant. Our job is very miniscule, maybe 20-30% at most, when it comes to stimulation. But in the end, we can still do that without physically doing that. And so what I would say to those patients are, I mean, those other doctors who want to do this, engage with your patients, talk to them, be a human, and they're not going to feel like they're not getting care because when you are with them, you give them 100% of your attention.

JONES  51:00  

And I might even take that a little bit further from the patient's perspective of feeling cared for. The not just advanced providers or the nurses, but all the way down to the welcome staff. It is the aggregate of everyone involved. And I won't say who it was if this person wants to acknowledge that it was their clinic, they can do so because they're in the webinar--but we worked with a client for years, that when we did their social media for them, the the celebrity of their group was the phlebotomist. People just adored this phlebotomist and she's drawing blood the same way that all phlebotomists do physically, but she did something to really touch people and that can come from multiple people in the practice. So we just have a few minutes left. And so I'd like to conclude with your opinion from all three of you on this because Dr. Kiltz you were talking about doing new different things. You know, you like doing so many things in house and you mentioned a lot of the things just take away and add to the cost. You mentioned in-house financing, you talked about IVF on Shopify. And I want to get your opinion in closing from each of you, either what innovations will come from the affordable care model? Or what innovations will impact and allow the affordable care model to scale even further. So what innovations will come from or aid the affordable care model?

KILTZ  52:29  

Well, first of all, thank you guys very much for being part of this and inviting m.e I really enjoyed it tremendously. I don't know many of the answers. And I think what we're doing is we're learning by doing something different. But we're also learning from many different models, but change is the most critical thing that we must learn as practitioners. If we cannot change, we will die. And it's always learning from others what they're doing. Fertility just happens to be this thing that we've sort of felt that this is the way it is and when we see these changes going on, it's uncomfortable. I wasn't trained as a business person. I didn't know anything about business when I started my practice almost 25 years ago, but I've learned and I continue to look at other areas and what are people doing in business that I can utilize in changing and growing what we do. And whether it's going to be more artificial intelligence, but ultimately, as you mentioned about the phlebotomist is, is really the person that people are drawn to. We're all in some ways--ultimately, the human touch is so important, as Mark talks about, you know, the patients and going and meeting them. We love that! We don't want to lose that. In many ways, we created something that so many people wanted to come to, so we need to always be innovative, and making it accessible and affordable. And that's some of the things that I really love to do more than anything, but we all need to be doing something we're passionate about. Every single day, and if you're not passionate and having fun in this business, there's plenty of other things to do in life.

AMOLS  54:06  

You know, I don't know if I can answer your question either about how to make it scale. I think what I would like to maybe give us the people who are interested in doing this, want to know a little bit about how to do it, I think, you know, again, hopefully, they're not scared to go into this. But one of the things that's interesting is that, once you start it, the biggest fear, I think the getting into is someone looks at my cycles and goes, Oh, my God, I don't think that Dr. Amols ever gets to go out and see his family. And it's actually not true. I mean, I come in at 8, I leave by 5pm, I get almost every weekend off, I get to work one or two weekends a month at most for a few hours. And I don't want anyone else to think that I'm making very little money. I do very well. And I'm pretty sure they do very well as well. And that's because again, it comes down to volume. And so what this is about is if you want to open the practice, where you're able to now allow more people to do IVF, who originally couldn't. And what's interesting is those people usually are pretty healthy. I mean, I get people who don't even need IVF who do IVF. And I even tried to talk them out of it. But the point is, is that it's not hard to get into. The trick is being efficient, and being able to talk to patients. Now, if you're not able to talk to patients, I don't think you're gonna do well anywhere, whether in our model or someone else's model, because who cares if you get to spend 20 minutes with a doctor. If they suck, and they don't like talking to them, it's still gonna be the same bad 20 minutes, whether it's five minutes or 20 minutes. So I think the biggest thing for people who are wanting to know about this is don't be afraid that you're working forever till the end of night. You won't be. But you’ve got to make sure you get a nice efficient system. Definitely talk to all of us. We've gone through the pains and stuff in the grind. And don't be afraid you're not gonna make money either because you will, because again, you may not make as much per patient, but you're so efficient, that you're able to make more. You're just doing it with more patients.

MAGARELLI  55:53  

So doing it with love, is what Dr. Kiltz is saying. Dr. Amols is saying is do it with the business acumen. And the question is can and all of us are saying this, we are successful in what we do. I think COVID has taught us something, and it certainly has taught me something is that I am actually more intimate with my patients now doing a Zoom meeting with them. And I'm much more efficient in terms of my office and functionality than I would ever have imagined ever in my career. I can tell you that probably 40% of them are still in bed as a couple talking to me on my Zoom. And to have the husband there and to have the partners there to have that intimate discussion, so I'm not going to lose that, but I probably am going to be able to double or triple the number of interfaces I have with them. And then as we all have said, hand them off to trained professionals to do the next steps. And then when we need to be involved, if it is the retrieval, and if it is the transfer, if it is the surgery, we do it, but if it turns out we have even a practitioner, a gynecologist who could do it just as well, trust that they can, track it--I'm a researcher--track it, and then as long as they can, you can assure the patient they're going to get the result. So I think Rob said change, change, change, but you know act with love. My dear friend, Dr. Amols is saying there's a business component to this, we can do it. He likes to be in there every minute to touch his patients so that he can show them he's there. I can tell you I've spent many a day with Dr. Kiltz walking up and down the clinic. He knows every patient, he knows every person, he knows every every staff member and what's happening with their children. It is being personal and interacting. We all are well-trained. We all have a passion to help people. And if that is your--and by the way, you will work hard. You have to also be willing to work hard. This is not something you're going to do half time. This is long hours. And yes, you can design a Sunday off or a weekend off or two. But this is long hours. And if you don't want to do long hours, this won't work for you.

JONES  58:12  

Well, gentlemen, it's been a great conversation. We’ve gotten lots of thanks and kudos in the comments. And I say, gentlemen, because people might say, why are there four men on a panel? Well, you're stuck with yours truly, and these are the three guys that are doing it. These are the three people that I know that are doing it. And I would love to have you all back on because I do think that this model is going to advance even further as near as six to 18 months. And so I'd love to have you back on in six months and revisit this because we had so many questions that we didn't have time to get to a lot of them. And Dr. Amols, Dr. Magarelli, Dr. Kiltz, thank you all so much for coming on this live show for Inside Reproductive Health. I look forward to having you back.

You've been listening to the Coronavirus Business Response Series on Inside Reproductive Health. If you find our free resources to be valuable, we ask that you share this episode on social media or with a colleague in the fertility field. Subscribe for the latest insights on managing and owning an IVF center or fertility business during the COVID-19 pandemic at FertilityBridge.com or anywhere you listen to podcasts.






154 What is Oma Fertility Doing With $37.5 Million?

This week, Griffin hosts Drs. Gurjeet Singh and Sahil Gupta, founders of Oma Fertility and Oma Robotics, to discuss their plans for utilizing $37.5 M in venture capital. Who will have access to the tech? How much automation can they bring to the industry? Tune in to the latest episode of Inside Reproductive Health, as Griffin Jones presses these entrepreneurs on their plans to scale their company.

Tune in to hear:

  • How Oma Fertility and Oma Robotics came to be, how they raised so much capital, and what role debt plays in their plans to scale their organization.

  • What Drs. Sahil Gupta and Gurjeet Singh have to say about the role of AI in increasing productivity and reliability in the labs.

  • Griffin ask about their growth, especially the pros and cons of purchasing clinics vs. beginning de novo, and where their footprint is expanding.


Gurjeet’s information:

CEO and Co-founder at Oma Fertility

LinkedIn: https://www.linkedin.com/in/gurjeetsingh/

Website: https://omafertility.com/


Sahil’s information:

Chief Commercial Officer & Co-Founder at Oma Robotics

LinkedIn: https://www.linkedin.com/in/sahilgup/

Website: https://www.omarobotics.com/


Transcript


Griffin Jones  00:00

So let's talk about the debt side for a second, because maybe I'm making an assumption. But my assumption is that many people aren't leveraging debt in that way, like directly from the financier that they're often they're either selling to private equity and then they might be leveraging some debt or, or they're selling equity to a venture capital firm. But it seems like people forget that you don't necessarily have to sell part of your company. If you want to get more money to invest in expansion. You can do it the old you can do it the old fashioned way. One way of getting your technology adapted in the field of reproductive health to advance assisted reproductive technology is to build clinics yourself and put it in those clinics. That's where Oma Fertility is. I have their co-founders Sahil Gupta, Gurjeet Singh on and they are the co-founders of Omar fertility and Omar robotics, they just raised 37 and a half million dollars, both in equity through venture capital. And in debt. We talk about the pros and cons of those two tools. We talk about how debt is often underused, and why they were able to get access to more debt than many people can often get from banks, we talk about their strategy of opening new centers as a means of advancing the technology that they're aiming to improve on the lab side trying to automate the lab trying to use artificial intelligence to dramatically increase the the productivity and reliability of embryologist. We talked about how they are buying clinics in order to be able to do that, how they're starting clinics de novo, the pros and cons of doing each of those things. So this is an interesting model guys, I think of all of the AI companies that are coming in and they might have excellent value to add, but they're kind of struggling to get adopted. This is one way of doing it and a lot of people are talking about some of the newer private equity backed fertility networks. I think you might be interested in this. I hope you enjoy this episode with Sahil Gupta and Gurjeet Singh. Mr. or Dr. Gupta Mr. or Dr. Saying Sahil Gurjeet Welcome to Inside reproductive health.


Gurjeet Singh  02:45

Thanks so much for having us.


Griffin Jones  02:47

So the that little joke for the audience was that Singh, he was a he was trained as a physician and Gurjeet has a PhD in mathematics. They both said they don't normally go by doctor but guess what on inside reproductive health you do you get the full honor of your previous degrees in training. And the reason why I think it was my team that reached out to you all to talk was that as we started to cover more of just what's happening in the field, like more of the current events, the name OMA fertility popped up. And the name Alma robotics is associated with that. But I want to stick on OMA Fertility for a second, because I think it wasn't really familiar with the group outside of your location, Southern California and then saw Oh, they're in St. Louis now. And so us deciding where to start this conversation is interesting enough, but let's start there. Where did OMA Fertility come from? And then what's the expansion that's happening? Is it fair to start there?


Gurjeet Singh  03:57

Yeah, that sounds great. I can give you a little backstory on OMA Fertility, and then I can tell you where we are and where we plan to go. Great. So we, you know, I had a friend of my wife's, I believe, of my wife, who was going through IVF. They went through six cycles of IVF treatments, didn't succeed, paid about $45,000 per cycle and ended up having to file for bankruptcy. You know, it completely destroyed their life. And very coincidentally, as all of this was going on, my wife was helping them think through how to put their life back together. cyl was visiting us as a family friend, both cyl and I had grown up in Delhi in India. And you know, Sahil as a physician, he had built a chain of IVF clinics in India where they see 15,000 patients a year and do 6000 cycles a year. And so my wife and I were venting at him about this whole thing. And he said, Why don't you come visit a lab? You know, just so you can see how it works, you know, you can get a sense for perspective. So I went to India and saw an IVF lab, and I was just completely blown away. You know, my I didn't know anything At the time, I'm a mathematician, as you mentioned, my expectation was that, you know, there will be some science fiction stuff going on behind the scenes, you know, but it turns out it was like a high school biology lab right at the same microscopes, incubators, the same kind of equipment that I had seen in a high school biology setting.


Griffin Jones  05:18

You were disappointed at the lack of sci-fi? Yeah, I was


Gurjeet Singh  05:21

like I was expecting there would be some science fiction stuff going on. They'd be like, some sequences of some sort. I'm gonna be naive. I didn't know it was so disappointing. I came back to the US, I visited a bunch of labs here, because I just couldn't believe it. And you know, I will say, perhaps they were slightly cleaner in the US the labs, but they had the same exact equipment, the same media, the same manufacturers, the same procedures. And I think there's something wrong, and then science had, you know, he had been going to fertility conferences for a decade, and he was like, they just don't change. That's just it's the same people show up every year, the same equipment, it just doesn't evolve. So tell


Griffin Jones  06:01

me what was wrong other than the aesthetics other than okay, that it looks so tell me what's wrong about it?


Gurjeet Singh  06:06

Yeah. So first of all, nothing is wrong, right. Like the labs are obviously doing well, you know, people who are struggling with infertility, babies are getting created, you know, so, so nothing is objectively wrong. It's just that it felt super manual, right. So when I, when I looked at the embryologist looking under a microscope, they are literally hunched over, right, looking at a petri dish, moving cells around manually with manipulators. It just felt super subjective. Right? What if somebody was having a bad day? What if they were tired? What if it was late in the evening, and they've been working since seven in the morning? So like, a lot of the decisions that they were making, with all of their great experience, felt so subjective, that anything could go wrong? Like not even the intent would always be great. But you could always make, you know, a mistake. And so I want it to be more automated. Sorry,


Sahil Gupta  07:03

yeah. I just wanted to add that one of the conversations, early conversations we had with between us was Gurjeet is asking, Where do embryologist train? Where are training schools? And, you know, I literally had no answer because the embryologist actually trained inside the labs. And you know, they are probably the most important part of the IVF process and the lab and, and then having to make subjective calls was really surprising to him at the time. Like how could such important decisions be made, you know, subjectively and cannot like, are not consistent. So I think that's probably where it started, where we decided that our focus, you know, as a company would be to make tools for embryologists to make it more consistent in order to give them tools to make it more consistent, and the results being more consistent.


Griffin Jones  07:58

Who and what are the tools that they needed in your view?


Gurjeet Singh  08:02

So I'm gonna go ahead.


Sahil Gupta  08:07

No, I was trying to break down the IVF process into two parts. The first being, you know, where the embryos are created. And once the embryos, embryos are created, the second half is about grading and biopsy. So I think we as a company started to focus on the starting part of the process, on creation of embryos, where embryologists have to sort of make this subjective call on which sperm to decide on when they pick it for ICSI and then ICSI iitself, you know, different embryologists trained differently. Some are better than others while doing xe, I think these are the steps we thought were the most objective. And we we decided to go after them first. But I think we can talk about more details on the technology. But sponsor elections and Ixy are the first thing that we are going after. But our Northstar as a company is to is to automate the entire thing. And just have a human in the loop. You know who can oversee the process? Good. Yeah.


Griffin Jones  09:17

What would you add? Well, where does where does the math background come in?


Gurjeet Singh  09:22

Yeah, so the math background is right, basically, let's do some math. So for sperm selection, as I was just describing, you know, in a typical IVF cycle, you're dealing with a handful of eggs, that's 20 eggs. And you know, the eggs are extremely precious. Right eggs become embryos, they are physically challenging for the patient. They are all with the egg retrievals which are obviously financially expensive and emotionally challenging. So eggs are you know, very, very precious, and you kind of get what you get right so the physician works with the patient, you get the eggs that you get, and you have to use all the exotic and get your hands on in a cycle. Right. On the other hand, on the male side, in a typical healthy male sperm sample, there are 100 million sperm cells also vary typically 4% normal morphology is considered good, which means that only 4% of those 100 million cells have normal morphology. Today, an embryologist looks at 20 cells, maybe 30 cells order of 20 to 30 cells out of 100 million for about 10 seconds before they pick one sperm cell to fertilize an egg. And if you again do the math, right, the probability that 20 cells seen out of 100 million would even contain one of the 4 million normal sperm cells is so abysmally small, that it's, uh, you know, it basically speaks volumes about the robustness of biology that it still works. So that's kind of where the math comes in. And using machine learning and AI to help embryologist make the determination would fit sperm cells to pink.


Griffin Jones  10:58

So, so the lab side is making sense, the AI side is making sense, how the heck does this end you up with a clinic in Southern California and in St. Louis?


Gurjeet Singh  11:11

Yeah. So then I think the main question is, what is the best way of building the tech? Right? Okay, you got up, the tech is important to build. And so how do you best build it? And what we, you know, I have I have done business in healthcare before I've sold into healthcare before. You know, there's a lot of potential benefits that AI brings to healthcare, which I've seen firsthand in my previous company. And so when we started building Omar, basically, we had a cold start problem, right? When you start to build this device, you need data to machine to, you know, for machine learning to train the systems. And so we decided that the most efficient way of getting this data would be actually to start a clinic, capture the data, because it needed, we needed some special hardware that we have developed to do this. So to the beginning, install the hardware, capture the data, build machine learning systems, and then deploy it in the in the lab can sort of see results in real time and then tweak it. So that's kind of how we initially decided on building the clinics. But then as we started building, we also noticed that patients or families who had gone through IVF, in the past, you know, we did user interviews, we spoke to them, even people who had been successful, you know, felt like there were a number in the system. They felt like they were just there to enrich the clinic, they did not feel empowered or educated. You know, they felt like they had lost power in sort of going into this whole situation. And so we then decide that we're going to double down and we're going to build a chain of fertility clinics. Where, you know, we will bring our technology to bear in in helping embryologist work consistently as well as serving patients in a in a consumer first customer first mindset.


Griffin Jones  13:02

Such an interesting, it's an interesting concept, because the challenge. Well, I've been selling to Fertility Centers for eight years, and I know how difficult it is I've gotten pretty good at it. But we're just a little client services firm. There are so many tech companies that are that, you know, there weren't like how are we going to get this into use? And you just said, eff it will buy it will buy one and we'll do it ourselves. So, so Did it start? So it started with one clinic, the clinic in Santa Barbara?


Gurjeet Singh  13:34

Yeah, yeah. It started with a clinic in Santa Barbara. And we've just started a clinic in St. Louis. We are actually we are about to announce an acquisition next week. We have acquired a clinic that's based out of Long Island. We are building one in Atlanta. We are building one in New York. And then we are hoping to launch two more clinics next year in LA. Yeah.


Griffin Jones  13:57

So who is this where you're coming in? So you've done this in in India before it was a via the group that you? You have seriously?


Sahil Gupta  14:07

Yeah, I started awareness in 2015 with one clinic. And affordability was kind of like the core of that clinic as well and accessibility. And by the time I sold it in 2019. It was a network of eight clinics in India and Nepal. And as Gurjeet mentioned, you know, we started with Santa Barbara and by the end of March 2023, will have seven, seven operations.


Griffin Jones  14:34

And so I help people chart the timeline. When did when did Santa Barbara take its inception?


Sahil Gupta  14:39

So Santa Barbara started somewhere in January of 2021. And I think this year, we are launching three clinics by the end of this year. So Atlanta, St. Louis and New York. Go live by the end of this year. As Gucci mentioned we have acquired a clinic in Long Island in New York, this, you know, hopefully in the next week or so it will be live. And then we are building the two clinics in LA, which will go live in March 2023.


Griffin Jones  15:15

Was Santa Barbara, was that an acquisition?


Sahil Gupta  15:18

No, no. So apart from Long Island, all the other six clinics are served in all those, we are building it from the ground up.


Griffin Jones  15:27

Why did you decide to go that route?


Sahil Gupta  15:33

So I think there are multiple reasons why we decided to do that. First of all, I think it's always easier to sign up, sort of bring about the change that we want to in terms of experience, when we are building things ground up, there's not only we also wanted to make the physical space, you know, change the digital and both digital and physical space that we were building, I think in terms of in terms of just the build, you know, I had experience building these clinics in India. So I knew what it takes the systems that are required. And then we found great physicians to partner with, with whom we could, you know, launch these clinics from from ground up.


Griffin Jones  16:26

Oh, why do you say this? I'm asking you to speculate about other folks. But most of the people coming into the unless they're already an established group, most of them are going acquisition, why do you think more people haven't tried the VC, venture capital de novo route?


Gurjeet Singh  16:48

So I think from a venture capital perspective, right the to do the de novo route, your venture capitalist model requires some tech innovation, it requires some step change that you can foresee in the future. And so I think if you're just going to start fertility clinics, without any tech innovation, inside it, that can lead to a step change in the, you know, along some metric, you know, it's not a venture scale business otherwise.


Griffin Jones  17:19

So what about us if you've done this before? Is it? Is this a model that could be that we're going to see more replicate? Like, are we going to see companies like Cooper, for example, or whoever the new AI companies, whoever IBM might spin off of a healthcare division, are they gonna start going this route of a build of, okay, we want to get our technology adapted, and we want to have a full tech stack, we're going to build, we're going to build the clinics ourselves.


Sahil Gupta  17:55

So again, you know, as you had mentioned, there's been a lot of private equity, you know, activity in this space over the last three, four years. And I think when, when there is private equity, there's a lot of roll up acquisitions, as you had mentioned, a lot of groups trying that. I think as good as you'd mentioned, with venture capitalists, there has to be some underlying tech that fundamentally changes or disrupts the industry, which we believe we are doing. And I think if other groups come up with, you know, similar other ideas there, there might be, you know, similar companies in the future. But I think we have the right mix. As a company, as you know, with with the team, we are, we have been able to put together over the last couple of years that we see ourselves growing with both the novel and acquisitions over the next couple of years.


Griffin Jones  18:53

How are you going to interact with those Fertility Centers, I will Oma Robotics sell to service Fertility Centers that are not a part of the OMA Fertility partnership.


Gurjeet Singh  19:08

So our plan is that our technology and devices are for exclusive use of Oma clinics, we're not selling our technology or devices into any other clinics, and don't plan to either. But there are several clinical practices across the US. You know, where the practice is great, but we do but they don't have their own lab, or they want to use a third party lab. So we definitely want to approach clinical practices, you know, that don't have their own lab or want to switch labs or want to use our technology to come use our labs. So that we are okay with but we are not, we are not selling technology into any other clinic.


Griffin Jones  19:47

Tell me about that decision.


Sahil Gupta  19:50

I think part of it. Part of what we are building and we have seen in different clinics in larger chains, is that if you go to let's say an A We see clinic on the East Coast versus, like the same ABC clinic on the West Coast, their results are different, just because they have the same name, but results are different from in all their clinics is because of the embryologist or could be any number of reasons. We believe that we are building a network, it doesn't matter if you go to St. Louis, or Santa Barbara, or New York, you're going to get the same consistent results and same consistent OMA experience. And that's going to be our differentiator, as we continue to build our own clinics and acquire clinics that have similar mindset or clinics that align with our mission and vision.


Griffin Jones  20:45

You don't see any application within the device other than the entire lab itself. But we could license this technology to these other surely you must have had that discussion with each other, hey, let's break off this piece. Let's license it. What was that conversation like when you decided against that


Sahil Gupta  21:04

our North Star as a company with in terms of building tech is full automation. And I think it was that time we reach there this this isn't a conversation that, you know, we want to have it next we want to make sure that we are able to build all these steps along the way. And I think we're at full automation, then the conversation to be had with other clinics or clinics outside the US where we might be willing to, you know, probably sell it to other clinics outside or inside the US.


Griffin Jones  21:40

You talked about it a little bit before but I think I need a clearer picture of what you mean when you say full automation?


Gurjeet Singh  21:50

Yeah, I think that's all we can say on that at this point, as we see a future in which we sort of build much, much more automated devices that do more than just bomb selection or just to automatic See, we want to sort of build more of the automation, the embryology process, to help embryologist basically get consistent results, even outside of just the fertilization and sperm selection where we are focused today.


Griffin Jones  22:18

So this is on the lab side. What about on the clinic side?


Gurjeet Singh  22:23

Yeah, I think thus far, I think AI has a role to play on the clinic side. And what we are planning to do is we are planning on mining data from the clinic to help physicians with better protocols, or to kind of have a better standard of care that we deliver to our patients. But at this stage, our focus is squarely on on the lab side.


Griffin Jones  22:48

So if you're not selling to clinics, and you're not, like you said for those clinics that don't have labs, or they want to switch labs that, that that's an opportunity. But if you're not going to be sending to clinics, how much of other companies will be up using in your labs?


Gurjeet Singh  23:07

Yeah, so for example, if you look at our Omar lab, today, it looks it basically I'm a little horrified to say it looks the same as any other lab, except that our devices are kind of, you know, built inside the microscopes and so on. So we, we buy equipment off the shelf, and then we install our hardware inside that equipment. So it from from the external viewpoint, it looks exactly the same, but kind of all the magic is inside.


Griffin Jones  23:34

Oh, are you working with? So like embryoscope? TMRW? Are those companies that are using the tomorrow tank? Or are those things that you all are using?


Gurjeet Singh  23:43

Not yet, we want to and so we are in discussions with TMRW? And you know, we are we are optimistic we can get to an agreement.


Griffin Jones  23:52

The discussion is the discussion about how does our stuff, talk to your stuff? And vice versa?


Gurjeet Singh  23:58

Yeah, how does that stuff work to your staff? And and just the business terms? Right.


Griffin Jones  24:04

So go ahead. So are you


Sahil Gupta  24:08

saying, you know, a lot of our value proposition for our patients is about accessibility and affordability? So that's the other thing we have to think about while we form these partnerships, if we are able to, you know, pass on savings to our customers and to our patients as well.


Griffin Jones  24:31

Are you focused on the United States right now? Are you also working on opening places in India and elsewhere?


Gurjeet Singh  24:39

Yeah, we are focused in the US. But we have done partnerships with some third party agencies that are international.


Griffin Jones  24:47

What about things that are not involved with the lab tech stack because you're doing this for your own clinics as well? What about EMR Do you have your own EMR? Are you using one of the others?


Gurjeet Singh  25:05

No, we don't have our own EMR. As of now. And we don't plan to build an EMR system.


Griffin Jones  25:16

How about things on the financial side? Like, like patient financing or the guarantee backings or employer benefits? Is that in your future scope?


Gurjeet Singh  25:31

We do. We are partnered with a company in LA called capeX Md. And we offer financing to organs or, you know, families that work with us to capex MD. And on the benefit side, we currently don't have any plans on going on the benefit side.


Griffin Jones  25:47

So for you all, it's it really has to do with this this lab focus and then the patient experience in the clinic. How are you getting Doc's? Everybody's fighting for doctors right now? And in your three years old as a company, how are you? How are you getting docs for these new clinics that you're opening?


Gurjeet Singh  26:06

We are two years old..


Sahil Gupta  26:13

So I think everybody in the industry knew that this is there's, you know, there's disruption coming. Everybody has been excited about it, you know, and I think whenever I talk to doctors, 100% of them actually get intrigued by what we are building. But when they see our devices working in our labs, that's when really, you know, there, you can see their eyes open up, right. There's like so much enthusiasm in them willing to talk and wanting to, you know, start the discussion of joining the network. And in general, I think we are trying to do things differently. I truly believe that Omar clinics are different considering, like, I've seen a lot of clinics in India, I've seen a lot of clinics in the US. And I think when we present our vision to our doctors, they get really excited and thus far, you know, the doctors that are working with us are super happy with what they're seeing and what we are building. And I think we are getting a lot of referrals from our existing doctors. So three of the doctors that we have hired are referrals from our existing doctors. And I think generally there's enthusiasm to join a company that is disruptive. And I think many of our Doc's are also aligning on the mission of accessibility. I think it's important work, you know, access in the US is a problem. Only 2.1% of the births happen via IVF compared to, let's say 10%. But in Denmark, where IVF is free. So I think it's important for a lot of people to solve the access issue as well.


Griffin Jones  28:04

Let's talk about the access issue, because a lot of people say that they want to solve that issue. And then some people say you're not solving for it at all, there's still the bottleneck. And there's at least two bottlenecks. One is the bottleneck of areas, there's only 1100 in the United States. And so we've had that discussion about top about what you can train, OBGYN and advanced providers to do. And then there's also the, the bottleneck in the lab, and mean the shortage of embryologist and I will tell you guys how blown away I am by how many young embryologists want to get the heck out of the lab. They're applying to jobs at my firm and marketing jobs. And I'm like, why are you everybody trying to hire an embryologist? Why are you applying here and some version of we don't want to stand in a box all day. We don't, we just don't want to stand here all day. So there. So there's, you already have a shortage of embryologists and then you have young embryologists wanting to get out of the lab. And as Dr. Carroll Curchoe pointed out on the show. So many of these labs are run by five lab directors that oversee multiple labs. And they're going to be retiring in the next half decade. And so let's talk about the lab bottleneck first, how is the AI going to solve for are you going to be able to do more cases? How are you going to solve for the lab bottleneck?


Gurjeet Singh  29:38

Yeah, on the lab part, the main way of scaling the embryology lab is by building more AI robotics and more automation. And that's kind of what we are working on. So we sort of foresee a future in which you know, most of what happens in an IVF lab is automated. And you know you basically build systems that bring out the best in Human embryologist, but then also since you automate the physical tasks that you require fewer of them and maybe they can even be remote. That's kind of what our vision for the future of the embryology lab is. It's massively automated.


Griffin Jones  30:18

And so then though, you would, you would still hit the other bottleneck if let's and that and the clinic bottleneck happened first, by the way, the lab bottleneck really didn't happen until late 2020, early 2021, in my view, that for the most part, there were there were many clinics that were they were, they were okay at capacity for new patients, but they still felt like they could have converted more to treatment. And then by the end of 2020, early 2021, is when people said, we can't even vert, even if we converted more to treatment, we don't have the lab space, or the lab staff to be able to fulfill all those cycles. And so what if most of your tech stack is focused? On the lab side, you solve this lab bottleneck? How will you improve access to care?


Sahil Gupta  31:17

You know, just just adding one more thing to the lab pod? I think there is enough. You know, there can be enough embryologists, I think the problem is, with all the apprenticeship that happens to make them skillful. So we are also making a lot of tools that, you know, Junior embryologist could use and still get the similar or consistent results that, you know, top five percentile embryologist would get. Talking about the clinic, I think one of the things that I was surprised or almost shocked to know when I moved from India is that the average number of cases that Rei does is about 150 to 200. So that was very, that sounded very low. So we actually spend a lot of time with Rei is with physicians and really like what we did was to map their time out what you know, most of their time look like and most of the time, actually went into tasks that were not related to clinical practice. So I think what we've done in our online clinics, is to actually take a lot of the tasks from the clinics, to our central or to our head office, remotely. And for example, we are not doing a lot of like billing HR, or, you know, a lot of our chart reviews are offline. You know, even, you know, some some of the stuff that was traditionally done inside Atlanta, is now done remotely by our, you know, central team. And I think what it has done is that it's made the physicians do things that they love doing, which is to see patients. So our physicians basically focus on three things, just to see patients and do the procedures. And just, for example, in Santa Barbara, our throughput for the physician right now is roughly about 400 cycles a year. And it doesn't feel to him that, you know, he's working longer hours, just the same amount of time. We are just running this more efficiently and taking a lot of this in house to in in our central office.


Griffin Jones  33:36

What are your views on using advanced providers in this mechanism?


Gurjeet Singh  33:47

Or do we


Griffin Jones  33:49

decide by advanced practice provider, I mean, nurse practitioners and physician assistants.


Sahil Gupta  33:56

So I think that's one of the things that we are using a lot in our clinics. For example, in our clinics, we've also hired ultrasound techs, that would do all the monitoring. You know, the physician doesn't, we feel like there's important touch points in which the physician has to be there for the patient and only those important touch points or milestones the physician would meet, meet the patient, and the rest of the time, either the ultrasound tech or nurse practitioners that will deliver the care to the patient. I think one more thing that I wanted to talk about why we are unique is that we have two points of contact for our patients. One in our remote team, what we call the care advocate, and there's a point of contact in the clinic. So each time a patient goes to the clinic they only meet this person who sort of project manages their cycle or their treatment inside the clinic. Similarly, when they are not in the clinic, they are only dealing with one person outside of the clinic. Home Project manages their treatment and gets them all the answers that they need. So from the patient experience side, it doesn't feel like you know, they're just a number and we make sure that all their questions are answered and they are, you know, taken care of throughout the process.


Griffin Jones  35:25

I should have asked Sahil and Gurjeet if they use EngagedMD in the so if the OMA fertility people are listening right now, this is my question to you. If you're using EngagedMD, and I was thinking after we're recording, then I'll then I'll ask them, and I forgot, because when I think of a group like this, it's that purports to improve the patient experience. It's become so clear from talking to clinic manager, practice director, Medical Director, nursing manager after the other one right after the other of how EngagedMD is no longer just a business plus, like it might have been if it were around 15 years ago, but it's now part of the standard of care that patients have so much on their plate, and they're so overwhelmed, and putting a stack of papers in front of them right now and trying to condense a whole course of information into a 3040 60 minute console. It's just so unfair, and then not giving them the opportunity to customize that to themselves. It's so hard on the patient that it's now part of the standard of care that EngagedMD is able to provide to patients. Most recently I've been talking about engagedMD’s benefits for nurses, staff providers, because those are the people that are texting me talking about how much they love the platform, how much time it saves them how much nursing time you can get back by using EngagedMD and provider time that you can get back and time clerical time from tray tracking down informed consents that, by the way, aren't as informed as they are, when they're through a module like EngagedMD, I've spent so much time talking about this, your staff side that I forget to talk about the patient benefits. And if you go online and look at EngagedMDin these reviews, from the patient side, it's overwhelming how in powered, engage them the makes them feel, and so you can get the benefits from your staff side, the benefits from the patient side. It's one of the quickest and biggest wins that you can do for your practice. If you're not already using EngagedMD, this goes for my friends at OMA fertility, but it goes for everybody listening, go on over to engagedmd.com/griffin They will give you a free workflow assessment, they're going to show you what it looks like that you're doing that other clinics are doing, that's free, whether you decide to move forward with EngagedMD or not after that, either one is going to be valuable, that you're going to get value out of it engaged md.com/griffin. Now back to the show.


 What about training OBGYN means to be able to do retrievals and then you can have more doctors and then a board certified Rei oversees those cases that's been that people are often on one side of the fence or the other about that, and a lot more people are on the OBGYN side of the fence now than than there were five years ago. And there are people that are vehemently opposed that Dr. Anate Brauer was on the show and and she said that we How Why are we even talking about this? And so there are some people that feel like that's a big risk. Other people think that it's it's a very minimal risk, and it's necessary to expand the clinical side of care. And then Rei should be practicing at the top of their license. Where did you all fall on that?


Sahil Gupta  39:18

I think we are on this side of you know, having OBGYN to as much or train them. But I think as a company, we've decided not to do it as far. And I think it's a decision we have taken collectively along with our positions and we are open to changing that in the future. But for now we've decided to stick to our API's.


Griffin Jones  39:39

So you're so well that's a smart way of doing it. By the way Sahil is because people have said that they're categorically against it. And then they come up and when necessity merits it they they end up doing it. Did you go with that decision? Because so you think it's necessary to expand access to care but I just don't feel ready to do it at this point.


Sahil Gupta  40:04

I think for us, it's, we have to first ramp up all sort of be at a level where we are running full capacity. And we can test the elasticity of, you know, how many cycles, we can go with a single physician. And I think after that, you know, we are in that position where we have to expand even with a single physician, we might look at other options.


Gurjeet Singh  40:32

Also, I think from a training perspective, right, we are not in the training game, right? We are alike, in some sense, if there is, you know, there is a future in which, you know, there's an exceptional OB GYN who has learned to sort of do retrievers and transfers and are great at the craft at medicine, I think we would absolutely consider them having them in our network. But we are not in the game of training OB gyns to becoming REIs. So are


Sahil Gupta  41:02

doing procedures? I think it's, it's, as I said, we are open to it, but we're not doing it. I know.


Griffin Jones  41:08

Okay, yeah. So then tell me a bit about the fundraising that you've done. And that was what caught my attention. Because as inside reproductive health, we want to start becoming more of a news media outlet and just covering some of these things. And, and that's part of what made me reach out. And so you raised 37, and a half million dollars, some of it is in equity, and some of it is in debt. Our audience is mostly used to talking about private equity. And they've heard me hammer the definitions in their mind private equity, typically taking controlling stake of businesses, typically mature businesses, typically, in an exit plan of a couple years. Venture capital, usually not taking a controlling stake, usually, for something that's new, and, and aiming to scale. And so talk to us a little bit about the this mix. Why? Why this much in debt, because I don't know if people are, are not in so by debt financing, is that from one of the VC partners, or that's the old fashioned way from a bank.


Gurjeet Singh  42:26

It's from our bank, it's our banking partners, Silicon Valley Bank. And again, I've had a long relationship with them. They were our bankers, my previous company, as well. And so the debt that you've taken, it's not like a private equity model. It's like a very standard, you can think of it as a more flexible loan, if you will. Right. So it's, it essentially does not dilute us from an equity perspective. And to the sort of, you know, if we are able to get clinics up and running and scaled and profitable, you know, you can easily pay off their debt, and then continue building.


Griffin Jones  43:03

So let's talk about let's talk about the debt side for a second, because maybe I'm making an assumption, but my assumption is that many people aren't leveraging debt in that way, like directly from the financier that they're often they're either selling to private equity, and then they might be leveraging some debt or, or they're selling equity to a venture capital firm. But it seems like people forget that you don't necessarily have to sell part of your company, if you want to get more money to invest in expansion. You can do it the old, you can do it the old fashioned way, and just borrow some power, some good old money and pay some good old interest. So why aren't people doing that more?


Gurjeet Singh  43:51

I think it's difficult. So banks typically don't underwrite too much risk. So in fact, in our case, right, the reason why Silicon Valley Bank has been comfortable with this is because we've had relationships, our investors have relationships with them, I have relationships with them. But then be you know, at the same time, we also raised a bunch of money in equity capital. So you know, they were convinced that, you know, one way or another, they would get their money and their interest back. So I think if you did not if we did not have the equity raise done, we would not it would be very difficult to get this level of debt.


Griffin Jones  44:25

Did they happen concurrently? Or did the 29 million raise in equity happens first?


Gurjeet Singh  44:32

I mean, it technically happened first, but call it within two weeks of each other like it's pretty concurrent.


Griffin Jones  44:39

And why Silicon Valley? I mean, normally that question would be obvious, but you because you've had such experience, and you have relationships and partners in New Delhi, I assume that there's a again, I'm assuming so you might take me to church right now and I'm totally wrong, but that there is a burgeoning venture. Your capital ecosystem in New Delhi Am I wrong about that? If I'm not wrong about that, why Silicon Valley?


Gurjeet Singh  45:10

Why are we building the company in Silicon Valley? Or why did we?


Griffin Jones  45:13

Why raise the money there? Why not raise the money from the venture capital ecosystem in New Delhi?


Gurjeet Singh  45:21

Okay, so I think first of all this the venture capital ecosystem in Silicon Valley is beyond compare. There is no other place in the world, which is anywhere near still


Griffin Jones  45:32

still, even in 2022. Even in Singapore and Hong Kong, they're still nowhere. No one's touching them.


Gurjeet Singh  45:40

No, no, there are venture capital firms and you know, they, it's, they have VCs and they are growing and so on. But if you look at the deal volume, the investor experience, you know, the deal terms are standard, like there's a lot of muscle memory that we've built up in Silicon Valley, to actually get deals like this done easily and painlessly.


Sahil Gupta  46:01

And the other answer is that we live here. That's right. Next door, and we can do this. You both


Griffin Jones  46:09

live in the Bay Area. Yeah. Yeah. So why did you start in Santa Barbara, then why not start in? In Northern California?


Gurjeet Singh  46:18

Yeah, that's actually a great question. So when we first started out, I remember when we decided on starting our Santa Barbara clinic. We were like three guys and a dog. And we did not have the dog yet. Didn't have any resources IPI? So you know, we went out to look for physicians. We were very lucky. We found Dr. Rich lake in Santa Barbara. And, you know, he saw the vision with us. And he took some risks join us.


Griffin Jones  46:48

Did you get your dog?


Gurjeet Singh  46:51

I did. He's like, Yeah,


Sahil Gupta  46:53

I think one of the other reasons for choosing Santa Barbara was, you know, there's an interesting mix of diversity in population in Santa Barbara in surrounding areas. So it was an interesting experiment for us to learn where most of our customers would come from. And, you know, that was one of the other reasons


Griffin Jones  47:19

I want to get an education from you Gurjeet about what makes Silicon Valley so much more robust and developed than other venture capital ecosystem, because most of our audience, they're not used to us talking about VC, and I think this will be interesting to them as well, I would have thought that there's no way that that Silicon Valley or I know that there isn't a way, but I just would have thought that they likely wouldn't have had the same differential advantage that they would have had 20 years ago to the whatever this the VC ecosystem is in Hong Kong and Singapore and New Delhi and London and, and New York. And but it sounds like it's still very much the place and by a longshot, so what are the things that make it so much more developed and robust for entrepreneurs?


Gurjeet Singh  48:21

So I think the first thing is that a lot of Silicon Valley is still run by operators, right. So these are people who have operated companies in the past who have experience. And, you know, when they, when they sort of grew up, or, you know, maybe are not in an operational role anymore, you know, they're, they have a great home, in various venture capital firms to go start operating there. But then I think, second, they're just muscle memory, right. So there are, you know, if you're going to do a seed financing, or a series, a financing, a lot of the terms are pretty common. And people know that. While for example, I have a friend, you know, who's based out of Switzerland, as an example. And Zurich has a venture venture capital ecosystem. But you know, the deal terms that they get there are very, very different, right, the amount of dilution. You know, if in many European venture ecosystems, if you go for a financing meeting, typically the investor will ask you, how much are you putting in? Right? And in Silicon Valley, things are different, right, where, you know, if a company is great, and obviously, only the great companies get invested in, you know, then there's a fight. There's a fight about, you know, how much money can you put into the company to be on the cap table? So in like, in other words, right, risk capital is something that's sort of everywhere in Silicon Valley. It's what people you know, talk about, it's what they live and breathe. It's kind of like, if you're going to make movies, is there a better ecosystem to be, you know, down in LA, or if you want to be in finance, is there a better place to be compared to, let's say, New York or London? Maybe? There isn't right because that's what that's people are used to those to that ecos stem, they have muscle memory, they know how to get deals done. And there's a concentration. So like the number of investors who are available, you know, call it within a stone's throw in Silicon Valley is, you know, beyond compare.


Griffin Jones  50:13

So what was the fundraising process? Like, because you had previous relationships, but are you going to multiple firms? And you're pitching all over the place? What's that? Like?


Gurjeet Singh  50:22

Yeah, so again, it you know, it depends. In our case, we, we had relationships with root ventures, and, and jazz ventures and, you know, we met, you know, when you're raising money, since in Silicon Valley, finding people who know and want to do deals is certainly not that difficult. The main thing that you optimize for is that you want people who are with you on the journey, who pie the same vision that you have. And we'll support the build of the company and the growth of it. And you know, in route ventures and jazz ventures, we certainly found partners who are super like minded, see the same future that we do, and you and you don't want it to help us build the company.


Griffin Jones  51:10

So what are you going to do with this 37 and a half million dollars, so you're buying clinics? That's that's part of it, you're starting your buying clinic on Long Island, the other six years starting, you know, or have started yourselves? What else are you going to use the money for?


Gurjeet Singh  51:27

So a significant amount of the financing is basically earmarked for research and development. Right, we are building more devices. We went public about our sperm selection device that's already being used in our clinics. But we are building more devices to automate parts of embryology.


Griffin Jones  51:45

And that certain that sperm selection device is not going to be available to any other groups until the lab is fully automated. Is that my understanding that right?


Gurjeet Singh  51:58

We'll see. I think it's in the foreseeable future, we are not selling it.


Griffin Jones  52:03

So okay, so there's more r&d, is there more fundraising to be done in the near future?


Gurjeet Singh  52:09

There's always more fundraising. You know, every CEO is always raising money. So yeah, there will be more fundraising. If he


Griffin Jones  52:19

asks any CEO, would they say that in that IPO? Is the the end journey to is that is that on your Horizon?


Gurjeet Singh  52:29

Yeah. So I think an IPO is a tool, right? It's a tool to kind of raise a type of capital to, you know, basically go after a type of growth. And I think certainly, that's something that's on our radar, right? We want to grow the company and build a company. And at a certain scale, we see that we will need an amount of money that will be viable with an IPO. So it's a means to an end. It's not a destination in and of itself.


Griffin Jones  52:55

What about when you get big enough? Yeah, so now you all are in the game. And because you're making de novo clinics, you're full network yourself. So now there's OMA fertility, there's pinnacle, there's CCRM, which as we're speaking, I see just bought IRM S. In New Jersey, there's IV, there's us fertility, Inception, Prelude first fertility, who am I forget, I'm forgetting somebody, and they're going to be picked up Boston, IVF. And so they're not all just going to the, they're not all just going to remain independent fertility partners, they're not all going to remain independent networks, some of them are going to merge with each other. And maybe some of them will be cashless mergers. I suspect most of them will be acquisitions. But why is that in? In your essay, you said, you want to have full control of the lab, and you'll work with clinics if they're building a new lab, but would you acquire a group, and update all of their labs?


Gurjeet Singh  54:02

I mean, absolutely. It's a question of capital. Right? If we have the capital, then yeah, absolutely. That's a super attractive option. I


Sahil Gupta  54:11

you know, one thing is capital. And we also need to make sure that we are aligned on on what we are building, I think, again, like I'll pull back and say, you know, if the leadership of whoever we are merging with it's not aligned on access, so affordability, that's something that that might not be a good fit for us in terms of an acquisition or so we will continue to look for partners that believe in a lot of our core values. And we want to make sure that we partner with the right people. And one more thing that I wanted to add is I think we also want to make sure that you know, the physicians are aligned and we want to make sure that you know we create any ecosystem for them in which they thrive. I think I've heard this a lot from a lot of physicians that we've interviewed, that they've been burned by a lot of the interviews that are happening in the past couple of years. And I think we make sure that we create a system or an ecosystem in which they are also taken care of.


Griffin Jones  55:26

Tell me a bit about the brand. What's the significance behind Oma?


Gurjeet Singh  55:32

Yeah, so OMA is a is a special word, you know, in, in Sanskrit, it means “the giver of life”. In many languages, it means mother or grandmother. So we love the name, it's a very caring name. And we believe it sort of espouses our value of caring for our patients above everything else. And if you, you know, bear the name, OMA alongside our logo, you will notice our logo has built up dots, and then there is one dot that we have highlighted. And so that dot that sort of thought process behind that is that it's, it's a notion of going from many to one, which sort of significant, you know, it's a, it's a story of IVF read, you have to go from many eggs to one embryo from, you know, two people being sufficient to make a child to sort of be taking a team of people to make a child. And so I think it's sort of this notion of many to one is embedded in our logo. And we kind of knew that we wanted the logo to be scientific and precise. And so that's why we chose the name, which was, which, you know, emanated a sense of care, and empathy.


Griffin Jones  56:41

I want to let each of you conclude, knowing that our audience is mostly for utility doctors, execs in the field. At practice owners, that's mostly who listens to this show. And I've asked you so much today about venture capital about the advantage or disadvantage of using debt of your plans for the lab have the bottlenecks in the clinic and the lab as well. I probably didn't ask you for something that I could have. So I will let each of you conclude the way you'd like to


Gurjeet Singh  57:19

say your first.


Sahil Gupta  57:22

Okay. So, I think about let me talk about Omar, we started Omar with a mission to democratize IVF I think we believe in a world in which whoever wants to have a child and cannot get pregnant naturally gets access to high quality, consistent care, you know, through our clinics, leveraging our technology, I want to end it by calling out to like all your listeners, especially doctors, and, you know, physicians to come talk to us, we want to build a network will with all of you, and, you know, with people who align with our mission, and we are acquiring practice, especially smaller practices, and we would also love to chat about that as well. So it's a bit of a plug.


Gurjeet Singh  58:19

What I would say is, look, we you know, there are three kind of key things that we care about, we want to get our patients successful in as few cycles as possible. That's why we are building our tech, we want to provide empathetic care, Human Centered Care, where we educate our patients and we give them support all along their journey. And third, we want to make IVF accessible, right, these are the three things that we are after. So, to that end, similar to what I was saying anybody who you know, listens to your to the show and and is interested in, you know, working with us jamming with us talking to us in whatever capacity we are super interested in, in sort of connecting. Second, what I would say is that, you know, personally I believe, I, you know, I believe that we are kind of at the very beginning of the beginning that we are sort of looking at this process, as in particularly in the lab as something that people do today and we are building engineering to you know, help and make it more consistent. But we but we see a future in which sort of this notion of operating on single cells using robotic devices similar to what we are building is going to have many, many other applications. And we are excited for that any academics or scientists who are listening to the show who are interested in that you know, or need help. We are happy to connect.


Griffin Jones  59:47

I suspect a couple of them will so we'll we'll link to each of you your LinkedIn profiles in the in the show notes and maybe people will reach out or they can email me Griffin and fertility dot com and I'll make an email connection. Be happy to make an intro if, if some of you that I know would like to talk to our guests today. So Gupta, Gurjeet Singh. Thank you so much for coming on inside reproductive health.


Gurjeet Singh  1:00:12

Thanks for having us. We appreciate it. Thank you so much.


1:00:16

You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society, visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health


149 Extend Fertility’s Lessons From The Market For Egg Freezing

Dr. Joshua Klein, REI,  Chief Clinical Officer, Medical Director, and Co-founder of Extend Fertility in NYC joins Griffin this week on Inside Reproductive Health to discuss the business of getting into business. Listen as they share perspectives on risk tolerance, people-management, financial backing, and the potential to lose -or gain- it all on the path to entrepreneurial leadership.  


Tune in to hear:

  •  Dr. Joshua Klein share how he successfully cornered an underdeveloped segment of the fertility market, and what steps he took to get there.

  • Griffin question Dr. Klein on how he knew when to time the change in his career path, and what others in the same position should consider before making a move.

  • Griffin question Dr. Klein when he says “people are the hardest part.”

  • How to not get way over your head in overhead before you even start.

Dr. Klein’s information:

LinkedIn https://www.linkedin.com/in/joshuakleinmd/

Website: www.extendfertility.com

Transcript

Griffin Jones  00:04

How many ways are there to start an REI practice? How many ways are there to start fertility business? Explore that today with my guest, Dr. Joshua Klein because a lot of younger REIs think about well, do I have to go partner with somebody? Do I get a salary right at an academic center? Do I go off on my own, and I risk everything, because I've got this stupid medical school debt. And I went to some very expensive undergraduate college and maybe my parents were wealthy enough to help me but maybe they weren't. And I've got that debt to some of you who are coming out with a lot of debt. And, and so starting a venture, your own entrepreneurial venture can seem pretty daunting. And so our guest today Dr. Klein talks about another possibility is finding other people with financial backing. And in starting your own endeavor, as a piece of that you won't necessarily be a majority owner and own everything. But that's one way to do it. So we talk about the massive learning curve that you're gonna go on, if you want to learn more about the business of fertility, whether you own it or not, that it's drinking from a firehose. So Dr. Klein talks about some of the things that he picked up and the challenges of managing people, a vision for an REI practice. To start the whole thing of looking at fertility preservation is something that was underserved in the market. And what Dr. Klein thinks is the right demographic, or the more appropriate demographics for fertility preservation, and why he saw that as a need in the marketplace, and other hard lessons learned, like cost per lead cost per new patient acquisition. And so we both we talked about those things, and Dr. Klein closes with thoughts of how younger dogs might approach making that choice. So I hope you enjoy today's episode, Dr. Klein originally was a he completed his fellowship at Columbia. And then he was an associate physician at RMA of New York. And now he is a partner at Extend Fertility. And I hope you enjoy this conversation with him. Josh, welcome to Inside reproductive health. 

.

Thank you so much for having me, Griffin. I am interested in the topic for today because we have had people to talk about egg freezing on in the past. And but I'm interesting because your group extend fertility was one of the first to make a brand around. Yes, you're a comprehensive IVF practice. But you did have a special focus in fertility preservation early on. And so I want to spend some time talking about that. Maybe we get to the business second, but you were where were you in your career, when you started to feel like, you know, fertility preservation was something that was clinically viable, because, you know, that wasn't the case. 20 years ago, maybe the people just getting on board now are late. So when was it for you? Yeah, that's a question that that I thought a lot about. When we first were putting this place together.


Dr. Joshua Klein  03:31

I came out of training in 2012. So I finished my fellowship at Columbia in 2012 and took my first job at RMA New York, which is as many listeners probably know, is affiliated with Mount Sinai. It's one of the big academically affiliated programs in New York City. And part of it is just history because ASRM? Well, I should say, the studies that demonstrated that egg freezing could be done through vitrification relatively reliably and reproducibly. And with relatively good success rates really came out in the late 2000s Going into the early 2010 2011. That sort of timeframe. And then actually was at the end of 2012, technically published, I believe, in January of 2013, when he ASRM sort of put their guideline out that said that egg freezing can be offered as a method of fertility preservation without the rubric of an IRB without an experimental protocol. There was a lot of buzz around that that didn't mean that ASRM was you know, endorsing egg freezing or something that everybody should be doing. But at the very least, it wasn't considered an experimental modality anymore. And so that that was 2012 2013 which was literally the first year I was out in practice and kind of getting my feet under me. And, you know, sitting in an office in New York City and Manhattan with that The culture around us, you know, certainly being the case that most women are not getting getting pregnant and building their families in their 20s People are, are sort of young if they're getting pregnant in their 30s. It felt like to me, egg freezing is something that might be super valuable to like, a lot of women, not just a select few, but to like, sort of in some way, the average educated professional 30 something year old Manhattanites, who isn't, you know, hasn't partnered up yet, or isn't ready to settle down yet is still building their career and not at that stage of their personal or professional life where they're ready to have kids. And so, you know, at that time, egg freezing was still very small, it was still new, most people didn't know about it, and this people weren't accessing it for one reason or another. And so even at a big program, like RMA, they were doing, I think, something like 120 Egg freezing cycles a year, which means, you know, maybe 10 a month and the entire practice. So I was seeing a small handful of patients of who are interested in egg freezing. And it just felt like it didn't match the demographics of what it should. So at some point, that kind of light bulb went off that there's a disconnect between the number of like single, professional educated women who might want to do this, and then people are actually doing it. And then of course, the question became like, what's the missing link here? How come? How come it's a mismatch. And so the things that I thought about and that kind of got parlayed into building extend fertility, where people don't know about it. So there was a lack of proactive education about fertility preservation, you know, IVF, clinics, are doing a really good job of keeping busy helping people build their families, people who are struggling to get pregnant with IVF. And so egg freezing was kind of not the center of their attention. So that's one was education and awareness. Two was sort of, I think, the environment, I think egg freezing was never really thought of as like an important piece of an IVF clinic. And so I always used to say that, like, you could pick out the egg freezers in the waiting room, because you know, they were the ones sitting by themselves younger, kind of looking awkward when most of the infertility IVF waiting room is couples who, you know, kind of sad and tortured a little bit in the egg freezers, or they don't have a problem, they just are wanting to be proactive about planning their, their their reproductive life. And then third is cost because egg freezing tends to be priced as sort of like the IVF pricing, but a tiny notch less, even though technically, it's a lot less work for the lab to do so. So it kind of was overpriced, I think at that time. And so those principles were the ones that we tried to harness when we created a Extend Fertility as a center that focused on egg freezing back in 2015 2016. To kind of build a brand and a culture around the idea of making egg freezing and fertility preservation more understandable, more accessible, making the experience a little bit less unpleasant, especially if it's a sort of a purpose built environment, and then bringing the price point down in a way that that could still allow us to have a viable business model. So that's kind of the threads that went into it.


Griffin Jones  08:11

So you saw the market. You saw the the the the flaw in the market when it came to pricing and availability. What about demographics? Because that is a point of maybe contention, but that I just I don't I don't hear a lot of consensus about is what is the ideal demographic, and there are both clinicians and egg freezers did say, the younger, the better. And it it should be something that, you know, 22 year olds parents gift to them for graduating college, I hear both clinicians and egg freezers say that I also hear clinicians and egg freezer say that no way, like it's a very narrow demographic, and it's for 3839 year olds, maybe who are right, right, just before the window of have a real DOI risk, I suppose. And so, where how do you? How do you come to what you think the proper demographic is? Yeah,


Dr. Joshua Klein  09:19

it's a that's a great question, because it is something that I think gets debated hotly, and we have patients every day that say, you know, can I wait a year? Can I wait two years and sometimes it gets a little silly, you know, how can I wait six months? It's like a negotiation. But I think what, what has to be recognized to sort of think through that intelligently is that it's in arguable that in general, if someone does egg freezing younger, they're going to get a more valuable end product meaning younger woman will get or any particular woman if she doesn't younger, will probably get more eggs and more healthy eggs and that same woman who in an alternative universe does it older So, by that rationale, it's, which is oversimplified, as I'll explain, everybody should do it, like you just said at 22. Like, it should be a universal thing, the younger, the better. And so there's not much to argue about. But the reality is that even even at a place like extendable, we tried to keep it on the more affordable side, it is a luxury good meaning between the cost of of the service and the cost of the medications, and then the cost of storage, it's a, it's a, it's a significant amount of money. It's not the easiest process, we try to make it as easy as possible. But it's not the easiest process, it does take a lot of wherewithal to kind of get through it. And so it's not, you know, if if it really was something that you can get come into the doctor's office, you know, get a procedure done for 10 minutes, and it costs $100, I probably wouldn't be singing that same song of everybody should just do it when they're 22. Because kind of why not. And it could, could really be an important thing in your life. But but it's a lot different than that. And so what I what I want to point out is that every year that passes that you don't do it is another year that you might not end up having to do it, right. Because if you're 25, and thinking about doing it, but you wait. And then by 28, you actually got married and then started your family naturally, then that you want that gamble, right? Because you didn't have to do it. And now you may never have to do it, because you're already getting getting your family started naturally. And so you kind of dodged that bullet and you save the money and you save the anxiety and the investment of time, energy and resources to do it. And so in a certain way waiting to do it longer makes sense. Because the younger you are, the more likely you're going to end up starting your family in an easier way than egg freezing, if you just give it some time. And that's why I don't think that the 22 year olds should be less, there's a special situation which I'll actually get to also in a moment. But for most average healthy women, 22 Doesn't make sense because you can afford to wait because if you do it when you're in your late 20s or early 30s, you'll still get a very good end product. And there's a large percentage of women who will in fact, the majority of women who are thinking about it 22 By the time they get to 30 they won't need it anymore. So I think we're overselling it if we're selling it to 20 year olds. So that's something I think isn't always articulated clearly. But that's a reason not to do it too early, even though it's true. If you do it at 22, we'll do it at 30, you'll get more out of it 20 at 22. But you might not need to do it at 30. And so a lot of times it makes sense to wait to sort of let your life unfold. And then but then you gotta be careful not to let that slippery slope slip. Right. So if you do it at 39, I certainly would think that that's a mistake, because that's already you're sort of reacting when egg freezing works best as a proactive maneuver, right? If you're freezing eggs that are mostly not healthy already, which is when you're getting close to 40. That's the reality, it might work. But it's certainly not a great situation. The other thing Oh, the other thing I wanted to emphasize is the fact that age is only half the story, which is to say age is the best marker of egg quality. But there's another issue which is quantity, right how many eggs a woman has and we've learned over the last 1020 years, especially through how Hmh testing has become very common. And actually a symbol of a test. That is , it's been a very important development, I think, in the last 1020 years of fertility, management and treatment. Because if you're a 28 year old with a very low Hmh, which there are a lot of healthy 20 year olds that are going to have a low AMI, it's something that's very highly individual variable, it will probably make a lot more sense than thinking about freezing eggs at that point. If you're 28 year old with a very great Hi imH. You could say okay, I've waited a year. And that's not such a terrible decision. So I think that's another thing that's often overlooked is it's not only about age, it's another dimension when it comes to egg freezing, which is your egg supplier ovarian reserve and Hmh testing is so easy to get it's almost a shame that, you know, I believe that that OB GYN should just be doing it routinely, they do a lot of other health maintenance stuff that may or may not be helpful. And this is something that could be really useful. And I think slowly they are doing it more and more. But I think that's another dimension of calculus that needs to be recognized. And that can help a woman who's trying to strategize to make that kind of decision is really useful to have.


Griffin Jones  14:16

I don't think that this question is gonna go away because it doesn't seem that it doesn't seem that we have hit the plateau for the age of first birth in this country. So I think everybody remembers that headlines from earlier this year hit the first average birth. For women in the US the median age hit 30. And if my records are right from the CDC, it was even just in 2014 it was a little over 26 years old. Yeah. So it went, it went up one and a half years from just shy of 25 and 2000 to 2026 in less than 26 and a half in 2014. And then in 2022, it's 30. So I suck at math, but I think most of the people listening can see the exponential growth. So I don't think that this is going away. What do you see in the marketplace? Do you see peaks and valleys? You know, what I wondered is when you started in 2015, in New York is like, okay, are we going to see this in Charlotte in three years? And then in Cleveland, two years after that, and talk to us about what you're seeing?


Dr. Joshua Klein  15:46

Well, I think you're right, first of all, that this is still a moving target, and the market is still maturing. The, it's interesting, because there were some well publicized predictions that were made 2014, let's say I think about what the expected size of the egg freezing market would be. And there's one quote that's out in the media that said something like 85,000, or 100,000 cycles of egg freezing by 2020. The truth is, it hasn't grown that explosively. And you could think about lots of different reasons why that might be the case. But I think that egg freezing has clearly grown a lot. I do think it's going to continue to grow, I actually think that some of the kind of spin off growth that we're seeing, and that others probably are seeing as well, is more and more married couples, or not just married, but I guess more and more couples are coming in to proactively plan their families, even as couples when they're not ready to have their children yet. And also, and this gets a little hazy, where the line gets drawn between fertility treatment and fertility preservation. And sometimes it's an issue with insurance coverage, and so forth. But lots of patients who, you know, come in in their late 30s, for fertility treatment, they do IVF, and they get an embryo. And they say, Well, wait a minute, we always wanted two kids, and we struggled to even get one good embryo. So what we want to do is we want to do another stimulation cycle to at least get one more before we go ahead and use this one. And that happens all the time, these days that people are trying to bank at least, you know, not bank inventory of embryos, in some unreasonable way. But to put away one or two good embryos for the second baby if they're having their first baby in their late 30s, or 40, which is actually very logical. And so the I think the fertility preservation concept is kind of growing and branching out into other in other ways that in some way, are still evolving, by the way, another, I think, idea that will come to fruition, but I don't think it's happened yet, is I've had a handful of patients who have read about and are interested in doing proactive couples who are interested in making embryos for PGPT, which is the polygenic testing, you know, looking at, particularly if let's say, a couple comes in, the guy says, you know, my, my dad has terrible Parkinson's disease. And I know there's no gene for a consensus disease that I can screen for, but it just scares me to death that that's something that I might have a kid and it's going to be at high risk for. And so what I want to do is do these kinds of polygenic testing, you know, involving multiple genes to say which embryos have a higher or lower risk for developing, whether it's Parkinson's or Alzheimer's or diabetes or heart disease and things like that. So that's something that's not common yet. But I think that it's coming, as this sort of feeling devolves into a lot of this proactive planning your family type of and then genetics is obviously evolving and improving as well.


Griffin Jones  19:02

So you made a brand that I think is pretty well positioned for that. The brand Extend Fertility really works for both sides of fertility preservation and fertility treatment, it is because it's the extension is very intentional. And so you, you started this in 2015 is when the was when the business started, right. So you completed a fellowship at Columbia in 2012. You go work for RMA for three years. This is the point that a lot of the listeners are at they're either just leaving fellowship or their associate docks and they're thinking about the next step. You are at a place where you're at a great practice. You could pursue partnership there, or you could go off and do something risky. What was your decisions? When did it start? to appear in your mind of I could go off and do a venture like how did that originate?


Dr. Joshua Klein  20:07

That's a great question. So, yeah, I mean, without getting, I guess, too personal, I have a lot of gratitude towards my years at RMA, I learned a lot. And it's a good place. I think that for me, I think that it well, it was a hard decision, let me just say that much. The truth is that when I started speaking to one of my associates, my business partners who was interested in investing money, putting together investors to build out Extend Fertility, my original expectations that I would sort of be some kind of consultant on the project and not actually do it myself. But as we kind of continue those conversations, and I got more enthusiastic and excited about the idea, and he got more enthusiastic about me actually getting in it, it took some time, to warm to the idea, but I kind of got more excited about about doing it myself. But it's scary, you know, especially first job out of training. And I was fortunate to have, you know, good training and at large academic centers at Ivy Ivy League institutions. And so I hadn't kind of been really out in the business world before before then. But I think that my mindset essentially was that I felt like a small fish in a big pond at RMA, which isn't necessarily passing a judgement, it just the way it is, when you're working for a large institution like that. It's a big pond, it's a big pond, and to their credit, it's a big pond. And so I felt like I was young enough at that point where if I was going to ever take a risk, you know, I didn't, I probably couldn't have done it the day after I finished fellowship. Or I certainly think it's very hard to do it. The day after you finished fellowship, there are those who do it, and I give them credit, too. But I felt like having gotten my feet under me at for a couple of years. If I if I stayed for another few years, it probably would have been that much harder to leave. Probably my income, presumably would rise slowly. And so that, you know, the better you're doing the more than make it attractive to stay. And so, you know, when you're young, you're just getting started, it's a little easier, because you're not giving up so much. And so, I don't know, I guess my thought process was basically I felt like this was a good idea. And at the end of the day, I felt like, before I started my before I finished fellowship, before I started my professional career, I felt like I questioned, like everybody has self doubt, I knew I was a bright kid. But like, it's hard to see yourself doing what your what your teachers and mentors and superiors are doing, like, Can I really handle it when when stuff gets, you know, kind of difficult when there's an unhappy patient? And how do you? How do you deal with that, or when you have some issue with like an inspection and there's regulatory stuff, and hiring and firing and all that it's very intimidating as a young, you know, kind of medical trainee. But I think that what I started to realize was that the hard stuff is still hard when you get older, and everybody does their best to handle it. And so and everybody's just human, I think that's what I what I really kind of it became clear to me that everybody's doing this is doing their best and no one knows all the answers in advance and kind of everyday brings another challenge with it. But if you know if the other guy can handle it, probably so can you and you just have to kind of have that courage and have that confidence in yourself. And so that was what I think allowed me to take that leap is sort of getting out in the world seeing that nothing's perfect. Even behind the curtain, every practice, every lab has its own questions and issues and, you know, uncertainties and every practice has its own issues that come up and like that's life and you kind of do your best to keep people happy and to do to keep the patients happy and go home, you know, doing the right thing and hopefully sleeping well at night. And you know, so it kind of lost that in that side of the intimidation. And then I felt like you know what, I'm going to take the leap. And by the way, if you take the leap and you kind of just fall on the floor. So you still have your training and you're kind of embarrassed probably but you can get up and go get a job and so you know, I felt like it's it's not if you if you let that opportunity go when you're young doc it may not come back to you. But if you take it and you swing and miss Well, no one's gonna fault you for taking the swing I think and and your career isn't ruined just because you tried something it didn't work so


Griffin Jones  24:40

and if you fall flat on your face and you're humble and self aware enough, it will make you a better partner somewhere else absolutely Well, as long as you are and those are two big as. Those are two big conditions. Not everybody is onboard and self-aware. But but if you are falling flat on your face can give can can make you do that much more valuable as a as a partner somewhere else is if the gays and then you know, if you are successful, then that's then you have you've done it long before most other people have. So in your view, what's harder? owning a business or residency


Dr. Joshua Klein  25:21

apples and oranges I guess I mean, I think I think Well, the obvious answer residency is harder, because it's physically so demanding. And then you also have to kind of keep your mind sharp while you're literally exhausted. To be clear, and for the record, I don't, I'm a very small part owner of extent, but I wouldn't call myself the owner of extent, because there's a lot of investor money that went into building this place out, and that and by the way, too, for, for the, for the, for the record for the listenership here also. So I'm talking like a big shot, oh, yeah, I'm gonna, you know, go off my own and start something new. And I in some ways, that's true. But I wasn't in a position to put up tons of my own capital, because I didn't have it. And so I did start off with investor money. And I guess I had to earn their their respect and their confidence to get that investor money, but I didn't, I didn't find $5 million in my own pocket to put down and build out a lab and build out a program. So I didn't have that much courage, or I guess, wherewithal at that point. But having said that, there's no doubt that running a program is hard. And I think that the reason that that's true is because literally you feel stressed and responsible for like 1000 different things that can come up and everyday, something does come up. A lot of it's the people, the people is the hardest thing. You know, they say hiring and firing. And that's, that's the most blatant example. But, you know, people who are thinking of leaving, and people are unhappy for X, Y, or Z and people who don't get along with each other. And they're both important pieces of your, of your of your of your team, and you gotta help them get along somehow. And, you know, the day to day, team, building, Team preserving is is is is complicated, and there's no playbook and you just got to do your best to sort of read people's emotions and feelings and instincts. And that's obviously not easy. Also, the fact that you feel responsible for everything, and maybe I that's one of the things I have to continue to mature to learn, let go. But like a silly little example, there was a, someone who dropped off a gift bag for a patient letter retrieval. Was it yesterday morning or two days ago. And somehow that gift bag disappeared. And it never got to the patient in their post op, it was supposed to be like some snack. It was nothing. It was like some snacks. And some, I don't know what, maybe a heating pad or something. And the person who dropped it off was obviously not happy because the patient was was was heard about and they were expecting and and I don't even know what happened. Somehow it never, never, never made the way and so then I'm was approached by the person who dropped it off. Because of course, like, you know, I'm kind of considered responsible for everything and like, Where can we figure it out? And then I'm asking you at the security cameras and the security camera wasn't focused, it wasn't working. And then I'm asking the lab and it's just like, this is the last thing I want to be you know, working on is finding the snack bag. Like Who else am I gonna you know, I did get help and and still not figure it out. But the point is, like, from the littlest to the biggest things, you worry about it because you feel responsible for everything that happens under the under the four walls or under the roof. And so that's that's not an easy way to live. And my hair's a lot grayer than it was five years ago, that's for sure. But well good news,


Griffin Jones  28:36

Josh. That means you're not a sociopath. So you it's, it's like it to be a business owner is one I it's so hard and I'm not running a medical practice but just you know, even running a client services are it is so hard for the reasons that you describe balancing, delivery and sales and, and the people that the to do all of those things and and you have to be so you have to be receptive to people. You have to listen and then there are other times where you have to forge ahead and say okay, we're moving on and and so you have to be agreeable enough to listen to not be a sociopath AND and OR a narcissist and but also not so agreeable, that you're just Oh, okay. Yeah, I guess I guess that is too much work for you to do. Yeah, I guess. I guess the patient doesn't really need that. You know, it's you have to you have to walk a line that can be pretty heavy.


Dr. Joshua Klein  29:48

It's funny the way you frame that because I also think it sort of tangentially but it connects to, in my opinion, how to be a doctor with a good manner in terms of how you manage patients and patient make patient recommendations. In the sense that, especially with infertility, where most of our patients are, you know, relatively young, relatively educated, lots of them are doing lots of Google research. And they're on the message boards, and they're talking to their friends and their and their sisters and whoever else that that their doctor said, you have to do this or that doctor said that never should be doing them like that, or Google, you know, says X, Y, and Z. So I think it's a really hard balance to strike, you always want to be open to hearing your patients feedback, or thoughts or questions or suggestions. If you're perceived as as dismissive of their input, that's going to be the kiss of death, patients hate bad. But at the same time, and this is something that I've also learned and continue to learn is that it's not healthy to just say, Oh, you read about that, you want to try that, or your friend did this, I'm sure we'll do that. Like, I think you not only is it not good practice, but it also you lose respect. And it's not a healthy dynamic for the patient, if you're just willing to do whatever. And so, you know, you have to really strike that balance of being being open minded, willing to discuss but also firm when you know, sort of what's right and what's wrong, and make sure that you express your opinions, so that people know that you kind of have something that you kind of believe in and that you're willing to draw boundaries and give firm recommendation. So anyway, tangential to the managing a practice. But I think it's the same skill set in a certain way to be able to read people and allow them to see that you're willing to listen to them, but not kind of just they're


Griffin Jones  31:43

both examples of leadership. So the idea of partly being is that you're meant to lead me as the patient Yeah, you have to listen to me in order to be able to lead me effectively. But at the end, you you are not the pharmacist and I am not the physician, you are the physician, I am the patient. And you have to be able to lead me in the same as drew in a business and for not just fertility practice owners and other business owners in the fertility field who listen to this show. But all of us business owners across the market think the last year and a half, two years have gotten unbalanced advice from it's all been about the employee, just go on LinkedIn. And see I haven't seen one post on frickin LinkedIn sticking up for a business owner in two darn years. Everything is and we deserve this too. And we also should have that and we're finally making what we're worth. It's like, really, that's what your worth is, is right now in the most unprecedented inflated economy of all time, like, is that house really worth a million and a half dollars? Okay, but then does that mean that that's what you're worth when there's a recession or or the pendulum swings the other way. And for business owners, the advice has been do whatever you can to retain, show that you care show that. Listen, give them what what they're asking for. And in many cases, you do have to do that. It also has to be balanced with leadership and saying this is where we're going and holding people accountable. And many people, the last few years, many of us have been afraid to hold people accountable, have been afraid to, to really, you know, leverage leadership. Because it's like, well, if I lose that person, you know, we're already down three people. And, but, but it sure makes things worse. Because then it becomes a cancer in the organization. And and then nothing you do is good enough, when you are listening when you are if you don't have the other side to balance and say this is where the organization is going. And we're all accountable to it.


Dr. Joshua Klein  33:56

Right, right. Yep. And it's not easy. You know, it's and it's, I think it's probably as hard as it's ever been for the reasons that you're talking about it. We all do appreciate our employees and our colleagues and genuinely, and they do deserve what they deserve. But yes, it can get out of hand pretty quickly if you don't set sort of some framework for what's reasonable. And that's not an easy thing to do. So


Griffin Jones  34:25

other than like principles like that, about people just even like function? What are things about business that you knew nothing about when you started? Like, I think now, good advice for most people, unless they're 100 on this on the entrepreneurial spectrum, and by 100, I mean, Mark Zuckerberg, I mean, Elon Musk, I mean, that type of but you know, your average business owner might be like a 70 on that spectrum. And, and so I think for most people, unless they're the most extreme on the entrepreneurial spectrum are better off I'm going to work for someone first learning as much as they possibly can, and then starting their own business, if they still think that's a good idea. And I say that and I believe that at the same time, though, I know things like I wouldn't even Effingham County what to look for, in many cases. So what are some of those things where you're like, I didn't even know, to look for that. Before I was, before I managed to practice.


Dr. Joshua Klein  35:30

I think I mean, in a very fundamental way, I think one of the things that has become clear to me is that so much of business relies on assumptions that are necessarily loose. You know, one of the things we struggled with and as they struggled with, but but that we, that we learned along the way was, I mentioned earlier that when we started extended, we wanted to push down the price point and egg freezing to help make it more accessible. And this has been an ongoing debate that's still ongoing, you know, what's a reasonable price for for an egg freezing cycle? And even more, it might sound crazy, but what does it cost for us to deliver an egg freezing cycle, because it's not simple math. You know, there's fixed costs and variable costs. And so I think when I when I agreed to join in San fertility, and I had some really accomplished smart business, people who joined as well, and we started, you know, kind of making decisions about how we're going to set things up in the framework. I was, I think, expecting that these business business people with their MBAs, Ivy League MBAs would have some magic formula, they're going to pull out some Excel spreadsheet, and they're going to just have it all figured out. And like this is, you know, it should cost x. And as it turns out, they don't know, at best, they say, well, let's assume that this year, we're going to do this number of cycles. And let's assume we're gonna have to do X number of embryologist, doctors and obviously, you all the different things you have to put on paper. And then yes, there is some smart math you can do to sort of make a smart, smart decision and a smart assumption. But I think that it was sort of a little bit disturbing about how much of a business is done in a way that you just have to like, make thoughtful decisions based on as much available data and often there isn't a lot of available data, and kind of just try it and see what happens and then adjust along along the way. So I think that, you know, it definitely I've learned a lot about business over the last number of years. And I've learned to respect people enormously for their successes in business. At the same time, I think the my perception that there's like this business secret book that like you only get if you're a business person, and that doctors aren't privy to that, I think misconception has been, or I've been abused of that notion. So you kind of just have to get comfortable with saying, Well, this is like the best guess we're gonna make. And let's, let's go with it. So that's something I think that you only learn when you're on the other side and really see the books and know how the some of those decisions are made with regards to the dollars dollars and cents. That's one, I'd say another sort of big learning item for me was, I think, when you're on the outside and thinking about a business, from a financial perspective, in a relatively unsophisticated way, are you tend to think mostly about revenue and not about overhead, and he's out while they're doing 1000 cycles of IVF. And every cycle is, you know, they're getting 10,000 bucks. And so that's like, well, whatever that is $10 million of revenue. And so like, it's 10 million bucks, like that must be rolling in the dough, except that you don't realize that, like, your annual rent, if you're in Manhattan can be easily a million dollars or more. And then you've got, you know, four or $5 million of payroll for all of your people. And then you've got all of your equipment, and then we got like, etc, malpractice insurance. Yeah, and the insurance and not just malpractice and liability and the cyber insurance and like, and all of a sudden 10 million bucks is not exactly a ton of money anymore, you know? So I think that the to the to the uninitiated, it's easy to see a business as as a revenue entity, but it's not it's it's a it's a P&L entity. And so and there's so many more overhead items that you never dream of before you're kind of in it. And so I think that's something that I would definitely caution people to think about if they haven't gotten on the other side of the curtain yet is just you got to realize that that delivering a product and certainly a high quality product and certainly a you know, a high touch service. highly regulated product, like health care in America, for fertility patients is a very expensive thing to deliver. And it's not so easy to cut out a lot of these major major expenses and so, you know, it's for full transparency, you know, I kind of imagined we'd be able to push price points down a lot more than than is realistic before I knew what goes into it. And so you know what we charge for our server He says now is more than I thought we'd have to charge but the reality is, it's it's it's very expensive to deliver good quality care or even mediocre quality care, let alone good call quality care. And so, so don't forget the overhead it's it's it's an important other


Griffin Jones  40:14

how I remember the first time you did a budget, the first time we tried doing a budget was like, it's like, I don't know how much that's gonna like before we launch the podcast, but I don't know how much it is to podcast, like, I don't know how much we're going to end. So it does take some, like some expense tracking, which is different from budgeting that helps that informs but you know, it's a lot easier for us to do a budget and forecasting, because like, How the heck are we going to sales forecasts in the beginning? I don't know, how many clients am I going to sell this year? How many. And so that's that's two areas that I really would recommend that if somebody's thinking about starting their own business, their own practice and their their in an organization, I would I would try to do two things. And the first, well, maybe three. First is is see as much of the financials as you can some people do like that our firm is moving towards open book management, where we share that with our team. And maybe some places you can only see a piece of it. But David sable recommended a book to me last year called how to read a financial report. That's exactly what it sounds like. It's as interesting as reading New York state tax code. But it is it's the basics. And it would be great if you could do that for your own practice, or even your own Rei division if you're at an academic center, and to see what that is to have some education that the second is to know what to know, the sales and marketing pipeline, how are people coming in? That is extremely important to know, as deeply as you can. And the third is the Human Resources pipeline. How are we getting in retaining people? And like those are three areas where I think it makes sense to really delve in May, maybe even more than operations and delivery, I might even put those three areas ahead of operations and delivery. In terms of priority of learning, what do you think?


Dr. Joshua Klein  42:15

I think you're right, because that's kind of how you get to have a team that can do the things you want to do. And if you have that, then you figure out how to do you know, if you have the right team, you're gonna do the things you want to do the operations and delivery, but you can't, you can't get there without sort of getting your Human Resources figured out without getting your sales and marketing figured out. So you have you know, a customer and that you get your finances straight. So yeah, I think that's probably right. And by the way, the sales and marketing piece is also another thing. And I can reflect with our own experience that extend you know, we came in to be open and came into the market heavy on the increasing, increasing is more so than, you know, infertility treatment, an elective service line, it has less insurance coverage than IVF does. Even today, you know, even with progeny and Karen and when fertility, there's still only a very small percentage of of women will have coverage for fertility preservation, and only a minority percentage of our patients have coverage. And we were very aggressive with our marketing and our marketing spend early on. And we grew very fast. And so it was clear to us from the first couple years of doing it that marketing works when it comes to egg freezing. The problem is that that only actually works. Ultimately, in the long run, if you can spend money to get customers in a way that allows you to still have a profit margin on what you're charging for your service. Meaning if you got to spend $5,000 on marketing for every customer that you're going to convert every patient you're going to convert, that may not be a viable business model, because you're not charging enough to justify it. And so you know, how you're gonna get your patients the best way, of course, is when they show up, you know, they word of mouth, it's free. But the reality of fertility in the US right now, certainly in any major metropolitan area for sure, is that there's lots of competition, and everybody's got an angle. And most practices, even the academic practices are doing something on the sales and marketing. And so it's important to be realistic about the fact that that stuff has to be done carefully, thoughtfully, and it costs money and you have to keep track of how much money you're spending and what you're getting for that for those dollars. And once again, like maybe I was way too naive, but this isn't stuff that I thought about, you know, figuring okay, just buy some Google ads and there's your marketing and like it, you know, it's a lot more complicated than that, obviously. So that's definitely another area that that I've learned a lot about over the last number of years.


Griffin Jones  44:55

We're talking about lessons learned, you know, owning a practice or owning a business in the future. silletti field and things that you may want to learn how to do or learn about before you go and start your own venture. Another thing is some of the systems that are used, and oh people that can give really good recommendations on the different EMRs. They've shopped and the depth and scope of functions. But I would ask someone that you know, that uses engaged MD, if you're not already, if you don't use engage them D in your system, you're thinking, I want to open my own office within my own group, or I want to open my own practice, I want to go join somebody else, and I want to be able to add something to it, engage them D is one of the surest bets that you can do, but you don't take my word for it. Ask someone that you know, because more than half of your colleagues are using EngagedMD and more than half of your colleagues are extremely delighted with EngagedMD because they got real informed consent. They don't have stacks of papers that people have to sign and then account for and then keep an eye out file cabinet somewhere. They have true informed consent from patients that have a module at their convenience, so that the staff isn't overburdened with questions that they don't need to be getting that they can help the patient with the attention that needs to be devoted to that patient's case. Because the elementary the rudimentary is covered, and now it's just what that patient is stuck on or what's unique to their case that the care team can focus their care on. That's what personalized care is. And more than half of your colleagues have seen the benefit from engaged MD that way, so just reach out to any of them. Hey, guys, do you use EngagedMDin the people you want to fellowship with people that you see it ASRM? Hey, do you use engage MD? What do you think I hear Griff, talk about it. But he doesn't want to practice? What do you guys think, and see what they say. But if you want that free workflow assessment, want to see what other practices are doing, you want those insights that engagedMD has, and you want to see how your practice stacks against that ideal workflow, then you go to engage them the.com/griffin. And you mentioned that you heard them on the show, you mentioned that you heard them from me, and then you're going to get that free workflow assessment. So ask somebody else, don't take my word for it, but go to engage them db.com/griffin Or say, or an on the show. So you heard from me, so you can get that free work assessment for you. That's one of the biggest system wins that you can have right off the bat. And you can verify that just by asking people you already know, I hope you enjoy the rest of this episode about things you need to know for the fertility business, you might start, I'm gonna let you conclude on whatever topic you want to but before that, because we have so many younger Doc's that listen. And they're thinking about like, how do I choose who I'm going to work with you were you chose your your business partners, and, and they chose you. And so talk about how you did that? Well,


Dr. Joshua Klein  48:21

I'd say I was probably luckier than I realized, the main person, the main business person that I that I partnered with, is a wonderful guy named Michael Kohn, whose private equity hedge fund guy, the truth is looking back, I got lucky that he is of as high integrity as he is, because I probably could have gotten really treated much more poorly or gotten abused more if I wasn't so lucky to find someone. So I think that the advice would be, you definitely have to choose we get into bed with very, very carefully, especially when it comes to business people because I think that they're not all going to be the most high integrity people. And to be fair, like business people are, their profession is to use business to make money. And that's true for doctors too, obviously, with our professionals, how we pay our bills and make a living. But I think the mindset of young doctors is a little bit more idealistic than the mindset of probably mid career fitness people is and you got to be very careful not to be too trusting or too idealistic in that sense, you know, for young blacks are coming out and looking at job opportunities. So it's, it's complicated, because I think that, you know, the people that you're going to work with day to day are the clinical team, you're going to have obviously Doctor colleagues, and then other clinical colleagues and embryology colleagues and so forth, but these days, a lot of practices are either owned or part owned or managed by business entities that you may or may not have much direct interaction with. And it's it's a very, very seen I think that I Have the level of involvement and exposure to the business behind the practice is going to be very different from one place to another. And I think that that's those are important questions to try to really investigate while you're looking at different practice opportunities, you know, if there are going to be places that are looking at the conversion metrics, you know, how many consults did you do, and how many of those turned into IVF patients, and if you're below a certain bar, maybe they're gonna get dinged, or you're not going to get your bonus. And, you know, to some degree, that's not crazy. But if that's gonna bother you, like you better you should be aware of it. And in other places, certainly in more academic environments, the culture, maybe more sleepy, but, but that might be more comfortable, to not have to sort of think about numbers like that. And so I think that I'm not sure that I have much brilliant insight other than to say, it's a very, very playing field out there. And so you really want to ask as many questions as you can and talk to as many people as you can, looking at to what degree is that practice run like a business or like a medical practice that has a business behind it, because the culture of the place and look, business is not terrible. And there are some very successful, very busy places out there that run like a business and that patients are happy, and the doctors are happy. And you know, that's not necessarily always the worst thing. But I think different doctors have very different priorities of how they want to practice medicine, and what kind of lifestyle they're looking for. And it's going to be pretty different from one practice environment to another. And so just Just do as much investigation and homework as you can. Because it is going to be very different from one opportunity to another.


Griffin Jones  51:45

So that's for the homework, let's conclude with the introspection thing, because a lot of people listening are in the position of the 2012, Josh or Jean Klein. And maybe there's a couple different routes for that type of person, but some of them should stay at Columbia or wherever their academic center is, wherever they're doing fellowship, because they're going to be happy, they're at another one, some of them should go on to be should should just gobble and gobbling, gobbling till they're a bigger fish in the bigger pond that they end up with it someplace like an RMA or or an RMA or wherever they end up, some should go off on their own. And then there's other people still that it's like, oh, there's somebody that just started their own thing couple years ago, I don't totally want to start my own thing that I don't feel like starting from zero. But there's also a lot of opportunity for me to help make this bigger, I want to go join the Josh Klein's out there. So there's a couple of different options introspectively. And then this will this will be your final thought for the program? What How should people decide what's best for them?


Dr. Joshua Klein  52:58

That's a great question. I think that you can't have everything, I think that it's important to be realistic about the fact that if you're someone who is going to prioritize, you know, maximizing income, then you're probably not going to get that at a pure academic program. Because you're going to be salaried. And usually, that's not the culture. If you're someone who enjoys teaching who enjoys having some abstract today's stream every year going to conferences, then you're going to get that at a more academic program, it's gonna be much harder, you're gonna be sort of swimming upstream at at a pure private practice. If you're someone who has, you know, family, or hobbies or outside interests that are very important to them, that that, you know, you want to be out of the office by 5pm every every evening and not work weekends, you know, that that's going to be something that you want to take into account. And I think the bottom line is that there's no job, probably, that's gonna let you be like the division chief, and academically active going to conferences every couple of months. And you know, making a seven figure income, and not working weekends, and being out of the office by 5pm, every month, and every week, every day. So, so I think it's just a matter of, and again, no brilliant insight here, but you really just have to think about what are the things that are most important to you and your lifestyle and money is important, but it really is not necessarily the most important. And so, you know, make your list and then try to get as many of those things as as you can, because you're just it's like buying a house you're just not going to get everything unless unless something's you know, your I guess our unlimited budget, but most people are going to have to pick and choose. And so just think seriously about what's going to make you happy in five years and 10 years and then chase after those things. And maybe some of it will come along with it. You know, you can be in a private practice and still be the research person who does put together some research abstracts every year and like that's fantastic. But as long as you you know, are are comfortable the fact that that's kind of if you can, you'll do it but it may not happen then you're being being smart. So I think it's it's really a matter of triaging what what is going to be highest priority for you and your career and, you know, being honest with yourself about what's going to make you happy. And if you do that you should be landing in a good place. And there's lots of good places. That's another comment is that there's not like one right job, I think there's a lot of ways to be happy. So we're in a good time, there's a lot of good going on.


Griffin Jones  55:27

Well, if if one of those routes makes sense to talk to you, as you say, talk to everybody is that an offer you would extend are there that you would extend to the younger dogs that they can reach out to you on LinkedIn. So we will include that in the


Dr. Joshua Klein  55:45

video, I think my journey has been an interesting one and not the most common, you know, working and big place academic place, and then in New York, kind of CO founding my own place, and it's been a journey and it's been a learning journey. And so I do think that I can give people guidance, or at least my, my personal, you know, perspective, so I'd be happy to be available.


Griffin Jones  56:05

Dr. Josh Klein, thank you for coming on inside reproductive health.


Dr. Joshua Klein  56:09

Thank you for having me. It's been my pleasure.


56:12

You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society. Visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health



153 Elizabeth Carr: What is U.S. IVF’s First Born Working For and What Is She Doing Now?

 This week on Inside Reproductive Health, Elizabeth Carr shares her experience from birth to where she is today, at TMRW, and everywhere in between. Born quite literally into the industry and its spotlight, Elizabeth has chosen to be an advocate for IVF, working to change public education, and further ‘industry’ advancements. 

Tune in to hear:

  • What Elizabeth Carr is doing to give back to the community that made her existence possible.

  • How her relationship with Dr. Jones and his family contributed to her life and ultimate career path.

  • What she wishes people in the industry would push harder for. 

Elizabeth’s information:

LinkedIn:https://www.linkedin.com/in/elizabethc

Twitter: @ejordancarr

Website: www.ejordancarr.com


Transcript

Elizabeth Carr  00:04

My speaking up and out has always been kind of my love letter to the industry as a thank you and to all the patients. As a thank you for saying thanks for not giving up and making sure that I got here.

Griffin Jones  00:17

unlimited human potential Do you ever think about the line of work that you're in, in those terms, unlimited human potential. That's what I think about when I think about the in finite or at least in depth finite number of IVF babies that can be born or babies born from art in general, my guest is Elizabeth Carr, you know who she is because she was the first baby born from in vitro fertilization in the United States, through Dr. Howard Jones and his Institute. And we talk about what that was like to always be in the limelight. But I think the reason why you'll get an interest in or you'll take an interest in this episode is because partly the relationship that she talks about with her family and Dr. Jones and, and then what the other IVF babies that she knows from the institute, what their relationship was like, and their fondness and even the way she thinks of Dr. Jones's colleagues, and that weren't there at the institute, but But everywhere. And so I think as you think about what kind of legacy that you're having, maybe we take a little break from the private equity and the hiring and the marketing and the business development and all of the this stuff, the important stuff that we do have to do we take a break for a second, so that you all can reflect on the legacy that you're leaving from someone who had one is very good about speaking about it, but to at least in this country, has been living it for the longest. So now she's with TMRW Life Sciences. And I get to talk a little bit about that, and a little bit about advocacy and an opening up. But think about this episode with regard to your legacy. And enjoy this interview with Elizabeth Carr. Ms. Carr. Elizabeth, welcome to Inside reproductive health.

Elizabeth Carr  02:23

Thank you so much for having me. It's great to be here.

Griffin Jones  02:26

You are the United States of America's first baby to be born through in vitro fertilization. So does Louise Brown, like ever? Just Does she ever throw some nationalistic crap at you that the UK beat us to it? Or does the stet you know, does that Steptoe Jones legacy does it? Does it manifest itself as a rivalry decades later, or was it the whole world collaborating to? To try to do the right thing?

Elizabeth Carr  02:57

Yeah, no, no shade, definitely no shade from Louise. And yeah, my doctors Jones actually worked with Steptoe and Edwards to kind of understand what they had success with, and then tried to replicate. In the US, of course, my distinction versus Louise, where maybe I'm throwing a little shade is that I'm really the first IVF baby, that, you know, when we think of modern IVF, I'm it so Louise was a natural cycle, whereas I was the first baby born using all of the, like, hormone protocols that we're also familiar with now.

Griffin Jones  03:35

Wow. So well, that's another reason why whenever somebody says, and normally there's playing around, but our country did this first or our team, our university, whatever did this versus like, but yeah, they did that one step first. And then because you did that one step and you help somebody out, they figured out another step. And then the other guys and gals over here figured out another step and as much better to think collegially Exactly. So. So when did that start to become a part of your life? Because it was always a part of your parents life, but But for you, it definitely wasn't, you know, in the first couple years of your life, in terms of like you knowing that, you know, at least age two and three

Elizabeth Carr  04:25

you Well, I mean, yes and no. So I let me put it this way. My first press conference ever was at three days old. So while I may not have had the cognitive realization of what was going on, I have always known that I was not like all of my other peers, you know, other kindergarteners weren't going on Good Morning America, but I was, you know, think things like that. So I may not have realized until I was older. What this meant: But, but I knew that my parents went through something different in order to get me here. That was kind of like my understanding when I was very young.

Griffin Jones  05:10

My assumption was no, it would have taken a few years before some of the to be able to explain it to you. But you were just never out of the limelight is what you're saying.

Elizabeth Carr  05:19

Correct? No. I mean, it was a media firestorm from the day that it was announced that there was a pregnancy even before I was born, just even a pregnancy there and woman impregnated was the headline that my father recalls reading. And he was like, yep, that's my wife. So yeah, it's always been a subject of media spotlight and scrutiny.

Griffin Jones  05:45

And so how long did that last for? You said you went to? You went to kindergarten, and then

Elizabeth Carr  05:54

I made its last my whole life. Yeah, it still happens. It's lasted my whole life. Basically, every reproductive milestone, somebody will want to talk to me about what this means, or you want to check in and make sure I was developmentally just like everybody else, because this was, you know, had never posted, by the way. Yeah, I mean, you know, mostly abnormal, I

Griffin Jones  06:19

think, crazy as everybody else.

Elizabeth Carr  06:22

Exactly. I don't think there's any real normal out there. But yeah, so I mean, it's been a constant. limelight. I mean, I had a camera crew here last week at my house, and I'm, you know, I'm just living my life. So

Griffin Jones  06:37

were there. Were there points in your life where people were less aware the media was less interested, like, oh, 13 year olds are gross. Let's bother again, when she's old enough to vote? Like, Were there ever lows in? Were there? And, or maybe at least lows compared to the peaks?

Elizabeth Carr  06:58

Yeah, I think, yeah, the ages that were less exciting, right. So like, nine was not a big deal. But 10 was a huge deal. Because it had been a decade since I had been born. You know, when I turned 16, it was like sweet 16. Right? When I turned 20, when I got married, when I had my son, when, you know, it's like, all of these kinds of life milestones that people go through. Mine had an additional level of media interest that I don't think many people realize until we start talking about it.

Griffin Jones  07:29

Hey, are you gunning for centenarian status? triple digits, because

Elizabeth Carr  07:35

I know that the running joke is, you know, this year, I turned 40. And I was like, you know, I can't lie about my age. Everybody knows when my birthday is exactly how old I am forever. Never. That's, you know, that's what I'm stuck with. So yeah, it's, it's crazy.

Griffin Jones  07:52

So when did this notoriety start to get you involved with the fertility field, like the fertility field had always known about you? The doctors knew who you were, and they certainly knew our Jones was. But at what point? Did it start to get you involved with them?

Elizabeth Carr  08:22

Yeah, so I mean, aside from the media attention, and all the interviews that I've had, over the course of my life growing up, I, I've always had an interest in science, I'm not good at math. But I've always liked to explain the science. So I've always, and I always, I think I was probably 10, when I started really paying attention to the industry and seeing what was going on and developing. So I've always paid attention to the reproductive field. But I also started realizing that because I had this weird platform in life, that I could use my voice for good and for change. And so I've really, from a pretty young age, started speaking up about different reproductive options out there, and became kind of like a junior advocate, you know, Junior age, probably 1011, I really started paying attention to what was going on with insurance. And I'm still actively fighting those insurance battles and testifying in front of various committees and on state by state basis and paying attention to all the laws and, you know, looking into just helping people understand their options. So I started really paying attention to that stuff, probably when I was 10. And then I went on to be a journalist and wrote, not surprising to many I don't think primarily about health and science and again, stayed up on everything going on. And then I've worked for a few fertility startups and done a bunch of free then to writing and social media for various companies. And now I'm at TMRW Life Sciences as director of marketing.

Griffin Jones  10:07

So you started off as a journalist, were you ever kind of covering just a regular beat? Or was it always Health and Science?

Elizabeth Carr  10:16

Yeah, so I did a range of things. When that you, when I started out, I worked from age 18, at the Boston Globe. And I actually started out as an obituary writer, because you can't label a dead person, believe it or not, so they let you start there. And then I did a lot of general assignment. And then I went into health and wellness was a writer, then I became a health and wellness editor. And so I've done you name that you name it, it runs the gamut in terms of journalism,

Griffin Jones  10:47

what made the switch or the transition from journalism to marketing.

Elizabeth Carr  10:53

So I spent 15 years of my career at the Boston Globe. And I actually jumped from the editorial side of the business to the marketing side of the business, because I wanted to learn, you know, the dirty little secret of newspapers is that you don't make money selling a newspaper, you make it doing events, and marketing, and in house advertising, and all these other kinds of modalities that a newspaper has available to them. So I just wanted to learn soup to nuts, the business. And so that's why I jumped to the marketing side. And then I figured out that, you know, this was an important skill in the fertility world for, you know, anyone looking to grow their practice or understand the business of infertility services or reproductive technologies as well. And, you know, it's hard, it's, it's complicated, right? If you don't understand the reproductive field, it's hard to translate it into plain English for people sometimes. And I that's, that's a skill that I wanted to learn and adopt very early, that I wanted to be able to explain something very complex in a way that people could understand it.

Griffin Jones  12:05

So what areas of marketing did you experience both at the Boston Globe and then afterward?

Elizabeth Carr  12:12

So I was one of the first digital reporters, you know, back before anybody knew what a blogger was, I was blogging, doing social media, tweeting, you know, doing kind of the early days of podcasting, where, you know, we did audio over stills, it wasn't really movies back then. But audio over stills kind of storytelling. You know, things like that, basically anything I could get my hands on and play around with I was experimenting with.

Griffin Jones  12:46

And then and then what happens after the Boston Globe.

Elizabeth Carr  12:51

Let me see, after the Boston Globe, I actually went to work for Runner's World Magazine, I was an editor there because in my free time, I am an endurance runner, and I run marathons. And so again, kind of still in that health and wellness bent, was a was a writer and editor there. Then I went to work for over science for a very short period of time, I then I worked for genomic prediction, I've done nonprofit fundraising, and leads kind of all the way up to today, TMRW.

Griffin Jones  13:27

All the while that you're doing like that you're at the globe that you're Runner's World. Are you? Are you involved in the advocacy? You said? Yeah, surance passion never left you. So what were you doing during that time?

Elizabeth Carr  13:42

Yeah. So it's all the stuff that nobody sees, right? It's all the stuff behind the scenes that we all know, hopefully we all know is going on, of, you know, fighting to get insurance mandates in various states where there aren't mandates and coverage, as well as making sure that bills that are being proposed have language that is protective of all, not just some seeking reproductive options. So all of the nitty gritty stuff that's behind the scenes that nobody really, you know, it's not visible, but it's critical work. So I've kind of always been doing that, since I was very young. It's just not something that people see.

Griffin Jones  14:23

So then how did you when did the logical or now seemingly logical conclusion of starting to work with startups in the IVF space? When did that happen? And how did it happen?

Elizabeth Carr  14:38

Probably. I don't I'm trying to think how many years ago probably 10 years ago, I think is when I started. Sorry, my dog is drinking water loudly off camera. Miracle. Thank you. So probably about 10 years ago, is when I started working in the infertility slash startup space in a in a professional capacity as opposed to just in a patient advocacy capacity? And how did it happen? You know, I'm not really sure I've just always kind of known a lot of people in the space. And I happen to have this like weird digital tool set to or skill set in my tool belt of various things I was good at. And I understood the needs of patients as well as the needs of clinics or providers as well. And so it was kind of marrying all of these various skills from journalism, marketing, patient advocacy, kind of all into one. You know, one multi tool, I guess you would call it,

Griffin Jones  15:47

as you've established, we all know how old you are. This took place about 30. Why not? Until then was was it? Was it just because you were just another person doing other things in your career? Or was it because there weren't as many startups in the fertility space at that? I think,

Elizabeth Carr  16:05

yeah, I think it was both to be honest with you, I think I was just kind of still, I felt like I still had a lot of growth to go at when i i left the globe, and I was 33. So I still kind of had this mini city of people to learn from and that was, I was really grateful that I spent a majority of my career there because I have learned so many different skills from so many different people. And then yeah, I think also, yes, we have seen more and more fertility startups survive those early days, to be honest with you. I think it's there's there's many, many out there, but not many of them become known until after they survived that first few bumpy like six months to a year. Right. And so that's kind of when I feel like people rise to bubble up to the surface.

Griffin Jones  17:02

What was it? What were people working on at that time that you found interesting in the fertility space?

Elizabeth Carr  17:09

I mean, back then, you know, it was a lot of the early days of pre Implantation Genetic testing, which is fascinating to me, because it was not even in the realm of possibility. And when I was born, I mean, this is really dating me, but they had a statement written, or my doctors had a statement written in their pocket about how it was a sad day for infertility that they had on backup, just because ultrasound was showing that I was really, really small and they were worried I was going to come out with birth defects because I was only five pounds 12 ounces. And ultrasound was so bad back then. Right. So people forget that, like the things that we take for granted now. vitrification I remember when vitrification became possible, and that was like, the catalyst and game changer in the field. You know, egg freezing was I remember being probably my late teens and touring a facility that had done the first egg freezing for fertility preservation for cancer patients, because that was it was very niche back then. And it was like groundbreaking that they figured out that, you know, we can freeze eggs and and they can still go on to become viable pregnancies. People didn't know that that was possible. So it's kind of like all of these milestone moments that I remember growing up with industry really in, in my view.

Griffin Jones  18:37

And then what, what landed you TMRW, and how long have you been there for?

Elizabeth Carr  18:44

So I'm trying to think I think I've been here six months now. I saw TMW at ASRM, actually. And I just thought, wow, this is the kind of safety and transparency that I hear from a daily basis that patients really are kind of clamoring for that they want, you know, they want more information. I know that we we all think it can be information overload because it can be right we didn't my my mother always jokes that she was kind of grateful that there was no Dr. Google back then when she was going through IVF. Because it is so overwhelming the amount of options and information out there. But I hear from people you know, I really wish there was a way I could just stay up to date on all of my eggs, embryos, health information, everything I needed to know and not wonder where things are or what the status of them is, in in the moment really, to know that everything is safe and I've worked so hard to you know, get these eggs or embryos that I want to protect them at all costs. And I think that you know, TMRW unique digital chain of custody and patented technology is just It's just, you know, so interesting in kind of leveling up that transparency and peace of mind for patients.

Griffin Jones  20:08

I don't know exactly when a startup becomes not a startup is.

Elizabeth Carr  20:13

I don't either.

Griffin Jones  20:16

Do we still call TMRW a startup?

Elizabeth Carr  20:18

I mean, I don't know. That's a very good question.

Griffin Jones  20:22

A lot of money, a lot of people.

Elizabeth Carr  20:25

We're all working very hard roster

Griffin Jones  20:27

at this point. So yeah. So in your director of marketing,

Elizabeth Carr  20:34

that's your director of product and clinic marketing,

Griffin Jones  20:37

clinic market? So do they pull you out like a dog and pony show? Yours? Which is, which is partly the role of marketing director anyway. But given your status, how was that used?

Elizabeth Carr  20:55

No, I mean, it's really kind of, I'm always the one saying like, Oh, I know them, or or, you know, like, let me I want to help or, you know, I'm really the one who kind of said, I want to help move the needle in whatever way I can for the industry. That is kind of my that is my, like, personal stake in the ground aside from TMRW, or any other company I've ever worked with? It's really how can I personally move the needle? For the better in the industry at for patients? That is, that is my end game. And so everything I do is kind of with that mindset, you know, moving forward? And no, it's really my job to kind of, again, translate all of the complex things about the about this technology that we have, and explain it to people in a way that makes sense. And let people know, you know, why it matters.

Griffin Jones  21:50

So our director of clinic and Product Marketing means of what TMRW is marketing to clinics, yeah, helping

Elizabeth Carr  21:59

helping clinics so that they can level up their practices in terms of having our cutting edge technology at their practice. And then as well as explaining the product itself, like soup to nuts, nuts and bolts in a very, you know, non technical way to understand.

Griffin Jones  22:16

So what are you doing to, to talk to practices now?

Elizabeth Carr  22:22

Yeah, so essentially, you know, my job now is to interface with all of our current partners, and help them explain to their patients, you know, this is the TMRW platform, this is why we're using it, this is what it means, you know, that kind of stuff. So I help them explain to their own patient populations, why this is important, and it matters as well. And then again, explaining the product to the clinic so that the clinic can then explain the product to their patients as well.

Griffin Jones  22:49

We're talking about lessons learned in owning a practice or owning a business in the fertility field and things that you may want to learn how to do or learn about before you go and start your own venture. Another thing is some of the systems that are used, and oh, people that can give really good recommendations on the different EMRs. They've shopped in the depth and scope of functions. But I would ask someone that you know, that uses engaged MD, if you're not already, if you don't use engage MD, and you're CISM, you're thinking I want to open my own office within my own group, or I want to open my own practice, I want to go join somebody else, and I want to be able to add something to it, engage them D is one of the surest bets that you can do, but you don't take my word for it. Ask someone that you know, because more than half of your colleagues are using engaged MD and more than half of your colleagues are extremely delighted with engaged and be because they got real informed consent. They don't have stacks of papers that people have to sign in then account for and then keep an eye out file cabinet somewhere. They have true informed consent from patients that have a module at their convenience, so that the staff isn't overburdened with questions that they don't need to be getting that they can help the patient with the attention that needs to be devoted to that patient's case. Because the elementary the rudimentary is covered, and now it's just what that patient is stuck on or what's unique to their case that the care team can focus their care on. That's what personalized care is. And more than half of your colleagues have seen the benefit from engaged MD that way so just reach out to any of them Hey, guys do use engage in the people you want to fellowship with people that you see it ASRM Hey, do you use engage them D What do you think I hear Griff talk about it. But he doesn't want to practice. What do you guys think? And see what they say but if you want At every workflow assessment want to see what other practices are doing, you want those insights that engage them D has, and you want to see how your practice stacks against that ideal workflow, then you go to engage them. the.com/griffin. And you mentioned that you heard them on the show, you mentioned that you heard them from me, and then you're gonna get that free workflow assessment. So ask somebody else, don't take my word for it, but go to engage md.com/griffin Or say you're on the show. So you heard from me, so that you can get that free work assessment for you. That's one of the biggest system wins that you could have right off the bat. And you can verify that just by asking people you already know, I hope you enjoy the rest of this episode about things you need to know for the fertility business you might start. When you're at SRM, especially like if you're either talking or you're involved with a session, or somebody invites you to be the guest. They're the guest of honor at their party, and you meet fertility doctors, what do they say to you?

Elizabeth Carr  26:05

Oh, it runs the gamut.

Griffin Jones  26:08

I want to hear the game I want to hear all the time, I want to hear

Elizabeth Carr  26:12

all of the games. I mean, I've heard everything from the very young embryologist who are like you're in all my textbooks, which makes me feel really old and weird, but in a good way. versus you know, some of the older physicians who remember by doctors, Dr. Howard and Dr. Georgiana Jones, and comparing notes to like, what it was like back then versus what it's like now. I've had people ask me really odd questions such as, Do I have a belly button? Spoiler? Yes, I do. I was born just like everybody else.

Griffin Jones  26:48

Doctors are asking that question. And doctors and patients have asked

Elizabeth Carr  26:51

me that question. I kid you not which it's always shocking when a clinician asks me that question. Mostly OBGYN so I have to be honest.

Griffin Jones  27:02

I wonder if there's what the reason that they're asking that question because

Elizabeth Carr  27:05

there's because in the early days of IVF, the slang term was test tube baby, right. And so the, the image in everybody's head was that I was grown in a test tube, which is just wildly inaccurate. Also, fertilization happened in a petri dish. And there were no test tubes involved in any way, shape, or form. So I always found that very amusing. And I've always hated that nickname.

Griffin Jones  27:30

But I thought there might have been like, but they didn't know that you that you went through gestation in utero, they didn't know that. They are a lot of people. A lot of people vitro fertilization also means grown

Elizabeth Carr  27:43

in a lab, like literally. Yeah. And I have to, I often have to remind people that that, honestly, the only difference was that fertilization happened in in a petri dish. And then I was placed back in my mother's womb. And nine months later, I came out just like everybody else does.

Griffin Jones  28:01

I mean, a lot of people think that, you know, like, Alaska is a country or that. Queen Elizabeth lives in Brazil. So like, it could, it could be, you know, I could see a lot of people thinking anything about that. But it surprise surprises me that OBGYN ins have

Elizabeth Carr  28:23

not awesome just to fit. You know, I'm just not I'm not saying everybody. But yeah, I mean, it's I think that's the one thing that surprises me still to this day, is that I have to do so much still basic education on what IVF? You know, I only primarily speak about IVF, because it's what what got me here, so I know it intimately well. But in terms of education on what exactly IVF is, there's still a lot of baseline education that needs to happen on a on a general level for a lot of people, many people have maybe heard about it, and think they understand what it is. But a lot of people there are still misconceptions about it. Yeah.

Griffin Jones  29:05

Unfortunately, it doesn't happen to me as much now that that generation is mostly gone. But I used to meet people that that knew my grandparents, I would meet older people that knew my grandparents, and they would talk about how they, how they knew my grandpa's. I guess that happens with my parents generation, too. But I guess I know more about my parents generation. So I'm just Yeah, a couple years ago, my brother and I were at a neighborhood bar in the neighborhood that were for the working class outside of Buffalo neighborhood for generation two, and we're at a neighborhood bar where like, all of the Irish working class stereotypes are coming together like our second cousin is our attending that we don't know that was oh, yeah, I know. And then there's this older couple there and that oh, and I know who your who your family where they were the Burns is and they were like telling me about my grant. parents and their family and great grandparents. I wonder, do you ever get that vibe from from older physicians like, who were maybe just behind the Steptoe Jones generation? And, like, do they want to tell you about Dr. Jones or duck, maybe even Dr. Steptoe, even though he wasn't in this country, like do they want to tell you about them in the same way that your grandparents friends would want to tell you about your grandparents?

Elizabeth Carr  30:33

Absolutely. And the grandparent analogy actually is a very good one, because that's how I've always referred to the Jones is my second set of grandparents. Our relationship for my whole life until they died was very, very close. Phone calls, emails, writing all sorts of correspondence. When I had my son, Dr. Howard wanted to make sure that I was going to a hospital with a level two NICU just in case, you know, all these kinds of things. So, yeah, people definitely want to share their stories with me of Oh, I was a fellow I was a Jones fellow or I went through the program, or, you know, I learned from so and so who was on the original team, or, you know, all those kinds of things, I actually really appreciate when people share those stories with me, because, you know, those were, those were kind of the Wild West days back then. Right? They were trying to figure out what was going to work, I don't think people realize that my parents you know, they didn't realize they were going to be the first until my mother got pregnant. And then the Jones were like, by the way, you're the first. And my parents, I think, naively assumed that there had been success, like it didn't dawn on them that there wasn't success. beforehand. And they weren't the only couple going through this. There were a group of other people going through this process at the same time, my parents were, but all the couples had a different protocol. And so none of the couples knew like, are we going to be the ones that the protocol works? Or is it going to be somebody else? And they weren't really allowed to share notes or talk about, you know, how their protocols were different. So it was kind of like, you'd pass in the hallway and wave and but you didn't know like, are they? Are they pregnant? Are we pregnant? What's going on? So yeah, it as I said, it was a wild west. So it's always interesting to hear those stories from from the very early group.

Griffin Jones  32:33

And so Dr. Jones passed away, like when I got into the fertility business, I started working with that, our first fertility client in 2014, but moved back to the US in June of 2015. And he passed away that summer. And how much correspondence did you have with Dr. Jones throughout your life?

Elizabeth Carr  33:00

Oh, as I said, so much correspondence. I mean, when I was little, we had a Mother's Day reunion every year at the Jones Institute in Norfolk, for the first 100 Babies essentially. And when it got to be 1000, and 1001 babies, that was our last reunion, because it just got to be too many people. And that was just from the one, you know, clinic. So throughout my life, you know, he would come to the airport and pick us up, or he would you know, I've got Birthday, birthday cards and phone calls every Christmas and on my birthday from them. I when I interned as a writer at The Virginian pilot newspaper, Dr. Howard actually helped me figure out my housing and I stayed with one of his fellows. And he and I had a standing lunch date every Wednesday. Well, I was there for the entire summer. He was one of the first people I told when I was pregnant with my son. He was invited to my wedding, you know, they were invited to my wedding. You know, anytime I had a newspaper article that made the front page or something like that, he would send me a note. So if people I think don't realize that we had such a close relationship, and they really were like a second set of grandparents, as I said,

Griffin Jones  34:23

so I just had a client asked me today, they were like, because we're doing a photo shoot for them. And we have a part of that where we we have just like an open period where people can come in and they can take their pick, they can bring their kids and they can take a picture and and they asked me what's the age limit because we just had someone in their early 20s who reached out to Dr. Toe and toe and said that they're now beginning medical school and as like there's no age like Yeah, that's great. That's incredible lady Yeah, like, that's it's not just a cute chubby cheeks that that is the whole story like, and you could argue that that's like, that's the story like, you know this, more broadly speaking this unlimited human potential you don't know what the human potential is, but we know that it wouldn't have existed if not for. Right. And so you like you were a part of of of that growing up. So I want to ask this question that has to do with the infertility community. If you think it's personal to me, I'll edit it out. I think it's, I think it's germane to the conversation. So sure. Did you go through infertility treatment

Elizabeth Carr  35:44

for everybody asks me that, no. So that was the other the other interesting thing about my mother's fertility journey to have me, she actually didn't have traditional infertility. She like where it was unexplained, or, you know, something was going on like that. It was scar tissue from a botched appendix surgery when she was in her teens. And she actually had three ectopic pregnancies before having me and so her fallopian tubes were removed, which, then that's where her fertility issues really came in. Because you, you know, back then you couldn't have a child unless you had fallopian tubes. So ironically, my mother could get could always get pregnant, she couldn't stay pregnant, the reason she couldn't stay pregnant was because of that scar tissue. So she was kind of the ideal candidate for this IVF program. And then No, I had no fertility issues at all. And I had my son at the same age actually, that my mother had me I was 28 when I had my son.

Griffin Jones  36:46

The reason why I asked is because I wonder what that's like the fertility community is such a tribe in many, in many cases, partly because they have at least some, some similar roots to draw upon. Like, even though the journeys are different, there's, there's some common threads, and sometimes those common threads are so distinct from the rest of society, that's where they form their bond. And, and you don't have that with them, you have a different kind of bond with them. It's like it's, it's as though they're, it's like their kids, you know, the the ones that have gone through treatment and been successful, are gone through time. Fast forward to be a grown up and now are with them in that community. So what what is that like, like to be to be not one of them at all, in one sense, and to them? And to be like, the most proud I know, there's so yeah, right, and product and and others? What's that? Like?

Elizabeth Carr  37:49

Yeah, so I mean, that's where, to me, I've always been very cognizant of that. There's like, I cannot speak to what it is like to exactly experience infertile infertility or trouble with your family building, right? I'm very aware of that. So I never speak to what that is like, what I can say is I can relate to what my, my parents went through, in their very unique situation. And that is where it has become my goal, that I am very humbled and privileged to be here. And I realized that I am very humbled and privileged to be here. And so my work as a patient advocate, or, as somebody who can be a resource or connector for somebody else going through this, my goal has always been for people to know what their options are before they need them. Because my parents really, you know, we're kind of given this option in a moment of crisis of like, Oh, my God, what do we do we have, we can have a child of her own, what are we going to do, and I never want anyone to feel like they don't know where to turn. And so my speaking up and out has always been kind of my love letter to the industry as a thank you and to all the patients. As a as a thank you for saying like, Thanks for not giving up and making sure that I got here. Because it took everybody it took all of my parents willpower of fighting. It took all of the scientists and lab technicians and embryologist and nurses, and even receptionists answering the phone and all the billing folks, it took so many people just for me to be here talking to you today. And so that's where I'm going to keep keep using my unique platform and voice to keep moving the needle ahead in this industry. And it's it's just it's it's honestly my only way of saying thank you because the words thank you seem wildly inadequate.

Griffin Jones  39:48

How old were you when you started meeting other adults that well, maybe now I won't even ask the question adults. How often How old were you? You when other people started introducing them to themselves, do you say I'm an IVF? Baby, too?

Elizabeth Carr  40:08

I mean, I think I'm a bad person to ask that question only because I have a magnet right at the end. And, you know, we had those reunions from from when I was very little with a Mother's Day stuff. So, so I always had other IVF babies around me, always. The only difference was, you know, when I was little, we would all introduce ourselves using our numbers. And so, you know, a friend of mine would be like, I'm never 10 and be like, I'm number one. You know, so nice to meet you. Where's number five? We don't know, like. So but then, you know, to have friends of mine. Now my age saying, Oh, I'm going through IVF or I'm having an IVF. Baby, myself. And they often say thank you. And I'm like, you know, I appreciate that sentiment so much. But like, honestly, I my, my joke is that I didn't really do anything I just showed up. It was really everybody else did the hard work, you know, I had no control. And whether I was here or not, it was everybody else.

Griffin Jones  41:06

Because you've got this passion, because you got this unique perspective. Are you ever asked to? Or do you take it upon yourself to be a public relations force when something bad happens, like when there is the the rare tank leak or embryo mix up? Or some sociopath in some, like OB GYN clinic from 30 years ago that fathers, how many embryos like when that stuff happens, and people are looking at the fertility field? Like, wait, what like, is that witchcraft? What's going on over there? And we know how rare that is, we know how much of a sliver it is to, in comparison to the good in the hundreds of 1000s of lives now over a million IVF babies that have been born from the treatment. But like, do you see yourself in in a unique position? Like do you feel an obligation to to be a counter voice when that stuff starts to get a larger share of voice in the public sphere?

Elizabeth Carr  42:23

I mean, yes and no. So obviously, especially with with my role TMRW, we're always trying to move the needle ahead for safety and you know, best practices and upping the standard of care, right? And so on, on that kind of mission level, I'm always saying like, this is why this technology is so desperately needed, so that in the rare circumstance or whatever that it happens, this is this is not a possibility, or the risk is mitigated to, you know, such a degree. On the other hand, I also know, because I grew up in this industry, how deeply IVF clinicians and lab techs and embryologist and everybody care about what they're doing. And, you know, I come at it from a very different lens of like, nobody would ever do anything on purpose, right? Like this is, as you said, like, these are catastrophic mix ups that I don't think anybody obviously ever wants to have happen. And so therefore, like, let's come together, link arms, let's talk about best practices, let's make sure that we're all doing everything in our power to make sure that this never happens, right, that this this is, this is the one thing we all collectively have agreed that we want to avoid from happening. So let's figure out how to do that together. And it is not from a place of, you know, fear mongering, it's, you know, we had a practice in place that was the best at the time. Now there's a new option, you know, let's let's go forward with the new option. Because it's new, it's a new standard. And it's just like, you know, kind of same thing with how the industry itself has grown up, right? We used to use certain hormones in the early days of IVF that now we don't really like my mom was on personnel, they don't make personnel anymore. There's now a new version out there. That's the next best, latest, greatest right? So we're always iterating we're always moving the needle. Again, even vitrification wasn't it was a moment in time where they were we were moving the needle, right? We went from fresh transfer to now we know we can vitrify and we can flash free. So what does that mean for moving the needle? And so that's where I always am kind of coming from like, what do we have to do now to move the needle? From an advocacy standpoint, from a safety and technology standpoint? What can we do together?

Griffin Jones  44:53

I'm curious a little bit while we're talking about that, I do want to conclude with you sharing what you think the field should be paying attention to. But I want to ask with regard to the extent that you're able to talk about what, what is TMRW’s vision or potential outside of just the IVF space? Like, I got to believe that this company is, is also going to do other things with this technology. So what's on the horizon?

Elizabeth Carr  45:25

Yeah. So I mean, I'm actually a terrible person to ask. Because I am so ingrained in this in this particular field and this particular dish that I'm like only, like a horse with blinders on that this is our goal right now, this is our mission, this is our drive. I'm, I'm the wrong person to talk about future looking, because at this point, it's we just want everybody to understand what we have going on. Right now. That's in the marketplace for patients and clinics to move forward. But I am excited about where where the potential of this could go. Although I don't necessarily I'm not the person that's necessarily involved in those discussions. But I am excited about yours, knowing about the person perceived benefits of this technology in, you know, potentially other fields. Who knows?

Griffin Jones  46:20

Well, let's talk then about what you think that the field should be paying attention to. And so let's maybe start this conclusion with what do you think that people aren't paying attention to enough of that, that you see, from your vantage point from having worked for all these different startups from our comfort mile from having talked to so many doctors and been involved in the institutional structure? What do you think that people just aren't paying attention to enough of right now?

Elizabeth Carr  46:55

I mean, that is such a hard question. For me, I think it's always the coverage and insurance landscape. We have known for many, many years that, you know, in many ways, reproductive technologies are cost prohibitive for so many people. And that continues to be a really tough nut to crack to make it more accessible to more people, and, and that is something that I know, we're all striving to change, but it's so hard, and it's so slow, that I think that that, you know, in this Roe v Wade overturned landscape, it's really come to the forefront even more, you know, as as a, as a worry that, you know, it will become less accessible, as opposed to more accessible. So I think, for me, personally, that's always one that I'm like, you know, if everybody can really pay attention, not just to the technology and best practices going on in the world, because we know that's going to continue to march forward. But really the landscape itself and, and making sure that everybody has access, and, and that is so key, and I don't think we can ever stop paying attention to it. Truthfully, like, if we take our eyes off that ball for one minute. I think it can be really harmful in the long run.

Griffin Jones  48:32

Well, then I'll let you conclude, however you want to clean our audience of practice owners and Doc's and fertility execs. Maybe it's it's a call for how you'd like them to get involved with that. But how would you like to conclude?

Elizabeth Carr  48:46

Yeah, I mean, I think, you know, for me, it's always, it always comes down to what do we think we need? And how do we think we need to get there. And I grew up in an industry where everything was highly collaborative, right? That was what everybody that talks about the Jones remarks how collegial and academic and collaborative they were, back then, that they, you know, wanted to share the latest and greatest research, they wanted to share best practices. And I think we all still need to kind of especially in this current landscape, continue to link arms and and kind of look around and say like, Yes, I know, we're competing, maybe for customer acquisition and those kinds of things. But let's make sure that we all agree that we want to provide the best care that we can to our ability, period, full stop, and whatever that looks like in the current day, landscape, technology, whatever it is, if we can all say that we're all driving towards the utmost best patient care. That's really all that matters to me. And I think that that's really all that matters to patients as well as they all want to know that we are marching in the same direction, you know, towards the best care and I think wholesale, you know, all of the practitioners that I've come into contact with, you know, embody that, which is a lovely thing. And it's very rare to have a whole industry care so deeply about, you know, their patients on it on a very human level. So I just hope that we continue that, and that we don't let any political landscapes or law changes kind of derail us from from really providing the best that we can.

Griffin Jones  50:34

And then we'll have a few more million Elizabeth cars. Oh, God. I'll be guests on the show. Maybe not me. But we'll, we'll do like every every million dollars or maybe 100,000. That can can be a guest.

Elizabeth Carr  50:50

That's that's the running joke of why my parents never had another they were like we were good with you. We decided to stop after you,

Griffin Jones  50:58

Elizabeth. Karen, thank you very much for coming on inside reproductive health.

Elizabeth Carr  51:02

Thanks so much for having me.

51:03

You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society. Visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health

152 Pinnacle Fertility: Where’d They Come From?!

Inside Reproductive Health guest, Andrew Mintz, shares the evolution of Pinnacle Fertility on this week’s podcast episode with Griffin Jones. The fertility network which now owns ORM (Oregon Reproductive Medicine), SRM (Seattle Reproductive Medicine) and others, seemingly came out of nowhere. Is their model scalable? Will it stand the test of time?

Tune in to hear:

  • Andrew Mintz detail the Pinnacle Fertility model, including how they constructed their Medical Director and Lab Director Councils, and how they contribute to the overarching success and development of their network.

  • Griffin press Andrew on the efficacy of Pinnacle Fertility’s physician buy-in program, and how it could potentially implode.

  • Griffin question whether or not Pinnacle Fertility’s private equity backing equally beneficial to physicians across the board, or only those stepping into retirement.

  • Griffin ask how Andrew Mintz and his team approached the selection of the ever-challenging EMR system, and how they decided on just one. 

Andrew’s information:

LinkedIn: https://www.linkedin.com/in/andrew-mintz-712a999/

Instagram: https://www.instagram.com/pinnaclefertility

Facebook: https://www.facebook.com/PinnacleFertility

Website: https://www.pinnaclefertility.com/


Transcript



Griffin Jones  00:04

Nobody says we put the patient last, Andrew, and nobody says we're a bunch of dishonest dirtbags that are going to stab you later. So how were you able to actually demonstrate that almost every Fertility Center in North America is going to be owned by one of two companies in the coming years. It's one of the things that I talk about with our guest, Andrew Mintz. He's the CEO of Pinnacle fertility. If you're like me, you didn't know about Pinnacle fertility last year until he was ASRM last year, maybe even PSP CRS this year that that name really took off, they acquired six groups at the end of 2021. They have acquired more since including Seattle reproductive medicine. So they're quickly becoming a big group. And we talk about their model for making protocols uniform, raising the standard of care in their view, including having a council of lab directors, a council of medical directors, which I think that concept is interesting for you to listen to. I push Andrew on the criticisms that people have of private equity is it really just for the benefit of the retiring Doc's? I asked him that question of do we think that this is going to become a two horse race in the future? I talked about brands, that Kindbody style of brand versus this network style of brand and tell him which side I think is better, and ask him for his opinion. I also asked him to talk about choosing an EMR what goes into that process and should go into any that process and why they chose the EMR that they did. I asked about the model of doctors buying into the parent company and not into not not the equity coming from the at the practice local level. So we get some good answers in there. If you feel that I can go deeper on a specific set of questions, email me, let me know and our next guest will be the victim for that. In the meantime, enjoy this interview with the CEO of Pinnacle fertility, Andrew Mintz. Mr. Mintz, Andrew, welcome to Inside reproductive health.

Andrew Mintz  02:21

Thank you, nice to finally meet you in person.

Griffin Jones  02:25

I had never heard of Pinnacle fertility before the winter of 2022. And then by the time I got to PCRs, it was all the buzz, it was blue Pinnacle liquid pinnacle is doing now. And it's and so here's a company that, as far as I know, didn't exist a year ago, or a year and a half ago, maybe you'll correct me on the timeline. But then, in short order, started making a splash in the field. So why don't we start with the timeline of Pinnacle. And the the opening or need that you all saw in the marketplace to to state your own existence?

Andrew Mintz  03:05

Sure. So we actually started in December of 2019, with the acquisition of Santa Monica, fertility out in California, and then you know, COVID, hit kind of right away, and there wasn't a lot done for the year 2020. But come 2021 We started to reengage in the market. And we closed six practices in 2021. In the second half of 2021. We didn't actually create our name of Pinnacle fertility until like October, which is why no one's ever heard of Pinnacle before. But we brought on first RGA of Ohio, which is out of Akron and Westerville. And brought on a Dominion fertility and Virginia ihr. In Chicago. We brought on advanced Fertility Centers in Arizona, California fertility partners in in California, and ORM in Portland, so a really good group. And I think, you know, there were a couple of things that we saw as an opportunity to partner with groups, and that was that I had this conversation with Richard Morris, who runs our medical director Council, which I'll tell you about in a minute. But years ago, the way the fertility industry used to work is that doctors were very collaborative with each other not competitive. So they would go to their meetings, and they'd really start sharing all kinds of information about what they did in the lab, what their clinical protocols were, what they were seeing in terms of outcomes, how they're trying to improve outcomes. It was a very collaborative approach. I think that over time, as more clinics were created, especially as those that were created in the same markets, it became more competitive and The willingness to share the secret sauce started to whittle away. And so I think we had lots of people who were doing their own thing, and seeing what their outcomes were and, you know, comparing themselves against national benchmarks, as they saw in SART or the CDC database, we really wanted to bring back the concept of doctors working together, sharing what they're doing in the lab, reducing the variation in care, and to really improve the outcome. And we saw that as an opportunity that we didn't see happening in this marketplace as much as it could have.

Griffin Jones  05:42

Well, what do you feel that you can do to facilitate that happening that many of the existing networks aren't or can't?

Andrew Mintz  05:50

Yeah, so I mean, we've done a several things. So one, we started a couple of councils, which have real teeth behind them. So we have a medical director, Council and a lab director Council. And those councils have a representative from each one of our clinics. And more as we brought in this year, we brought on another few practices this year. And what we do is we talk about in the lab, for example, we talk about making sure embryologist are using same techniques and protocols, the media that we're using in the lab are the same, that the equipment that we're using are the same. And really just starting to compare the outcomes and talking about what people are doing. So we actually have lab directors that are going from one lab to the other, to look at what others are doing and then sharing that in in a forum under which they're making decisions about how to reduce that variation and improve the outcome. And I don't know that we see that in a lot of other clinics, I think there's a lot of talk about it. But we've done a lot of that and, and the other piece that we've had to do is come out of the lab director councils, the fact that as we continue to expand, some of the problems that we're facing in the lab have to do with just what you can fit through the lab from a volume perspective. And there just aren't enough embryologist. And so our lab director console, for example, started our own embryology school. We're looking now at a certification for the students in terms of how they become certified which doesn't really exist outside of ASHRAE. And really trying to get a lot more embryologist out into the marketplace. So we can they started the school, we do it in two places. One in Arizona, one in Ohio. We have four students at any one time, we get them trained in about 100 days. And we can train about 30 embryologists a year. And so we're really dedicated to one being able to have more embryologists available for the industry, and also specifically about making sure that we are teaching them the kinds of processes that we think lead to the best outcomes, and to ensure that in fact, we see that across our network.

Griffin Jones  08:18

Are you doing the same thing on the clinic side with a council of medical directors or practice directors?

Andrew Mintz  08:26

We are so we do have a medical director console as well. They making decisions in terms of you know, what kinds of genetic testing are we doing? Where do we send it? Who do we do it on? What kind of Mosaic embryos are we going to transfer? Which ones are we not? They're looking at safety protocols. They're looking at recruitment and retention issues. So there's a whole set of initiatives that our medical directors looking at as well, including clinical stimulation. So, you know, what are we doing to, you know, really reduce that variation, make sure that, in fact, we're doing the right thing for the patients and being able to maximize the, you know, their outcomes. And so there's a lot of sort of deep dive data that we pull and start sharing and discussing in those consults about the ways under which we're going to be practicing medicine within within pinnacle.

Griffin Jones  09:25

Is each practice represented by one medical director in the council?

Andrew Mintz  09:31

Yes. So we have one medical director regardless of size, so we brought on Seattle reproductive medicine just a few weeks ago. They have 14 rei physicians, but they only have one representative on the council, and then we've got Dominion fertility, which only has two physicians. And so they have one representative as well. It's a little bit like the Senate having two representative from each state. But But yeah, I mean, because the reality is, is that regardless of whether they're just talking to one other doctor or 12, they really need to make sure that that information is brought forward. It's discussed locally, and they are able to provide feedback in terms of what those what those protocols are.

Griffin Jones  10:12

Do they offer an equal vote and how the protocol comes to be?

Andrew Mintz  10:16

Yeah, so I think it's more of, you know, I think it's more of a discussion. And they come to consensus as opposed to voting things up or down. So you know, everyone recognizes that you can adopt a guideline that you think is going to be best for the organization, and then look at those outcomes. And if those outcomes aren't what you want, then you need to adapt your, your guidelines. So I'm not sure that we've actually taken a vote as much as there's been conversation and debate about the right thing to do. And, but everyone is dedicated to following the guidelines as they're created within the organization. So I don't think it's a majority rules type of, of atmosphere.

Griffin Jones  10:59

So that's my second question is, is how is the council governed, then, who makes the final decision who who releases the document, who drafts the document after, after the consensus is reached?

Andrew Mintz  11:16

Yeah, so we have the head of our medical director Council is Richard Mars, out of CFP. And he's the one that helps set the agenda. Um, he's collecting information from the clinics, and then coming up with recommendations to be discussed at the meetings. And so he is really kind of the driving force behind helping us prioritize what's important to the outcome, and the kinds of things that we're going to be addressing first, and how we're going to get there. So that's really how that's kind of organized, it's, it's a very, it's a free flowing set of conversation. So there's not a it's not a I wouldn't call it real formal, but they do come to decisions. And they do decide, you know which direction they want to go to. And we're just starting to scratch the surface. I mean, we're a new organizations, so they're addressing a handful of items, and they've got a handful or a long list of items that they really want to address going forward as well. You are

Griffin Jones  12:15

just scratching the surface, because now you've got a couple you your congratulations on that SRM acquisition, by the way, now you have a couple of dozen doctors across the, the the group thus far across the organization. Now, and, and, and people can come to consensus, but inevitably, people do not come to consensus every time in any organization. And we work with five Doctor clinics, and Dr. Nixon and I, I hear them not on the same page as each other. And very often, one doctor will be practicing a protocol in in office a and Dr. B is practicing a different protocol in office B. And and so when you inevitably run into, okay, there isn't a there isn't a complete consensus, maybe 70 or 80% are really on board and really feel strongly inevitably there's going to be a couple of people that feel strongly the other way. What do you do when you have established that protocol based on what the majority of the council sees it as best given the evidence? But there are a couple of people involved that don't want to practice that way.

Andrew Mintz  13:27

Yeah, so I mean, the first step is to create the protocol, the second step is to measure who's following it and who's not. And that's what we're in the process. So one of the things that we've also done is we've converted everybody to the same electronic record. So it makes it easier for us to be able to set things up within the system and for us to measure whether people are following the process as it's been decided. And so, you know, those are conversations, doctor to doctor, look, it's not a matter of whether they follow the protocol 100% of the time, there's no such thing as someone following the protocol 100% of the time, the issue is, are they documenting why they are not following the protocol, and there's going to be good reasons for it. So if there's a specific way under which we want to be stimulating a patient with a certain condition, and a doctor does not follow that protocol and does something else, if they're documenting why they're doing it, that allows us to be looking at that to understand how we need to expand our protocols to take care of different variables. So, again, being new, we have not yet I mean, we've created a handful of protocols and working on more. But really, these are long term studies for us to really determine whether in fact, they're giving us the outcomes we need, and who's following them. But we're really at the first step here of just making sure we create those protocols and and then we're going to start looking at who's following them and who's not and why.

Griffin Jones  14:50

And he talked about getting that measuring that as part of the EMR. You got everyone on the same EMR which is also not easy to do, which EMR did you choose? Did you make your own

Andrew Mintz  15:00

No, I mean, we don't start from scratch. So I mean, you know, there are, you know, everyone talks about using evidence based medicine. But the reality is that there's more than one protocol that's considered evidence based medicine. So I think there's not a lot of variation to begin with. And so I think

Griffin Jones  15:17

we're now referring to the protocol referring to the EMR that you chose your own proprietary, did you create your own proprietary EMR you chose another,

Andrew Mintz  15:26

we did not know, we, we moved to an assistant called Enable. And so we put everyone on enable, which we felt was has, right now the best capabilities to help us really connected with other technologies. So we've been really working hard on trying to use all the components of that system, to allow us to automate processes, and to really enhance the patient experience. So I've been talking a lot about, you know, creating and improving the clinical outcome. But the other piece of this is that we also really need to focus on the patient experience. And I think by having everyone on that same system and using technology to help us and the patient get through the process, I think that we're going to we're laser focused on that piece as well. So we need to make sure that patients are able to communicate to us effectively on time, we can be responsive to them, and there are the right people available to them. And the technologies are there to be able to interact with them appropriately get the information together and be able to present that to the patient, as well as recommendations and next steps. So we have not, at this point create our own electronic health record.

Griffin Jones  16:45

Well, let's talk about that shopping process. Because I think it'll be interesting to people. I'm not plugging one EMR over another. I am not I'm not qualified to do that we our clients use a number of them some of our clients use enable. But I think some people will be interested in to how you made that decision. I imagine there was a bit of a shopping or vetting process.

Andrew Mintz  17:06

Talk to us about that. Yeah, so we did that through all the IVF specific EHR systems out there. So we eliminated the ones that are more general electronic health records are used in the healthcare industry. And so there's a handful of ones in there. And we've actually done a review last year, and we recently did another one and just felt like it would meet our needs the best, especially in the way again, that it can integrate with technology, how some of the security issues that are, I think, available to it. And so really, we have a specific operational model that we have been employing in our practices. And we felt that this was just the best fit for that. And it's so far, it's, you know, it's worked for us because we're able to really collect the data. So at the end of the day, it's about how you use the electronic record system, as opposed to necessarily which ones you pick, this had features that we liked better that we think worked for us. And so that's how we made that decision. And that's what we're have moved are moving everyone onto that platform, what were those features that you liked? Oh, again, it was, you know, they have like two way texting with patients that gets embedded in the medical record and interfaces with the phone system, certainly in the way that it is built for the cloud. So it's not a server based system that was put in the cloud. It's a true cloud based system. So it has, we think some good security pieces in there. We felt that it was able to interface with vendors and and equipment more easily, giving us some good information, allowing us to bring it in and present it to the patient or want to, we'd like the patient portal, and the way that we could communicate to the patient. So there's just a bunch of things in there that sort of check the boxes for us. And, again, for the kind of operational model we use, I think that it just was a better fit. And so you know, the other ones have their I'm sure it have their advantages. We just felt like all the ability to use technology, all the think all of the capabilities that are built into the system that we are trying to take advantage of. We're just, you know, slightly ahead of, of where I think the other sports are there.

Griffin Jones  19:41

You mentioned wanting to improve the patient experience at a process level. What are some of the points in the process that you see is in need of fundamental repair?

Andrew Mintz  19:57

So there's there's a A fair amount, I think one is, you know, a number one has access. So, you know, being able to get patients in and get them through a IVF cycle that's efficient, that can make it efficient for the providers as well as the staff, I think is, is keep. So the biggest, I think hurdle in this industry for any practice is the fact that we still have a significant greater demand for services and supply of physicians and other providers to provide those services to them. And I believe that there is a room for innovation within practices that can allow for us to be able to service more patients in a very friendly way to get them through the system. And we can really sort of maximize the ability for patients to get in. So we still have clinics that have appointment, wait times that are three and four months out. It's too long, it's really unacceptable. And we need to solve that problem. So we think that the system will help us with automating processes and communicating to patients in a way that will make them more efficient. And so that's the first thing that I think needs to happen. The second thing is, is that I think we also need to meet the patients to where they are. So, you know, obviously, since COVID, you know, telemedicine has really caught on and it's here to stay. And I think patients like the convenience, I think a lot of them like the convenience, I think that they want to be communicated in a way other than a phone call, especially for the patients that we serve and the age group they're in. And so having the technologist that's allowed that we can text them to weigh that we can make sure that they're getting the information they need, we can embed the, the the videos that we have the educational materials that we have, and make sure they're getting through the process without someone having to call them and check in and we can sort of look at electronically will also help with that. So a lot of patients get lost through the process, they get lost at the beginning, because it's so overwhelming. And then they get lost through the process. And so to the extent that we can create processes, and have technologies that support getting these patients to understand what they're entering, and to help them get through the system efficiently, without being confused without being you know, without anyone falling through the cracks without missing something. Those are the things that I think are really key. And there's you know, story after story that I have seen where you know, patients, they get, you know, they get lost in this and they end up dropping out when they really need to continue through their IVF process or whatever fertility process. And

Griffin Jones  22:59

I have to say that I have to disclose that they're a sponsor before I ask the question, so it doesn't sound like a shameless plug, what are you using EngagedMD and all of your centers?

Andrew Mintz  23:10

Yeah. So I mean, we are rolling all these out and all of our practices. So they will all B have, they will have similar ways under which they are going to be processing patients. Obviously, there are differences from clinic to clinic, but we will be you know, we are continuing to roll out and refine our processes to make this efficient.

Griffin Jones  23:35

For those clients that are there, excuse me, those clinics that are three, four month out booking waitlist, and it's usually it's a couple physicians that are booking, it's often not the whole clinic unless it's a really small clinic in a really busy place. But for those that are booking out 12 plus weeks, is making that process more efficient include bringing some some of the testing that normally would happen after the first visit, and between the first visit and the follow up before the first visit.

Andrew Mintz  24:08

Yeah, so we are looking at the total process of care. And some of that is also, you know, some of the testing that we maybe can do in house to make that efficient as well. But we are looking at, you know, what's involved in a new patient visit what's involved in a follow up consult. And what information do they get between the first and the second and then before they start their cycle? What information do they get? And when do they get their medications and, and on and on. So we are looking at the whole process of care. We have mapped this out. And so we have a sort of a very specific philosophy about what should be happening at each step through the process. And the more consistent we can make that the better job we're going to do, of making sure that the patients aren't getting caught in the middle, you know, or Last,

Griffin Jones  25:00

can that also include some places the nurse does the follow up visit and the Ri does the initial visit, sometimes the REI does both. But some places the nurse does the first visit. And and so is that also part of this solution is a we? Well, maybe we used to do testing after the first visit. But now with this, with with booking this far out, that would mean that people can't get into the care system until that point. So we can we can do our testing before they come in for their visit we can we we can maybe have them meet with a nurse earlier so that that 12 week isn't isn't the first time they're seen. But it's the follow up with the RBI does does having either a nurse or an AP do the first visit is that in the playbook?

Andrew Mintz  25:50

Yeah. So I mean, we are invoking a type of license model. So we do not want physicians doing things that really only physicians can do we want advanced practice nurses to be able to do the things that they can do, we want RNs to do the things that they can do. And so we do have a general, a core set of services that we want each level to be to be doing. It depends on each mark, and, you know, each clinic. So in some clinics, we employ OB GYN who are doing some of that work as well. Some are have a really used nurse practitioners a lot others less so. But we do have a, a top a license philosophy. And so as we continue to integrate the practices, we will continue to be working on making sure that, you know, we're able to get doctors to do what doctors can do, which will help with the access issue. So if they're doing for example, you know, every single ultrasound, you know, that's not necessarily the most efficient use of physicians time.

Griffin Jones  26:57

I want to ask about the the inherent financing models of private equity, I'll let you know, Andrew, that I've been chewed out more than once by each side of being accused of being shill for private equity, that, you know, I'm in bed with these new private equity companies coming in and just using them to help buy clinics, which I'm not. And I've also been accused of being anti private equity and that, you know, I'm anti network and which I'm also not, I just I'm not qualified to evaluate the business models at that level, yet, I'm not strong enough in the finance piece of business in order to be able to say that maybe 510 plus years from now we'll be but right now, I'm very strong in the sales and marketing side. And I still feel like I have some pieces to shore up on that. And I and we are as a firm and so that's what I feel comfortable evaluating people on and I just ask people questions and I try to get them to respond to the counterpoints and, and so but I do hear a lot of the the model is inherently flawed, partly because of the debt that they have to service. And partly because I was stacked in favor of retiring doctors, and one of these folks that that mentioned, these boys is Dr. Ben White, he's a radiologist. And he's not in in Rei, but he writes about this a lot. And he says that the only doctors who can reliably benefit in private equity, are those senior partners close to retirement who can take their money and retire. So I'd like you to respond to that point.

Andrew Mintz  28:36

Yeah, I mean, to toe the truth grip, and I think it depends on who the private equity sponsor is, and what they are, you know, what are they trying to achieve? And what are they allowing the company to do? And so, so on one hand, I think there's two pieces to this one is, you know, and we see the stories is private equity, you know, destroying healthcare. And I can say that, in my experience working with Webster, which is the private equity, that company that controls, Pinnacle, is that they are very supportive of the strategies that that have been created. And that have been, you know, rolled out to the practices. And so we find a very, we have a board that is really pushing towards the successes of clinical outcomes, and patient experience, and caught and trying to find cost efficiencies for the patient. And I think that it creates a company that is sustainable strategy that's sustainable, that goes beyond who the private equity firm is. And so depending upon who it is, and I've worked with some that I think are very geared towards what's my return And I've quickly come to get it. And there are some that are really geared towards how can we build a great company? And what is it that we need to do to make that happen? I think we're gonna see more advances in healthcare is in fertility, particular, because of the investments being made. So I actually am very much in favor of allowing for investment in the industry, which I think it needs, when it comes to who does it benefit. I think it depends on how you define the benefit. But if you're talking about creating a company with with longevity, that is going to be competitive in the marketplace that has, you know, the latest technologies and equipment and provide the best outcome to the patient, I think that's a benefit to all physicians, whether they are near retirement age or not. And, in fact, those people who are younger will benefit from the investments that are being made now, that others may not in terms of the buyout that's going it goes out, you know, the buy up those towards the partners who own the clinic at the time. And so there is a one time, you know, financial gain to those positions. But I think if it's structured, right, you ensure that there, everyone's incentives are aligned. And that really, everyone's going to benefit from that. So we give, for example, we give equity to physicians that are, that did not own the practice, at the time of the sale, who have either we're either employed at the time or even employed after the transaction, we actually grant equity towards those associates. So they're tied into the whole value and, and the strategy, because the more successful the company, we want them to benefit from that as well. So

Griffin Jones  31:49

I think Woody in the private industry, me equity in the practice, or in the parent company, the parent company, for every associate or just for some associates that look like those are the ones that you want to stay on,

Andrew Mintz  32:02

for every Rei. So we give it to every REI has, is either been granted or is in the process of being granted equity in the parent company. And so they will own, you know, shares in the company, as does the private equity firm, as does the physicians who, you know, who bought who sold, you know, we're partnered with Pinnacle on that. So we find that an important aspect of tying everyone in. And for us, I think it helps with some of the some of the issues with turnover. So you know, the last thing that clinics can stand in this industry is to have physicians who are coming and going, it's disruptive, they're hard to find, access is already at a premium. So the better you can tie them into the success of the company, I think, the better chance you have of them staying and, and if you also create processes, and given technologies that make it easy for them to do their job, and they enjoy that and you create a culture of collaboration. And then they get to create a peer network of other physicians within pinnacle in this in this instance, I think it creates a winning strategy for doctors,

Griffin Jones  33:19

the investments that you talked about making it even if they all work, at the end of the day, it's about those investments are in service of getting our eyes to see more patients to be able to do more procedures. How much is there left to squeeze? Do you suppose before you're actually just squeezing?

Andrew Mintz  33:45

Yeah, it's not necessarily about the doctors working harder. Remember, we really want to move to a top a license model. So we really want them doing things that only physicians can do. So if they're working a 10 hour day, and, you know, they're doing, you know, consults for a few hours and and ultrasounds for another couple hours and then procedures for another couple of hours. The question is, what's the best use of their day? And how can that work? As opposed to how can we make you work harder, so that our support systems, more staff, more nurse practitioners, they may be able to assist and alleviate the work that are done by the doctors. And so the problem is still this imbalance between supply and demand. So the more that we can get people through the system, and the smarter we can work, the better we're going to be servicing the patient population.

Griffin Jones  34:41

I know a lot of doctors are seeing by 30 new patients a month it depends on how many partners they have and what kind of systems they have. But if we weren't to add hours into their week, and we were to do it with efficient processes, investment what What do you do? What do we suspect that that number is? Is it 50 new patients per month? Is it 60 new patients per month that we can, that we can get them to with pure efficiency and not hitting them with a, with a stick and dangling a carrot in front of their face?

Andrew Mintz  35:17

Yeah. First of all, I think that differs by doctor. So you know, they each process, you know, differently. I think we also need to be thinking about, you know, other ways to bring patients into the system. So, we talk about top of license, but the question is, can we train OBGYN is to do things that we aren't allowing OBGYN to generally do? Can we train nurse practitioners to do things like new patient intake, or to handle patients for cryopreservation, or for egg banking or some of those other things? So, again, I think we need to continue to innovate to make sure that people who want the service that they need can get it. But I'm not sure that that necessarily means that doctors have to see more patients in their day in order for us to significantly increase the ability for people to access and get through the process.

Griffin Jones  36:13

I want to shift gears for a second. Because I've had two different guests on with with different views on this. And I think it was back in episode 100. I had Mark Segal asked about he was asking about my opinion on what do I think about a network brand or partnership brand versus individual practice brands? And then I also had Gina bar tz on from kind body to talk about her brand, the global brand, that kind bodies building? In my opinion, Andrew is that I think that you all meaning that groups that have different brands from the parents organization and individual markets SRM in Seattle, or, or I'm in, in Portland. And I think that that I think that you all are at a disadvantage. It's like the IGA true value model where it's hard to scale brand to become a consumer brand. That is the pretty green lady from Starbucks that I think kind body has that advantage. Some people disagree with me, they think that it's better to have the local identity. Ultimately, I don't I don't think so in the in the longer run, I think you still have local reputation. Reputation is different from brand. But the whole point of brand is, is to be able to scale and identify. So you might think differently than I do. So I'd love to hear your side.

Andrew Mintz  37:44

Yeah, I mean, I think the branding strategy is to us not necessarily top of mind, in terms of some of the things that we're trying to accomplish. The reality is that these practices have local reputations, and the doctors themselves have local reputation. So there are some of our doctors who I think are known more so than for the name of the practice that they're in, let alone the national network that they're part of, I think that we will see over time that we'll be putting in some kind of tagline to our practices, such as, you know, a member of the pinnacle family, or something along those lines and create that, but I don't see the need for you know, the Starbucks of fertility, I just don't know that, that we need to create that kind of patient experience where they feel they can get the same thing when they go one to the other. If they're in Seattle, and they're going to go to LA and they want to go to Starbucks, they want they want to, they want to know that they're getting the same coffee made the same way. With the same process. I don't think that that's necessarily holds true in fertility, that what we do in Chicago, and what we do in Phoenix has to be exactly the same because we're not really servicing the same patient population, I think we will eliminate variations, but I'm not sure that that's going to be important to patients who are going to be accessing those services.

Griffin Jones  39:03

That's a good point from the repeat, you know, from the the repeat visitor, the repeat patient or in other fields, repeat customer side, it's not as necessary, which is part of what you want in a brand. You want people to just know what they're going to expect next, and they and they keep coming back. But in some areas like social media, especially, lots of people have lots of friends and they follow people in different markets. So to just being able to say I went to this place in New York, it was great. I went to this place in Chicago, and oh, there is one by me here in LA that that is useful. But also I think one thing that's just tremendously underused on the clinic side in our field is influencer marketing. We've seen the tip of it, but part of the reason why we haven't seen more is because up until very recently, there hasn't been somebody with one name that justifies a there a big price tag or a big Campaign for, you know these influencers to say, Yeah, we use x company.

Andrew Mintz  40:08

I just think that if we can provide the patient with the best possible outcome better than our competitors, and we can provide them with a good experience, I don't think that name is going to make a difference. And I think we're just going to stay focused on really those two aspects of the business and worry about the branding as time goes on. But at the end of the day, I'm on a much more sort of focused in on, how can we improve our outcomes? How can we improve our live birth rates? How can we make sure that patients are feeling like they were cared for through the process? And if that feels the same from clinic to clinic over time? That's great. If they're not called the same thing? I it, frankly, not that important to us.

Griffin Jones  40:51

You're doing something right, because you move very quickly, you said October of 2021 is I think, is when you decided on the pinnacle name, and it was in the second half of the 2021 that you closed on? Is it six practices. And and some of those are are ones that all of the other groups would have loved to have closed down. And so talk to us about your courtship process. Why was it successful in that short amount of time?

Andrew Mintz  41:22

I think that they buy into our strategy and our value. So our core values that we have around, you know, putting the patient first collaboration, integrity. These are I think, what speak to them. So we have

Griffin Jones  41:38

nobody says we put the patient last Andrew and nobody says we're a bunch of dishonest dirtbags that are gonna stab you later. So how were you able to actually demonstrate that?

Andrew Mintz  41:47

Yeah, I think that when we talk about not just that we have values, but that we live our values. So the creation of our lab director Council, and our medical director Council, for example, is a tangible thing that they can see that we're actually living our values. And so I think that's important when we go and have conversations with them about, we have these values, and this is how we live them. Here's our strategy, here's specifically how we are achieving these goals that we set up for themselves in terms of outcomes in terms of, you know, patient care, in terms of, you know, the patient experience in terms of all kinds of things. So we have some very specific goals for ourself. And, and we tell them specifically how we're going to get there, and what their and what their role is. And I think they get excited about it. Frankly, there's a there's more than one several practices that we had conversations that either we didn't think that they would fit well into our strategy in terms of them really participating it or they didn't like our strategy. And so from our perspective, that's okay, too. In that we think that we are partnering with those that are really dedicated to making that happen. And they have to take actions to make that happen. So the fact that they are participating on these committees, that they're adopting our protocols that they are, you know, we announced a partnership with genomics for our, our PGT testing, and everyone's now going to be sending to a genomic so that we can get consistency in terms of results. I mean, these are things that we are doing tangibly to make sure that we're getting the best outcomes. And I think that they see in the early days, they saw the vision and they bought into the vision. In the more recent days, they're seeing that we're actually executing on our strategy. And I think that speaking to who are partners in?

Griffin Jones  43:41

Yeah, so how did you how did you paint the vision? Because you, you did it before you even had a company name in many cases? So did you did you like bring a handful of people with you? Did you have Did you have some kind of storyboard? How did you you're successful in bringing some pretty big groups in before you even had like a cohesive exterior identity. So how did you How were you able to articulate the vision without that,

Andrew Mintz  44:12

so we set our we set a strategy and our strategy has some very specific goals. And so we were able to bring that out with us in terms of what we were going to do and how we were going to get there. Some of it is definitely leap of faith. So they looked at this and maybe they just saw something different than what others were doing. I can't speak to what the other networks are doing or what their strategies are other than what they share on your podcast or or on LinkedIn or something else. But I think that they really liked the concept and you know, selling the, you know, the whole collaboration piece you're going to work with other clinics are going to have peers, you're going to be sharing information and you're going to be making changes and making improvements and those be Pull to recognize that, in fact, that needs to happen. Even though some of our clinics have some of the best outcomes, I think in the country, the reality is that they all know that they can do better. And so the those that are more entrepreneurial, and spirit, those that are really understanding that, you know, change is not going to be avoided, that they have to embrace it. I think those are the ones that are really sort of gravitated to our strategy and our and our values, our mission, in terms of, you know, the thing that the steps that we're going to do to take to make some change now, you know, some of that is also, you know, comes with changes in process and changes and in partnerships and those kinds of things. And everyone recognizes that all that has to be reevaluated. So I think the clinics that we've been able to partner with have that same mindset, and those that have decided that we're not the best partner, maybe just have a different view or, or buying into, you know, the, you know, the mission of, you know, a competing platform, which is fine, too, there's plenty of that to go.

Griffin Jones  46:14

So you mentioned sometimes that it isn't a good fit, either. They don't think you're good for you don't think they're a good fit, what are some of the things that that tell you fairly early on or not even early on, at some point in the process, that it's not going to be a good fit.

Andrew Mintz  46:31

So two things are real red flags for us. One is, when they're only discussing money, then we know what the motivation is. And I'm not saying that money is not an important part of the conversation, but when they're fixated on the money and only the money, then then we know that they're really in it for the money. And that's not really the partner that we're looking for. The second thing is that we have a specific business model, you know, we when we ask them to roll equity, they roll it into the parent, not into the local. And so when they start when they start having conversations with you about changing the way and your philosophy about how you're approaching your partnership, then we recognize that maybe that's not there, too. And then, you know, we also do our own reviews of that as well. So, you know, we are looking at operations in the lab before we, you know, before we sign, you know, our definitive agreements, and we really need to make sure that, you know, they have a basis that we can build from, and not all clinics that we saw necessarily.

Griffin Jones  47:43

So they're getting equity in the new so part of you taking equity in their group is that they are doing that in exchange for equity, some partly, your cash is involved, too, but equity in the in the parent company, is that what you're

Andrew Mintz  47:59

talking about? Correct? That's correct.

Griffin Jones  48:03

What's the advantage of doing it that way?

Andrew Mintz  48:06

I think, you know, it allows them to buy into the full strategy of the organization. So if we are going to be building their own egg bank, for example, then they're going to be interested in figuring out how to make that as good as possible. And for them to be participating in the building and the use of an egg bank, as opposed to well, that's a separate financial, it doesn't really hit me. And therefore I'm sort of less invested in the outcome of how some of these, you know ventures are doing. So from our perspective, we like them to be supporting the strategy as a whole and them to be, again, part of that collaboration is that for all on the same page, so if it's good for, you know, if it's good for the organization, it's good for them, as well, as opposed to maybe advantage, one group over another for whatever reason. And, you know, we certainly don't want there to be competition within the organization, regarding who's getting more profits, we really want that ball to come into pinnacle. And for them to be incentivized to the pinnacle level.

Griffin Jones  49:19

I can see the upside of that. And sometimes there's a downside if people don't buy into the parent organization, and then it's just, it's just flipping the current. It's just flipping that the current practice, it's like, well, how much efficiency was really added and how much did we miss out on by not being a part of the network? So I can see the advantage of that does that put them at more of a risk for an Integra mat situation if my equity is here in this parent company now and then this parent company just took? Yeah, just bit the dust and, and now I don't have anything over there.

Andrew Mintz  49:53

Well, I think there's a lot of learnings from Integra med that I think everyone has taken with them Whether they were part of that network or not work, I mean, I think that because we have so many physicians involved at so many levels in the organization. So it's not just the medical director and the lab director concept, but we got someone who, you know, one of our physicians acts as a part time cmo for us. One of our physicians is leading a, our, our efforts on research and clinical trials, we have a physician who's leading our efforts on international marketing and other kinds of activities that sort of get them engaged and how it's going to work for the network as a whole, the more they participate in that, the more excited they are for it, and the more they're sort of willing to, to make it work. You know, I can see on the downside, which is, you know, what I do individually doesn't have as big of an impact to the whole organization as if it was just my clinic, but really don't have people thinking that way, at this time, at least. And so for us, it's been nothing but exciting to see the growth and the engagement that we're getting from our physicians and our practices to help Pinnacle be successful. And, and there were, they're starting to refer themselves as Pinnacle clinics, you know, over the name of their local brand. And, and, you know, internally, I mean, we don't clinical is not a patient facing brand, but it certainly is speaking to them in terms of what we're trying to do. So we're just loving the engagement that we're getting. And we're finding new ways to engage more and more physicians in the process.

Griffin Jones  51:45

For the audience that doesn't know Al Ries and Jack trout were two of the the like marketing thinkers of probably 80s, early 90s. I think Donny Deutsch, David Ogilvy, nowadays, Gary Vaynerchuk, they have that many books, they have a book called The 22 Immutable Laws of marketing, which I don't think is as relevant, I don't, I don't think they're I no longer think they're immutable, or at least many of them. I think some of them are mutable, but one of the rules that they have is the law of the category. And, and in that if you can't be the leader of a category, you create a new category of think of, well, you know, I'm not going to be the top personal injury attorney in my marketplace, but I can be the top personal injury attorney maybe for workplace accidents, and I'm going to own that category. And so, as long as we're speaking of just IVF centers, Fertility Centers is one category that hasn't fragmented in that way. Another one of their laws is that every in the end, every category becomes a two horse race. There's no RC Cola anymore. It's Coke and Pepsi. And, and I think there's, I don't know that that's true in every category. But do is that what we're going to see in the fertility field, is it so we've got pinnacle, we've got inception, Prelude we have. We've got us fertility, we've got the fertility partners, we've got IV somebody's gonna be really pissed at me for forgetting, you know, first facility, Boston, IVF, you know, somebody's gonna be mad at me. I'm going to forget somebody. But we have, you know, 678 network groups now. And is it inevitable that there's two of them and a number of years?

Andrew Mintz  53:33

Yeah, I mean, I think we'll see that we saw that with EDR. Ma. Right. So that was there an international play, and more so than, than local, but I would think that over time. The network's you know, there's only there's only 450 Some clinics in the United States. And, you know, some of them just are, you know, maybe investable. And so I think at some time, there will be conversations, if they're not already happening among the platforms to be combining their efforts into, you know, a single play, it would really, really have to show the advantages to making that happen. And I think that there, there is an could be. And so I would expect over the next few years, we may see that we may see platforms starting to come together. So if that's

Griffin Jones  54:25

the case, then it seems to me like some platforms would be incentivized to get gobbled up rather quickly. They they acquire a number of clinics, all of a sudden they are a company with a healthy balance sheets, they can get a multiple of the multiple that they purchased on which returns what their obligation to their limited partners. And so I could see some companies that may be where they were in business as a network partnership for a year or two. Become acquired by another one and And if that's the case, our practice owners not missing out on something because it's like, well, should, I should I could have just tried to build that multiple, that we ended up selling for more by myself.

Andrew Mintz  55:18

Welcoming, hindsight. 2020 So the reality is though, the woulda, coulda conversations I'm sure people have with themselves all the time, I think that we are going to see that. I think that in this industry, what we're going to find is that strategy, and and I think culture are going to win out. You know, we're, we're working in a very niche healthcare environment, right. And so certain, there are certain things that we don't see in fertility that you see in many other areas like, like burnout. Burnout is not nearly as prevalent in fertility as it is, let's say, an OB GYN. And so I think that we're going to find that people will continue to engage and stay engaged. And I think that these as these platforms come together, you'll find that you'll find a lot of interest from the partners to make it that much more successful. So if they have rolled equity or granted equity, I think that they will continue to want to have a stake in the game, and make sure that the kinds of collaboration and strategic initiatives that need to happen will happen. And I think we're going to continue to see that, at least in my lifetime.

Griffin Jones  56:46

I've, I've grilled Jaya, and you've been a great sport and and showed people what what they can consider with Pinnacle the our audiences, almost all practice owners, fertility execs, peers of yours, how would you want to younger Doc's? How would you want to conclude with them? Andrew?

Andrew Mintz  57:06

Well, I think what we really want is we want physicians to step up. So we are plagued infertility with a whole set of physicians that are called in or close to retirement. And what we need is we need future leaders. And I think the time is better now than ever. And so being able to go into a platform, such as pinnacle, or any of the others that you mentioned, and and be able to create opportunity for themselves in terms of leadership is never been stronger. And so I would really encourage physicians who are already in or about to enter the rd by field to really think about how to make it better. What can they do that their predecessors haven't? Haven't done? What kinds of ways can they take advantage of new technologies and investment that can take it to a whole different level, and I'm eager to see what some of these new strategies and some of these new adopters are going to come forward with and, and then see what happens. So I'm excited for the future and I can't wait for you know, seeing what's next, what new competitor comes in and what our existing competitors are doing to raise the bar.

Griffin Jones  58:33

We will link to Pentacles website in the show notes and as well to your LinkedIn profile for those that want to get in touch with you. Andrew Mintz, CEO of Pinnacle fertility, thank you very much for coming on inside reproductive health.

Andrew Mintz  58:48

Thank you, Griffin. Appreciate it.

58:50

You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society. Visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health

151 3 REI Fellows Walk Into A Podcast…

What They Really Want Out of Their Future Permanent Position

This week on Inside Reproductive Health, Griffin Jones hashes out the goals, aspirations, and challenges of three prominent REI Fellows in their search for the right permanent placement.  Dr. Megan Sax, Dr. Victoria Jiang, and Dr. Zoran Pavlovic share their experiences on recruitment, what factors weigh in on their decisions on job selection, and how much they’re willing to put at stake for their professional (and personal) success. 

Tune in to hear:

  • What they are looking for in a partnership and/or position.

  • How factors such as location and politics have a huge impact on the appeal of job offers.

  • Griffin press all three and question how much accountability they are willing to take on in exchange for the autonomy they crave.

  • What you might say to a recruit to catch their interest.

Dr. Megan Sax Information:

Dr. Sax is a 2nd-year REI fellow at the University of Cincinnati. She has engaged in leadership roles as a women’s health advocate and medical educator. She previously served as the ACOG Junior Fellow Chair of Ohio and currently sits on the CREOG Council as the Junior Fellow liaison to ACOG. She has received recognition for exceptional teaching and humanism and intends to continue a career in medical education after her fellowship.

Twitter: @saxmeg8 



Dr. Zoran Pavlovic Information:

Dr. Zoran Pavlovic: Zoran Pavlovic is a second-year fellow at the University of South Florida Morsani College of Medicine and splits his fellowship training time between Shady Grove Fertility and Tampa General Hospital. His areas of interest include reproductive surgery, fertility preservation, third-party gestation, genetics, and IVF. Zoran loves meeting and conversing with great minds, innovators, and creators within the field of REI and is excited about the future of fertility care. He hopes to one day be an active contributor in the field of REI and a mentor to the next generation of physicians.

LinkedIn: https://www.linkedin.com/in/zoranpavlovic27/

Dr. Victoria Jiang Information:

Victoria S. Jiang, MD is an REI fellow at Massachusetts General Hospital. She is board eligible in Obstetrics and Gynecology and is currently completing her second year of fellowship in Reproductive Endocrinology and Infertility. She graduated from Emory University with a double major in Chemistry and Biology, with a focus in Organic Chemistry. She received her MD from Wake Forest School of Medicine in 2017 and completed her residency in OB/GYN at Emory University School of Medicine. She has received numerous awards for her teaching, research, and wellness efforts. Her interests include the integration of AI in medicine, genetic testing, and the ethical expansion of PGT, and PCOS.

Instagram handle: @vsjiangmd 



Transcript

Dr. Victoria Jiang  00:04

For people who want to have a seat at the table and make those decisions, I think for me that's at least where I'm seeing myself now. I want to be able to sit at that table and have a little bit more of a say in how these practices are developed. Because I think the biggest frustrations that I see in kind of these big, you know, corporates, like scenarios is that loss of autonomy

Griffin Jones  00:28

already everybody's trying to learn, you're probably trying to hire them. Everybody wants to get an associate doc or someone out of fellowship, and they're in short supply. So I talked to three of them today, and they're already in conversations with potential employers there. They've just started their second year. They come from different parts of the country. I'm gonna let them introduce themselves in terms of where they've studied. It's Dr. Victoria Jiang, Dr. Zoran Pavlovic, and Dr. Megan Sax. And we talk about how important being active as a fellow is and how important being active as a recruiting physician is, in order to tap into this person. We talked about how important partnership is to them or not, as long as we talk about how important academics are to them, or not as much as political advocacy, the things that they're paying attention to, when they are interested in partnership, I pressed them about okay, what are you expect you to put forth? What are you expecting to be accountable for in order to have that level of autonomy, and that level of share of the product, the company in the practice? So this is not meant to be confused with data. These are anecdotes, but I'm introducing you to three sharp fellows who are active who are plugged in. And knowing people like this helps you get in touch with more folks like them and knowing what they're paying attention to can give you a recruiting advantage. So hope you take advantage of that. And I hope you enjoy this conversation with three Rei fellows about what they want out of the practice that they ended up joining and what they want out of their careers in terms of partnering with other companies in the facility. To talk doctors Sax, Pavlovic, Jiang welcome all of you to the inside reproductive health show. Meg Zoran Victoria, it's good to have you. Thanks for having me. Great. So I did I just mess up your last name even though you told me right before we started recording is it Pavlovic?

Dr. Zoran Pavlovic  02:47

No of Pavlovich. Close you know

Griffin Jones  02:51

that that's a tough that's starting to make a little bit of a name for yourself, which is interesting. Meg was just mentioned in a podcast that I recorded earlier today. I'm on the board for the Association of reproductive managers a subgroup with in ASRM and there was some sort of programming that we're talking about for younger Doctor fellows. And the three of you were mentioned because of the role that you had at ASRM. So. But no, I mean, Rei fellows are coveted. And I don't like to do man on the street interviews meaning like I don't like to have anecdotes be representative of population, I don't have a ton of data necessarily, but it is kind of useful to at least it's at least somewhat, if taken with a grain of salt to go through some of your experiences and maybe your aspirations and what you want to accomplish because people want to recruit you, not just the three of you, but the 100 and however many 120 or so 130 140 fellows that are out there, and and that all listen to this show religiously. So we're going to do that. So each of you just want to give a little bit of background of where you are, what year you are, what were your fellowship and let's just start with that.

Dr. Victoria Jiang  04:33

Sure I can. I can go ahead. My name is Victoria Jiang. I am originally from Atlanta, Georgia. I went to Emory undergrad and majored in chemistry and biology with a focus on organic bio organic chemistry. Then I went to Wake Forest for medical school and marine for residency and now I am a second year Fellow at Massachusetts General Hospital.

Dr. Megan Sax  04:58

Meg Sounds good and happy to be here. Thanks for having us again Griffin classic 2024 coming around the bend. My name is Meg sacks. I grew up in Michigan, huge Michigan Wolverine fan went there for undergrad and yet somehow married a Buckeye against all of my family's wishes. That's gross. It is gross. Let me tell you. I studied neuroscience and then went to rush Medical College in Chicago for med school and then match at University of Cincinnati for OB GYN residency where I stayed on as an REI fellow and I'm currently a second year. I'm very interested in patient advocacy, Uncle fertility and education. I work both via different initiatives that ACOG and Korea ag and I'm hoping to continue a career in medical education.

Dr. Victoria Jiang  05:51

Yeah, Meg is our advocacy queen.

Dr. Megan Sax  05:54

You gotta be when you live in Ohio. Gotta be oh, we're

Griffin Jones  05:57

gonna have to talk about some of that. Then what about us on?

Dr. Zoran Pavlovic  06:01

Yeah, happy to be here, Griffin. Thanks for having me on the show as well. My name is Zoran Pavlovich. I'm a second year fellow at the University of South Florida in Tampa, where I split my training between surgery at Tampa General and also Shady Grove fertility for the IVF part. I'm originally from Chicago, and I went to residency in Chicago. And then college was at Creighton in Omaha, Nebraska. So kind of been a little bit of everywhere. And I came back here to Florida because I also did my medical school here at UCF. So you see up to USF enjoying the weather, and it's it's, you know, 90 degrees and super hot right now, but I'm glad to be here. And our focuses are down. Oh, sorry. Go ahead.

Griffin Jones  06:41

You all just started second year.

Dr. Zoran Pavlovic  06:43

I'll just start a second year.

Griffin Jones  06:46

Have any of you looked at employment agreements yet? Have any of you been in conversations with people about you know, I should say later conversations with people about where you're going to end up after fellowship?

Dr. Victoria Jiang  07:02

Well, I will say, Oh, go ahead.

Dr. Zoran Pavlovic  07:04

You go ahead. We go first.

Dr. Victoria Jiang  07:06

Oh, well, I guess I will say, you know, I think one thing that's been really terrifying is that the employment kind of timeline has very much moved so early in our fellowship. So as you're trying to grasp, like, how do I be a human? How do I be a physician? How do I be an REI, you're suddenly faced with finding this would be my first job since I was literally a waitress in high school. And so there's definitely been a bunch of really great like, podcast people to be able to lean on. I actually came back from an interview yesterday. And so this was definitely the first very early foray into the employment kind of piece. But it's exciting that the idea of gainful employment that our future.

Griffin Jones  07:44

Yeah. Yeah, like, Do you know any medical students? Let's interview them, because it's starting early. And earlier. Sorry, I interrupted us.

Dr. Zoran Pavlovic  07:55

Oh, no probs can see I agree with Victoria. And that I think I started having my first conversations back in the SRA retreat in Park City, which was November of my first year, just a few months in still trying to figure out my research project and already talking about places for to visit them to interview to send emails and have zooms and that's it started way earlier. So as Victoria said, when you're a resident, you're just thinking about how to be a doctor. Now, as a fellow, you're already thinking about, Oh, what's my career gonna look like? What job do I want? What environment do I want to be in? And that's definitely different. And I think, something tough to tackle for everyone.

Griffin Jones  08:30

What about you, Meg? Are you having these conversations yet? Or?

Dr. Megan Sax  08:33

Yeah, it's just wild. We had heard last fall at Esrei that they're going to start come in and you know, prepare yourselves, get in mind what kind of practice you're interested in what location and other kind of aspects of that. And I think historically, it was really the ASRM conference that people had their first interviews. And now that timeline has really scooched up. So we're having places reach out to us as soon as at the end of the first year, just like Soren and Victoria had said, and I'll be honest, these two have been my gurus in terms of what I'm looking for, and practices and things like that, and even what questions to ask from these employers.

Griffin Jones  09:17

I don't think that was the case a couple years ago, I think it was like, you know, you get towards the end of your third year and you start talking about it or that was before every last place was looking for an REI. I'm not saying that every practice is hiring for an REI, but I don't think any of them are not not hiring at the very least they're like, Yeah, we would hire somebody if, if if it was the right fit at the least. And then of course, many are really actively searching. So at this point, until we see a major reversal in supply and demand, at least which isn't on the immediate horizon. I think that at this point, first year, like once you're in fellowship, you're going to be an RA I therefore you are fair game for recruitment. It's like we might as well just try to beat everybody. Because if it's like college football, right, like it used to be, yeah, you just sign the people after they had a stellar senior year, then then the big sec, schools are recruiting for the most competitive players, and they start signing up, and then their junior year, and then sophomore year, etc. So, same thing has happened here. So I want to I want to go into some of these questions that you have, which by the way, when I have podcast, guests, I asked them for three to five questions ahead. And I would say, at least a quarter of them, give me nothing ahead of time. And by producers, bugging them for quiet, you guys gave me 30 questions. So we're not gonna get to all of your 30 classes a day. But I love that that that continuing education mind frame that three of you are still in, you're very welcome, way more prepared than the vast majority of podcast guests ever do. So let's talk about what are some of the key elements in your job search. And I'd want to just start with, like, I want to do a little bit of I mean, you can go into detail if you want to, but I want to do a little bit of a lightning round. Let's start with location. And Victoria, let's start with you. Do you have a location or a number of locations that you would like to be in? Yeah,

Dr. Victoria Jiang  11:24

great question. I originally was trying to go back down to the southeast because that's where my family was. And that's where I'm interested. Interestingly enough, with the dogs were stocks in rolling that has really put a wrench kind of in that big planning picture. My husband's a dermatologist, so we're looking at big cities with reproductive rights.

Griffin Jones  11:41

So you're now more flexible than you were? Is that what you're?

Dr. Victoria Jiang  11:46

Yeah, definitely more flexible than we were, I think there are gonna be big limitations as far as certain geographical regions, as far as just density of population need for an REI in that case, and, you know, competition and whatever those pieces are. But yeah, big kind of big cities kind of all around the US are kind of looking very broadly, and kind of seeing where we land.

Griffin Jones  12:09

So how, like, is it still? Is it a shortlist of cities that are on there? Or are you in on a scale of, of one being we're going to this exact city 10 being where we're open to Fairbanks, Alaska, we're open to anywhere? Where are you?

Dr. Victoria Jiang  12:26

You know, I have Fairbanks, Alaska is great for freezing eggs. Constantly. I would say on a scale of one to 10 we have definitely our top five favorite picks. And I'm definitely looking in those kind of top five cities. So like looking at places that have opportunities like the space for potentially my husband's a dermatologist, so he wants to open up a hair practice. So if you guys need any hair advice, I got the man for you.

Griffin Jones  12:52

Those all like top 20 cities, are they all more or less coastal? Like Are we more or less talking about? Is Boston New York's or Chicago LA? Like? Is that what we're talking about?

Dr. Victoria Jiang  13:03

Yeah, so I think we're looking at, you know, big cities. And so we had looked at like, you know, Nashville, Tennessee, we were looking at Northern Virginia, we're looking at, you know, Denver, Colorado, parts of Montana, and like, kind of that Montana, Wyoming area. And so a slightly, you know, second, like, we're not like top 10 biggest cities, but maybe areas that have a need that we can fill that kind of give us a nice, kind of I think one thing that's actually really interesting that we've been thinking about more than like the, the go getter academic, like you have to go from place to place to place is really starting to value quality of life, and seeing where we can raise a family. And so kind of see where that kind of falls into that has been a really interesting transition of goals for me, which I think isn't the most natural thing for really anybody in medicine, because that's not what we're used to.

Griffin Jones  13:49

No, I want to see more of that. Let's ask the go getter, academic mag, where do you want to end up location for Yeah, well,

Dr. Megan Sax  13:55

I love what Victoria is saying about transition into this new mentality. You know, our whole career thus far has been get into the next program match into the specialty match into the sub specialty, with a little less freedom of selecting your location or ideal city. For me, I'm also kind of that Doctor, Doctor couple, my husband's Arad ONC. So we'd be centering more along the bigger cities where we have opportunities for both of us. We are definitely born and raised Midwesterners, but just like Victoria said, you definitely need to consider this political climate change. But I will say you can be surprised by the institution you join by the kind of coalition network you can form again, I I love a cog staying involved in advocacy, you form your network and you you fight and stick it to the man the best that you can, but you also need to look at the long term and your future. So I would say for us, I'm very interested at staying at a academic institution or a practice that works closely with residents and fellows which can restrict the field a little better where you're applying to but I'm very open minded in terms of cities across the Midwest cities where we have family We're also very interested in Denver with most of my my big brothers are all moving out that way. So kind of keeping that eye on family where you're going to have that network where there's some academic opportunities.

Griffin Jones  15:23

Would you also do the Wyoming thing like Victoria is thinking about and have that focus on the quality of life? Are you looking for a big city partly because your spouse is also a specialist and you have to Yeah, you have to needs to fill

Dr. Megan Sax  15:38

right Victoria is way cooler than than I am I'm not sure I would do as well in Wyoming if

Griffin Jones  15:44

you want to be in a major city you want to be a bit more city

Dr. Megan Sax  15:47

I think having lived in places to me Ann Arbor, you know, the Midwest is a city so I think something like Ann Arbor, Chicago, Cincinnati, Denver would be more like ours. You

Griffin Jones  15:58

want you want to stay generally in the Midwest, though. Yeah. Are you like what about New York? What about LA? What?

Dr. Megan Sax  16:05

Yeah, that's a great question. I think with the right practice, if you find a good fit, that I'd be open opened anywhere I need to need to kind of keep the whole family in mind though, for sure.

Griffin Jones  16:15

What about us on?

Dr. Zoran Pavlovic  16:17

Like, yes, I'm also in a doctor, Doctor relationships. There's all three of us here. Well, my wife my wife's maternal fetal medicine fellow, second year Fellow at University of Cincinnati. So you know, her making friends, which is nice. For my situation is actually a little different. And that's because she or her father's private practice is in the Boca Raton Delray area. And so she's going to go join him after fellowship. And so I have to follow her, you know, we're going to stay together. So I got a winter follow her and down to Florida. And we're going to be in the southeast. So I'm looking basically between Jupiter to Miami, that south eastern seaboard of Florida. And so my practice locations were much more specific. I wasn't looking at different cities or even regions, but much more specific. And I think that's kind of one of the reasons why I may have started my job search earlier by asking questions, networking, asking some 30 year fellows if they knew anybody, or had any connections, because I knew where I wanted to go. So I didn't want to wait till the end of second year, beginning of third year where maybe the spots where I needed to go have to go, we're already filled up and taken by somebody else. So that's why I started my job search earlier. But I also was looking for not straight academics, but not small one to two person private practice, something in the middle, kind of private academic model, which REI has a great field for. We have a big enough practice, you can still do clinical research, or mentor residents and fellows, but not have to be part of an academic center or be too small to do anything like that.

Griffin Jones  17:48

This is also where the marketplace for REIs can be beneficial for someone like us. So you like Boca is not the biggest market, but you're kind of looking between Miami and Jupiter. And this is a time where a lot of those Miami groups, they'll be like, oh, yeah, yeah, yeah, we need a bulk office. We're just kind of sure, like you. And so that may not have been the case a few years back. But for the fellows listening, I think that, you know, like, a lot of Detroit people do have an office like or, you know, like might have offices elsewhere in Michigan and or like, so you want to be in Toledo, Ohio, you don't actually want to be in Detroit. Well talk to the Detroit people, talk to the Chicago people, even talk to the Cleveland people, like you want to be in you want to be in Bar Harbor, Maine, like, maybe there's not a big enough area for that, but talk to the people in Boston. And so that's something that I don't think was as feasible a couple years ago. I think that you'll have options talking to some of those groups. So how about so it's a May you straight up want to be in, in academics? How hard are we on that?

Dr. Megan Sax  19:05

Oh, yeah, no, that's a great question. I think just like Zoran said, that Rei is a really unique field and that these private practices still work with residents, do a lot of research, do data analysis within their own clinic and database. And honestly, some of the best data that we have in the field comes from those large private practices because they do so much more, so many more IVF cycles and other HRT. And so, again, I'm pretty open minded. I think as long as there are those opportunities to work with learners and continue research

Griffin Jones  19:44

are either a view or are either view really wanting to be in academics for Victorians are on or Do either of you really not want to be in academics?

Dr. Victoria Jiang  19:55

I will say one thing that really drew me to the field I sound like I'm about to interview for fellowship. Uh, I will say one thing that I do think is really unique about Rei, that is really special. It's kind of playing on what Baggins Warren was kind of saying, is that a lot of practices are still participating and have really robust research infrastructures. And I think being an academic for me means a lot of different things. It's not just working with learners. But it's also like staying up to date having Journal Club, like being able to stay involved with the most recent evidence that is being published and staying up to practice with X y&z And so I think for me, we're joining a kind of middle sized practice where I can get mentorship and making sure that I get like, you know, library access and have like a continual journal club or team review, like those kinds of academic pieces, I think, carry over to a lot of different types of private, domestic and private jobs. And I think that with a lot of the local hospital affiliations, you can a lot of the time still work within a private practice structure, and still have residents and fellows that you can mentor and kind of work with, which I think is really special. I know that one of my uncles, like my in law, is an REI in Chattanooga. And his practice partner is, for example, one of the MCS faculty at a local hospital and is able to work with all of the fellows in that capacity. Shout out to Tennessee reproductive medicine. And I think that's what's really great is because you can have a lot of opportunity, but not have to fit that like cookie cutter academics, because a lot of the challenges that I've seen with the academic programs is, is they're all being bought out by a lot of private equity firms. And so even if you join what is under the academic affiliation of you know, one program or another, you may not actually be buying into that true academic structure. And so I think finding the right program for me, is more important than really like whatever the definition of academic or private or private MX really is.

Griffin Jones  21:44

I think that's why you have answered that same questions. I want to talk about that point, Victoria, I think it's worth every fellow considering. This is, this is an actual data, this is just what I think it could be that the chance, whatever, of practicing ownership, you end up signing up for the chances of it actually being that ownership in three years time is less than 50%. Maybe it's 50%. Or no, it's fine. It's probably somewhere around there. And that's actually something to consider as you sign earlier and earlier, right? Because if you sign in at the end of your third year, then you can have a little bit more of a conversation with the ownership of what kind of direction you plan to go in. If you sign early on in the first year, a whole lot can happen in two years. And I've, I've I've seen this a bunch of times as far as like, and I'm going to join this practice right now can't wait to join this independent brand owned by Sierra. I'm gonna be an academic Sierra going to the Cleveland Clinic man, and they're owned by the Maven click. So zone, what about you? How hard or not hard? Are you wanting to be in the academic sphere?

Dr. Zoran Pavlovic  23:06

Pretty hard on not wanting to be at a straight University, academic situation more. So I think for me, I found that to be a little more, I guess the freedom of the clinical practice that I wanted to do in the private academic setting. I'm not a big person for grant writing, which I think there's a lot of that in academics. And I think there's people that do that and do it really well. And I'm really happy that they're in our field. And I respect them and love them a lot. But for me personally, that would be very difficult. And when I look at the clinical research that I would rather do you see all these biggest groups around the country, the CRMs, RMA, shady groves, US fertility is all that they have these huge clinical databases where you can have up to 100,000 patients and your sample sizes. And you can be really great robust clinical data. And like Megan said, you can drive the conversation, you can change practice patterns, you can help create committee opinions based off of that. And so that's why for me, I felt like I could find an impact within research and still be involved in that academic capacity without being an academic setting. And I personally also have more of an entrepreneurial business sites and one of my minors in college was was business. And so I do want to go to a place where there's that opportunity for either equity or partnership or growth or some kind of opportunity where I can help create and build something together with the practice that I'm at. And that would be hard to do at other other facilities in an academic centers would be more so moving up a professorship and becoming tenured. Whereas in a private practice, it's it's a kind of a different situation that just more so appeals to me. Well, I can still remain Tane some of that academic rigor.

Griffin Jones  24:44

So I'm just hearing that more from people in general, they still want a bit of the involvement with either research or teaching and this is probably something that some private practices need to figure out a lot of this a lot of the larger ones are already involved with at academic centers, but many of the smaller ones are not. So they have to figure out some way of scratching that itch, whether it's, you know, whether it's teaching the residents or whether it's sponsoring some type of research or going in and research with someone else or allowing time for their Doc's to submit an abstract answer. I think that that's something that private practices that aren't that don't have an academic relationship probably need to consider, because what the three of you just said, seems to be a recurring pattern from what I'm hearing from fellas. But now let's talk about partnership, which you started to talk about. so on. So I'll go back to you, which is on a scale of one to 10. How much do you want to be a partner meaning someone that owns a piece of the practice that they're working at?

Dr. Zoran Pavlovic  25:53

That's a tough question. I think it's anywhere from eight out of 10 to 10, out of 10. And the partnership can mean different things that can be either owning a piece of the practice and of the laboratory, or being able to bind to equity of the overall practice. So all of those options to me are appealing and things that I asked questions about and looked into. But some of the practices that have been talking to you to offer these more structured partnership tracks, and that have defined milestones of how you get there. And what that means. That appeals to me a lot, because then I know what I can do to work to get there. What that means when I get there, what does it mean to be a voting member of the facility to be able to help to drive the practice to improve the laboratory outcomes, and work with my colleagues and where we can actually be kind of a almost like a family unit in in making our practice as best as possible. Rather than either being a number in an Excel spreadsheet, or just like one person in a huge conglomerate, or even just in a one to two to three person practice where you make a partnership and that, but how much clinical decision making can an impactful decision making can you make when you're not involved as much in research or academics or mentoring others. So for me, it's an important I think the three things I would say, that I look for when I'm talking to all these practices are the culture, they really want to be surrounded by great people and great mentors that I can actually get along with and vibe with and feel like they're my friends and family, not just someone at work with the ability for opportunity for advancement, which is either partnership or equity or some kind of situation like that. And the ability to pursue some of the endeavors and passions that I have within the field of Rei. So I personally would like to have a day a week to do reproductive surgery, fibroids, endometriosis, laparoscopy robotics, and to be at a practice that will allow me to do that and schedule that into my clinic time instead of just making me do IVF all the time is really important to me as well. So those are kind of three categories that I look at when I talk to practices,

Griffin Jones  27:53

the millennial that wants it all right, well, let's, let's just talk about that, that that passion, and we're in regard to the criteria for advancement as you were talking about. So because what I see happening is a lot of associate Doc's getting to a point where they've been, it's almost always at the two year mark, it's somewhere around there, maybe a little bit shy, sometimes it goes up to three years, but it's almost always around a two year mark, where they feel like they can buy into the practice that they should be allowed to. And the partners don't see it that way. They don't think they're in a position to buy. And it's very often because it wasn't spelled out black and white, this is the volume we expect from you. This is the revenue we expect you to bring in. And or maybe here's some of the other business responsibilities that we expect you to take on. So I think it's a problem because people are hearing I can have my cake, I can do my reproductive surgery this time. And I want this partnership track and what they're telling me and that they're telling me I can buy into the partnership track, but that means that I do have to do as much IVF as possible. So let's talk about what first seconds are on of what like when they're giving you when when you're talking about a clear partnership track, like I they showing this is these are the volumes that you like these are this is the number of procedures that you'd have or the number, the amount of revenue that you would have to bring in. And is that commensurate with what you can do while still having a day for your passions.

Dr. Zoran Pavlovic  29:30

Yeah, some practices are more specific than others. And I think that that's something that every fellow if I have a bit of advice to give is to get really specific and what those details mean. And also have the contract lawyer review that with you and go over all those details. And don't be afraid to ask those questions. Because for some practices, they say it's a four year track mark, you meet the milestone of being board certified or board eligible and then board certified and that your volume is at least this much per year, you're reaching this productivity bonus. And then you become eligible to be considered for that partnership track. And then you can buy in for that. And this is what the buy in typically is, or this is what it was these past couple of years for our partners. And so they tell you this defined ways to do it and that I think I really appreciate so you can actually have a goal you can build a game plan in your mind going forward, as opposed to be more vague, saying, well, after the three to five year mark, we'll see where you're at or or or if the partners agreed, then yes, you can become eligible to maybe buy into something those the vague language I think is something that we should always look at and try to define as best as possible. Because the ones that are more structured I think are better for fellows and allows you to really kind of plan your time there. What

Griffin Jones  30:45

better for the practice so there's nothing to be gained from mutual mystification. It's why I sometimes think I'm a dick, my sales process because it's so specific, I create so much content about the sales process itself, and then the delivery process? Because it's like, no, no, like if we if I don't have partners, agreeing on what we're doing here and what it takes to do that. I'm not letting you engage in anything. I'm not letting you just create what my company does in your mind, and then still hold me accountable to that same result. I don't think the mutual mystification benefits everyone, that's what results in in the in the discrepancy, you can always still have discrepancy no matter how specific URL but the more specific you are, the less likely you are to have to enforce something later on or have to dispute something later on. Back. What about you for partnership one at a time?

Dr. Megan Sax  31:44

Yeah, that's a good question. For me, it's really more about the fit, I would say. And I love how Zoran kind of prioritized his 123 I think, honestly, it's so important to be transparent when on those interviews with that and vice versa, kind of turn the tables to what are you expecting out of me or out of a new hire? What role do you guys really need to be filled? And am I going to be the best fit for that because you both want this to be a relationship you might be moving across the country for and to make sure that this is going to be a long term sort of, you know, beautiful relationship here. So I would say for me having an opportunity to become a partner would be in more of a private Demick setting would be important and to have that outlined and have those goals set up. But I would say overall, you know, I'm kind of open to various models here, I can see. My note is not a deal breaker for you. Right, I think the most important thing is, you know that longevity, I want the security of having a job that I love. And if that means every day I go to work thinking you know, I get energy from teaching, I get energy from doing research, having colleagues who want to write papers, which Zorah and I know is so sick of fun. But I think being able to have that energy is the most important thing and really loving where you work. Having a partner opportunity, I think is only only a good thing and in the way that I view entering this process.

Griffin Jones  33:20

Fair. So you're, you're you're lower on the spectrum, then John, John is not going to work for anybody where he can end up owning a piece of it. And you're open to others, you're you're you're interested in it, but you're also weighing in other factors. Victoria, where do you fall on that spectrum?

Dr. Victoria Jiang  33:37

You know, I've thought about this a lot. And I would say I'm probably closer to where Zoran is like the seven to nine, eight to 10 kind of range. As far as partnership partnership means something that isn't just like, you know, buying into the company, it's like for me partnership is really more of like, do I have the autonomy to be able to do the things that I want to do? Can I contribute meaningfully to the way that this clinic is operated in practice? And can I be able to have a say in the really important decisions that are being made? And I think at the end of the day, I mean, you touched upon it like practices are being bought out so quickly, like the landscape of a lot of different areas are really changing very rapidly. And to be in a situation where you're an associate provider in like a scenario where you know, your value, you bring a lot of value to the clinic say it's reproductive surgery, and you're otherwise referring out all those cases, I think being really kind of straightforward about that and asking for it's going to be important, but I also don't want you know, the rug pulled from under me saying that like oh, by the way, surprise, you're we're actually getting bought out by XYZ company in the next six months. We're transitioning all of our leadership and we're all suddenly like an employee model. And I think that's what's really challenging for me is that you'll build a life you'll build a home, and you'll live somewhere for three to five years and if you don't have a clear plan of where that next step is going to mean for you. I think that's going to be really challenging for career longevity because I think a lot of the burnout that we see He is that, you know, KPI metrics, like you have to meet these certain, like UVF conversion criteria, and you have to do X amount retrievals a year, and it very much feels like the industrial IVF machine. And, you know, I think we, as physicians, should see that we bring a lot of value and being able to negotiate that earlier on, if that means less compensation, to be able to do the surgery that you want to do. If that means carving out like a stake in your contract to say, you know, I'm really interested in artificial intelligence. So I want to be able to have the opportunity to develop that kind of technology freely, and you know, thoughtfully, being able to negotiate that at the beginning is kind of like being able to have like a good practice partner is it's kind of like the philosophical idea, but then also like that whole legal idea. And I really just want to work with a group of people that understand where my mission is, we have a combined vision that we want to bring forward. And we want to be able to expand our influence in a more meaningful way. And I think that can be negotiated in a very unique manner, and whatever kind of job that you're going to be looking at,

Griffin Jones  36:04

might be worth examining autonomy and flexibility. Because they're not totally the same thing. Some of the things that you mentioned seemed to me like it would be more advantageous as an associate employee, like if, if, if I don't want to be a production machine, I feel like okay, this is what I'm willing to, like, this is what I'm willing to work, this is the scope that I also want to be able to do those things. And in, sign me up for that salary. Whereas if it's like, if you're, if you want to be a partner, somewhere, you're gonna be a production machine for a little bit. It's like it's better if it's something worth buying into. There's a reason why that is.

Dr. Victoria Jiang  36:42

Yeah, no, totally. And I think that, you know, it's all about I think, what I learned in residency, the most valuable lesson that I learned in residency is if you have a problem, being able to propose a solution to the person that needs to solve your problem is a much easier way of getting something done than to just like, be like, Oh, I don't like this structure, but I don't have an alternative, right. And so like, for example, if you're like about to start a start working for a practice and say, they're worried about your productivity, you want to start doing reproductive surgery, you go say to them, you know, I, you know, really love doing reproductive surgery, I know that as my clinic volume revs up, that may not be something that I can do once a week, but in the interim, could you just refer all of your patients, as I'm filling my schedule, we can kind of get that money back for our clinic, we can reclaim some of those reimbursements from the surgery that we otherwise would be referring out. And then we could come back and say, you know, as my clinic starts filling up, you're gonna get referrals, you're gonna get friends, you're gonna get all these different, you're gonna be drumming up more business, that I think that they weren't necessarily having seeing as an avenue of revenue, and being able to sell that value that is very uniquely you, I think it's not just being a fellow that can do IVF. But it's also like, I can, you know, represent us at local, you know, marketing events, I can do all of these little pieces that kind of build into that practice that I think also builds rapport with your practice partners. And I think part of the whole practice partner piece is is that your partner is trust you and do your partners, think of you as somebody that they can lean on to make decisions. And I think I want to be able to build that trust with my partners.

Griffin Jones  38:12

Boom, that's bringing a solution that's coming proactively to make that selling your case for what you want to do. You also made another point that I think we should talk about, which is because I think it can go either way, it's something for people to consider and that has to do with future risk. Are you better? Are you in a better position to to mitigate that as a partner as an associate, meaning like all the people that are selling their practices? And it's like, Wait, this isn't? This isn't what I signed up for? I could see it going either way, if you're a partner, you potentially have more you potentially have a lot more to benefit from. If they're flipping that and and the partners are, are part of who gets to make that and they're not always that's one of the things that they can get screwed over on they did they get to make that decision, they get to vote on that decision to begin with. You could also be, you could also straight up get screwed ie Integra mat, like the people that were partners that those practices got screwed there. They had to find new payroll company money they had to the people that had paid ahead of time that year, they had to make that up. And if you're associate that's not really like that's not coming out of your overall bank, and God forbid if it doesn't work out overall, you just go get a different job somewhere else. So I could see I could see that. Like you mitigating risk. Are you taking more risk on? I think it could be either one? Well, I think

Dr. Victoria Jiang  39:46

it's like what do you think is like risk first benefit, right? Like I think the associate model like if you're able to say you have a side hustle, something that you're into, like say you have a really popular fertility podcast, and you really want to like figure out How to really lean more into that like that may be better for you to be an associate more like an associate partner in that capacity because you can work on side hustles, you can have things carved out, have a little bit more time in that capacity. But I'm a strong believer that without risk, there is no reward. And it may be that you take on a big risk, and it doesn't necessarily play out and what you want it to be. But the alternative is that you're going to be putting in just as hard of work on a day to day clinical level. And whether or not you're going to be able to be the person that's at the, you know, helm of the ship. I think that's the phrase, I think that's going to be per person, I think that's going to be what people deciding, you know, I've met people who are saying, this second phase of my life, I'm done with training, I want to focus on my family, I want to pass my boards, I want to buy a house and I want to like, you know, snuggle at home, I think that's fantastic. And just as important as any of these other aspects of your job. But you know, for people who want to have a seat at the table and make those decisions. I think for me, that's at least where I'm seeing myself now is I want to be able to sit at that table and have a little bit more of a say in how these practices are developed. Because I think the biggest frustrations that I see in these big, you know, corporates, like scenarios is that loss of autonomy, you know.

Dr. Zoran Pavlovic  41:21

That's a return. I've talked about this so many times via text message and phone calls. And we talked about how being at that table being able to participate in that decision making is so much more, it's better than not being there at all. And I think that can even carry over into advocacy, which may you can speak about if you're not at the table making those decisions, and other people will be making those decisions for you. And that's doesn't work out well in politics and advocacy in medicine. I don't think it works out well. And the business aspect, either. And if we're physicians, and this is our field, we should be participating in this situation, not everyone will want to which is totally okay, as victorious. There are some of us that do. And I think that that's we may be some of the people that want to hear in this conversation. And I think that's important because I would rather be there and at least try to put my two cents or help make a decision or put a vote in versus not having that decision taken. For me, I would almost regret that saying like, Oh, I didn't actually do my utmost or my best to try to change this outcome or influence it in any way. And that's why that kind of decision making capacity is important to me.

Dr. Victoria Jiang  42:28

He is in fact, a millennial who wants it all.

Griffin Jones  42:31

So that's this is what I'm trying to think about. Because it's like, okay, there has to be something in exchange for the decision making authority. I've had, I had, I had a real struggle with my employees at one point in the past year, which is because one of the things that I do promise them is autonomy, they get to make decisions for their seat. That doesn't mean they get to make every decision about everything. And, and so I also learned that I need to be specific about what that means, like, No, I own this company 100%. And I am ultimately accountable for everything I am accountable for if I have to make payroll every single time I have, I have mouths to feed, lots of them. And I have an accountability to our clients that nobody has that level of accountability in our organization. And the more accountability you have, the more the more autonomy you have. So it's like, okay, we want to make these decisions. So what are you taking on? What are you being accountable for, you know, in a partnership agreement that that gives you that seat at the table?

Dr. Zoran Pavlovic  43:47

Yeah, absolutely. I don't think you can want to be involved or be a partner or in a decision making position or seat without taking on some of the responsibility and accountability and look into those details of that practice and diving into your your functions, your operations, how that could be better, where things could change, dealing with issues at the with, with employees, or between patients or bad reviews, I think you have to you do have to take on some of that administrative work. And I'm not much not a big fan of administrative work, but I know I would have to have it, it's going to be part of my life. If those are the kinds of decisions, if that's the kind of position I want to be in one day, and you're right, you have to it's going to be some it's going to be additional responsibility. And so you decide for yourself, is that a responsibility that's worth it to you to have that partnership or decision making process or is it not? I think that can change throughout your life as well.

Griffin Jones  44:38

We're talking about lessons learned in owning a practice or owning a business in the fertility field and things that you may want to learn how to do or learn about before you go and start your own venture. Another thing is some of the systems that are used and help people that can give really good recommendations on the different EMRs they've shopped in that depth and scope. Both functions. But I would ask someone that you know, that uses engaged MD, if you're not already, if you don't use engage them D in your system, you're thinking, I want to open my own office within my own group or I want to open my own practice, I want to go join somebody else, and I want to be able to add something to it, engage them D is one of the surest bets that you can do. But you don't take my word for it. Ask someone that, you know, because more than half of your colleagues are using EngagedMD and more than half of your colleagues are extremely delighted with EngagedMD, because they've got real informed consent. They don't have stacks of papers that people have to sign and then account for and then keep an eye out for a file cabinet somewhere. They have true informed consent from patients that have a module at their convenience, so that the staff isn't overburdened with questions that they don't need to be getting that they can help the patient with the attention that needs to be devoted to that patient's case. Because the elementary the rudimentary is covered, and now it's just what that patient is stuck on or what's unique to their case that the care team can focus their care on. That's what personalized care is. And more than half of your colleagues have seen the benefit from engaged MD that way, so just reach out to any of them. Hey, guys, do you use EngagedMD in the people you want to fellowship with people that you see it ASRM? Hey, do you use EngagedMD? What do you think I hear Griff, talk about it. But he doesn't own a practice. What do you guys think, and see what they say. But if you want that free workflow assessment, you want to see what other practices are doing, you want those insights that EngagedMD has, and you want to see how your practice stacks against that ideal workflow, then you go to engage them the.com/griffin. And he mentioned that you heard them on the show, you mentioned that you heard them for me, and then you're gonna get that free workflow assessment. So ask somebody else, don't take my word for it, but go to engagedmd.com/griffin, or say you're on the show. So you heard from me, so you can get that free work assessment for you. That's one of the biggest system wins that you can have right off the bat. And you can verify that just by asking people you already know, I hope you enjoy the rest of this episode about things you need to know for the fertility business, you might start, I think there's there's a couple of different ways that you all can look at your careers, which is everybody talks about being an entrepreneur, like it's the greatest thing, it's not the greatest thing, there are advantages to it, one of the advantages is leveraging systems and capital so that you're not just trading time for money, and that so you potentially have the freedom to do a lot of other things. But it comes with a ton of risk, a ton of spotlight, a lot of obligation. And then another way of looking at your career is is you're a craftsman and and craftsmen can also have really great lives because they have a trade that is so in demand that they can call a lot of shots, then they don't have to have a whole system to they don't have to leverage a whole system. They can say this is what I charge like I'm this good at it. And make it seems a little bit more interested in I mean that you're still interested in the entrepreneurial route too. But but you're also open to this this craftsman, right? So what like, what is it that you also want to be able to do and advocacy is one of those things. So why is that important?

Dr. Megan Sax  48:44

Yeah, for me, it was really just being in medical school in Chicago, I did a lot of work with a program called the Midwest access project that did some elective termination training. We spent a lot of time at Planned Parenthood. And then coming to Ohio for residency was almost like a culture shock for women's health. But I will say in Cincinnati, it was really incredible place to do residency because it's, for those of you who don't know, the Ohio geography, it's on the river, and the other side is Kentucky. So it's really the first safe haven for most women seeking abortions from the south. So you got this incredible training at Planned Parenthood, which was five minutes from our hospital. And you just heard all of the stories saw incredible experiences and women going through just about everything to get there. And I can we have this Fetal Care Center and all these other you know, everything that you hear about in terms of fetal anomalies, medically indicated abortions. And so the dog's decision has just been tragic for the woman of Ohio. We overnight really went from 20 weeks, six days elective termination now down to six weeks. And like I said, this was the first is a place for a lot of the South to come to. And so I think not only do you have to Did it teach me coming here that you need to be familiar with the legislation in your state surrounding women's health, but you also have to be a fighter and you have to be vocal on behalf of your patients and share those stories with legislators, obviously, in a HIPAA compliant fashion. Because nobody else is going to speak the scientific truth if you don't. And so to me, you know, hearing Victoria mention this risk benefit and, and that I'm really thinking of it more from a perspective of, I want to be in a leadership position, I do want to make these decisions for my practice, whether I'm at an academic institution, but whether that's as a medical school clerkship director or fellowship program director, or division director, you know, to be in the room, where it happens, is definitely very important to me. But whether I take that risk financially to have that possible financial gain, I would say, you know, it's definitely very appealing and interesting, but I would be seeking, you know, consult from these two on that, as I typically do with with anything business oriented.

Dr. Victoria Jiang  51:15

I mean, for what it's worth, I think Meg is a great testament to the whole idea of finding that passion and learn, like feeling that spark for something and then chasing right after it like she has, we always say she's our advocacy queen, because she always has like, gonna sign this petition and like, we have this thing going on, like, oh, my gosh, we're trying to fly it in protests and do all these things. But I think that for me is like, that's the autonomy, right? It's like finding that passion, doing that passion, and then making something out of it. And I think that's the true spirit of entrepreneurship, right? It's like, finding something that you can have like a very specific niche and focus and being the best in that field and doing that. And I think if you bring those skills in that focus, then you can really like one of the biggest things I learned in fellowship is that you can't say yes to everything, and you shouldn't say yes to everything. And it's okay to not have your like eggs and every baskets, even though we like a lot of eggs hashtag. But it's like, you know, you can't say yes, everything, you can't do everything, you've got to focus what you're gonna do and market yourself from that perspective. And, you know, being partner for Meg, maybe being clerkship director or fellowship director, and that in and of itself would bring value and joy in that long, like career longevity. And I think for us, as at least for me, up to this point in training, it's been blinders on just clinical practice patients above everything, you know, you're in this hyper competitive academic environment is all about publishing papers. And then realizing and this last year doing research, there's so much more to the field that you can bring, that isn't necessarily the most traditional medical aspect, because the traditional medical aspect is becoming something so much more different than what it was 15 years ago, and being able to navigate that in stock to job search, but also like, life goal searching, I think, is been the most kind of interesting revelations, at least for me when thinking about that philosophical kind of partnership role, like what do you want out of your job? What do you want the freedom to be able to do?

Dr. Zoran Pavlovic  53:13

And other career I would say, the more the more philosophical, global aspect medicine, I think if you become complacent, right, medicine becomes run by someone or something else. And as physician burnout increases, I think a lot of that burnout comes from just us becoming complacent or being forced to be complacent. And so other people are making decisions for us. Other people are dictating our time, where we do anything from reimbursements to how much advocacy to do to what the laws are. And if we want to make medicine, you know, health care oriented, you know, physician and provider run system, we got to be a little bit less complacent at the least, that's what I feel like I want to be involved and that's what drives me. And I get the passion from that to be part of it. To help make it our own again, instead of just letting either businesses or politics or other other outside forces drive health care and medicine, if we can make any

Griffin Jones  54:09

change. Well, that can quickly become that can quickly become perverted, though candidate like corrupted that because like, it's like, then the business person really could just like the doctor can become the business person like and it's, it's, it's not immediately obvious where it's like, okay, that's the clinician, that's the business person over there. And, and especially when you can also as we see in marketing all the damn time, you can use ethics, you can even use or what's perceived as ethics to drive a marketing message. It reminds me of the Simpsons episode where Mr. Burns. He gets involved in recycling for some reason and like he's just using it to dry up the oceans or something and Lisa says, Eat you You're so evil and when you're trying not to be evil, you're even more evil. I saw this all over the place in business. Some of them the marketing messaging is, it is like just totally dishonored. It's perverse. And I don't think we're immune to that in the REI field. So I want to go down that rabbit hole, I want to ask you like, one other question, going back to the basket is Victoria talked about the basket, and maybe that will bring us back to this, of like, like this mission and message? Because I've asked you one question out of your 30 questions. And looking at this sheet, it's not just 30 questions, because each of them are like five quiz all like, all the things that we talked about were from one question, although we probably we did cover a lot that we covered what I wanted. But I want to ask you, well, there is another question that I'm glad you all put on here, which is do your do you see yourself in any role outside of medicine? So maybe that ties back to what we were talking about, like of keeping the mission Hall. And Meg was talking about advocacy. But that can really mean anything? Like what roles? It can mean anything? I mean, sitting on a board that has nothing to do with reproductive medicine? I could it could be not actually practicing medicine, but sitting on advisory forum for for a Silicon Valley company. What roles do you all see yourselves outside of medicine?

Dr. Victoria Jiang  56:30

Meg Sax for President 2036 Go.

Dr. Megan Sax  56:36

up right here. You got it.

Dr. Victoria Jiang  56:38

I'll be revised. I mean, all jokes aside, I guess for me, oh, gosh, I think that for me, I've always had this this is like totally. So like thinking totally outside of medicine, I've always wanted to learn how to bake like really fancy French pastries. So I feel like in the second life that I'll have, I'll probably go to like chef school and learn how to be like a patisserie, like person like pastry chef. And like the more realistic kind of like logical, field oriented way, I kind of imagined myself pivoting into more of a data science space, I think that one of the biggest untapped, you know, really untapped and truly understood like power of big datasets and clinical processing is going to be thoughtful developments of artificial intelligence and data processing, to be able to better diagnostics to be able to better die, like better, like genetic information processing. And I think it's going to be revolutionary towards the ability for us to have image processing. And so I imagined myself either doing my own kind of startup in that capacity, or potentially like joining a advisory board or serving in that capacity, kind of feeling how I can disrupt the field in a different way that is going to be bigger than me seeing patients myself, I think that is what I imagined my long term legacy to be and what I hope it to be because I think we have this one short life on the world, and I want to be able to make the biggest impact and get the most people pregnant as I can.

Dr. Zoran Pavlovic  58:06

Yeah, I agree with Victoria in the sense that there was a question on there that I think we pull it what do you think was the biggest things coming up in infertility and REO the next biggest innovation or what that and I think artificial intelligence and genetics are those two sectors that are really booming in our field, ai ai being closer to and like genetic engineering, all that being a little further away. But both of those are have such powerful capacities to make a lot of change in people's lives. But also, like you were saying, Griffin, there could be a double edged sword, you know, things different technologies may not be may be marketed as being great, but they may not actually be as great. Or we may be talking about when we get to the point of actually AI dictating care or genetics being able to be modified and embryo like what does that mean ethically? And I think there's these crazy ethical questions and business questions and medical questions that need answering. And I see myself as hopefully one day becoming knowledgeable enough and enough of an expert in my field, that someone would trust me to be part of a consulting group or a CMO of our company, or an advisory board or somebody people to sit down to help make these difficult decisions and have these difficult discussions. And I would like to train myself and gain my knowledge to get to that point one day, that would be really amazing, because I do feel like we have these epic situations and questions that we need to answer coming up. And if I can be a part of that and at least contribute in a positive way that I would look back at my life when I'm retired or just sitting on a beach somewhere in Bali, hopefully, like I did something, you know, beyond just like tutorial was saying, being in my clinic and taking care of patients, which is extremely important and the utmost importance of medicine, but that's how I would want to try to see if I can add to the field.

Griffin Jones  59:54

Yeah, I want to maybe just remark on that because it's amazing how It subspecialist physicians you're so you're so educated, you're so trained, you're so freakin smart. And, and, and truly are exceptional in many extra ordinary in many senses. And then in other senses, it's like, just as human as everybody else. And it's amazing. When I'm in a room of a very eyes, it's, it's a natural human tendency that likely comes from evolutionary biology that when you see someone getting more, you really want more, and because so much is coming into our field right now. It's, it's, it's very easy for me to say like, I want that, and I would just caution people a little bit yet you've worked really hard, where you're gonna be okay, no matter what you do, you're gonna, you're gonna be all right. Remember that the vast majority of human life up to this point throughout history, and even in great many parts of the world today is extreme poverty. And, and even by the standards of our country, you're going to be you're going to be doing well, no matter what. So I think it's just something to keep in in mind. As for all the the, for all the artists was for all of us, that it is our tendency to look at people and be like, they gave him what he's getting what for being on that board. He sold his practice for what? And it's like, you know, focus on some of the other things as well. And maybe you compare yourself to your ancestors, as opposed to the other colleague all of the time. I know, and just your competitive rate, especially REIs. So you're going to do it some of the time. But

Dr. Megan Sax  1:01:48

Matt, towards our patients for a second, too. Yeah. Yeah. I mean, you're so right. I think, unfortunately, that is kind of the human nature. But we feel that for our patients, too. And I know I've talked to these two about it. And one of the most frustrating things about our field is the accessibility and really lack thereof for such a huge proportion of the population. And I mentioned earlier onco fertility, huge passion of mine, as well as just fertility preservation for transgender population among other kind of medically induced infertility. Right. eugenic infertility. And so I mean, to kind of swing together the two questions of what's your passion outside of your clinical practice? And Zoran bringing in the where's this field going in the next decade or so I would say increasing access, I'm gonna make it back to advocacy for a second just say, you know, currently, we have 12 states that have fertility preservation laws, or in other words, mandating insurance coverage for that I intragenic. Infertility. And to me, this is this is not enough. And I can tell you, Ohio is not one of them. But, you know, we're seeing the state mandates increase now with 20 states, and we're seeing IVF coverage in 14 of those states. And I think that's going to go up. And I think in the next decade or two, maybe even sooner, we'll see a much larger patient population, I think that's part of the reason why they're coming for the REI fellows earlier in earlier is anticipating this huge increase, but I know the three of us will, will be fighting for our patients and increasing that accessibility and, and that's going to be hopefully part of something that I do outside of my clinical practice,

Dr. Victoria Jiang  1:03:35

I think that's really important to always like think of is that as you accumulate more resources, you also get to be the person who delegates the utilization of those resources. And I think what's what, you know, Meg was really thoughtful about kind of touching upon is even being able to practice right now, as a fellow in a mandated state, you know, even the state mandates aren't perfect, and there's a lot of insurance hoops, you have to jump through each case, you're you're spending a lot of time with patient, you know, authorizations and pieces like that. And so there's a lot of work to be done in the field that, you know, disrupting the field isn't just like, you know, the big bucks and making millions of dollars, it's like, allowing, it's like starting a genetics company and allowing people to have cheaper, more affordable carrier screening, so that they can actually know what carrier screening is, and being able to offer that at a price point that they can afford, instead of $1,000 a panel, it's increasing access to patients who otherwise would be afflicted with genetic diseases and offering genetic testing from that capacity and like being able to really utilize the resources information in the best, most thoughtful way. And I think that, you know, any physician that I have ever met always, you know, is thinking, what about my patient? How can I get the best care for this person? How can I get around these hurdles? And I think that that's something that uniquely positions, you know, physicians to be leaders and ethical development of the fields because we're always having that patient in mind and that may not necessarily be as easy to see, for, you know, politicians. I know, it's been a huge challenge with being able to bridge that gap of politicians being able to see like, what does it actually mean to have a six week abortion ban? And how is that going to actually impact the patients that you're seeing on a daily basis. And so I think having a bigger voice, and being able to be at that position is going to be hard work, you know, it's going to be seeing 1000s of patients and having good reporting good outcomes and doing the best for them. Because at the end of the day, that's what we do. We are craftsman, a craftsman with an idea for bigger.

Dr. Zoran Pavlovic  1:05:33

It's our job to kind of sift through all these things to these different technologies. You know, you go to ASRM every year and there's all these new booths or this brand new technology coming out. But how much of it is actually helping patients? How much is more marketing and a marketing gimmick? And what does it actually mean? And sometimes it's years of using that device or that idea before people are looking at the outcomes and say, this actually didn't help anybody. And so that's where we need physicians that are patient, mind and patient focus to be there at these advisory boards at these tables and to discuss these things to see what will actually be beneficial, what won't be beneficial, what is the research back what's evidence base, what might not be evidence based, but we don't have any other treatments for it. So maybe we should go down that avenue, and be able to make those decisions for patients so they get the best possible care and the best possible access is big in Victoria, we're staying.

Dr. Victoria Jiang  1:06:20

Clearly I've been doing these conferences wrong, I thought the best technologies were the ones that gave out the best sperm pens,

Griffin Jones  1:06:26

are getting the swag is something to be said for that. Well, one of the things I say frequently is that it's hard to provide, it's hard to to have a valuable business mean, it is hard to have something so valuable, that it is worth getting more money than then what you're what you're giving away, it's so hard to be able to do are you meaning actually, the opposite, I think I'm trying to say is that you have to give away so much value that it's it's worth more than the money being received for it. And in order to to actually like deliver something so high in value, all of the systems and people that need to be it's hard to do. And, and I take that obligation so seriously, as a business owner that when we're not doing our best, as a firm, we're just taking people's money, we're just I hear I say they all say they're going to add to the pie, but we just feel like, they're they're just taking away a piece of our pie. And when you fail a business, that's what you're doing, you're just taking away a piece of the pie. When you succeed a business you are adding to the pie. And it's so much harder to do than to say. But I want to conclude with let's just say each of you have interviewed at this point, each of you are talking to people, names, specifics. And I know you're not going to give those but give us some insights or just what are you paying attention to like as you're we've talked about the like what's important to you, but I'm talking about when you're interviewing with people, like what are the impressions that you're getting from interactions? What is it that you're paying attention to? Let's conclude with that? Dr. Sachs? We'll start with you.

Dr. Megan Sax  1:08:10

Sure, I think something that has really stood out to me and kind of gives you that that nice feeling like oh, wow, this could be a really good fit, is when they say we want to make sure that this is where you're going to be happy. You know, when you start to get into well, which clinics would it be? Or which you know, other kinds of details? Like Zoran would say, really that importance of the details. They'd say, you know, this is we want you to be happy. And that really stood out because I feel like as as a resident as a fellow, maybe it was more like No, no, I want you to want me What can I do? And it's really nice to kind of have this table flipped this time. And I think it feels a lot more comfortable than those kinds of stage we did. We were the first rate I think we were the first COVID interviews for fellowships. And we were so used to the zooms on zooms and those kind of, you know which answer which story am I am I tell him for this question, which just feels silly after a while. But these interviews, it's like, Who do I want to be my partner? This could be for 2030 years. So I think that's important. And I did also want to include that. I don't want any fellows out there feeling like Why haven't I heard anything yet? I think the three of us have, you know, gone to conferences,

Griffin Jones  1:09:28

I'd be thinking that I would think of that. You're gonna suck you suck if nobody's called. Nobody's college by the end of the second is something to be said for that make which is Be active. The more active you are, the more opportunities you have. And that isn't just there. It's not just for fellows to i, there's been a couple of people that I know are trying to hire fellows, and I've invited them on this show. And, and there's like they just don't It's like this, this fellows are listening to the show you're trying to I'm giving you free advertising to talk about whatever. I, the people that are really good at recruiting fellows, I'll just make up I don't want to say any doctor. So I'll just make one up Dr. Angeline. bolsos is so good at recruiting fella is because she's all over the place. And she's super generous. And, and there are other people like that. And it's tougher for some of the smaller people to do that. But the more active they can be, the more likely they are to be able to be connected with people like you. And and the same thing is true for you guys that opportunity begets opportunity. You are active at Mrs. Ai, you ended up on this show that's going to result in a couple of phone call or an email from somebody here there. Yeah, it was you met somebody from the armed group, which is going to lead to another opportunity. So no, I wouldn't be a little concerned. Like if you haven't gotten a call. Maybe I should start being a little bit more active.

Dr. Victoria Jiang  1:10:59

I will say I think a lot of people wait until ASRM of their second year. And I think that's a really great touchdown point for a lot of people because it's really easy to connect with people. So if any fellows out there I knew for me, like thinking of ASRM as like kind of a deadline or kind of like a touch base point of like putting out feelers and networking, I think was a good place to start. And I definitely think that we're really early in kind of looking at the field. But soon, you know, time flies, and you're going to be graduating sooner than we I mean, hopefully,

Griffin Jones  1:11:33

you're early and this is the least busy time of your lives for the at least the five years on either side of it. Right? Like you were busy as hell and residency and yeah, this is a brief window, you're gonna be busy as hell again. And so yeah, it's not like you're it's not like you're behind the eight ball if you are if you haven't talked to anybody by by second year, but but the more you put yourself out there, the more opportunities you get. There's one: What are you paying attention to?

Dr. Zoran Pavlovic  1:12:05

Yeah, pay attention again, but big for me is culture, how the different partners talk to you know, interact with one another, how they say the practice runs together, how they say the console. It's a big deal for me, when I talk to someone at the actual practice, and they say things like, Oh, I'm gonna have an issue, I just walked down the hall and my partner, I call this person or if I have a tough surgical case, this person is there to help and backing me up just just shows me that strong culture of collegiality and togetherness and collaboration, which collaboration is a big word for me, Megan will here has heard me say it a million times. And back when we met in the NIH, that's like all we did was collaborate on a bunch of things, and now Victorian and also doing some stuff. So that's that collaborative togetherness environment is big for me, because I think as a team of physicians, we can do so much more as a team of physicians and of course, other practice providers together, we can do so much more than an individual. And so it's important for me to be part of a great team. And so I pay attention to that team environment, how are they within one another? How did it happen? How does the practice run together? How cohesive are they to help each other out? And I get that from actually having personal conversations, not just from the interview? But I'll find people at the practice and email say, Hey, do you have time for a phone call half an hour here? Half an hour there and just speak to me one on one so that I can get them one on one? And really hear from them? What they think, what are their thoughts? What are some of the pros, what are some of the cons and that goes back to what you said Griffin about being active. If I had advice for residents, incoming fellows, new fellows or current fellows, now it's that don't be afraid to just kind of put yourself out there to network to have conversations with everybody around you even even if you're introverted, which may be harder to do that. Just put yourself out there, we have such a great field of so many people that want to help and there'll be excited if you're excited about the field and passionate. So walk up to that person after the presentation or go to the poster presentations or when some guy that you recognize from podcast walks up to you to pull up PCRs, you know, talk to that person. I think that was huge. When I met you for the first time, I was like, wait, I know your podcast. And that's our first conversation started, but just be active in those conversations, because that will continuously lead to more and more connections and doors and situations. And we can help each other that way. I mean, that's what makes them united. She asked me for some help with connections in Chicago people that I did research with, and I was just like, yes, let me text that person right now about you how awesome you are. And that's how it worked out. And so keep having those conversations and just be active. We're here to help.

Griffin Jones  1:14:33

Victoria, did I ask you what you're paying attention to or to interrupt you with calling people losers?

Dr. Victoria Jiang  1:14:39

Maybe a little bit of both. I will say the things that I'm looking out for definitely the same layer of collegiality. I definitely want to be practicing with people that I just love working with. But I think for me, it's going to be the little details of clinical care that I think are going to be the make or break it or you know, I want to be in like a medium sized practice. I don't want to be by myself. I want to have a little bit of mentorship. I don't want to be driving to 55 Different satellite clinics, you know. And I think what's really important for me is Journal Club and team review and being able to like lean on my practice partners to learn and get better. Because I think the great thing is, is that you're going to pull together people that have been trained in all different places in different times. And I think that you can learn a lot and make your practice like your own. And I think for me staying ahead on the literature on the new findings, the new technology is going to be something that's going to be more challenging as we get into the nitty gritty and I want to be in a like environment that pushes me forward and allows me for like professional development in whatever capacity that they may mean and being able to be around the right people to do that. And be able to have good mentors in that capacity I think is going to be what's the most important

Griffin Jones  1:15:52

if you go to Montana or Wyoming you're absolutely driving to six different satellite your your driving hours to go to the gym. Doctors Jiang Pavlovic, Sachs, Megan, zone, Victoria in reverse order. Thank you so much for coming on inside reproductive health. It's been a pleasure talking with you all. Yeah, thanks so much.

1:16:16

You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society. Visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health

150 EngagedMD’s Prescription For Reducing Fertility Center Pain Points, Featuring Co-Founder Jeff Issner

In this sponsored episode, Griffin Jones and co-founder of EngagedMD Jeff Issner discuss the unique ways the company provides added value for practice owners, employees, and their patients. How informed is your informed consent? Does your practice unknowingly carry added risk? EngagedMD’s education and informed consent solutions help to increase provable informed consent, reduce practice risk, increase and personalize provider-to-patient face time, increase patient education, save time, add to practices’ bottom lines, and ultimately increase access to care.

Tune in to hear:

  •  Jeff and Griffin discuss ever-present nurse burnout, and what EngagedMD does to take some of the weight off of nurses’ shoulders.

  • Griffin question how EngagedMD’s program roll-out can be successful with varying practice size and demographics.

  • Griffin question how business advantage and patient standard of care can both be bolstered by partnering with EngagedMD.

  • Staggering statistics on the EngagedMD analysis of ROI on just a two-practitioner clinic, and how these results increase patient access to care.

Jeff’s information:

LinkedIn profile: https://www.linkedin.com/in/jeff-issner-0620a912/

Website:  https://engaged-md.com/

Facebook: https://www.facebook.com/engagedmd


Jeff Issner  00:04

If somebody blindly signs off on something, and then an issue happens, if you can't demonstrate that the informed part of informed consent occurred, it's not helpful. It's not very valid. So all of these things are, of course, litigated through the courts. And but it's very clear that just signing a piece of paper is not informed consent, you need to ensure that patients are informed and actually understand before consenting, fertility, nursing, burnout, Rei, productivity, fertility, patient satisfaction, the standard of care, revenue, these are just a couple of things that I talked about with my guest, Jeff Fisher, he's the co founder of  EngagedMD, and you've heard of them, because they're a sponsor of this show. And you've heard of them. This happens, all fertility clinics in North America are using them. And you've heard of them, because so many people have come on the show and at conferences and other places and been talking about how amazing they are. It is a sponsored episode. And so you'll hear me sing their praises, because I legitimately don't. I don't have anything to counter with, it's been the most lopsidedly Positive reported company that I know of, in the fertility field. And

Griffin Jones  01:14

but I still tried to make it more about things than EngagedMD in the scene. So that's what Jeff talks about. On the show, he talks about areas of nursing burnout, and what clinics are doing to solve that. He talks about areas where physician productivity is limiting or, or the hindrances to it are limiting access to care what they did to improve access to care, we talked about what the bridge is between business, like a business advantage versus now is integral for the patient experience and for the standard of care that patients receive. And we talk about the risk that practices face in informed consents, and the hindrances, that that can lead to people moving on to treatment and practices being liable. So all of these things we cover in this episode today. And if you want to engage MD to take a look at your workflows, if the examples that Jeff talks about in this episode are interesting to you, he is somebody who will look at your work and they'll do a free assessment. If you go to engage them d.com/grip. And they'll do that assessment for you for free. They'll point some of these things out to you. It's a free eye opener for you from a third party that works with more than 200 fertility clinics. And if for no other reason, it is nice to say that you heard about them on the show that you heard about them from me, because that helps us create more free content for you. So I really enjoyed this conversation with Jeff, I liked hearing about what  EngagedMD is going to do next. And the case studies that Jeff refers to and the problems that clinics are facing, I think will be of interest to you too. So please enjoy this episode with Jeff Isner, co-founder of engaging Mr. Listener. Jeff, Welcome back to Inside reproductive health. Yeah, thanks, Griff. Glad to be here. You're the first person to ever do a sponsored episode of  EngagedMD and I get a lot of messages from companies, what can we sponsor the show? Can we be a sponsor? And I'm gonna work it out, you know, we're gonna work out inside reproductive health, eventually to where I would say eventually, because I'm still working on this, you know, fertility bridge Client Services stuff. But inside reproductive health is getting big enough to the point where we can start to work out things that aren't an endorsement, but because right now, it's been the podcast, it's been my voice. It's almost like there's no way there hasn't been a way for me to do a sponsorship, that isn't an endorsement. And I have to be really careful about what that is, like when people say, You're a shill for this company or a show for that. It's like, the only sponsor that I have is EngagedMD and I tell all of you that and it's because I've known Jeff and Taylor since 2015. And more than half of our clients have used it and all of the things that people tell me about EnagedMD so I've only even had the sponsorship conversation like the opportunity to be a sponsor with like three companies. And ultimately, so far you are only the only one there was a good fit for at this like endorsement type level. And it is because you hear me on the show Jeff puts out a challenge every week where I'm like, Okay, if if you're the person that's gonna tell me the for There's a bad thing about EngagedMD, send me the email. I'm not saying the email will never come. I suspect that one day it has to write like one day it has to come where somebody's like EngagedMD do. No one ever has no one ever has up to this point. It's all been like glowing reviews. And so I just like for the three people that are living under a rock, what is the  EngagedMD from the owners perspective? And what's the value that you sought to bring in the marketplace to begin with? 

Jeff Issner  05:31

Sure, sure. First of all, thanks again, for having me. We appreciate what you do, in terms of the podcasts and all this amazing information that you share with this community. And we're not perfect, enga EgagedMD is not perfect, but we work really hard to create amazing experiences for our users and ultimately for patients. 

Griffin Jones  05:47


Jeff Issner  05:48

So to answer your question, now, the way I like to explain engaged MD is through the story of how we actually got started. And about in 2015, when we met, our medical director really felt this problem day in and day out and his practice. And he was explaining the same things over and over and over and over again to patients and their partners. And making sure people understood what the process looks like for fertility, treatment, the risks, the alternatives, and medications, all these really important things that patients need to understand in order to make good informed decisions. And he realized, well, I'm repeating myself over and over again, and I'm probably only covering maybe 60, or 70%, of what I ideally like to and I've got all these kind of external factors that are pressuring what I can cover, whether it's the time I have for the appointments, or what else is going on in my life, or in my day. And he realized, well, I'm doing it this way. And every provider in my clinic is doing it a little bit differently. And ultimately, the patients are on the other side of my desk trying to just drink from the fire hose and absorb all of this very complex medical information for the first time. And so when patients go home, they try and remember everything that they had just been told, whether it be from their doctor or their nurse, or medical assistants or any other staff, it's too much. It's just too much. It's a ton of information that we're jamming into these appointments. And so they go online, they look for answers, they end up calling their nurses and their medical teams to try and get those answers. The nurses are picking up the brunt of this. They're doing IVF classes, med teach classes, really trying to fill in the gaps again, so that patients can make those good informed decisions. And they make those decisions historically on pen and paper. So documents are being printed, they're being given to patients, they've got to take them home, they're getting notarized, they're getting filled out incorrectly, and they're getting lost before, hopefully they get scanned back. And so we looked at this problem and said, Wow, it's so much time and energy that everybody is putting into this. And it's a suboptimal patient experience, clinic experience. There are all sorts of risks that are introduced. And so there's just got to be a better way to go about what we viewed originally as just informed consent, making sure that people are educated and consent to the right things in the way that aligns with their behaviors and what they want to do with their treatment and their goals. So we EnagedMD. And that was kind of the impetus for the platform and the company. And we have two primary product lines. The first one is Elon, so a library of educational modules that we've developed, that cover everything from COVID-19 protocols and fertility one on one, all the way through all the different types of treatment that patients may be pursuing, through the very end of the patient journey, what to do with extra gametes or embryos that you may have that OurCrowd preserved that. And these modules can be pushed to patients so that they can watch this content on their own time. They can rewatch it as many times as they want answer questions, demonstrating that they actually understood everything and then come back into their next appointment, and have a much more effective, much more efficient discussion with their medical team that's focused on the nuances of their care. Let's talk a little bit about that informed consent part for a little bit. Because anytime you talk about informed consent, you have to say, I'm not a lawyer, talk to a lawyer, get legal advice. Don't get it from me, because I'm not giving it to you because I'm not qualified to give it to you. But when I ask attorneys in our field, and

Griffin Jones  09:18

I'm chairing this session that you're actually speaking at SRM and I asked people about like, just like, what's the standard for informed consent? They'll just engage them D A N, like, What do you mean by and so what do they mean by that?

Jeff Issner  09:36

 Yeah, well, ultimately, it's a non delegable duty for the provider to provide informed consent and it's making sure that patients understand everything that they need to know all of the process the risks, the alternatives, in order to and also they comprehend everything, not just or being told everything but they actually understand everything that they need to know in order to make a good decision a shared this vision with their medical team about their care.

Griffin Jones  10:03

So I didn't really think of it in this way until I was on one of Dr. Katz's webinars and the viewer, you may have also been speaking on it. And and, and this may have been in the beginning of the pandemic, when people like the people that hadn't figured it out already kind of like had to figure out their the E signature, and people were asking about informed consent. And it and Dr. Katz said, What what's, what's greater evidence of informed consent, a stack of papers, that it's that like, there's a signature and at the end, and a couple initials throughout that, like 10 point font of language that people have never heard before, or a series of videos where they have to sign off at where they have to complete each module where they have to take a quiz, demonstrating that they that they did and then a a trackable digital signature at the end. So Ken, like you talk about that level of informed consent.

Jeff Issner  11:16

Yeah. And it's the way that you're talking about it. It's kind of how we break up our product lines, I've always related the informed part to our elearning product line and the consent part to our esign product line. But consenting is much more than just signatures on paper, if somebody blindly signs off on something, and then an issue happens, if you can't demonstrate that the informed part of informed consent occurred, it's not helpful, it's not very valid. So all of these things are, of course, litigated through the courts. And but it's very clear that just signing a piece of paper is not informed consent, you need to ensure that patients are informed and actually understand before consenting,

Griffin Jones  11:55

and it's pretty easy to me, it happens a lot you can ask your turn, how often is somebody able to argue that they weren't informed and in cuts out just went through, you know, just got married not too long ago, and then, you know, talking about just family law and in figuring things out like that, and, and they don't even let people do pretty, you know, they don't even honor prenups that are within like, oh, let's say a week or two, because or I should say many courts, many courts will not honor that prenup set or within like a week or two because it's like, well, it can't really be informed consent, many courts will throw out prenups that don't have where the other person isn't represented by counsel. Many courts will throw out them where they were represented by counsel, but there isn't the documentation that they were properly informed. I think that's how Eduardo Saverne successfully sued Facebook to get back his stake. And that, I think it is because he signed everything. But he said that he wasn't properly informed. And I think he won't, and that's why his name is back on the Facebook mass that is co founder. So is that like,

Jeff Issner  13:09

it's all of these components. And Dr. Letteri from Seattle reproductive, wrote a great paper a few years back about the primary components of various litigation that has occurred over a certain period. And even if informed consent, isn't the primary reason for the case, is very often a supporting issue around the case

Griffin Jones  13:29

that it was that Was that intentional from the beginning? Or was that just kind of like a happy byproduct? Like originally, you're trying to inform patients to help with client workflow or just help with clinic workflow to help with the patient experience so that they're better informed? And oh, yeah, well, we'll include the e-signing. At the end was, was it a byproduct of this being used for informed consent in this way? Or like, like, which came first? Was it the patient experience focus, kind of workflow experience? Or was it the informed consent?

Jeff Issner  14:09

Yeah, so it was very purposeful about informed consent at the beginning. But that's not our primary value proposition anymore in terms of how we talk about the product. So when we originally developed EngagedMD, we started with the elearning modules, and really started with IVF and IUI. And it was all about ensuring that every single time people were consistently and comprehensively informed and understood what they were just being informed about. And we realized we had that informed part. And we needed the, what I'm calling the consent part, the digital signing part. So we built out our esign engine that helps digitize all of the consenting signature workflows. And it was only once we really started getting traction in the market. And one of our primary demos is to listen really closely to our customers to determine what we develop next. And what we're hearing is informed consent is super important. This is great. It's very helpful. Bye To the real benefits that we try and the real problems that we try and create benefits around our saving time, improving patient experience, reducing risk where we can, and going paperless. So it was only after we launched it, we realized, wow, this is much bigger than we originally thought. It's not just legal informed consent. This is creating these other benefits that are much bigger than what we had originally intended.

Griffin Jones  15:23

I want to talk about that, because I saw the benefit immediately, like as soon as I figured out what you guys did, and it probably took me a little bit to be fair that I probably don't know what half of the people in ASM do. But it didn't take me too long. Like as soon as I met you guys, and we talked and I was probably 2015. And I thought, Oh, these guys are nice. I kind of, you know, I have an idea of what they're doing. But it wasn't probably until I started people, I started hearing people say, this is what we're using. This is how we're using it. I'm like, oh, light bulb, I need to pay attention to what this is. And very early on, I saw the I saw the value and but I could also see what the potential objection would be. And I could almost immediately also know how to address that objection. And that objection was, well, you know, people expect personal care from us, they want to be able to talk to a nurse, and they want to be able to talk to a provider and you know, they're paying all this money for care, they shouldn't be at home and, and watch a video and and I just immediately thought like, yeah, they're paying all this money for care. And is this stressful to go through this process? They shouldn't, they shouldn't get the least amount of value out of their time with you that they can, they should be getting the most amount of value with you that they possibly can. And if they can only remember 30% of what you told them. If they're asking you questions that are completely generalized questions as opposed to specific to their case, then that is not the highest amount of value. So did you all have to work on that positioning it for? How do you help clinics position it the right way.

Jeff Issner  17:20

And it was my biggest concern, when we launched to, quite honestly, was this just going to be homework for patients when they're paying 10s of 1000s of dollars for care, and a few things to know. One is what you call about, we are trying to make that in person time more valuable, so that patients can come in with that baseline knowledge and actually have a good interaction. That's two ways that really focus to their personalized care, not the basics of how the menstrual cycle works. And what stimulation is, we want to focus on your specific issue when we've got that really valuable in time, that time together in person. So that's kind of like the core reason why this improves those interactions is you're giving that baseline info at home. But we study this obsessively. We are extremely data oriented at our company. And we measure every single step along the way, both from the patient experience and the clinical experience where I'm just wrapping up a case study right now with Seattle reproductive medicine. And this aligns with the rest of our data points where we surveyed patients and clinics but 98% of patients that the videos were helpful addition to their consultations with their medical team, and 89% agreed or strongly agreed that engage them D actually made them more satisfied with their care. So we've got to meet patients where they are, I know personally and patients who would agree based on our survey results, that people want to do things on their own time at their convenience, and they want to use that time together with their care team as effectively as possible.

Griffin Jones  18:55

That's, that's, that's huge buddy. If anybody had a nine or a close to a 10 on a net promoter score, that would be through the roof, you know, almost almost unheard of, and and SRM is not a little practice. I don't know how many Doc's they're up to now at least 12. Maybe they might even have more than that at this point. They at least two abs and they're really great group that serves a diverse patient population from all over the Northwest. So to have something like to have people say that I'm jealous of you. And and if I can go on a little tangent of why I'm jealous as a business owner of  EngagedMD. I was watching I was on LinkedIn and one of my favorite marketers was talking about he was making fun of a lot of b2b marketing companies and he was saying we make blank easy. And he's and then he's like this is this is the value prop that most b2b marketers put forth, he's like, how about you just take blank off my plate entirely. And there's so much that you guys are able to take off the plate that as a client services firm, it's like I am always trying to develop to develop further develop what we can take off people's plate, but you guys just you take off so much of people's plate that they can actually provide that level of care that the patient needs.

Jeff Issner  20:29

Yeah, we're, again, we're obsessive about the data. But we're really, really obsessive about listening to our market and listening to our customers. And every single new interaction that we have with a fertility clinic, we start with a needs analysis, we really want to listen, what is your current workflow? What is the current patient journey? Where are you spending time that is manual redundant, that you don't need to be spending so that you can operate at the top of your license. So we're just absolutely obsessive about finding those pain points and helping support clinics to get better about them and to improve on upon them, whether it's using engaging DEA or not, but we're trying to develop all of our products around those issues that we hear directly from our market and our customer base,

Griffin Jones  21:13

I want to talk about those pain points, because they're not getting less painful. There's a lot of things that people could or, or more might do to improve their business that would be beneficial for their best business. But it's not necessarily. It's not painful enough. It's the adage of the old man on the porch with the dog and the motorist stops by and he's visiting the old man. And while he's having the conversation with the old man, that dog keeps whining. And finally, he asks the old man, what what is he whining about? And the old man says he's sitting on a tech, is it? Why doesn't he just get out? Why isn't it quiet? Why isn't he get up, and he has heard some bad enough to whine it doesn't hurt him bad enough to get on. And, and, and in your space? I think that there's it with the pain that your company is addressing. There's a lot where it's the point where the dog has to get up and maybe even, you know, prior to two years ago, maybe they could have sat on the tack longer. But nurses are so burnt out and embryologists are burnt out if people can't get enough staff, but you can't get an even get enough people to answer the phone. And so you need to make what you have with people, the time that you have with people as productive as possible. So we've talked about a couple of these problems, like I want to talk about the nurse time savings. I know, like there's examples of people everywhere, but they just talked to me about you know, what nurses, you know, like the time savings, and and yet, otherwise having to deal with appointments, that has been a pain for them and and how you've helped to solve that.

Jeff Issner  23:01

Yeah, to your point, the pandemic definitely accelerated a lot of these problems. And the the nursing shortage that we're facing right now is certainly exacerbating the issues that we're trying to help support. So I think it's it's pretty well agreed upon that nurses take on a huge brands of patient education and patient support throughout the entire patient journey. And that forms in IVF consults or IUI costs, whatever treatment starts before that, honestly, even through diagnostic testing, and talking through all the different things that you may want to consider prior to starting treatment and determining your treatment plan. And then throughout treatment, as well. As you're getting ready, you've got your Med teach. So I think that's a great example of an area where we heard that things we actually partnered with SNP pharmacy on this. Together, we heard that this issue of really non personalized injection, teach classes where everyone is coming in sometimes one on one, spending an hour with a nurse learning how to inject themselves through with all these different types of medications. And you've got to go home and you've got you know, videos that you can find on YouTube that you can try and search down that aren't particular to how your clinic does it or particular to your plan. So we built med ready together, which is a very personalized approach to injection training. So together with SMP, we built all this content, it's all done through motion graphics so that we can keep it up to date. And we can keep on modifying it and customizing it so that it makes sense for the clinic's protocols and their approach and how they use their medications. And when you assign these modules, you're assigning a module that is specific to the medications that the patient will be using. And this really engaging 3d Motion Graphics manners, that patients can go back and watch it over and over again, and not only understand how to use the medications, but understand why they're using each medication as it relates to the protocol. So I'll use an example from our friends at RTI, Ohio. and they were having 45 to an hour minute or 45 to 60 minute long consultations with patients just for injection training, and those were with every single patient and couple. And they adopted our med Ready program. And you know, I think, as most people are a little bit hesitant to reduce the time with patients, but they realize that this was actually able to completely replace their injection training classes for the majority of their patients. So the patients who didn't need that extra time, again, very specific questions about their injections, the majority of things are answered through the module. So they're saving four to five hours per day of nursing time by just using one of our module components. So you can apply that kind of math and apply that logic to all these different stages where you have the redundant conversation happening again and again. So that you're focusing keep on saying this nursing time, physician time, and that's provider time, they're operating at the top of their license really focused on the personalized issues, not the general things that can be repeated through a video series.

Griffin Jones  26:05

I'm just picturing the nursing managers that listen to this show here that like four to five hours per day of nursing time. And if they're one of the few clinics that aren't working with engagement, busting into the practice owners door right now with their iPhone in their hand playing this piece of the podcast, we get what for? And a lot of people can think that are listening, but what would you do if you had four to five hours of nursing time? Back like, you know what, that four to five hours is being wasted on right now that you're not getting to where your where your nurses are burnt out where they're where they're saving calls for the next day, because they just can't get to any more else, they're never going to leave the office, and then the patient's pissed off about that, because they aren't getting the answer back that day that they they were hoping to because the nurse is answering some other question or doing something else. So I think that's it. I think that's incredibly useful, no matter what employment market we're in. But especially with people being so short on nurses, it's just like a necessity now.

Jeff Issner  27:22

Yeah. And you know, you're looking at that. And so we're, we're starting with this kind of base level, ensuring comprehensive, consistent education occurs. And then it builds on that and you're actually improving the patient experience and the clinical the nursing provider experience. But when you start taking that problem a level higher, from a business perspective, you have more time to see more patients. So ultimately, you're generating more revenue, you're helping more patients access better care, and you're able to generate more revenue as a business. So it's really a win win win. And that those layers of value proposition continue to build on each other.

Griffin Jones  28:00

Let's talk about maybe the consent side, too. And at some point, I want to talk about of just like, of like how this impacts of weightless or rather what you can do during long wait periods, because that I would say the average is eight weeks now and some are 1216. And so but let's talk about consent for a little bit like what of the the issues been for clinics pre gauge MD? What are they struggling with?

Jeff Issner  28:37

Yeah, so it goes back to just the issues of paper. And, you know, it's 2022, and things have gone completely digital. But in the fertility world, this paper is really important, you've got to make sure that the right person is signing the right thing at the right time, you're authentic, getting all of that in song, the right workflows. And with paper, you're not really fully sure what's going on outside of the office. So you give people this information, they have to read it. It's an incredibly complex medical legal format, they've got to make their decisions on it. Oftentimes, they need to go to a notary to get that authentication done. And then they have to bring it back in or ship it back in or scan it back in. And if anything goes wrong along the way, you got to redo that whole process, right. So if somebody fills out the wrong thing or signs in the wrong place, notaries aren't trained to fertility treatment and what people should be doing with their decisions. You've got to go back and do that whole process again. And then if it comes back and you actually do collect it correctly, it's got to get back into the medical record so it can get lost, they can get caught up on a doctor's desk or somebody's desk, ultimately needs to get scanned and to have that proof that you've got the official informed consent. And so there's a lot of costs and a lot of time and a lot of again, suboptimal experiences in corporate added in that workflow. So with our esign engine, we're really just trying to make sure that all of that can be handled through your inbox. So you can digitize all of your documents we'll work through with our customers, for anything, not just consent, anything from patient intake through financial documents to test requisition forms, we have the ability to create those workflows digitally. Ensure you can track all the education and all the documentation in one place. So things are never getting lost. They're following these digital workflows that make it really hard to choose the wrong thing or to make errors on the consent, you're never going to miss a signature and nobody's ever going to get skipped in the signature process. And you can always go back to engage them data, see that digital copy are never going to be searching for the paper version that might have gotten shuffled somewhere.

Griffin Jones  30:48

Which that in and of itself of how long that can take people and like the anxiety when you can't find it because it is in that one file that it's supposed to be in. Yeah, it's just amazing how people use paper for for anything, at this point,

Jeff Issner  31:07

nothing worse than somebody getting ready to start their cycle or even worse, somebody's getting ready for retrieval and say, Oh, no. Where's that consent? That's the that anxiety that we're trying to completely eliminate?

Griffin Jones  31:20

Well, it was. It's funny, you should say that, because when I did my talk at PCRs, it was originally supposed to be about like, like bizdev. And then they gave me the talk to the nurses, the nursing track, they gave me the the last talk of the of the week, it was like the 11am Saturday talk. And he gave it to it was to the nurses. I was like, great, like the people who couldn't give two craps about business development. And this is what I do. So how am I going to make my talk relevant to them. And it was it had to do with branding, it had to do with creative and I had to tailor it to how to get patients to want to engage with your practices, processes. And I was just asking nurses ahead of time. Like, like, what's the biggest thing that when you tell like, you could tell patients 100 times, but you still feel like you're struggling with this problem with them. And consent was at the top of the list, like having their consents ready having their paperwork done ready to go before it started protocol?

Jeff Issner  32:30

Yeah, it's, um, nobody likes paperwork, right? I think we can say unanimously, nobody likes chasing down paperwork. But it's critical. It's really important. And so what we're trying to do is build that into the workflow, throw that in as part of, you know, these engaging videos that you're watching, tie it into a bigger part of the journey, make it digital, make it engaging, exciting, make it so that people want to do it, at least more than they would want to do it. If it was just trying to go find a notary and sign some things on paper.

Griffin Jones  32:59

You guys are right at this junction point of something that I've wrestled with since I've been in the field, which is I could just tell it like that eventually, something that might be a business plus, it first, eventually becomes part of the standard of care or elevating the standard of care. And, you know, 10 years ago, probably having a digital module would have been a business plus, it would have been Yeah, a nice little advantage to have. But now, it's like, man, you're dealing with the biggest stress in your life as a patient and a top five, and you're usually spending a lot of money. And you're, you're doing this all at a time when you like, you have to keep track of all these different things that add all this different times. And you guys are kind of like almost a little. I'm not saying the same way. But like how when you sign up for Airbnb, like it's a lot to list a property on Airbnb like to go through everything, but they break it up. So you know, you're not filling out 100 question form. It's like, what kind of house do you have? And then next, and I'm not saying that everything that you do is like that is like that, but you break things up in a way for the patient that I do feel that it is the state like that's the standard of care that's necessary for improving the standard of care now, it's not just a business plus anymore.

Jeff Issner  34:38

Yeah, I think there's a few things that you just call out there. We'll start with the standard of care. You know, we're, we're operating with about 60% of the US fertility market. We've got a very large market share and Canada, UK and Europe as well. And so, I would say that it's becoming the standard of care, especially in terms of informed consent. We're really proud of how widely adopted, this has become, and it's really become the way to educate and to consent. So really proud of those statistics. But the the other thing that you called out is the way that we're breaking things up. And we're taking experts and adult learning and elearning. And we're taking all of the best practices that are constantly evolving. I mean, we're in the world of Instagram, and Tiktok, and video, education and video. You know, absorption is definitely the standard. And we're taking all those best practices, and applying them within our platform, so that people are getting the right information at the right time, that is unique to their journey. So we're really, really focused on making sure that that overall journey, we're pushing the right information and nice chunk size bits, so that people get the right amount at the right time to properly absorb it properly make the right next decision.

Griffin Jones  35:58

For the listener, just imagine, imagine going through something as legally intense, and as outside of your expertise that requires deep expertise that you can think of like you're going through a, you know, some some very detailed estate planning. Or even more, maybe you're going through, like the you're building your dream house, and you've never built a house before you just you've been a good Rei. And now you can afford it. Now you're building your dream house, do you want to get it all in one huge sum? Like, here's the dot, like, here's the here's this stack of papers, and you got this limited amount of time to talk to me? Or do you want to have an extremely thorough module that you can go through piece by piece on your time, go back and make sure that you understand, and then use your time with the expert to be able to ask any any question I, I think if people think about it, if if they had that same opportunity, in other realms, it becomes even more heir apparent of of how useful it is. Yeah, it's

Jeff Issner  37:12

hard. And you know, we're all biased because we live in this industry. And so some of it is it becomes second nature to us. But it's so hard learning about fertility. For the first time, I remember when I first started working in the industry, all the acronyms of the, you know, different ideologies of infertility, all the different treatments and medications, there's just so much to comprehend. So I think we take that for granted sometimes that this is second nature to us. And people who are exploring treatment for the first time, it's all completely brand new, down to the vocabulary,

Griffin Jones  37:49

we're talking about improving workflow, which means improving productivity, which means potentially improving revenue, and that is flush with the topic that we cover on the show a lot. It is a business show. And we talk about private equity, we talk about venture capital, and one of the one of the claims that private equity has, and one of the gripes against them has to do with increasing productivity. And so I say on every episode that I talk about private equity, I don't have a dog in that fight. I don't I don't know I don't feel qualified to analyze the standard of care that private equity either improves or, or worsens. I just bring people on and I try to challenge them. But the the argument for private equity is that they increase efficiencies. And the argument against private equity is that ultimately, whatever those efficiencies are just means like squeezing more cases out of the provider. And so it's like, okay, we could squeeze more cases out of the provider by making them work more by packing in patients by by taking away time that they actually need to see the patient. Or we could do things that legitimately improve the experience for the patient and allow the provider to not do things that are redundant or lost, because the patient is a deer in headlights. So can you talk about? I mean, have you done any kind of analysis for return on investment?

Jeff Issner  39:35

Yeah, definitely. And just to kind of address the goals of private equity. I mean, I think process optimization is clearly one of those in order to generate a more efficient business. And if you can do that, while creating better care, that's amazing. And if you can do that, creating better care and also improve access to care by creating more time and more efficiencies in that whole process, you're helping more people ultimately have a child. So I think that's a really positive thing I know there's many different angles to private equity and with all things, there's pros and cons. But to take it this on a much smaller scale of how we look at ROI, again, going back to that initial needs analysis and workflow analysis that we do with every clinic, every clinic has unique problems, they all kind of revolve around the value propositions that we talk about. But one example that I'll give them a needs analysis that we recently completed and completed the ROI analysis for this company, they were to provider clinic. And they had 45 minute new patient consults, and 45 minute IVF consults. And we did all the math with them in terms of how much time you had save, what you could be doing with that time, how many more patients you'd be able to see with that time your margins on that. And we came out with an ROI of over $100,000 per year just on a to provider clinic, saving those 15 minutes on each of those consults, where you're able to accomplish by just spending your time more effectively, more efficiently, ultimately helping more patients access care.

Griffin Jones  41:12

That, to me, seems huge for the places that just can't get another Rei. And in a two provider clinic, there's a lot of those in your smaller cities. And, and it's the smaller cities that really struggle to get new Docs, it seems to me like 80% of the docs go to 20 cities in the US. And it seems to me, I still don't have any data. But it just seems that every anecdote that I can think of supports that that the only time that you see someone from an REI go to a Buffalo, New York, where I'm from, or a Youngstown, Ohio or Lincoln, Nebraska, is when they are their spouse are from within a few hours of their it's just so hard to get Doc's and so the alternatives like what we're just not going to, we're just not going to provide care to these people that are here. And so I often think of like EngagedMD, like being useful for ROI for for for bigger groups, because you know, they're the ones that kind of have their their eye on the p&l, but more but is there's not really separating the Pro and revenue from the from the increase in access to care is there.

Jeff Issner  42:37

Yeah, I think so. I think so. And people who really embrace that are where we see the most success. And even with, you know, the smaller local clinics, you can still make this your own right. And I think the fear sometimes as well, I don't want to be like everybody else. The people that really embrace this and start customizing the video modules and produce their own content to have as part of the patient journey and make it branded and talk about their practice and talk about their locations. That's that just warms my heart to see because they're really taking this technology and making it their clinics and making it using all those kind of efficiencies of what's being built as a baseline, but really customizing it so that it meets their needs. It really does give that boutique feel to each of their patients that come through the door.

Griffin Jones  43:32

How have you seen engage them the influence patient behavior, have you?

Jeff Issner  43:39

Yeah, that's a great, really great question. We've been doing a lot of research on EngagedMD. So we've been very fortunate to have third parties say, Oh, this is interesting. Let me get a study going. And we've had a couple of papers published. And we've got a great one that Dr. Meg sacks from University of Cincinnati. She's an REI fellow there is presenting at ASRM. So this is an example of how we've seen patient behaviors and outcomes change. And we're just starting to explore this because I think, anecdotally, it makes sense, and it happens, but we want to prove it with data. So let me give the example that she's been studying. We've been really focused on carrier screening. So just to give some background on what carrier screening is and why it's so important, from my perspective, we can prevent genetic conditions from being passed down if patients do pursue carrier screening. And it's one of a bajillion different things that has to be explained to patients as part of that initial console diagnostic testing phase. So like everything else that can be kind of shortcut, and patients may not have the right information in order to make an informed decision about actually pursuing or declining carrier screening. And not only is that kind of a workflow issue, but it's also a risk issue. We've seen massive lawsuits in the space of a patient's who feel that they weren't properly informed and ultimately had a child and Fortunately, that was affected by a genetic condition, because they declined

Griffin Jones  45:03

carrier screening because they didn't. And they didn't feel they were informed

Jeff Issner  45:08

correctly, they didn't understand the impacts of not pursuing carrier screening, informed declination is what we would call it, and didn't realize that they could go through PG TM and prevent this genetic condition from being passed down. So that information is important from, you know, population health perspective, it's important from a risk mitigation perspective. And also, it's just one of the like I said, bajillion things that has to be covered with every patient. So we developed a module on carrier screening in a workflow to allow patients to learn about what carrier screening is at home, just like the rest of our elearning modules. And then they can flow directly into making their decision about either moving forward or not moving forward. And what we saw when comparing the patient cohort that went through the  EngagedMD workflow, versus the cohort that went through the traditional provider console, is nearly double the amount of patients who went through  EngagedMD in deep decided to pursue carrier screening, which is just gonna let that sit for a second, that's massive, that's a huge impact that we can create.

Griffin Jones  46:09

Do you know the sample size off the top of your head, I don't know

Jeff Issner  46:13

off the top of my head, but we replicated it at a completely different clinic with a completely different group and completely different researchers kind of creating the study and is nearly identical results. And that was at a very large group that we had a ton of volume going through, but Dr. Sacks will be presenting SRM quick plug for her. She's got the poster is gonna be

Griffin Jones  46:34

on this podcast. I'm actually recording recording that episode with her and two other Rei fellows later today. So I don't know if their episode will come out before yours or yours will come out before there's I don't know how we have it scheduled right now. But yeah, little little shout out to her.

Jeff Issner  46:50

Yeah. And I think this is just the tip of the iceberg. We're really motivated to figure out what drives these patient behaviors? And how can we create really positive outcomes and health outcomes, not just patient behaviors, like positive health outcomes from using this tool, and providing great education and great patient journey management? Every single step along the way?

Griffin Jones  47:12

So yeah, maybe people should let that there's a couple of things that need to sink in people's minds from from this conversation so far. One is four to five extra nursing hours per day, what would you do if you had four to five extra hours for your nurses per day? Another one is, what would the quality of care be like for your patients? If double the normal number were going through carrier screening? But how do you make sure that engagement is actually rolled out successfully, because people have asked me to build software before and the first reason I declined is because I'm not a build. It's just not my core competency. I'm a creative I'm a salesman and building out that is what I'm good at. And, and even a CRM is too far away from that, that core competency, but the other thing is just like until it until it talks to everything. In many cases of software, it's just one more damn thing for for staffs. And, and people very often aren't even using the same EMR for scheduling as they are for billing as they are for the actual medical records. And, and then much more like, yeah, there's some people that use HubSpot and and Salesforce, I've never seen somebody like really use it like really, really, at best. I've seen a sort of rudimentary use of, of CRMs. And that's true for Yeah, like project management software that I've seen workflow software, I've seen kind of shoes. So how the hell have you been able to be like, how do you actually get people to, to roll it out? Because it's obviously being rolled out? You're at least half of clinics are using it. Everybody's telling me they like it. And and you have these surveys from both patients and staff that give you the glowing reviews. But how do you actually make sure that the rollout gets you to that place?

Jeff Issner  49:18

Yeah, well, no one likes change, right. I think that's people humans in general don't like change so that the

Griffin Jones  49:25

it's because it comes at a cost, right? It's because there's Eduardo Harrington, Dr. Harrington sent me a book. Oh, and the name is escaping me. So I'll put it in the in the show notes. But he was a Harvard professor. And and he talked about this very dynamic of like, of why companies especially don't change because the cost to change can be so disruptive to what it is that they're working on that very often when there is a disruptor in the marketplace. It is the new To company because they don't have the current obligations that the established companies have to serve us. So it's hard to implement change.

Jeff Issner  50:12

Yeah. And I think it goes back to having a big enough pen, the problem has got to be big enough, and we have to understand it well enough. So the that needs analysis that we start with, that turns into a workflow analysis, and really understanding the problems that we are trying to solve together, that are big enough to introduce this change. That's where it all begins. So we are, while there's best practices that we've learned with the about 200 clinics that we've launched at, each one uses it slightly uniquely, to solve their specific problems. So we need to understand we need to really intimately understand those problems, so that we can introduce a workflow and associated training for staff that aligns to solve their problems so that they're able to feel those efficiencies. With this has been a, an area that I've focused on from day one in town, I've really made a priority. The first person we hired as a customer as a Customer Success lead, we want to make sure that people are supported through that onboarding, that implementation, so that they start to feel and see that value. And then on top of that, we going back to being obsessive about data, we create dashboards, we're monitoring every step along the way to make sure that people are being successful. And we provide that data and those dashboards back to our clinics so that they can see which of my staff members are being compliant, which are not being compliant. How are things being received by patients? Where can we tweak and modify the workflows. So a really great example that the customer success team shared with me SEMA over at SCRC, has created a dashboard that we provide all the data into, and she actually creates competitions about who can send the most modules and forms and who can follow these workflows, the best to really encourage that compliance. So I thought that was a fun way to kind of leverage that data to make sure you're creating that optimal outcome. So it starts with really understanding the problems we're trying to solve. It ends with really closely monitoring and supporting our clinics to ensure that that change curve is overcome so that people can really see and feel the value. Talk to me a little bit

Griffin Jones  52:19

more about what your customer success leads do, like how do they help people implement? Yeah, so

Jeff Issner  52:26

we've got a number of people who are focused on this, the customer journey, I'll call off the customer buying journey. So starting with our sales team, who's really kind of understanding the problems that we're trying to solve. We have a professional services team, who's doing all of the digitization, helping with the workflow analysis, and ensuring that the right training takes place. So really making sure that the the workflow and the needs that we understand are translated appropriately into solutions within  EngagedMD. And then as we launch, our customer success team is there on an ongoing basis to check in to make sure that things are going successfully to compare across benchmarks, and to listen to things that change because we all are clinics or businesses are going to evolve, whether it be through legislation or through growth, or whatever it might be. So we're here to listen and to introduce other ways that you can keep on tweaking your workflows, tweaking the platform, growing within introducing other modules, customizing your modules, changing your consent, workflows, whatever it might be to ensure that ongoing success.

Griffin Jones  53:31

What about at the financial piece of the journey in the fertility bridge, fertility patient marketing journey, it appears in the third column, there's four columns, the third is conversion from a pointment to treatment. So they become they be they've gone through their first konsult They have not yet gone on to treatment there's some drop off their finances one of those pieces so we we like to make videos about finance, we like to we like to create more content ahead of time we'd like to insert some of the content that people get before they meet with the financial counselor so that again, it's not a deer in the headlights thing and that they just it's not like their Sally down the hall go talk to her now like they they have a little bit of familiarity with with Sally there, if not looking forward to seeing Sally that they know who Sally is what they're going to talk about with her in a way that doesn't try to answer their questions that can't be answered before. It's actually one to one specific to that person. So what do you all do you all help with that? That part of the journey at all and how?

Jeff Issner  54:53

Yeah, we're really starting to make great headway just recently in this area of the patient journey and So the way that the majority of our products have been developed is by hearing our customers say, Yeah, we started using engaging D to do this. And it was like, Whoa, I hadn't even thought about that. How did we not? How do we not think of that, let's try and develop more of a productize solution for that issue. So Shady Grove, as a great example of the financial area, their financial counselor started using our esign engine to get financial documents squared away. And as we dug in a little bit deeper to that, we started learning about all the things that people are saying over and over again, very similar to a US an IVF patient as an example, the way that nurses and providers are explaining the medical process to financial counselors, we're explaining the same financial programs, how to navigate your insurance, what to be looking for what to be thinking about. And so we've just started building modules, that helps support that financial decision making just like the medical decision making. So this is allowed Shady Grove to help support their financial concepts, they've got a massive financial counseling team to help ensure that patients can make those good financial decisions. And this allows their team to not have to repeat things about their payment programs and their financial programs, instead have a much more impactful, much more efficient discussion with patients about what their options are and how to move forward. So we're starting to, you know, as  EngagedMD continues to grow and to look to other areas, we want to be exploring other places the patient journey, other places of the clinic journey, and other types of users within the clinic who are looking to save time looking to improve the patient experience looking to reduce risk, we're looking to go paperless, that's how we want to keep on growing is finding ways that we can help support them best those issues best, so that the practices can keep growing and seeing more patients and we can keep growing as business as well.

Griffin Jones  56:57

I think that people often just stop at the financial challenge and think like, well, either patients can afford it or not. It's like, that's that that's not as far too simplistic of a conclusion. There is a range within there. And sometimes that there's no financial option to where a patient could feasibly pay for treatment. And that's, that's very sad. There's often a range of people that if they could, if they understood what the options were for them, then that's what household budgeting is. It's all a calculus, and the things that win are the things that one seems higher priority, but to that you understand that you understand how you're going to, you're going to pay for something and it isn't just simply a question of, well, they can afford it or they can't.

Jeff Issner  57:51

Totally totally. And it's that kind of plethora of topics that need to be explained. And as a staff member at a clinic, you have to prioritize your time and what's going to help people the most to make decisions, and it's impossible to cover everything. As you know, a consumer of healthcare is I think all humans will be at some point, navigating insurance is super hard. It's really complicated. And I work in healthcare, and I understand the space very well. And it is so complex to navigate insurance. It is so complex to navigate out, taking out loans to look through these different types of shared risk type programs. There's a lot to comprehend there. So we're trying to serve hacking away at that. Everything down to what is the deductible and what does that mean? And what does it copay through loan terms? And how do you actually navigate these different financial programs many clinics offer,

Griffin Jones  58:48

I want to ask you about the future of EngagedMD, but I want you to give me something that I can like, talk crap on you at because yeah, it's a sponsored episode and you guys pay me but you don't pay me well enough that I wouldn't bring that I wouldn't jab you with a thorn. If I had it. I just kind of love doing that. And like I do it with every guy I tried to. But I also hate it when I watch the news. And I feel like they're trying to get somebody to a specific conclusion. I just like playing with each side of an argument. And I just don't have anything for the argument against you and I don't have anything. I appreciate

Jeff Issner  59:33

that. But we are not perfect and we are trying to become more and more perfect every day our team is growing. Our processes are growing. Our product is growing. It's evolving, because you have to keep on evolving. And we do run into issues with any technology as any business does. And we're really just trying to be the best selling cannon. Our ultimate mission is to make life easier for everybody so that we can improve patient access to care. And so we're trying to center on that. And we're trying to be really thoughtful about the solutions that we bring to market and the way that we support our customers. As with any company, there's growing pains that come along with that. But we're working really hard to add value to the industry to really be a positive light as an industry player who can help support clinicians, staff, members, embryologist, patients, their partners, really all the players that take part in an episode of care,

Griffin Jones  1:00:31

will tell me a little bit about some of those things like, give me some of the earnest struggle that you're having and one of ours has been in that, like that third phase of the patient, or because we're never going to be pure operations consultants, that's not us. But you get to a point where sales and marketing can say, well, it's out of our hands, now it's in it's in our hands. And to me, that just always seemed like a dereliction of responsibility. Like, at the end of the day, someone is hiring a marketer because they want more revenue, they're not, there are some other things that they hire that person for, but a marketer needs to be able to set up the sale. And, you also should be able to set up a sale, that is delighted. And so I've had challenges with my team. And if you've made some personnel changes in the last year, because we couldn't get on the same page of what that is. But an example is, you know, we're talking about reputation management, like we help with reputation management, like the online reviews, and, and we know how to get people more positive reviews to a point. And then we might reach a point where it's like, okay, they're still getting these types of complaints. And, and what I want to be able to do is give people clients, the procedure of this is exactly what's broken. This is how you fix or this is exactly how you implement this into your EMR, I don't want to just give people something that could have been written in a blog post. And because I agree with Rita Gruber, when she says marketing throws the ball, it's the practice's job to catch it. But the practice doesn't care if you're Tom Brady, and you throw the perfect spiral. If they can't catch it, I want to make the ball land into their hands. That's the idea. And so, and that takes a ton of work. It takes discipline. And you have to be able to say like we don't, we don't totally have this yet. Because every marketer just wants to say they're the, they're the cat's pajamas. And the only reason why other people suck is because they're not as good as it No, it's it, it is connecting all of these dots, that's what it is, you're supposed to connect all of the dots. And, and so that's what, you know, that Fertility Bridges are in a struggle, what's EngagedMD?

Jeff Issner  1:03:00

Yeah, you know, I kind of go back to all the ways that people have stretched the platform in ways that we didn't fully expect. And it's great. They've created these workarounds. And sometimes there's things that people want to stretch the platform and do things that intuitively make sense in the vein of education and documentation and patient journey management, that when they even on the expense, it's like, oh, yeah, I wish we could do that today. But we, you know, we're building out a platform that needs to be scalable, it needs to be secure, it needs to be well managed, it can't break down. So we were just constantly trying to build out things in a very thoughtful way to meet these kinds of workaround methods and workflows that people have put together on our platform. And I wish we could do it as fast as possible because what it ultimately creates is people might run into a bug or they might run into an issue where they can't complete the workflow. And that's not the experience that we want people to have and our support team has helped people through that come up with other workarounds. So we're constantly trying to build the platform out again, in that scalable, secure way. So that your data is safe, your patients are safe, you're safe. And we're working really hard on that we've got a give a little bit of teaser to the next generation of  EngagedMD they're getting ready to launch that will help ensure that scalability and more flexibility so that all those crazy use cases that our customers come up with will be able to better support them and continue to build upon at a faster clip to help make sure that we're supporting people even better so. It's not perfect, I think we're doing a really good job of creating as many workarounds as possible and supporting people but that would that would be the area that kind of keeps me hungry and keeps me you know, Taylor and me working really hard and growing the team and growing our resources so that we can support more of these things that really should feel fall within our wheelhouse education documentation patient journey manage met, we want to keep on growing the functionality so that there's nothing this will never be the case, of course, but we want it to be as close as nothing that we can't help solve for.

Griffin Jones  1:05:10

As the challenge with the business owner, right, you're, you're steering the ship. And it's either the iceberg that you want to avoid, or the part of the water that you want to turn towards. You can see it like you can see, it's like, can you turn fast enough for that is the challenge of a business owner. When Marc Andreessen says that software is going to eat the world? One, I believe him too. I think he's talking about  EngagedMD, as you're as you're just is, as you're competently absorbing each of these spheres as you expand. So let's conclude with what do you, what can you tell us about your your roadmap, where, where, as specific as you feel comfortable going on public record, what can you share with the audience?

Jeff Issner  1:05:58

Yeah, so I mentioned we have a new version of our platform coming out, that's going to continue to expand upon the ways that we help support patients through their ultimate journey. So while some aspects of our platform right now are very much like, here's where you are, here's what you get, we're trying to create a more cohesive patient journey that's easier to manage, from soup to nuts to create a very consistent, comprehensive experience for all of the different patient journeys that you can have, and then track and manage. We're also to that point, expanding into other areas of the patient journey. So like the financial counseling journey, we'll call it, we want to keep on building out products, content, things that can help support patients through all those different stages, and we don't currently do right now. And then the last thing is just introducing more industry partners and working with more industry partners that can benefit from having this interaction with both patients and clinics to help, you know, support through things like the medication management processes, or the genetic testing processes or whatever it might be, we want to make sure that we're plugging everybody together to create, again, a great patient journey. So software contents, the people to help support it. That's where we're growing so that we can keep on helping more and more people access that amazing care.

Griffin Jones  1:07:21

Yeah, fastener it has been a pleasure having you on we're going to link to engage MD obviously, in the show notes and tag you in social but people can actually go to engage md.com/grip, and they can get a workflow assessment where EngagedMD looks at a lot of the things that Jeff talked about today. So if you want to see how your clinic stacks up, they will look at that for you. And they'll do it for free if you go to engage md.com/griffin first sponsor I ever had, because of how many people have just been blown away by your company. And I know that my own company isn't at that same echelon. Yeah, I can, I can save that. And so I admire that you've been able to do that because I'm really really trying and I know how hard it is. So thanks for sharing that on the show.

Jeff Issner  1:08:18

I really appreciate the kind words, appreciate your support and really excited to continue growing with you and growing with the industry. And so thanks again for having me. Can't wait for the next one.

1:08:30

You've been listening to the inside reproductive health podcast with Griffin Jones. If you're ready to take action to make sure that your practice thrives beyond the revolutionary changes that are happening in our field and in society. Visit fertility bridge.com To begin the first piece of the fertility marketing system, the goal and competitive diagnostic. Thank you for listening to inside reproductive health

148 "Physicians Are Bad Business People" And The MedikalPreneur Author Who Says That’s A Lie

This week on Inside Reproductive Health, Griffin hosts MedikalPreneur author, board-certified REI and OBGYN, and Inside Reproductive Health fan-favorite, Dr. Francisco (Paco) Arredondo to discuss the misguided concepts of physicians as business owners and operators, and what it takes to make it as both a healthcare provider as well as a successful proprietor. https://medikalpreneur.com/product/medikalpreneur/

Listen to hear:

  • Dr. Arredondo’s 5 H’s for hiring success.

  • Griffin point out that doctors can get away with bad business techniques because their trade is so high in demand.

  • Griffin press on the tension between employee satisfaction and client retention, and question who really comes first, and why it matters.

  • How much culture influences business success, and what to ask yourself about your own clinic operations.

  • Dr. Arredondo’s crash course in business success as a practicing physician.

147 The Fertility Private Equity Playbook: The Players And The Payors. As Analyzed by David Stern, CEO of Boston IVF

Boston IVF CEO David Stern describes some of the challenges of private equity backed businesses. Griffin grills David on the models of Boston IVF and their parent companies.

Listen to the latest episode of Inside Reproductive Health to hear

  • David Stern talk about how little of their own money private equity firms typically use

  • Griffin press David Stern on whether business decisions and clinical decisions are always separated

  • David Stern and Griffin discuss the meaning of “trapped equity”

  • What happens when Private Equity doesn’t flip at the right time, who pays for claw back provisions, and what about those hidden fees?

  • David Stern talk about Boston IVF’s model for partnership

146 Held Over The Coals: Fertility Insurance Not Created Equal

This week on Inside Reproductive Health, Griffin gets to the root of the insurance debacle in the fertility industry with Holly Hutchison, managing partner of Reproductive Health Center in Tucson, Arizona. Are cash pay patients subsidizing insurance companies’ poor coverage? How can practice owners survive when insurance authorizations are exceedingly slow, reimbursements are laughable, time to pay is unpredictable, and patients don’t understand their own coverage- or lack thereof? Who is left holding the bag when insurance doesn’t cover what it claims to, and can anything be done about it?

Listen to hear:

  • The evolution of insurance in the fertility space: how it began, when it was successful for a hot second, and where it is today.

  • Griffin question which is more beneficial to the provider- employer benefit groups or insurance companies- and why.

  • Griffin question why fertility clinics haven’t cut out the insurance companies who are draining their bottom line.

  • Griffin discuss the cost-benefit analysis: (Reimbursement, time to authorization, time to payment, volume to practice, patient cost sharing) and how to bring more leverage back to the provider.

145 Two Founders Trying to Flip The Script in The Challenging Fertility Start-up Space: Abby Mercado and Kristyn Hodgdon

On Inside Reproductive Health this week, Griffin Jones chats with Rescripted founders, Abby Mercado and Kristyn Hodgdon about their business model, how it came to be, and what risks they have in this space. How has Rescripted’s capital been invested? How do they keep content fresh? Will they survive and thrive in this space, even though so many others before them have failed- despite having massive capital? Listen now and join the conversation, with Griffin Jones on Inside Reproductive Health.

Listen to hear:

  • Griffin point out that pharmacies missed the boat- they could’ve seized the direct to consumer route, but did not.

  • Abby and Kristyn break down their business model, why it works, and what they won’t allow in their space.

  • Griffin discuss raisers of capital who had the cash, but ultimately failed, and question whether or not Rescripted has what it takes to beat the odds.

  • Abby and Kristyn explain why, and how, Rescripted was founded, and where it hopes to go in the future.

144 More Dangerous Than Overturning Roe? The IVF Legislation You Really Need to Watch, According to Atty. Igor Brusil

Griffin hosts embryologist-turned-attorney, Igor Brusil, to discuss what he, as an attorney, believes is a bigger threat to the fertility space than the overturn of Roe v. Wade, and why. What implications could changing donor privacy laws have on your practice-even if you don’t practice in the state that overturns them? Could they extend beyond donor rights and result in an inspection of your business? Listen to hear one specialist’s opinion on Inside Reproductive Health with Griffin Jones.

Listen to hear:

  • Who is advocating for the release of donor information, including medical history.

  • What laws, changing in states like Colorado, could impact your practice (even if it is not in the same state).

  • Griffin press on whether Roe v. Wade has a larger potential to damage the fertility space than changing donor privacy laws.

  • Griffin question why no one is protecting the rights of the donors.

  • Igor’s opinion on what you, as a practitioner, can do to protect yourself and your business.

143 Tips and Tricks to Publishing Your Book: An Inside Perspective with author and IVF Doctor, Dorette Noorhasan

This week on Inside Reproductive Health, Griffin talks with Dr. Dorette Noorhasan, fertility doctor (and patient) as she shares her journey to publishing not one, but two books in the fertility field- with a newborn at home. Always considered writing a book? What is stopping you? Listen as Dr. Noorhasan shares her experience writing and publishing her self-authored books, and find out what she wishes she knew sooner.

Listen to hear:

  • How the book writing process truly takes place, and how you can expedite it.

  • What you need to do first to save yourself time and energy in the publishing process.

  • Who you need on your side, and how to find them, in the publishing world.